<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004364.pub2" GROUP_ID="DEPRESSN" ID="444602091116074806" MERGED_FROM="" MODIFIED="2008-11-01 18:53:11 +0100" MODIFIED_BY="Rachel Churchill" NOTES="&lt;p&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.4&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-01 17:43:52 +0000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="099" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.0">
<COVER_SHEET MODIFIED="2008-11-01 18:53:11 +0100" MODIFIED_BY="Rachel Churchill">
<TITLE>Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia</TITLE>
<CONTACT MODIFIED="2008-11-01 18:53:11 +0100" MODIFIED_BY="Rachel Churchill"><PERSON ID="13142" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Toshi</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Furukawa</LAST_NAME><POSITION>Professor &amp; Chair</POSITION><EMAIL_1>furukawa@med.nagoya-cu.ac.jp</EMAIL_1><URL>www.ebpcenter.com</URL><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Mizuho-cho, Mizuho-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>467-8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 52 853 8271</PHONE_1><FAX_1>+81 52 852 0837</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-11-01 18:53:11 +0100" MODIFIED_BY="Rachel Churchill"><PERSON ID="13142" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Toshi</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Furukawa</LAST_NAME><POSITION>Professor &amp; Chair</POSITION><EMAIL_1>furukawa@med.nagoya-cu.ac.jp</EMAIL_1><URL>www.ebpcenter.com</URL><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Mizuho-cho, Mizuho-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>467-8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 52 853 8271</PHONE_1><FAX_1>+81 52 852 0837</FAX_1></ADDRESS></PERSON><PERSON ID="13242" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Norio</FIRST_NAME><LAST_NAME>Watanabe</LAST_NAME><POSITION>Psychiatrist</POSITION><EMAIL_1>noriow@med.nagoya-cu.ac.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Kawasumi 1</ADDRESS_1><ADDRESS_2>Mizuho-cho, Mizuho-ku</ADDRESS_2><CITY>Nagoya</CITY><ZIP>467-8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 52 853 8271</PHONE_1><FAX_1>+81 52 852 0837</FAX_1></ADDRESS></PERSON><PERSON ID="7289" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Rachel</FIRST_NAME><LAST_NAME>Churchill</LAST_NAME><POSITION>Reader and Co-ordinating Editor, Cochrane Depression, Anxiety &amp; Neurosis Group</POSITION><EMAIL_1>r.churchill@iop.kcl.ac.uk</EMAIL_1><EMAIL_2>ccdan@iop.kcl.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>Academic Unit of Psychiatry, Community Based Medicine</DEPARTMENT><ORGANISATION>University of Bristol</ORGANISATION><ADDRESS_1>Cotham House, Cotham Hill</ADDRESS_1><CITY>Bristol</CITY><ZIP>BS6 6JL</ZIP><REGION>Avon</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0)117 954 6667</PHONE_1><FAX_1>+44 (0)117 954 6672</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-11-01 18:53:11 +0100" MODIFIED_BY="Rachel Churchill" NOTES="&lt;p&gt;New studies found and included or excluded: 11/10/05&lt;/p&gt;" NOTES_MODIFIED="2008-11-01 17:43:02 +0000" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="9" MONTH="9" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="10" YEAR="2005"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="2" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="1" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="9" MONTH="9" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Health and Labour Sciences Research Grants (Research on Health Technology Assessment) H13-018</NAME>
<COUNTRY CODE="JP">Japan</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-01 17:43:52 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-11-01 17:43:52 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-01 17:43:52 +0000" MODIFIED_BY="[Empty name]">Psychotherapy combined with antidepressants for panic disorder</TITLE>
<SUMMARY_BODY>
<P>Psychotherapy plus antidepressant treatment were compared with each of the two individual treatments alone for panic disorder. At the end of the acute phase treatment, the combined therapy was superior to psychotherapy or antidepressant treatment alone. After termination of active treatment, the combined therapy was superior to antidepressants alone and was as effective as psychotherapy alone. Either combined therapy or psychotherapy alone may be chosen as first line treatment for panic disorder with or without agoraphobia, depending on patient preference.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Panic disorder can be treated with pharmacotherapy, psychotherapy or in combination, but the relative merits of combined therapy have not been well established.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To review evidence concerning short- and long-term advantages and disadvantages of combined psychotherapy plus antidepressant treatment for panic disorder with or without agoraphobia, in comparison with either therapy alone.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>The Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References) were searched on 11/10/2005, together with a complementary search of the Cochrane Central Register of Controlled Trials and MEDLINE, using the keywords antidepressant and panic. A reference search, SciSearch and personal contact with experts were carried out. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Two independent review authors identified randomised controlled trials comparing the combined therapy against either of the monotherapies among adult patients with panic disorder with or without agoraphobia.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two independent review authors extracted data using predefined data formats, including study quality indicators. The primary outcome was relative risk (RR) of "response" i.e. substantial overall improvement from baseline as defined by the original investigators. Secondary outcomes included standardised weighted mean differences in global severity, panic attack frequency, phobic avoidance, general anxiety, depression and social functioning and relative risks of overall dropouts and dropouts due to side effects.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>We identified 23 randomised comparisons (representing 21 trials, 1709 patients), 21 of which involved behaviour or cognitive-behaviour therapies. In the acute phase treatment, the combined therapy was superior to antidepressant pharmacotherapy (RR 1.24, 95% confidence interval (CI) 1.02 to 1.52) or psychotherapy (RR 1.17, 95% CI 1.05 to 1.31). The combined therapy produced more dropouts due to side effects than psychotherapy (number needed to harm (NNH) around 26). After the acute phase treatment, as long as the drug was continued, the superiority of the combination over either monotherapy appeared to persist. After termination of the acute phase and continuation treatment, the combined therapy was more effective than pharmacotherapy alone (RR 1.61, 95% CI 1.23 to 2.11) and was as effective as psychotherapy (RR 0.96, 95% CI 0.79 to 1.16).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Either combined therapy or psychotherapy alone may be chosen as first line treatment for panic disorder with or without agoraphobia, depending on patient preference.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P>Panic disorder is characterised by recurrent, unexpected panic attacks and persistent concern about having an additional attack, or worry about the implications of an attack or its consequences. It is estimated to affect around 2% of the population for any one year and around 2% to 5% of the population sometime during their lifetime (<LINK REF="REF-Kessler-2006" TYPE="REFERENCE">Kessler 2006</LINK>; <LINK REF="REF-Carlbring-2002" TYPE="REFERENCE">Carlbring 2002</LINK>). One third to one half of individuals diagnosed with panic disorder in community samples also have agoraphobia, although a much higher rate of agoraphobia is encountered in clinical samples (<LINK REF="REF-Weissman-1997" TYPE="REFERENCE">Weissman 1997</LINK>). It is estimated to account for 0.5% of the global burden of disease for humankind in 2002, a percentage figure as great as epilepsy and greater than breast cancer, for example (<LINK REF="REF-WHO-2004" TYPE="REFERENCE">WHO 2004</LINK>).</P>
<P>Two broad categories of treatment have been shown to be effective in treating panic disorder with or without agoraphobia; one is psychotherapy and cognitive-behaviour therapy in particular, and the other is pharmacotherapy with antidepressants and benzodiazepines (<LINK REF="REF-Nathan-2002" TYPE="REFERENCE">Nathan 2002</LINK>; <LINK REF="REF-APA-1998" TYPE="REFERENCE">APA 1998</LINK>). It remains to be seen, however, whether combining these two effective forms of treatment confers any additional benefit over and above either of the treatments alone, especially with regard to long-term outcomes.</P>
<P>It is important to examine this issue for many reasons. Firstly, typical response rates for these two effective therapies are only in the range of 50% to 70% at the end of acute phase treatment. Moreover, it is now increasingly recognised that pharmacotherapy alone tends to result in substantial relapse rates, not only when discontinued (<LINK REF="REF-Mavissakalian-2002" TYPE="REFERENCE">Mavissakalian 2002</LINK>; <LINK REF="REF-Pecknold-1988" TYPE="REFERENCE">Pecknold 1988</LINK>), but even when maintained at adequate dosage (<LINK REF="REF-Simon-2002" TYPE="REFERENCE">Simon 2002</LINK>; <LINK REF="REF-Toni-2000" TYPE="REFERENCE">Toni 2000</LINK>). Cognitive-behaviour therapy may not always be able to prevent relapses over the long term either (<LINK REF="REF-Burns-1986" TYPE="REFERENCE">Burns 1986</LINK>; <LINK REF="REF-Fava-2001" TYPE="REFERENCE">Fava 2001</LINK>). We are therefore in need of "stronger" treatment. Secondly, combination therapy appears to be practiced very frequently in the real world, possibly because of the above-mentioned inadequacy of either of the monotherapies. For example, Schmidt et al reported that, at their research laboratory, 75% of patients with panic disorder had received at least one medication and 65% were receiving medication at the time of their initial assessment (<LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>).</P>
<P>However, the evidence regarding the incremental effectiveness of combined therapy remains inconclusive. Several reviews can be found in the literature but their conclusions have been variable, with some favouring the combination therapy (<LINK REF="REF-Mattick-1990" TYPE="REFERENCE">Mattick 1990</LINK>; <LINK REF="REF-van-Balkom-1997" TYPE="REFERENCE">van Balkom 1997</LINK>; <LINK REF="REF-Pollack-2003" TYPE="REFERENCE">Pollack 2003</LINK>), some favouring monotherapy (<LINK REF="REF-Taylor-2000" TYPE="REFERENCE">Taylor 2000</LINK>; <LINK REF="REF-Westra-1998" TYPE="REFERENCE">Westra 1998</LINK>; <LINK REF="REF-Gould-1995" TYPE="REFERENCE">Gould 1995</LINK>) and others with mixed or guarded conclusions (<LINK REF="REF-Clum-1993" TYPE="REFERENCE">Clum 1993</LINK>; <LINK REF="REF-Telch-1994" TYPE="REFERENCE">Telch 1994</LINK>; <LINK REF="REF-APA-1998" TYPE="REFERENCE">APA 1998</LINK>; <LINK REF="REF-Schmidt-1999" TYPE="REFERENCE">Schmidt 1999</LINK>; <LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>). Unfortunately most of these reviews have been either unsystematic or narrative only (<LINK REF="REF-Schmidt-1999" TYPE="REFERENCE">Schmidt 1999</LINK>; <LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>; <LINK REF="REF-Taylor-2000" TYPE="REFERENCE">Taylor 2000</LINK>; <LINK REF="REF-APA-1998" TYPE="REFERENCE">APA 1998</LINK>) or, where meta-analytic summary was essayed, did not focus on head-to-head comparisons (<LINK REF="REF-van-Balkom-1997" TYPE="REFERENCE">van Balkom 1997</LINK>; <LINK REF="REF-Gould-1995" TYPE="REFERENCE">Gould 1995</LINK>; <LINK REF="REF-Clum-1993" TYPE="REFERENCE">Clum 1993</LINK>; <LINK REF="REF-Mattick-1990" TYPE="REFERENCE">Mattick 1990</LINK>). The precariousness of comparing different treatment conditions by way of their within-group effect sizes or between-group effect sizes against placebo conditions has been well documented (<LINK REF="REF-Bucher-1997" TYPE="REFERENCE">Bucher 1997</LINK>; <LINK REF="REF-Klein-2000" TYPE="REFERENCE">Klein 2000</LINK>; <LINK REF="REF-Song-2003" TYPE="REFERENCE">Song 2003</LINK>).</P>
<P>Not only does the incremental effectiveness remain unproven, but there is a possibility that combination harms. Several reports have suggested that benzodiazepines are not only associated with several disadvantages including sedation, reduced coordination and development of dependence but that they may actually interfere with and detract from cognitive-behavioural interventions (<LINK REF="REF-van-Balkom-1996" TYPE="REFERENCE">van Balkom 1996</LINK>; <LINK REF="REF-Brown-1995" TYPE="REFERENCE">Brown 1995</LINK>; <LINK REF="REF-Otto-1996" TYPE="REFERENCE">Otto 1996</LINK>; <LINK REF="REF-Westra-1998" TYPE="REFERENCE">Westra 1998</LINK>). We do not yet know if the same applies to the other form of pharmacotherapy, i.e. antidepressant medication, although there are some suggestive findings (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>).</P>
<P>Therefore, the primary objective of this systematic review is to evaluate and synthesise evidence from randomised controlled trials that examined effectiveness and adverse effects of combined treatment by psychotherapy and antidepressants in comparison with either therapy alone in the treatment of panic disorder with or without agoraphobia. This review focuses on antidepressants, and a separate companion review focuses on benzodiazepines (<LINK REF="REF-Watanabe-2005" TYPE="REFERENCE">Watanabe 2005</LINK>).</P>
</BACKGROUND>
<OBJECTIVES>
<P>The primary objective of the present systematic review is to evaluate evidence from randomised controlled trials that examined effectiveness and adverse effects of combined treatment by psychotherapy and antidepressants in comparison with either therapy alone in the treatment of panic disorder with or without agoraphobia.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All relevant randomised controlled trials (RCTs). Quasi-randomised trials, such as those allocated by using alternate days of the week, were excluded. For trials using a cross-over design, we used the first comparative phase only.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Adult patients with panic disorder with or without agoraphobia, diagnosed according to any of the following criteria: Feighner criteria, Research Diagnostic Criteria, DSM-III, DSM-III-R, DSM-IV or ICD-10. When the study eligibility focused on agoraphobia, rather than panic disorder, and was operationally diagnosed according to the above-named criteria and when it could be safely assumed that at least some of the patients were suffering from panic disorder as defined by the above criteria, such a study could still be included. An informed estimate tells us that over 95% of patients with agoraphobia seen clinically suffer from panic disorder as well (<LINK REF="REF-Goisman-1995" TYPE="REFERENCE">Goisman 1995</LINK>). However, the effect of their inclusion was examined in a sensitivity analysis.<BR/>The patients had to be 18 years old or older.<BR/>Patients with comorbid physical or mental disorders were not excluded but the effect of including these patients was examined in sensitivity analyses.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Trials were included if they compared the combined psychotherapy and antidepressant pharmacotherapy against either of these single approaches for at least one week.</P>
<P>The following individual, group, extensive or intensive psychological treatments were included:<BR/>(i) Behaviour therapy that used some kind of exposure.<BR/>(ii) Cognitive therapy that used some kind of cognitive restructuring.<BR/>(iii) Cognitive-behaviour therapy that contained both cognitive and behavioural therapy elements.<BR/>(iv) Psychodynamic therapy that used interpretation of current maladaptive patterns as repetition of earlier childhood experiences.<BR/>(v) Any other psychological approach, such as Rogerian therapy, Morita therapy or Eye Movement and Desensitisation Reprocessing (EMSR).</P>
<P>The following antidepressants were included:<BR/>(i) Tricyclic antidepressants (TCA): imipramine, amitriptyline, clomipramine, desipramine, nortryptiline, doxepin, dosulepin/dothiepin, trimipramine, lofepramine.<BR/>(ii) Selective serotonin reuptake inhibitors (SSRI): fluoxetine, sertraline, paroxetine, citalopram, fluvoxamine, escitalopram.<BR/>(iii) Monoamine oxidase inhibitors (MAOI): phenelzine, isocarboxazide, tranylcipromine, moclobemide, brofaromine.<BR/>(iv) Serotonin-noradrenaline reuptake inhibitors (SNRI): venlafaxine, milnacipran.<BR/>(v) Others: bupropion, trazodone, nefazodone, mianserin, maprotilin, mirtazapine. </P>
<P>Studies where irregular use of benzodiazepines took place were included. Excluding such studies would be meaningless because it has been documented that a minority of patients take benzodiazepines and antidepressants surreptitiously when they are prohibited by the protocol (<LINK REF="REF-Clark-1990" TYPE="REFERENCE">Clark 1990</LINK>). Studies where benzodiazepines were regularly administered at a constant dosage for long-time users were also included but the effect of this decision was examined in a sensitivity analysis. Studies where benzodiazepines were regularly administered as part of the study medication were excluded.</P>
<P>The value of psychotherapy in helping medication discontinuation is not the focus of this review and, therefore, such trials were not included.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>
<B>(A) Effectiveness</B>
</P>
<P>(1) Short-term, i.e. during the acute phase treatment which normally would last 2 to 4 months</P>
<P>(i) Our primary outcome was the rate of "response", i.e. substantial improvement from baseline as defined by the original investigators. Examples would be "very much or much improved" according to the Clinical Global Impression Change Scale, more than 40% reduction in the Panic Disorder Severity Scale score, and more than 50% reduction in the Fear Questionnaire Agoraphobia Subscale.<BR/>(ii) Rate of "remission", i.e. satisfactory end-state as defined by global judgement of the original investigators. Examples would be "panic free" and "no or minimal symptom" according to the Clinical Global Impression Severity Scale.<BR/>(iii) Global judgement on a continuous scale. Examples would be Panic Disorder Severity Scale total score (0 to 28), Clinical Global Impression Severity Scale (1 to 7), Clinical Global Impression Change Scale (1 to 7), etc. When multiple measures were used, preference was given in the order as above, and the actual measure entered into meta-analysis was indicated at the top of the listings in the Table of Included Studies.<BR/>(iv) Frequency of panic attacks, as recorded, for example, by a panic diary.<BR/>(v) Agoraphobia, as measured, for example, by Fear Questionnaire, Mobility Inventory, behavioural avoidance test etc.<BR/>(vi) General anxiety, as measured, for example, by Hamilton Rating Scale for Anxiety, Beck Anxiety Inventory, State-Trait Anxiety Index, Sheehan Patient-Rated Anxiety Scale, Anxiety Subscale of SCL-90-R etc.<BR/>(vii) Depression, as measured, for example, by Hamilton Rating Scale for Depression, Beck Depression Inventory, Depression Subscale of SCL-90-R etc.<BR/>(viii) Social functioning, as measured, for example, by Sheehan Disability Scale, Global Assessment Scale, Social Adjustment Scale-Self Report etc.<BR/>(ix) Quality of life, as measured for example by SF-36, SF-12 etc.<BR/>(x) Patient satisfaction with treatment.<BR/>(xi) Economic costs.</P>
<P>(2) Long-term, i.e. after the acute phase treatment</P>
<P>(2.1) On continued treatment</P>
<P>(i) Response/remission on continued treatment.<BR/>Although some studies reported on remission but not on response, we also pooled such studies under the outcome "response/remission", in order to increase statistical power.<BR/>(ii) Quality of life.<BR/>(iii) Patient satisfaction.</P>
<P>(2.2) On treatment discontinuation</P>
<P>(i) Withdrawal symptoms on treatment discontinuation within one month.<BR/>(ii) Response/remission after treatment discontinuation at 6 to 24 months.<BR/>Although some studies reported on remission but not on response, we pooled such studies as well under the outcome "response/remission" in order to increase statistical power.</P>
<P>
<B>(B) Adverse effects</B>
</P>
<P>(i) Total number of dropouts for any reason as a proxy measure of treatment acceptability.<BR/>(ii) Number of dropouts due to adverse effects.<BR/>(iii) Number of patients experiencing at least one adverse effect.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>
<B>1. Electronic search</B>
<BR/>We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References), a study-based register of randomised trials incorporating results of group searches of MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), PsycINFO (1974 onwards), PSYNDEX (1977 onwards) and LILACS (1982 to 1999), and conducted handsearches of major psychiatric and medical journals (see Collaborative Review Group Search Strategy). Because the concomitant administration of psychotherapy was often either not mentioned in the abstract or indexed in the database, we used the following simple search terms: panic AND antidepressants, which included:<BR/>
<B>
<BR/>CCDANCTR-Studies </B>(searched on 11/10/2005)<BR/>Diagnosis = Panic<BR/>and<BR/>Free-text = "Antidepressive Agents" or "Monoamine Oxidase Inhibitors" or "Selective Serotonin Reuptake Inhibitors" or "Tricyclic Drugs" or Acetylcarnitine or Alaproclate or Amersergide or Amiflamine or Amineptine or Amitriptyline or Amoxapine or Befloxatone or Benactyzine or Brofaromine or Bupropion or Butriptyline or Caroxazone or Chlorpoxiten or Cilosamine or Cimoxatone or Citalopram or Clomipramine or Clorgyline or Clorimipramine or Clovoxamine or Deanol or Demexiptiline or Deprenyl or Desipramine or Dibenzipin or Diclofensine or Dothiepin or Doxepin or Duloxetine or Escitalopram or Etoperidone or Femoxetine or Fluotracen or Fluoxetine or Fluparoxan or Fluvoxamine or Idazoxan or Imipramine or Iprindole or Iproniazid or isocarboxazid or Litoxetine or Lofepramine or Maprotiline or Medifoxamine or Melitracen or Metapramine or Mianserin or Milnacipran or Minaprine or Mirtazapine or Moclobemide or Nefazodone or Nialamide or Nomifensine or Nortriptyline or Noxiptiline or Opipramol or Oxaflozane or Oxaprotiline or Pargyline or Paroxetine or Phenelzine or Piribedil or Pirlindole or Pivagabine or Prosulpride or Protriptyline or Quinupramine or Reboxetine or Rolipram or Sertraline or Setiptiline or Teniloxine or Tetrindole or Thiazesim or Thozalinone or Tianeptine or Toloxatone or Tomoxetine or Tranylcypromine or Trazodone or Trimipramine or Venlafaxine or Viloxazine or Viqualine or Zimeldine</P>
<P>
<B>CCDANCTR-References</B> (searched on 11/10/2005)<BR/>Keyword = Panic<BR/>and<BR/>Free-text = "Antidepressive Agents" or "Monoamine Oxidase Inhibitors" or "Selective Serotonin Reuptake Inhibitors" or "Tricyclic Drugs" or Acetylcarnitine or Alaproclate or Amersergide or Amiflamine or Amineptine or Amitriptyline or Amoxapine or Befloxatone or Benactyzine or Brofaromine or Bupropion or Butriptyline or Caroxazone or Chlorpoxiten or Cilosamine or Cionotome or Citalopram or Clomipramine or Clorgyline or Chlormerodrin or Scopolamine or Deanol or Demerit or Deprenyl or Desipramine or Dibenzyline or Diclofenac or Dothiepin or Doxepin or Sulbentine or Sialograms or Metroperitoneal or Entoretina or Fluorescent or Fluoxetine or Guaroa or Fluvoxamine or Midrazolam or Imipramine or Iprindole or Iproniazid or isocarboxazid or Alloxanthine or Lobelamine or Maprotiline or Etidocaine or Melitracen or Metathrombin or Mianserin or Mulaire or Inapsine or Oracaine or Moclobemide or Nefazodone or Nialamide or Nomifensine or Nortriptyline or Mexitil or Opipramol or Oxaflozane or Oxaprotiline or Pargyline or Paroxetine or Phenelzine or Piribedil or Pirlindole or Pivagabine or Prosulpride or Protriptyline or Quinupramine or Reboxetine or Rolipram or Sertraline or Setiptiline or Teniloxine or Tetrindole or Thiazesim or Thozalinone or Tianeptine or Toloxatone or Tomoxetine or Tranylcypromine or Trazodone or Trimipramine or Venlafaxine or Viloxazine or Viqualine or Zimeldine<BR/>We therefore sought all randomised controlled trials with antidepressants for panic disorder and manually checked to ascertain if they had co-administered any credible psychotherapy. The searches were conducted with the assistance of the Depression, Anxiety and Neurosis Review Group.</P>
<P>Two complementary searches for additional relevant trials were conducted on the Cochrane Central Controlled Trials Register with the search terms: panic AND antidepress*, and on MEDLINE using the search terms: panic disorder [MeSH] AND psychotherapy [MeSH] limited to Randomized Controlled Trial [Publication type].<BR/>No language restriction was imposed.</P>
<P>
<B>2. Reference search</B>
<BR/>The references of all selected studies were inspected for more published reports and citations of unpublished research. In addition, relevant review papers, both systematic and traditional ones, were checked (<LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>; <LINK REF="REF-Taylor-2000" TYPE="REFERENCE">Taylor 2000</LINK>; <LINK REF="REF-Schmidt-1999" TYPE="REFERENCE">Schmidt 1999</LINK>; <LINK REF="REF-APA-1998" TYPE="REFERENCE">APA 1998</LINK>; <LINK REF="REF-van-Balkom-1997" TYPE="REFERENCE">van Balkom 1997</LINK>; <LINK REF="REF-Gould-1995" TYPE="REFERENCE">Gould 1995</LINK>; <LINK REF="REF-Telch-1994" TYPE="REFERENCE">Telch 1994</LINK>; <LINK REF="REF-Mavissakalian-1993" TYPE="REFERENCE">Mavissakalian 1993</LINK>; <LINK REF="REF-Mattick-1990" TYPE="REFERENCE">Mattick 1990</LINK>).</P>
<P>
<B>3. SciSearch</B>
<BR/>All the selected studies were sought as a citation in the SciSearch database in order to identify more studies.</P>
<P>
<B>4. Personal communication</B>
<BR/>To ensure that all RCTs were identified, the authors of significant papers and other experts in the field were contacted (Isaac Marks and authors of included trials).</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>
<B>1. Selection of trials</B>
<BR/>Two review authors (TAF and NW) examined titles and abstracts of references identified by the electronic search strategies described above to check whether the study was likely to be relevant. Full articles of all the studies identified by either of the two review authors were then obtained and inspected by the same two review authors for trials meeting the following broad and simple criteria:<BR/>(1) Randomised trial.<BR/>(2) Panic disorder as diagnosed by operationalised criteria.<BR/>(3) Combination of any form of psychotherapy plus antidepressant versus either of these treatments.<BR/>Two independent review authors (TAF and NW) then examined the strict eligibility of these broadly defined trials. The eligibility criteria consisted of five items which operationalised the above-listed criteria for considering studies. The inter-rater reliability of these judgements was evaluated by means of weighted kappas.</P>
<P>
<B>2. Quality assessment</B>
<BR/>Two independent review authors (TAF and NW) assessed the methodological quality of the selected studies.<BR/>The criteria for the quality assessment were based on the recommendations of the Cochrane Reviewers' Handbook (Clark &amp; Oxman 2000). Firstly, on the basis of explicit criteria (available from the authors upon request), quality of randomisation in treatment conditions was assessed, and trials were assigned to one of the three categories: A: adequate concealment, B: unclear concealment, and C: inadequate concealment. There is empirical evidence that quality of randomisation can produce biased results (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>, <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>, <LINK REF="REF-Chalmers-1983" TYPE="REFERENCE">Chalmers 1983</LINK>, <LINK REF="REF-Egger-2003" TYPE="REFERENCE">Egger 2003</LINK>). Secondly, we also rated the study as 'blinded' when at least one outcome measure was assessed by an independent assessor blind to treatment allocation and 'unblinded' when the outcomes were assessed by someone who was aware of the allocated treatment. There is some evidence to suggest that trials that are not double blind yield biased results (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>, <LINK REF="REF-Coldiz-1989" TYPE="REFERENCE">Coldiz 1989</LINK>).<BR/>In addition to the methodological quality assessment of the selected trials, we assessed the adequacy of the psychotherapy according to the following criteria. We determined the quality of the administered psychotherapy according to the following criteria: A, when the psychotherapy alone arm was shown to be superior to the placebo arm in the same trial or when the same group of investigators had proved effectiveness in a separate randomised controlled trial; B, when the conduct of psychotherapy was examined by a third reviewer through audiotapes etc; and C, when the authors gave sufficiently detailed descriptions of the therapy procedure. We did not include trials which did not give detailed descriptions of the psychotherapies they administered.<BR/>The effect of including studies with lower quality ("unblinded" for blinding, and C on adequacy of psychotherapy) was examined in a sensitivity analysis.</P>
<P>
<B>3. Data extraction</B>
<BR/>Two review authors (RC and NW) independently extracted data from the original reports using data extraction forms. Any disagreement was resolved by consensus between the two or, where necessary, between all three review authors.<BR/>Some studies did not provide response rates but reported the baseline and endpoint means and standard deviations (SD) of their global severity, agoraphobia and/or panic frequency measures. In such instances, response rates can be imputed by calculating the percentage of subjects scoring less than half of the baseline score from the endpoint mean and SD. This imputation method has been shown to work excellently when imputing response in depression trials, the agreement between the imputed and actual values being an ANOVA ICC of 0.97 (95% CI 0.95 to 0.98) (<LINK REF="REF-Furukawa-2005" TYPE="REFERENCE">Furukawa 2005</LINK>). </P>
<P>
<B>4. Data synthesis</B>
<BR/>Data were entered into Review Manager 4.2 and double-checked for accuracy by TAF.<BR/>For dichotomous outcomes, relative risks and their 95% confidence intervals were calculated using a random-effects model. The random-effects model's relative risk has been shown to be superior in clinical interpretation and external generalisation compared to fixed-effects models and odds ratios or risk differences (<LINK REF="REF-Furukawa-2002" TYPE="REFERENCE">Furukawa 2002</LINK>). For dichotomous outcomes, we used intention-to-treat (ITT) analyses according to the following principle. When data on dropouts were carried forward and included in the efficacy evaluation by the last-observation-carried-forward (LOCF) in the original reports, they were included as such. When drop outs were excluded from any assessment in the primary studies (for example, those who never returned for assessment after randomisation), they were considered to be non-responders in both active and comparison groups. The same principles applied to outcomes at or after end of maintenance treatment, because we were interested in the percentage of patients remaining well among those who had entered the trials at all, and not among those who successfully entered and/or finished the maintenance treatment phase.<BR/>For continuous outcomes, the standardised weighted mean difference (WMD) and their 95% confidence intervals were calculated using a random-effects model. When the study failed to report SD, it was imputed from the other studies in this review that employed the same scale (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>). The ITT approach was not feasible as studies only perform LOCF or endpoint analyses. Therefore, continuous outcomes were analysed on an endpoint basis, including only patients with a final assessment or with a last observation carried forward to the final assessment.</P>
<P>
<B>5. Assessment of heterogeneity</B>
<BR/>Heterogeneity between studies was assessed by the I-squared statistic, the Q statistic and by visual inspection of the results. If significant heterogeneity was noted, sources were investigated (I-squared &gt; 50% was taken to be indicative of moderate heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>); due to the known low sensitivity of the Q statistic, P &lt; 0.10 was taken to be suggestive of heterogeneity).</P>
<P>
<B>6. Funnel plot analysis</B>
<BR/>Funnel plot analysis was performed to check for small study effects, including publication bias.</P>
<P>
<B>7. Subgroup analyses</B>
<BR/>Subgroup analyses should be performed and interpreted with caution because multiple analyses lead to false positive conclusions (<LINK REF="REF-Oxman-1992" TYPE="REFERENCE">Oxman 1992</LINK>). However, we performed the following subgroups analyses, where possible, for the following a priori reasons:<BR/>(1) For each type of psychotherapy separately (behaviour therapy, cognitive therapy, cognitive-behaviour therapy and psychodynamic therapy and others), because they may not, a priori, have the same degree of effectiveness when administered alone or the same degree of combinability with pharmacotherapy.<BR/>(2) For classes of antidepressants, such as tricylic antidepressants, selective serotonin reuptake inhibitors, and others.<BR/>(3) For patients with agoraphobia and for those without agoraphobia, because the same treatment may have differential effectiveness with regard to panic and agoraphobia.<BR/>(4) For patients with and without depressive disorder, because it is likely that antidepressants may confer more benefit for those patients with panic disorder comorbid with depression.</P>
<P>
<B>8. Sensitivity analyses</B>
<BR/>The following sensitivity analyses were planned a priori. By limiting the studies for inclusion to those with higher quality, we examined if the results changed and aimed to check for the robustness of the observed findings by limiting to: <BR/>(1) Randomised controlled trials where at least one measure was assessed by an independent assessor blind to treatment allocation.<BR/>(2) Randomised controlled trials where the administered psychotherapy had a demonstrated effectiveness rating of A or B according to the above criteria.<BR/>(3) Randomised controlled trials which used operational diagnostic criteria for panic disorder with or without agoraphobia.<BR/>(4) Studies whose participants were clearly without significant psychiatric or physical comorbidities including primary or secondary depressive disorders.<BR/>(5) Studies whose protocols explicitly prohibited concomitant use of benzodiazepines. According to <LINK REF="REF-Clark-1990" TYPE="REFERENCE">Clark 1990</LINK>, 10% to 20% of those assigned to placebo or imipramine arms in a randomised controlled trial took explicitly prohibited anxiolytic medication.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>The electronic search identified 139 studies from the CCDANCTR, an additional 164 from the CCCTR and 35 from MEDLINE. Browsing their titles and abstracts, 135 articles were identified by either of the two independent review authors (TAF and NW) as possible candidates, and their full copies were obtained. The inter-rater reliability of the two raters with regard to the first-stage broad criteria was percentage agreement = 91% and kappa = 0.79 (95% CI 0.68 to 0.90). Discrepancies were resolved by consensus. Two independent review authors (TAF and NW) then examined the strict eligibility of these 42 papers, representing 20 RCTs. The inter-rater reliability of these strict eligibility criteria was percentage agreement = 94% (weighted kappa = 0.35, 95% CI 0.06 to 0.64). Disagreement was resolved by consensus between the two review authors. <LINK REF="STD-Ba-1999" TYPE="STUDY">Ba 1999</LINK> was excluded because the investigators prescribed both an antidepressant and alprazolam at the same time as a pharmacological intervention. Therefore we arrived at 19 studies that compared the combined therapy against monotherapy.</P>
<P>Once this preliminary list of selected studies became available, their references, along with references of other relevant review papers, were checked by TAF for further reports and four additional studies were identified (<LINK REF="STD-Agras-1991" TYPE="STUDY">Agras 1991</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Solyom-1981" TYPE="STUDY">Solyom 1981</LINK>; <LINK REF="STD-Lipsedge-1973" TYPE="STUDY">Lipsedge 1973</LINK>). All the selected studies were sought as a citation in the SciSearch database; seven additional articles reported on already identified trials, and one new trial was identified (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>). Authors of significant papers and other experts in the field were contacted, who were able to identify no further studies. When the five additional studies were examined for their strict eligibility, <LINK REF="STD-Agras-1991" TYPE="STUDY">Agras 1991</LINK> reported that their randomisation procedure was flawed and they could not obtain groups with comparable baseline characteristics (personal communication). <LINK REF="STD-Solyom-1981" TYPE="STUDY">Solyom 1981</LINK> did not report separate results for their social phobia and agoraphobia patients; the original author was contacted by telephone but could not provide suitable data. <LINK REF="STD-Lipsedge-1973" TYPE="STUDY">Lipsedge 1973</LINK> did not use operational diagnostic criteria; moreover, they used iproniazid, which has some MAO inhibiting effect, but which is not a widely recognised antidepressant.</P>
<P>All total, we identified 21 studies which satisfied the strict eligibility and validity criteria. Because two studies provided two comparisons each (<LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>), we had 23 comparisons from the 21 studies, comprising 1709 participants altogether.</P>
<P>
<B>1. Participants</B>
<BR/>For diagnostic criteria, four studies used DSM-IV panic disorder with or without agoraphobia, nine studies used DSM-III-R panic disorder with or without agoraphobia and three studies used DSM-III agoraphobia with panic disorder. Seven studies (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>) focused on agoraphobia, but contained descriptions indicating that the participants were suffering from panic attacks as well (e.g., moderate to high scores on measures of panic attacks); they were therefore included in the present meta-analysis.</P>
<P>Only one study (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>) focused on patients with panic disorder without agoraphobia. On the other hand, 13 studies (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>) focused on patients with panic disorder with agoraphobia. In the remaining studies, either the percentage of participants with agoraphobia was not specified or, when it was given, between 42% and 85% of participants suffered from agoraphobia.</P>
<P>Typically, the majority of the participants were women, and their average age was in the 30s. They had suffered from panic disorder for 5 to 10 years.</P>
<P>Eleven studies explicitly limited their participants to those without significant comorbid psychiatric (including depressive) and medical comorbidities (<LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>). The other studies included patients with major depression (primary or secondary to panic disorder) or personality disorders. No study focused on patients with comorbid panic disorder and depression, or reported results separately for such a sub-population.</P>
<P>
<B>2. Interventions</B>
<BR/>Twelve studies administered behaviour therapy that consisted of exposure and/or breathing retraining and/or relaxation exercises (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>). No study used narrowly-defined cognitive therapy relying only on cognitive restructuring. Nine studies administered cognitive-behaviour therapy consisting of both behaviour and cognitive therapy elements (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>). For two studies, their psychotherapies were classified in the "psychodynamic and others" category: <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK> administered cognitive-interpersonal group therapy, involving elements of cognitive-behaviour therapy and interpersonal psychotherapy; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK> used brief dynamic psychotherapy without encouraging exposure.</P>
<P>Six studies used a psychotherapy alone arm (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>), whereas 17 studies used a psychotherapy plus placebo arm (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>; <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>).</P>
<P>With regard to medications, 14 studies used tricyclic antidepressants (imipramine in ten, clomipramine in three, trazodone in one study), seven studies used selective serotonin-reuptake inhibitors (paroxetine in four, fluvoxamine in three), and two other studies used monoamine oxidase inhibitors (moclobemide and phenelzine).</P>
<P>The typical length of the acute phase active treatment was between 8 and 12 weeks; two studies were shorter (<LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK> and <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK> lasted six weeks only), and two studies were much longer (20 weeks for <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK> and 26 weeks for <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>). Seven studies took explicit caution for the study participants not to take benzodiazepines during the trial (<LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>). Three studies (<LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>) screened the urine for surreptitious benzodiazepine use but in the others the success of this prohibition was not ascertained. </P>
<P>Five studies provided continuation treatment, in which the drug regimen of the acute phase treatment was continued (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>). It was extremely important to know the outcomes of patients after the active treatment phases consisting of acute phase treatment and, in some cases, continuation treatment. Eleven studies provided follow-up data for the study participants after discontinuation of active treatments (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>). The patients were mostly free to seek further treatment between trial termination and follow-up assessment. Of the originally randomised cohorts, between 33% to 100% were successfully followed up at 6 to 24 months after termination of active treatment, and between 30% and 77% of these participants are reported to have received further treatment in the interim.</P>
<P>
<B>3. Outcomes</B>
<BR/>Among the 21 included studies, there was no standard measurement instrument for panic disorder or no agreed-upon definition of response or remission. We therefore used the following scale scores for meta-analyses:<BR/>Global severity of panic disorder was measured with PDSS (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>), with CGI Severity and/or Change (<LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>), or with the authors' original scales (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>).<BR/>Panic attack frequency/severity was measured by counting the number of panic attacks for a certain time period preceding assessment (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>) or with the authors' original scales (<LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>).<BR/>Agoraphobia was assessed with FQ Agoraphobia subscale (<LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>), Mobility Inventory (<LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>), Fear Survey Schedule (<LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>) or with the authors' original scales (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>).<BR/>General anxiety was measured with HAM-A (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), Beck Anxiety Inventory (<LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>), Zung Self-Rating Anxiety Scale (<LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>), SCL Anxiety subscale (<LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>), Taylor Manifest Anxiety ( <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>), FQ General Anxiety (<LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>) or with the authors' original scales (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>).<BR/>Depression was measured with HAM-D (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), MADRS (<LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>), Beck Depression Inventory (<LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>), SCL Depression subscale (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>), Zung Self-Rating Depression Scale (<LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK> or with the authors' original scales (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>).<BR/>Social functioning was reported in 13 studies; they used Sheehan Disability Scale (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), SAS-SR (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>) and some ad hoc measures (<LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>).</P>
<P>The definition of response and remission varied from study to study. We therefore sought to re-define "response" as substantial improvement from baseline, and "remission" as satisfactory end state. The operational definition of "response" then corresponded with "very much or much improved" on CGI Change (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>), more than 40% reduction in the PDSS (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>), more than 50% reduction in self-rated severity of phobia (<LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>), more than 50% reduction in panic frequency (<LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>) or some other original definitions by the authors (<LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>). In addition, we imputed response rates by the method described above in the Methods section by defining response as more than 40% reduction in the CGI Severity (<LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>) or an ad hoc global severity scale (<LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), more than 50% reduction in the FQ Agoraphobia subscale (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>), more than 50% reduction in the self-rated severity of phobia (<LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>), or more than 50% reduction in the frequency of panic attacks (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>). The validity of this imputation method was confirmed because the agreement between the actual values and the imputed values, when both were given in the original reports, was an ANOVA ICC of 0.93 (one-way random, single rater, 95% CI 0.83 to 0.99). "Remission" was operationally defined as "panic free" (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), "no or minimal symptom" according to the Clinical Global Impression Severity Scale (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>) or some other original definitions by the authors (<LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>; <LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>; <LINK REF="STD-Zitrin-1980" TYPE="STUDY">Zitrin 1980</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>).</P>
<P>No study reported on the quality of life, patient satisfaction and economic costs during the acute phase treatment or continuation treatment. Some studies reported the number of patients who dropped out due to side effects, but no study reported on the total number of patients reporting side effects or on the withdrawal symptoms upon discontinuation of treatment. Total number of dropouts during the acute phase treatment were in the range of 0% to 9% (<LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK>; <LINK REF="STD-Stein-2000" TYPE="STUDY">Stein 2000</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), 10% to 19% (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>; <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK>), 20% to 29% (<LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>; <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>; <LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>; <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>; <LINK REF="STD-Sheehan-1980a" TYPE="STUDY">Sheehan 1980a</LINK>; <LINK REF="STD-Sheehan-1980b" TYPE="STUDY">Sheehan 1980b</LINK>) and over 30% (<LINK REF="STD-Johnston-1995" TYPE="STUDY">Johnston 1995</LINK>; <LINK REF="STD-Marks-1983" TYPE="STUDY">Marks 1983</LINK>).</P>
<P>
<B>4. Commercial involvement</B>
<BR/>Four studies acknowledged financial support from pharmaceutical companies (<LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>; <LINK REF="STD-Fahy-1992" TYPE="STUDY">Fahy 1992</LINK>; <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK>; <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>); these companies marketed the drugs involved in the trials. <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK> had some drug company employees as co-authors. <LINK REF="STD-Oehrberg-1995" TYPE="STUDY">Oehrberg 1995</LINK> did not acknowledge financial support from a drug company but three of the co-authors were company employees. </P>
<P>See Tables of Excluded Studies and Included Studies for further details.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>With regard to validity, based on information from published materials, all but two (<LINK REF="STD-Mavissakalian-1986a" TYPE="STUDY">Mavissakalian 1986a</LINK>; <LINK REF="STD-Mavissakalian-1986b" TYPE="STUDY">Mavissakalian 1986b</LINK>) of the 23 comparisons scored B for allocation concealment. Personal contact with the original authors revealed two more trials with adequate concealment (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>). Nineteen trials conducted blind outcome assessments, and four trials were unblinded (<LINK REF="STD-Azhar-2000" TYPE="STUDY">Azhar 2000</LINK>; <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Mavissakalian-1983" TYPE="STUDY">Mavissakalian 1983</LINK>; <LINK REF="STD-Spinhoven-1996" TYPE="STUDY">Spinhoven 1996</LINK>). The inter-rater reliability of these two validity criteria was a percentage agreement of 94% (kappa was incalculable because one rater's ratings were constant) for allocation concealment and 83% (weighted kappa = 0.51, 95% CI 0.16 to 0.87) for blinding; any disagreement was resolved by consensus between the two raters.</P>
<P>With regard to quality of the psychotherapies provided, only three studies scored A, i.e. provided direct evidence of operationalising an effective psychotherapy compared with a drug placebo arm; these were <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>, <LINK REF="STD-Loerch-1999" TYPE="STUDY">Loerch 1999</LINK> and <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>. Four more studies scored B, i.e. examined the adequacy of the psychotherapies through audiotapes; these were <LINK REF="STD-Kampman-2002" TYPE="STUDY">Kampman 2002</LINK>, <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK>, <LINK REF="STD-Fava-1997" TYPE="STUDY">Fava 1997</LINK> and <LINK REF="STD-Zitrin-1983" TYPE="STUDY">Zitrin 1983</LINK>.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>
<B>
<BR/>1. Psychotherapy plus antidepressant versus antidepressant alone<BR/>
</B>
<BR/>
<B>
<I>(1.1) Acute phase treatment</I>
</B>
<BR/>Combining 322 patients in the psychotherapy plus antidepressant arm and 347 patients in the antidepressant alone arm from 11 studies, the combination arm was 1.24 (95% CI 1.02 to 1.52) times more likely to produce response at the end of two to four months of acute phase treatment than the antidepressant alone arm. The test for heterogeneity was significant with p = 0.05, and moderate with I-squared at 44.9%. Furthermore, the funnel plot (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) was suggestive of some publication bias, with one small study reporting an extreme result (<LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>). When we omitted this outlying study and studies which used "psychodynamic and other" therapies (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>; <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK>), thus limiting the included studies to those employing behaviour or cognitive-behaviour therapies, the RR was similar (RR 1.28, 95% CI 1.08 to 1.52) and there was no longer statistical heterogeneity (p = 0.18, I-squared = 30.5%) or funnel plot asymmetry. The superiority of the combination therapy was no longer apparent, though, when we looked at the remission rates rather than the response rates (RR 1.12, 95% CI 0.84 to 1.48), possibly because of the smaller number of included studies (seven instead of 11 studies).</P>
<P>The superiority of the combination therapy was corroborated by secondary analyses employing continuous data. The combination arm decreased global severity of the disorder (SMD -0.36, 95% CI -0.60 to -0.11), depression (SMD -0.52, 95% CI -0.76 to -0.28), and social malfunctioning (SMD -0.47, 95% CI -0.89 to -0.05). Non-significant trends in favour of the combination therapy were noted for panic frequency (SMD -0.20, 95% CI -0.56 to 0.16), phobic avoidance (SMD -0.32, 95% CI -0.68 to 0.05) and general anxiety (SMD -0.43, 95% CI -0.88 to 0.03). Limiting the studies to those administering behaviour and cognitive-behaviour therapies decreased heterogeneity but did not materially affect the overall effect estimates.</P>
<P>There was no difference in overall dropouts, or in dropouts due to side effects.</P>
<P>
<B>
<I>(1.2) Continued treatment</I>
</B>
<BR/>There was strong heterogeneity (p = 0.005, I-squared = 76.8%). Limiting the studies to behaviour and cognitive-behaviour therapies, heterogeneity disappeared (p = 0.55, I-squared = 0%), and the combination therapy was 1.63 (95% CI 1.21 to 2.19) times more likely to produce response/remission than the antidepressant alone treatment. The effect size in reducing global/avoidance/panic severity was also statistically significant in favour of the combination therapy (SMD -0.60, 95% CI -1.00 to -0.19).<BR/>
<B>
<I>
<BR/>(1.3) After treatment discontinuation</I>
</B>
<BR/>There was only one study that reported outcomes immediately after tapering paroxetine over four weeks (<LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK>): no statistically significant difference was noted for dichotomous or continuous measures.</P>
<P>Five studies reported outcomes after 6 to 24 months of naturalistic follow-up. Combining outcomes based on 376 participants, the combination therapy was still superior to antidepressants alone in terms of response/remission (RR 1.61, 95% CI 1.23 to 2.11). No heterogeneity was noted (p = 0.50, I-squared = 0%). This advantage was not apparent on a continuous measure, probably because of the smaller number of trials reporting such outcomes.</P>
<P>
<B>2. Psychotherapy plus antidepressant versus psychotherapy alone<BR/>
</B>Although the comparison psychotherapy plus antidepressant versus psychotherapy alone is theoretically different from the comparison psychotherapy plus antidepressant versus psychotherapy plus placebo (<LINK REF="REF-Hollon-1981" TYPE="REFERENCE">Hollon 1981</LINK>), our meta-analytic summaries for the former comparison were surprisingly in accordance with those for the latter comparison, save for the fact that the former comparison had a smaller number of studies and produced a smaller number of statistically significant results.</P>
<P>
<B>
<I>(2.1) Acute phase treatment</I>
</B>
<BR/>Five studies compared, in total, 169 participants in the combination arm and 183 participants in the psychotherapy alone arm. None of the comparisons of effectiveness between these two arms were statistically significant, but their point estimates were very similar to those between psychotherapy plus antidepressant versus psychotherapy plus placebo. For example, RR of response was 1.09 (95% CI 0.91 to 1.32), that of remission was 1.22 (95% CI 0.99 to 1.51), and SMR for global severity was -0.31 (95% CI -0.63 to 0.02). None of these meta-analytic comparisons were heterogeneous; unfortunately, there were too few studies for the funnel plot to be meaningful.</P>
<P>The two arms did not differ in terms of dropouts for any reason, but dropouts due to side effects were more frequent in the combination arm (RR 7.46, 95% CI 1.73 to 32.26).</P>
<P>
<B>
<I>(2.2) Continuation treatment</I>
</B>
<BR/>There was only one study which examined the effect of continued treatment (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>). Again, the advantage of the combination therapy appeared to continue as long as the treatments were continued. Only the SMD was significant (-0.46, 95% CI -0.80 to -0.13).</P>
<P>
<B>
<I>(2.3) After treatment discontinuation</I>
</B>
<BR/>Two hundred and seventy two patients were assessed at 6 to 24 months after treatment discontinuation. Any advantage of the combination therapy seemed to disappear (RR 0.97, 95% CI 0.71 to 1.33).</P>
<P>
<B>3. Psychotherapy plus antidepressant versus psychotherapy plus placebo</B>
</P>
<P>
<B>
<I>(3.1) Acute phase treatment</I>
</B>
<BR/>Comparing 550 patients in the psychotherapy plus antidepressant arm and 482 patients in the psychotherapy plus placebo arm from 17 studies, the former was 1.17 (95% CI 1.04 to 1.32) times more likely to produce response at the end of two to four months of acute phase treatment than the latter. The test for heterogeneity was not significant, with I-squared of 12.0%. Funnel plot of response (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) was somewhat suggestive of publication bias, with one small study reporting results much in favour of the combination therapy (<LINK REF="STD-Telch-1985" TYPE="STUDY">Telch 1985</LINK>). Excluding it reduced heterogeneity further, and the RR was unaffected.</P>
<P>The same tendencies in favour of the combined therapy were noted for the remission rate (RR 1.30, 95% CI 1.10 to 1.54) and global severity (SMD -0.45, 95% CI -0.63 to -0.26). Looking at different aspects of panic disorder, although no statistically significant difference was found for frequency of panic attacks, the combination therapy was again significantly superior in terms of reduction in phobic avoidance, general anxiety, depression and social functioning.</P>
<P>Although the two arms did not differ in overall dropout rates, dropouts due to side effects were more frequent in the combined therapy arm than the psychotherapy plus placebo arm (random effects RR 2.43, 95% CI 1.23 to 4.81). </P>
<P>
<B>
<I>(3.2) Continuation treatment</I>
</B>
<BR/>As long as the treatments were continued, the advantage of the combination therapy appeared to continue, as the response rate at the end of continuation treatment was non-significantly in favour of the combination therapy (RR 1.29, 95% CI 1.03 to 1.62) and the global severity was significantly lower in the combination arm (SMD -0.65, 95% CI -0.97 to -0.33). The test for heterogeneity was not significant for either of these two meta-analyses, although the I-squared was 52.7% for the global severity; for the response rate, it was only 3.1%. During the continuation treatment, there were no differential dropout rates between the two arms.</P>
<P>
<B>
<I>(3.3) After treatment discontinuation</I>
</B>
<BR/>In total, 658 patients were assessed at 6-24 months after discontinuing treatment. Any advantage of the combination therapy seems to disappear, because neither the response rate (RR 0.96, 95%CI 0.79 to 1.16) nor the global severity measures were significantly different between the two arms. The test for heterogeneity was significant for neither of these meta-analyses.</P>
<P>
<B>4. Psychotherapy plus antidepressant versus psychotherapy alone or plus placebo<BR/>
</B>Here and in the following subgroup and sensitivity analyses, we examine the aggregate results of trials comparing psychotherapy plus antidepressant with psychotherapy alone and those comparing the former with psychotherapy plus placebo. Although these two types of comparisons are theoretically different from one another (<LINK REF="REF-Hollon-1981" TYPE="REFERENCE">Hollon 1981</LINK>), our meta-analytical summaries were remarkably similar for the acute phase and follow-up evaluations. We therefore made a post hoc (i.e. after the data were collected) decision to increase the statistical power by combining them. When one study contributed both comparisons, i.e. one between the combination versus psychotherapy alone and another between the combination versus psychotherapy plus placebo, the name of the study was automatically given a suffix of i or ii; such was the case with <LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>, <LINK REF="STD-de-Beurs-1995" TYPE="STUDY">de Beurs 1995</LINK> and <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>.<BR/>We will here briefly summarize the combined results.</P>
<P>
<B>
<I>(4.1) Acute phase treatment</I>
</B>
<BR/>Comparing 599 patients in the psychotherapy+antidepressant arm and 672 patients in the psychotherapy alone or +placebo arm from 23 studies, the former was 1.17 (95% CI: 1.05 to 1.31) times more likely to produce response at the end of 2-4 months of acute phase treatment than the latter. The test for heterogeneity was not significant, with I-squared of 12.6%. </P>
<P>The same tendencies in favour of the combined therapy were noted for the remission rate (RR1.26, 95%CI 1.10 to 1.44) and global severity (SMD -0.43, 95%CI -0.60 to -0.26). Looking at different aspects of panic disorder, although no statistically significant difference was found for frequency of panic attacks, the combination therapy was again significantly superior in terms of reduction in phobic avoidance, general anxiety, depression and social dysfunction.</P>
<P>Although the two arms did not differ in overall dropout rates, dropouts due to side effects were more frequent in the combined therapy arm than the psychotherapy alone or +placebo arm (RR 3.01, 95%CI 1.61 to 5.63). </P>
<P>
<B>5. Subgroup analyses<BR/>
</B>
<BR/>
<B>
<I>(5.1) Types of psychotherapy</I>
</B>
<BR/>For all the outcomes during the acute phase or continuation treatments or after treatment discontinuation, the confidence intervals of the pooled estimates of the effectiveness of behaviour therapy and cognitive-behaviour therapy overlapped to a significant degree. Pooling these two kinds of psychotherapies together seldom resulted in statistically significant (p &lt; 0.10) or substantive (I-squared &gt; 30%) heterogeneity.</P>
<P>The only exceptions were "Psychodynamic psychotherapy and others" category for the comparison psychotherapy plus antidepressant versus antidepressant alone. <LINK REF="STD-Berger-2004" TYPE="STUDY">Berger 2004</LINK> administered what the authors called cognitive-interpersonal group therapy for panic disorder, adapted from cognitive therapy and interpersonal psychotherapy. <LINK REF="STD-Wiborg-1996" TYPE="STUDY">Wiborg 1996</LINK> administered brief dynamic psychotherapy, developed from concepts and techniques from Davanloo, Malan and Strupp. The results from these two studies were often qualitatively different not only from one another but also from the other studies administering behaviour or cognitive-behaviour therapies, and combining them altogether often resulted in significant and substantive heterogeneity.</P>
<P>
<B>
<I>(5.2) Classes of antidepressants</I>
</B>
<BR/>We performed a meta-analysis of 14 studies that used TCAs and seven studies that used SSRIs as antidepressants. The pooled estimates of effect size of these two meta-analyses were very similar to each other, and to the overall results. For the TCA meta-analysis, only one out of 15 major outcomes had a qualitatively different estimate than the overall results; for the SSRI meta-analysis, only two had such. In all these instances, the 95% confidence intervals were rather wide and overlapped significantly with the overall results.</P>
<P>
<B>
<I>(5.3) Panic disorder with agoraphobia versus panic disorder without agoraphobia</I>
</B>
<BR/>We performed a meta-analysis of 13 studies which focused on patients with agoraphobia only and compared their response/remission rates and changes in global severity. The point estimates of the pooled effectiveness were qualitatively different from those of the only study which focused on patients without agoraphobia (<LINK REF="STD-Barlow-2000" TYPE="STUDY">Barlow 2000</LINK>) in only two out of 15 comparisons; in either case, the confidence intervals were very wide and there was overlap between those for agoraphobic patients and those for non-agoraphobic patients.</P>
<P>
<B>
<I>(5.4) Patients without depression</I>
</B>
<BR/>Because there was no study that focused on patients with comorbid panic disorder and depressive disorder, and no study reported results for depressed and non-depressed participants separately, it was not possible to examine if the effect sizes were comparable when the participants suffered from depression or when they did not. We therefore performed a separate subgroup meta-analysis of 12 studies which explicitly excluded subjects with comorbid psychiatric (including depressive) and medical conditions. The pooled estimates of effectiveness from those studies focusing on pure panic disorder patients were again largely in accordance with the overall estimates. In two out of 15 comparisons, the point estimates were qualitatively different, but the confidence intervals overlapped between those focusing on patients without comorbidities and those including all the trials found for this systematic review.</P>
<P>
<B>6. Sensitivity analyses<BR/>
</B>
<BR/>
<B>
<I>(6.1) Limited to RCTs where at least one measure was assessed by an independent rater blind to treatment allocation.</I>
</B>
<BR/>Nineteen studies were included. The pooled estimates were virtually identical to and qualitatively no different from the overall results.</P>
<P>
<B>
<I>(6.2) Limited to RCTs where the administered psychotherapy had a demonstrated effectiveness rating of A or B.</I>
</B>
<BR/>Seven studies were included. Again the pooled estimates were virtually identical to and qualitatively no different from the overall results.</P>
<P>
<B>
<I>(6.3) Limited to RCTs that used operationalised diagnostic criteria for panic disorder with or without agoraphobia.</I>
</B>
<BR/>Sixteen studies were included. Again the pooled estimates were virtually identical to and qualitatively no different from the overall results.</P>
<P>
<B>
<I>(6.4) Limited to studies whose participants were explicitly without significant psychiatric or medical comorbidities.</I>
</B>
<BR/>Please see the subgroup analysis 5.4 above.</P>
<P>
<B>
<I>(6.5) Limited to studies whose protocols explicitly prohibited concomitant use of benzodiazepines.</I>
</B>
<BR/>Nine studies could be included. There were three point estimates of effectiveness that were qualitatively different from the overall estimates out of 15 comparisons we made, but the small number of trials included allowed wide confidence intervals which overlapped significantly with those from the overall estimates. Otherwise the pooled point estimates were very similar between the overall results and those which prohibited benzodiazepines.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>The combined psychotherapy plus antidepressant treatment turned out to be robustly superior to either monotherapy for the acute phase treatment of panic disorder with or without agoraphobia. Taking the average response rates of between 50% to 70% for monotherapy, the pooled RR of 1.2 for the combination therapy was translated into NNTs between seven and ten. During the acute phase treatment, combination therapy resulted in more drop-outs due to side effects than psychotherapy alone, and the NNH was around 26.<BR/>The superiority of the combination appeared to hold as long as the antidepressant treatment was continued. There was, however, a differential advantage to the combination therapy vis-a-vis antidepressant alone or psychotherapy alone after the acute phase and continuation treatments were discontinued. The naturalistic follow-up of the included RCTs demonstrated the sustained advantage of the combination therapy over antidepressant alone for 6 to 24 months but no differential effectiveness over psychotherapy alone at 6 to 24 months. At 6 to 24 months after treatment discontinuation, the combined therapy still showed an NNT around six over antidepressant pharmacotherapy alone. With regard to the comparison between the combination therapy and psychotherapy, there was no evidence of long-term benefit of the former compared with the latter. In this respect, it is important to note that, despite recent admonitions from several experts (<LINK REF="REF-Foa-2002" TYPE="REFERENCE">Foa 2002</LINK>; <LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>; <LINK REF="REF-Taylor-2000" TYPE="REFERENCE">Taylor 2000</LINK>), no disadvantage was observed for the combination therapy in the long term.<BR/>These results were robust against several sensitivity analyses. We observed similar effectiveness for three of the four a priori defined subgroup analyses, namely for TCAs and SSRIs, for patients with agoraphobia and those without, and for patients without comorbid depression. In terms of differential effectiveness of various forms of psychotherapy, however, only behaviour therapy and cognitive-behaviour therapy were homogeneously effective; the other two therapy modalities, brief psychodynamic therapy and cognitive-interpersonal therapy, produced mixed results which lead to increased heterogeneity. Funnel plot analyses were suggestive of some publication bias. However, excluding outliers and limiting to behaviour and cognitive-behaviour therapies, we were able to arrive at effect estimates which were more homogeneous, and yet materially no different from the overall results.</P>
<P>The major strengths of the present systematic review may be as follows:<BR/>(1) We performed a systematic and comprehensive search of the relevant trials: we identified 23 comparisons from 21 studies, whereas the previous reviews were able to include a maximum of 11 to 13 studies (<LINK REF="REF-Telch-1994" TYPE="REFERENCE">Telch 1994</LINK>; <LINK REF="REF-Taylor-2000" TYPE="REFERENCE">Taylor 2000</LINK>; <LINK REF="REF-Schmidt-2001" TYPE="REFERENCE">Schmidt 2001</LINK>).<BR/>(2) We contacted the original authors for missing data and applied empirically validated imputation methods (<LINK REF="REF-Furukawa-2005" TYPE="REFERENCE">Furukawa 2005</LINK>; <LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>) to represent the identified trials in the meta-analytic summary as much as possible.<BR/>(3) We abode by the ITT principle when meta-analysing dichotomous outcomes by counting all the dropouts as non-responders. This policy is especially pertinent when considering the relative merits of the combination therapy over monotherapy in the long term, because we were interested in the number of patients doing well out of those who started the acute phase therapy, and not out of those who successfully completed it.<BR/>(4) The a priori planned sensitivity analyses and subgroup analyses confirmed the overall findings.</P>
<P>Several possible weaknesses of the present study must also be highlighted:<BR/>(1) Firstly, the funnel plot analyses suggested the possibility of publication bias among the identified trials. Excluding outliers, however, did not affect the pooled estimates.<BR/>(2) Secondly, generalisability of the present findings beyond specialist psychiatric settings is not straightforward. Only one study (<LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>) was conducted in the primary care setting but in this study patients were seen in their local GP clinics but by qualified clinical psychologists. Only two studies in this review assessed a psychological approach other than CBT. Where CBT therapists were not available, the research evidence, as accumulated and presented in this systematic review, would not be readily applicable to clinical practices.<BR/>(3) Up until recently, there have not been widely accepted and validated rating scales for panic disorder, and many studies included in this systematic review used the authors' original scales. One study has indicated that rating scales which have not been validated or standardised are more likely to report statistically significant findings than those which are validated (<LINK REF="REF-Marshall-2000" TYPE="REFERENCE">Marshall 2000</LINK>). Due to this lack of accepted assessment methods for panic disorder, the definition of "response" (our primary outcome) had to be operationalised by a variety of measures. However, these overall results were corroborated by analyses that focused on specific aspects of the symptoms of panic disorder.<BR/>(4) Last, but most importantly, the comparability of the treatment arms after termination of acute phase and continuation treatments may have been compromised by the naturalistic nature of the follow-ups. Except for <LINK REF="STD-Sharp-1996" TYPE="STUDY">Sharp 1996</LINK>, which explicitly required patients not to receive any psychotropic drugs or psychotherapies, participants were free to seek further treatment between treatment termination and follow-up assessments, and 30% to 77% did receive additional therapies. This does not necessarily undermine the comparability of the treatment arms per se; had the published studies reported number of patients who did well without further treatment, the interpretation of the relative merits of the combination versus single therapies would have been more straightforward. It is also important to note that overall only about half of the acute phase treatment studies included long term follow ups after the acute phase (five out of 11 that compared the combined treatment against antidepressant pharmacotherapy, and 12 out of 23 that compared the combination against psychotherapy alone or psychotherapy plus placebo).</P>
<P>It must be noted that our review does not answer the question of relative merits of combination versus sequential treatments. However, this is not, strictly speaking, a weakness of our study, because we did not plan our review to answer such questions. Given the present findings, some might argue for psychotherapy alone as first line treatment, and to consider combination therapy only when the former fails; it appears to be a viable option but remains unproven as far as the present review is concerned.</P>
<P>In conclusion, the current findings from the best available evidence suggest that either combined therapy or psychotherapy alone may be chosen as first line treatment for panic disorder with or without agoraphobia. Treatment decisions might depend on patient preference and values. Antidepressant pharmacotherapy alone is not to be recommended as first line treatment where appropriate resources are available. Although none of the included studies examined cost issues, economic consideration of years of medication versus one-off psychological treatment would also favour inclusion of psychotherapy (<LINK REF="REF-Otto-2000" TYPE="REFERENCE">Otto 2000</LINK>). It remains, however, that where quality psychotherapy is hard to obtain (which unfortunately is the case for most parts of the world, and which therefore needs to be remedied through national health policies), antidepressant medication alone will still remain the only treatment accessible. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Combined therapy is more effective than psychotherapy alone or antidepressant pharmacotherapy alone in the short term. Combined therapy is as effective as psychotherapy alone and is more effective than antidepressant pharmacotherapy alone in the long term. The strongest evidence existed for behaviour or cognitive-behaviour therapy. It therefore follows that either combined cognitive-behaviour and pharmacotherapy or cognitive-behaviour therapy alone may be chosen as first line treatment for panic disorder with or without agoraphobia, depending on patient preference. Antidepressant pharmacotherapy alone is not to be recommended as first line treatment where appropriate resources are available.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Three lines of inquiry warrant further investigation. Firstly, in the acute phase treatment, if we adhere to the strict ITT principle, the remission rates are only slightly above 50% for combination therapy and slightly below 50% for psychotherapy alone. We need to develop strategies to deal with partial and non-responders to these therapies. Secondly, for the long term outcome, our review suggested that combined therapy does not interfere with or detract from psychotherapy. Further research is necessary to confirm this finding by counting the number of patients completely recovered, without further treatment at follow up. Lastly, there are currently only limited data available on the effects of combining antidepressants with non-cognitive-behavioural therapies, such as psychodynamic and interpersonal therapies. In this review, the only available trial that involved psychodynamic therapy showed increased benefit when combined with antidepressants. This suggests the potential value of future trials designed to investigate this type of combination in the treatment of panic disorder.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The review was supported in part by Health and Labour Sciences Research Grants (Research on Health and Technology Assessment) H13-018 from the Ministry of Health, Labour and Welfare, Japan.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>TAF has received research funding and fees for speaking from the following pharmaceutical companies:<BR/>Asahi Kasei, Astellas, Dai-Nippon, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Kyowa Hakko, Meiji, Organon, Pfizer, Tsumura and Yoshitomi.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>TAF, NW and RC contributed to the planning and writing of the protocol. TAF and NW selected the studies, assessed their quality and extracted data. All contributed to the writing of the final manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Azhar-2000" NAME="Azhar 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Azhar MZ</AU>
<TI>Comparison of fluvoxamine alone, fluvoxamine and cognitive psychotherapy and psychotherapy alone in the treatment of panic disorder in Kelantan--implications for management by family doctors</TI>
<SO>Medical Journal of Malaysia</SO>
<YR>2000</YR>
<VL>55</VL>
<PG>402-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barlow-2000" NAME="Barlow 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<PG>2529-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gorman JM, Martinez JM, Goetz R, Huppert JD, Ray S, Barlow DH et al</AU>
<TI>The effect of pharmacotherapist characteristics on treatment outcome in panic disorder</TI>
<SO>Depression and Anxiety</SO>
<YR>2003</YR>
<VL>17</VL>
<PG>88-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grilo CM, Money R, Barlow DH, Goddard AW, Gorman JM, Hofmann SG et al</AU>
<TI>Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder</TI>
<SO>Comprehensive Psychiatry</SO>
<YR>1998</YR>
<VL>39</VL>
<NO>6</NO>
<PG>323-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK et al</AU>
<TI>Pretreatment attrition in a comparative treatment outcome study on panic disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>155</VL>
<NO>1</NO>
<PG>43-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Shear MK, Barlow DH, Gorman JM, Hershberger D, Patterson M et al</AU>
<TI>Effects of panic disorder treatments on personality disorder characteristics</TI>
<SO>Depression and Anxiety</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>1</NO>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huppert JD, Bufka LF, Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2001</YR>
<VL>69</VL>
<PG>747-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barlow-2000i" NAME="Barlow 2000i" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<PG>2529-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gorman JM, Martinez JM, Goetz R, Huppert JD, Ray S, Barlow DH et al</AU>
<TI>The effect of pharmacotherapist characteristics on treatment outcome in panic disorder</TI>
<SO>Depression and Anxiety</SO>
<YR>2003</YR>
<VL>17</VL>
<PG>88-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grilo CM, Money R, Barlow DH, Goddard AW, Gorman JM, Hofmann SG et al</AU>
<TI>Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder</TI>
<SO>Comprrehensive Psychiatry</SO>
<YR>1998</YR>
<VL>39</VL>
<NO>6</NO>
<PG>323-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK et al</AU>
<TI>Pretreatment attrition in a comparative treatment outcome study on panic disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>155</VL>
<NO>1</NO>
<PG>43-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Shear MK, Barlow DH, Gorman JM, Hershberger D, Patterson M et al</AU>
<TI>Effects of panic disorder treatments on personality disorder characteristics</TI>
<SO>Depression and Anxiety</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>1</NO>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huppert JD, Bufka LF, Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2001</YR>
<VL>69</VL>
<PG>747-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barlow-2000ii" NAME="Barlow 2000ii" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<PG>2529-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gorman JM, Martinez JM, Goetz R, Huppert JD, Ray S, Barlow DH et al</AU>
<TI>The effect of pharmacotherapist characteristics on treatment outcome in panic disorder</TI>
<SO>Depression and Anxiety</SO>
<YR>2003</YR>
<VL>17</VL>
<PG>88-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grilo CM, Money R, Barlow DH, Goddard AW, Gorman JM, Hofmann SG et al</AU>
<TI>Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder</TI>
<SO>Comprehensive Psychiatry</SO>
<YR>1998</YR>
<VL>39</VL>
<NO>6</NO>
<PG>323-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK et al</AU>
<TI>Pretreatment attrition in a comparative treatment outcome study on panic disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>155</VL>
<NO>1</NO>
<PG>43-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hofmann SG, Shear MK, Barlow DH, Gorman JM, Hershberger D, Patterson M et al</AU>
<TI>Effects of panic disorder treatments on personality disorder characteristics</TI>
<SO>Depression and Anxiety</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>1</NO>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huppert JD, Bufka LF, Barlow DH, Gorman JM, Shear MK, Woods SW</AU>
<TI>Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2001</YR>
<VL>69</VL>
<PG>747-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Berger-2004" NAME="Berger 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Berger P, Sachs G, Amering M, Holzinger A, Bankier B, Katschnig H</AU>
<TI>Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2004</YR>
<VL>80</VL>
<PG>75-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Berger P, Sachs G, Amering M, Holzinger A, Maierhofer D, Bankier B et al</AU>
<TI>Predictors of treatment-response in panic disorder</TI>
<SO>151st Annual Meeting of the American Psychiatric Association</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Katschnig H, Berger P, Sachs G, Amering M, Holzinger A, Maierhofer D et al</AU>
<TI>Drugs and psychotherapy in panic disorder: methodological issues</TI>
<SO>151st Annual Meeting of the American Psychiatric Association</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Beurs-1995" NAME="de Beurs 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R</AU>
<TI>Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>152</VL>
<PG>683-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Van Dyck R, Lange A</AU>
<TI>Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1999</YR>
<VL>99</VL>
<PG>59-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Dyck R, Lange A, van Balkom AJ</AU>
<TI>Perceived upbringing and its relation to treatment outcome in agoraphobia</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>78-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Balkom AJ, de Beurs E, Koele P, Lange A, van Dyck R</AU>
<TI>Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1996</YR>
<VL>184</VL>
<NO>2</NO>
<PG>133-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;van Balkom AJ, de Beurs E, van Dyck R, Lange A. Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress. 1995.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>van Balkom AJ, de Beurs E, van Dyck R, Lange A</AU>
<TI>Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress</TI>
<SO>8th European College of Neuropsychopharmacology Congress</SO>
<YR>1995</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Beurs-1995i" NAME="de Beurs 1995i" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R</AU>
<TI>Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>152</VL>
<PG>683-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Van Dyck R, Lange A</AU>
<TI>Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1999</YR>
<VL>99</VL>
<PG>59-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Dyck R, Lange A, van Balkom AJ</AU>
<TI>Perceived upbringing and its relation to treatment outcome in agoraphobia</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>78-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Balkom AJ, de Beurs E, Koele P, Lange A, van Dyck R</AU>
<TI>Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1996</YR>
<VL>184</VL>
<NO>2</NO>
<PG>133-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>van Balkom AJ, de Beurs E, van Dyck R, Lange A</AU>
<TI>Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress</TI>
<SO>8th European College of Neuropsychopharmacology Congress</SO>
<YR>1995</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Beurs-1995ii" NAME="de Beurs 1995ii" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R</AU>
<TI>Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>152</VL>
<PG>683-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Balkom AJ, Van Dyck R, Lange A</AU>
<TI>Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1999</YR>
<VL>99</VL>
<PG>59-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Beurs E, van Dyck R, Lange A, van Balkom AJ</AU>
<TI>Perceived upbringing and its relation to treatment outcome in agoraphobia</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>78-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Balkom AJ, de Beurs E, Koele P, Lange A, van Dyck R</AU>
<TI>Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1996</YR>
<VL>184</VL>
<NO>2</NO>
<PG>133-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>van Balkom AJ, de Beurs E, van Dyck R, Lange A</AU>
<TI>Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress</TI>
<SO>8th European College of Neuropsychopharmacology Congress</SO>
<YR>1995</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fahy-1992" NAME="Fahy 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fahy TJ, O'Rourke D, Brophy J, Schazmann W, Sciascia S</AU>
<TI>The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1992</YR>
<VL>25</VL>
<PG>63-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Rourke D, Fahy TJ, Brophy J, Prescott P</AU>
<TI>The Galway study of panic disorder III: Outcome at 5 to 6 years</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1996</YR>
<VL>168</VL>
<PG>462-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fava-1997" NAME="Fava 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fava GA, Savron G, Zielezny M, Grandi S, Rafanelli C, Conti S</AU>
<TI>Overcoming resistance to exposure in panic disorder with agoraphobia</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1997</YR>
<VL>95</VL>
<PG>306-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Johnston-1995" NAME="Johnston 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson DG, Troyer IE, Whitsett SF, Dalby JT</AU>
<TI>Clomipramine therapy and behavior therapy with agoraphobic women</TI>
<SO>Canadian Journal of Psychiatry - Revue Canadienne De Psychiatrie</SO>
<YR>1995</YR>
<VL>40</VL>
<PG>192-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kampman-2002" NAME="Kampman 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kampman M, Keijsers GP, Hoogduin CA, Hendriks GJ</AU>
<TI>A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone</TI>
<SO>Journal of Clinial Psychiatry</SO>
<YR>2002</YR>
<VL>63</VL>
<NO>9</NO>
<PG>772-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loerch-1999" NAME="Loerch 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loerch B, Graf-Morgenstern M, Hautzinger M, Schlegel S, Hain C, Sandmann J et al</AU>
<TI>Randomised placebo-controlled trial of moclobemide, cognitive- behavioural therapy and their combination in panic disorder with agoraphobia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1999</YR>
<VL>174</VL>
<PG>205-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marks-1983" NAME="Marks 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen SD, Monteiro W, Marks IM</AU>
<TI>Two-year follow-up of agoraphobics after exposure and imipramine</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1984</YR>
<VL>144</VL>
<PG>276-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lelliott PT, Marks IM, Monteiro WO, Tsakiris F, Noshirvani H</AU>
<TI>Agoraphobics 5 years after imipramine and exposure. Outcome and predictors</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1987</YR>
<VL>175</VL>
<NO>10</NO>
<PG>599-605</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E et al</AU>
<TI>Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1983</YR>
<VL>40</VL>
<NO>2</NO>
<PG>153-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mavissakalian-1983" NAME="Mavissakalian 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L, Dealy RS</AU>
<TI>Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1983</YR>
<VL>143</VL>
<PG>348-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mavissakalian-1986a" NAME="Mavissakalian 1986a" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Agoraphobia: behavioral and pharmacological treatments, preliminary outcome, and process findings</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1982</YR>
<VL>18</VL>
<PG>91-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>1986</YR>
<VL>47</VL>
<PG>117-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia</TI>
<SO>Behavior Therapy</SO>
<YR>1983</YR>
<VL>14</VL>
<PG>506-19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Two-year follow-up of exposure and imipramine treatment of agoraphobia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1986</YR>
<VL>143</VL>
<PG>1106-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Perel J</AU>
<TI>Imipramine in the treatment of agoraphobia: dose-response relationships</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1985</YR>
<VL>142</VL>
<PG>1032-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M</AU>
<TI>Combined behavioral-therapy and pharmacotherapy of agoraphobia</TI>
<SO>Journal of Psychiatric Research</SO>
<YR>1993</YR>
<VL>27</VL>
<PG>179-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mavissakalian-1986b" NAME="Mavissakalian 1986b" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Agoraphobia: behavioral and pharmacological treatments, preliminary outcome, and process findings</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1982</YR>
<VL>18</VL>
<PG>91-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine</TI>
<SO>Journal of Clinial Psychiatry</SO>
<YR>1986</YR>
<VL>47</VL>
<PG>117-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia</TI>
<SO>Behavior Therapy</SO>
<YR>1983</YR>
<VL>14</VL>
<PG>506-19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Michelson L</AU>
<TI>Two-year follow-up of exposure and imipramine treatment of agoraphobia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1986</YR>
<VL>143</VL>
<PG>1106-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M, Perel J</AU>
<TI>Imipramine in the treatment of agoraphobia: dose-response relationships</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1985</YR>
<VL>142</VL>
<PG>1032-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M</AU>
<TI>Combined behavioral-therapy and pharmacotherapy of agoraphobia</TI>
<SO>Journal of Psychiatric Research</SO>
<YR>1993</YR>
<VL>27</VL>
<PG>179-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oehrberg-1995" NAME="Oehrberg 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J et al</AU>
<TI>Paroxetine in the treatment of panic disorder. A randomised, double- blind, placebo-controlled study</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>167</VL>
<PG>374-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharp-1996" NAME="Sharp 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Anstee JA</AU>
<TI>Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care</TI>
<SO>British Journal of General Practice</SO>
<YR>1997</YR>
<VL>47</VL>
<NO>416</NO>
<PG>150-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA et al</AU>
<TI>Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia</TI>
<SO>Journal of Anxiety Disorders</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>219-42</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE=","/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Predicting treatment outcome for panic disorder and agoraphobia in primary care</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>5</NO>
<PG>336-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care</TI>
<SO>Behavioural and Cognitive Psychotherapy</SO>
<YR>1998</YR>
<VL>26</VL>
<PG>13-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies</TI>
<SO>Journal of Psychopharmacology</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>4</NO>
<PG>373-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharp-1996i" NAME="Sharp 1996i" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Anstee JA</AU>
<TI>Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care</TI>
<SO>British Journal of General Practice</SO>
<YR>1997</YR>
<VL>47</VL>
<NO>416</NO>
<PG>150-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA et al</AU>
<TI>Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia</TI>
<SO>Journal of Anxiety Disorders</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>219-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Predicting treatment outcome for panic disorder and agoraphobia in primary care</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>5</NO>
<PG>336-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care</TI>
<SO>Behavioural and Cognitive Psychotherapy</SO>
<YR>1998</YR>
<VL>26</VL>
<PG>13-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies</TI>
<SO>Journal of Psychopharmacology</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>4</NO>
<PG>373-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharp-1996ii" NAME="Sharp 1996ii" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Anstee JA</AU>
<TI>Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care</TI>
<SO>British Journal of General Practice</SO>
<YR>1997</YR>
<VL>47</VL>
<NO>416</NO>
<PG>150-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA et al</AU>
<TI>Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia</TI>
<SO>Journal of Anxiety Disorders</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>219-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Predicting treatment outcome for panic disorder and agoraphobia in primary care</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>5</NO>
<PG>336-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care</TI>
<SO>Behavioural and Cognitive Psychotherapy</SO>
<YR>1998</YR>
<VL>26</VL>
<PG>13-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharp DM, Power KG</AU>
<TI>Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies</TI>
<SO>Journal of Psychopharmacology</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>4</NO>
<PG>373-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sheehan-1980a" NAME="Sheehan 1980a" YEAR="1980">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sheehan DV, Ballanger J, Jacobsen G</AU>
<TI>Treatment of endogenous anxiety with phobic, hysterical, and hypochondriachal symptoms</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1980</YR>
<VL>37</VL>
<PG>51-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sheehan-1980b" NAME="Sheehan 1980b" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sheehan DV, Ballanger J, Jacobsen G</AU>
<TI>Treatment of endogenous anxiety with phobic, hysterical, and hypochondriachal symptoms</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1980</YR>
<VL>37</VL>
<PG>51-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spinhoven-1996" NAME="Spinhoven 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spinhoven P, Onstein EJ, Klinkhamer RA, der Klein EA</AU>
<TI>Panic management, trazodone and a combination of both in the treatment of panic disorder</TI>
<SO>Clinical Psychology and Psychotherapy</SO>
<YR>1996</YR>
<VL>3</VL>
<PG>86-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-2000" NAME="Stein 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein MB, Ron Norton G, Walker JR, Chartier MJ, Graham R</AU>
<TI>Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study</TI>
<SO>Psychiatry Research</SO>
<YR>2000</YR>
<VL>94</VL>
<PG>191-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Telch-1985" NAME="Telch 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roth WT, Telch MJ, Taylor CB, Agras WS</AU>
<TI>Autonomic changes after treatment of agoraphobia with panic attacks</TI>
<SO>Psychiatry Research</SO>
<YR>1988</YR>
<VL>24</VL>
<NO>1</NO>
<PG>95-107</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Telch MJ, Agras WS, Taylor CB, Roth WT, Gallen CC</AU>
<TI>Combined pharmacological and behavioral treatment for agoraphobia</TI>
<SO>Behavior Research and Therapy</SO>
<YR>1985</YR>
<VL>23</VL>
<PG>325-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wiborg-1996" NAME="Wiborg 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dahl AA, Wiborg IM</AU>
<TI>Pharmacotherapy and brief dynamic psychotherapy of panic disorder</TI>
<SO>9th European College of Neuropsychopharmacology Congress</SO>
<YR>1996</YR>
<CY>Amsterdam, The Netherlands</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wiborg IM, Dahl AA</AU>
<TI>Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1996</YR>
<VL>53</VL>
<PG>689-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wiborg IM, Dahl AA</AU>
<TI>Pharmacotherapy and brief dynamic psychotherapy of panic disorder</TI>
<SO>Xth World Congress of Psychiatry</SO>
<YR>1996</YR>
<CY>Madrid, Spain</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zitrin-1980" NAME="Zitrin 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zitrin CM, Klein DF, Woerner MG</AU>
<TI>Treatment of agoraphobia with group exposure in vivo and imipramine</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1980</YR>
<VL>37</VL>
<PG>63-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zitrin CM</AU>
<TI>Differential treatment of phobias: Use of imipramine for panic attacks</TI>
<SO>Journal of Behavior Therapy and Experimental Psychiatry</SO>
<YR>1983</YR>
<VL>14</VL>
<NO>1</NO>
<PG>11-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zitrin-1983" NAME="Zitrin 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klein DF, Ross DC, Cohen P</AU>
<TI>Panic and avoidance in agoraphobia. Application of path analysis to treatment studies</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1987</YR>
<VL>44</VL>
<NO>4</NO>
<PG>377-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klein DF, Zitrin CM, Woerner MG, Ross DC</AU>
<TI>Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients?</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1983</YR>
<VL>40</VL>
<NO>2</NO>
<PG>139-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lipsitz JD, Mannuzza S, Klein DF, Ross DC, Fyer AJ</AU>
<TI>Specific phobia 10-16 years after treatment</TI>
<SO>Depression and Anxiety</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>3</NO>
<PG>105-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Zitrin CM, Klein DF, Lindemann C, Kaplan JH, Ganz VH</AU>
<TI>Comparison of short-term treatment regimens in phobic patients: a preliminary report</TI>
<SO>Evaluation of Psychological Therapies</SO>
<YR>1976</YR>
<PG>233-250</PG>
<ED>Spitzer RL, Klein DF</ED>
<PB>Johns Hopkins Press</PB>
<CY>Baltimore, MD</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zitrin CM, Klein DF, Woerner MG, Ross DC</AU>
<TI>Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1983</YR>
<VL>40</VL>
<PG>125-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zitrin CM, Klein DF, Woerner MG</AU>
<TI>Behavior therapy, supportive psychotherapy, imipramine, and phobias</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1978</YR>
<VL>35</VL>
<PG>307-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Zitrin CM, Woerner MG, Klein DF</AU>
<TI>Differentiation of panic anxiety from anticipatory anxiety and avoidance behavior</TI>
<SO>Anxiety: New Research and Changing Concepts</SO>
<YR>1981</YR>
<ED>Klein DF, Rabkin J</ED>
<PB>Raven Press</PB>
<CY>New York, NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zitrin CM</AU>
<TI>Differential treatment of phobias: Use of imipramine for panic attacks</TI>
<SO>Journal of Behavior Therapy and Experimental Psychiatry</SO>
<YR>1983</YR>
<VL>14</VL>
<NO>1</NO>
<PG>11-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Agras-1991" NAME="Agras 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Agras, WS, Telch, MJ, Taylor, CB, Roth, WT, Brouillard, M</AU>
<TI>Imipramine and exposure therapy in agoraphobia: untangling the actions and interactions</TI>
<SO>Telch and Lucas (1984)</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ba-1999" NAME="Ba 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ba G, Vigano C</AU>
<TI>Integrated therapy of panic disorder: a controlled study</TI>
<SO>152nd Annual Meeting of the American Psychiatric Association</SO>
<YR>1999</YR>
<CY>Washington DC, USA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Ba G, Vigano C</AU>
<TI>Integrated therapy of panic disorders: a controlled study</TI>
<SO>Unpublished manuscript</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Vigano C, Bielli A, Carozzi A, Divino T, Pagliarulo E, Ba G</AU>
<TI>Panic disorder: A two-year follow-up of an integrated treatment approach.</TI>
<TO>Il disturbo di panico: follow up a due anni di un modello di trattamento integrato</TO>
<SO>Italian Journal of Psychopathology</SO>
<YR>in press</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chambless-1979" NAME="Chambless 1979" YEAR="1979">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chambless DL, Foa EB, Groves GA, Goldstein AJ</AU>
<TI>Exposure and communications training in the treatment of agoraphobia</TI>
<SO>Behavior Research and Therapy</SO>
<YR>1982</YR>
<VL>20</VL>
<PG>219-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chambless DL, Foa EB, Groves GA, Goldstein AJ</AU>
<TI>Flooding with Brevital in the treatment of agoraphobia: countereffective?</TI>
<SO>Behavior Research and Therapy</SO>
<YR>1979</YR>
<VL>17</VL>
<NO>3</NO>
<PG>243-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-1988" NAME="Cox 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox DJ, Ballanger JC, Laraia M, Hobbs WR, Peterson GA, Hucek A</AU>
<TI>Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia</TI>
<SO>Journal of Behavior Therapy and Experimental Psychiatry</SO>
<YR>1988</YR>
<VL>19</VL>
<NO>2</NO>
<PG>119-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lipsedge-1973" NAME="Lipsedge 1973" YEAR="1973">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lipsedge, MS, Hajioff, J, Huggins, P, Napier, L, Pearce, J, Pike et al</AU>
<TI>The management of severe agoraphobia: a comparison of ipronizaid and systematic desensitization</TI>
<SO>Psychopharmacologia</SO>
<YR>1973</YR>
<VL>32</VL>
<NO>1</NO>
<PG>67-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Solyom-1981" NAME="Solyom 1981" YEAR="1981">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Solyom, C, Solyom, L, LaPierre, Y, Pecknold, J, Morton, L</AU>
<TI>Phenelzine and exposure in the treatment of phobias</TI>
<SO>Biological Psychiatry</SO>
<YR>1981</YR>
<VL>16</VL>
<NO>3</NO>
<PG>239-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-APA-1998" NAME="APA 1998" NOTES="&lt;p&gt;American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. American Journal of Psychiatry 1998;155 May Supplement:1-34.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>American Psychiatric Association</AU>
<TI>Practice guideline for the treatment of patients with panic disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>155 Supplement</VL>
<PG>1-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-1995" NAME="Brown 1995" TYPE="JOURNAL_ARTICLE">
<AU>Brown, TA, Barlow, DH</AU>
<TI>Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1995</YR>
<VL>63</VL>
<PG>754-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bucher-1997" NAME="Bucher 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bucher HC, Guyatt GH, Griffith LE, Walter SD</AU>
<TI>The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1997</YR>
<VL>50</VL>
<NO>6</NO>
<PG>683-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burns-1986" NAME="Burns 1986" TYPE="JOURNAL_ARTICLE">
<AU>Burns, LE, Thorpe, CL, Cavallaro, LA</AU>
<TI>Agoraphobia 8 years after behavioral treatment: a follow-up study with interview, self-report, and behavioral data</TI>
<SO>Behavior Therapy</SO>
<YR>1986</YR>
<VL>17</VL>
<PG>580-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carlbring-2002" NAME="Carlbring 2002" TYPE="JOURNAL_ARTICLE">
<AU>Carlbring, P, Gustafsson, H, Ekselius, L, Andersson, G</AU>
<TI>12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2002</YR>
<VL>37</VL>
<PG>207-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chalmers-1983" NAME="Chalmers 1983" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers TC, Celano P, Sacks HS, Smith H Jr</AU>
<TI>Bias in treatment assignment in controlled clinical trials</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>309</VL>
<PG>1358-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clark-1990" NAME="Clark 1990" TYPE="JOURNAL_ARTICLE">
<AU>Calrk DB, Taylor CB, Roth WT, Hayward C, Ahlers A, Margraf J et al</AU>
<TI>Surreptitious drug use by patients in a panic disorder study</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1990</YR>
<VL>147</VL>
<PG>507-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clum-1993" NAME="Clum 1993" TYPE="JOURNAL_ARTICLE">
<AU>Clum GA, Clum GA, Surls R</AU>
<TI>A meta-analysis of treatments for panic disorder</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1993</YR>
<VL>61</VL>
<PG>317-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coldiz-1989" NAME="Coldiz 1989" TYPE="JOURNAL_ARTICLE">
<AU>Coldiz, GA, Miller, JN, Mosteller, F</AU>
<TI>How study design affects outcomes in comparisons of therapy. I: medical</TI>
<SO>Statistics in Medicine</SO>
<YR>1989</YR>
<VL>9</VL>
<PG>441-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-2003" NAME="Egger 2003" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Juni P, Bartlett C, Holenstein F, Sterne J</AU>
<TI>How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study</TI>
<SO>Health Technology Assessment</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>1</NO>
<PG>1-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fava-2001" NAME="Fava 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fava, GA, Rafanelli, C, Grandi, S, Conti, S, Ruini, C, Mangelli, L et al</AU>
<TI>Long-term outcome of panic disorder with agoraphobia treated by exposure</TI>
<SO>Psychological Medicine</SO>
<YR>2001</YR>
<VL>31</VL>
<PG>891-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Foa-2002" NAME="Foa 2002" TYPE="JOURNAL_ARTICLE">
<AU>Foa EB, Franklin ME, Moser J</AU>
<TI>Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination?</TI>
<SO>Biological Psychiatry</SO>
<YR>2002</YR>
<VL>52</VL>
<PG>987-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2002" NAME="Furukawa 2002" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Guyatt GH, Grifitth LE</AU>
<TI>Can we individualize the Number Needed to Treat (NNT)? An empirical study of summary effect measures in meta-analyses</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2005" NAME="Furukawa 2005" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa T, Cipriani A, Barbui C, Brambilla P, Watanabe N</AU>
<TI>Imputing response rates from means and standard deviations in meta-analysis</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>1</NO>
<PG>49-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2006" NAME="Furukawa 2006" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N</AU>
<TI>Imputing missing standard deviations in meta-analyses can provide accurate results</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2006</YR>
<VL>59</VL>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goisman-1995" NAME="Goisman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Goisman RM, Warshaw MG, Steketee GS, Fierman EJ, Rogers MP, Goldenberg I et al</AU>
<TI>DSM-IV and the disappearnace of agoraphobia without history of panic disorder: new data on a controversial diagnosis</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>152</VL>
<PG>1438-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gould-1995" NAME="Gould 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gould RA, Otto MW, Pollack MH</AU>
<TI>A meta-analysis of treatment outcome for panic disorder</TI>
<SO>Clinical Psychology Review</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>819-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hollon-1981" NAME="Hollon 1981" TYPE="JOURNAL_ARTICLE">
<AU>Hollon, SD, DeRubeis, RJ</AU>
<TI>Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug-psychotherapy comparative trials</TI>
<SO>Psychological Bulletin</SO>
<YR>1981</YR>
<VL>90</VL>
<PG>467-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kessler-2006" NAME="Kessler 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE</AU>
<TI>The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2006</YR>
<VL>63</VL>
<PG>415-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klein-2000" NAME="Klein 2000" TYPE="JOURNAL_ARTICLE">
<AU>Klein DF</AU>
<TI>Flawed meta-analyses comparing psychotherapy with pharmacotherapy</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>157</VL>
<PG>1204-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marshall-2000" NAME="Marshall 2000" TYPE="JOURNAL_ARTICLE">
<AU>Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M</AU>
<TI>Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>249-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mattick-1990" NAME="Mattick 1990" TYPE="JOURNAL_ARTICLE">
<AU>Mattick RP, Andrews G, Hadzi-Pavlovic D, Christensen H</AU>
<TI>Treatment of panic and agoraphobia: an integrative review</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1990</YR>
<VL>178</VL>
<PG>567-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mavissakalian-1993" NAME="Mavissakalian 1993" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian M</AU>
<TI>Combined behavioral therapy and pharmacotherapy of agoraphobia</TI>
<SO>Journal of Psychiatric Research</SO>
<YR>1993</YR>
<VL>27 Suppl 1</VL>
<PG>179-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mavissakalian-2002" NAME="Mavissakalian 2002" TYPE="JOURNAL_ARTICLE">
<AU>Mavissakalian MR, Perel JM</AU>
<TI>Duration of imipramine therapy and relapse in panic disorder with agoraphobia</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2002</YR>
<VL>22</VL>
<PG>294-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nathan-2002" NAME="Nathan 2002" TYPE="BOOK">
<AU>Nathan PE, Gorman JM</AU>
<SO>A Guide to Treatments that Work</SO>
<YR>2002</YR>
<EN>2nd</EN>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Otto-1996" NAME="Otto 1996" TYPE="JOURNAL_ARTICLE">
<AU>Otto MW, Pollack MH, Sabatino SA</AU>
<TI>Maintenance of remission following cognitive behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment</TI>
<SO>Behavior Therapy</SO>
<YR>1996</YR>
<VL>27</VL>
<PG>473-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Otto-2000" NAME="Otto 2000" TYPE="JOURNAL_ARTICLE">
<AU>Otto MW, Pollack MH, Maki KM</AU>
<TI>Empirically supported treatments for panic disorder: costs, benefits, and stepped care</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2000</YR>
<VL>68</VL>
<PG>556-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oxman-1992" NAME="Oxman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Oxman AD, Guyatt GH</AU>
<TI>A consumer's guide to subgroup analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1992</YR>
<VL>116</VL>
<PG>78-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pecknold-1988" NAME="Pecknold 1988" TYPE="JOURNAL_ARTICLE">
<AU>Pecknold JC, Swinson RP, Kuch K, Lewis CP</AU>
<TI>Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1988</YR>
<VL>45</VL>
<PG>429-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pollack-2003" NAME="Pollack 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E et al</AU>
<TI>WCA recommendations for the long-term treatment of panic disorder</TI>
<SO>CNS Spectrums</SO>
<YR>2003</YR>
<VL>8</VL>
<PG>17-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-1999" NAME="Schmidt 1999" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt NB</AU>
<TI>Panic disorder: cognitive behavioral and pharmacological treatment strategies</TI>
<SO>Journal of Clinical Psychology in Medical Settings</SO>
<YR>1999</YR>
<VL>6</VL>
<PG>89-111</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-2001" NAME="Schmidt 2001" TYPE="BOOK_SECTION">
<AU>Schmidt NB, Koselka M, Woolaway-Bickel K</AU>
<TI>Combined treatments for phobic anxiety disorders</TI>
<SO>Combined Treatments for Mental Disorders: A Guide to Psychological and Pharmacological Interventions</SO>
<YR>2001</YR>
<PG>81-110</PG>
<ED>Sammons, MT, Schmidt, NB</ED>
<PB>American Psychological Association</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simon-2002" NAME="Simon 2002" TYPE="JOURNAL_ARTICLE">
<AU>Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH</AU>
<TI>Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2002</YR>
<VL>69</VL>
<PG>201-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Song-2003" NAME="Song 2003" TYPE="JOURNAL_ARTICLE">
<AU>Song F, Altman DG, Glenny AM, Deeks JJ</AU>
<TI>Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>326</VL>
<NO>7387</NO>
<PG>472</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Taylor-2000" NAME="Taylor 2000" TYPE="BOOK">
<AU>Taylor S</AU>
<SO>Understanding and Treating Panic Disorder</SO>
<YR>2000</YR>
<PB>John Wiley &amp; Sons</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Telch-1994" NAME="Telch 1994" TYPE="BOOK_SECTION">
<AU>Telch MJ, Lucas R</AU>
<TI>A. Combined pharmacological and psychological tretment of panic disorder: Current status and future directions.</TI>
<SO>Treatment of Panic Disorder: A Consensus Development Conference</SO>
<YR>1994</YR>
<PG>177-97</PG>
<ED>Wolfe BE, Maser JD</ED>
<PB>American Psychiatric Press, Inc.</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Toni-2000" NAME="Toni 2000" TYPE="JOURNAL_ARTICLE">
<AU>Toni, C, Perugi, G, Frare, F, Mata, B, Vitale, B, Mengali, F et al</AU>
<TI>A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2000</YR>
<VL>33</VL>
<PG>121-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Balkom-1996" NAME="van Balkom 1996" TYPE="JOURNAL_ARTICLE">
<AU>van Balkom AJ, de Beurs E, Koele P, Lange A, van Dyck R</AU>
<TI>Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1996</YR>
<VL>184</VL>
<NO>2</NO>
<PG>133-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Balkom-1997" NAME="van Balkom 1997" TYPE="JOURNAL_ARTICLE">
<AU>van Balkom AJ, Bakker A, Spinhoven P, Blaauw BM, Smeenk S, Ruesink B</AU>
<TI>A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1997</YR>
<VL>185</VL>
<PG>510-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Watanabe-2005" NAME="Watanabe 2005" TYPE="COCHRANE_REVIEW">
<AU>Watanabe N, Churchill R, Furukawa TA</AU>
<TI>Combined psychotherapy plus benzodiazepines for panic disorder with or without agoraphobia [Protocol]</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>1</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weissman-1997" NAME="Weissman 1997" TYPE="JOURNAL_ARTICLE">
<AU>Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG et al</AU>
<TI>The cross-national epidemiology of panic disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1997</YR>
<VL>54</VL>
<PG>305-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Westra-1998" NAME="Westra 1998" TYPE="JOURNAL_ARTICLE">
<AU>Westra HA, Stewart SH</AU>
<TI>Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?</TI>
<SO>Clinical Psychology Review</SO>
<YR>1998</YR>
<VL>18</VL>
<NO>3</NO>
<PG>307-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2004" NAME="WHO 2004" TYPE="OTHER">
<TI>World Health Report 2004</TI>
<SO>WHO</SO>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Azhar-2000">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: not blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-IV panic disorder (% agoraphobic unspecified)<BR/>AGE: mean=31.4 to 31.7 years<BR/>SEX: men and women<BR/>HISTORY: -<BR/>PSYCHIATRIC COMORBIDITY: No comorbidity was allowed.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 9 weeks<BR/>1. fluvoxamine (mean=64 mg/d) + CBT (9 weekly sessions)<BR/>2. fluvoxamine alone (mean=154 mg/d)<BR/>3. CBT alone</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: None.</P>
<P>FOLLOW-UP: None.</P>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in panic frequency [imputed from mean&amp;SD]<BR/>REMISSION: -<BR/>GLOBAL: -<BR/>PANIC ATTACK: panic frequency<BR/>AGORAPHOBIA: -<BR/>GENERAL ANXIETY: HAM-A, BAI<BR/>DEPRESSION: HAM-D, BDI<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Barlow-2000">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with mild to no agoraphobia<BR/>AGE: mean=34.1 to 37.8 years<BR/>SEX: 62% women<BR/>HISTORY: mean duration of panic disorder=5.5 to 6.6 years<BR/>During wash-out, up to 10 doses of benzos were allowed during 2 weeks.<BR/>PSYCHIATRIC COMORBIDITY: 27% suffered from current major depression.<BR/>MEDICAL COMORBIDITY: Significant medical illness was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. imipramine (mean=214 to 239 mg/d by week 12) + CBT (11sessions during 3 months)<BR/>2. imipramine alone<BR/>3. CBT alone<BR/>4. CBT + placebo<BR/>5. placebo alone (not used in the current meta-analysis)</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients were permitted up to 20 doses of benzo (0.5 mg of alprazolam equivalent) during 3 months after the study started.</P>
<P>MAINTENANCE: 6 months of monthly appointments</P>
<P>MODE OF DISCONTINUATION: Abrupt (?)</P>
<P>FOLLOW-UP: at 6 months after treatment discontinuation. 33% of the original cohort was successfully followed up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: described as "no treatment" but more details lacking</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;= 40% reduction on PDSS; "much improved" or better on CGI Improvement and "mild" or less on CGI Severity<BR/>REMISSION: 2 or better on CGI Severity<BR/>GLOBAL: PDSS, CGI<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: -<BR/>GENERAL ANXIETY: -<BR/>DEPRESSION: -<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Barlow-2000i">
<CHAR_METHODS>
<P>Same as (Barlow 2000) but refers only to comparison with psychotherapy + placebo.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Barlow-2000ii">
<CHAR_METHODS>
<P>Same as (Barlow 2000) but refers only to comparison with psychotherapy alone.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Berger-2004">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: adequate<BR/>BLINDING:unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (81% with agoraphobia)<BR/>AGE: mean=33.9<BR/>SEX: 66% women<BR/>HISTORY: mean duration of panic disorder=4.8 years<BR/>PSYCHIATRIC COMORBIDITY: 19% with major depression, 27% with social phobia, 16% with simple phobia, 10% with GAD, 32% with personality disorder. Melancholic depression, bipolar disorder, OCD, substance abuse/dependence were excluded.<BR/>MEDICAL COMORBIDITY: Concurrent medical illness was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 20 weeks<BR/>1. paroxetine (mean=31 mg/d, range: 10-60 mg/d) + cognitive-interpersonal group therapy (2 individual sessions + 20 weekly group sessions, including elements of CBT and IPT)<BR/>2. paroxetine alone</P>
<P>ACUTE PHASE CO-INTERVENTION: Concomitant p.r.n. intake of alprazolam up to 1 mg/d was allowed.</P>
<P>MAINTENANCE: None.</P>
<P>MODE OF DISCONTINUATION: tapering from week 20 to week 24</P>
<P>FOLLOW-UP: at 24 weeks, i.e. at the end of tapering. 50% of the original cohort were successfully followed up.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: Much or very much improved on CGI<BR/>REMISSION: Free of panic attacks<BR/>GLOBAL: -<BR/>PANIC ATTACK: panic frequency<BR/>AGORAPHOBIA: 4-point rating of agoraphobia<BR/>GENERAL ANXIETY: 11-point rating of anticipatory anxiety<BR/>DEPRESSION: -<BR/>FUNCTIONING: Sheehan Disability Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-de-Beurs-1995">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with moderate to severe agoraphobia<BR/>AGE: mean=38.8<BR/>SEX: 75% women<BR/>HISTORY: mean duration of panic disorder=9.4 years<BR/>PSYCHIATRIC COMORBIDITY: Current major depression was included if it developed after panic disorder. Patients with psychotic disorders, organic mental disorders, or psychoactive substance use disorders were excluded.<BR/>MEDICAL COMORBIDITY: Patients with severe medical illness, pregnant and lactating women were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. fluvoxamine (100-150 mg/day) + exposure (12 weekly sessions)<BR/>2. exposure alone<BR/>3. placebo + exposure<BR/>4. psychological panic management plus exposure (not used in the current meta-analysis)</P>
<P>ACUTE PHASE CO-INTERVENTION: 18 out of 97 patients used benzo during the trial. Concomitant use of benzo was permitted when patients had been taking benzo for more than 3 months and were willing to keep use at a constant dosage during the trial.</P>
<P>MAINTENANCE: None.</P>
<P>MODE OF DISCONTINUATION: Continue the drug for the time being</P>
<P>FOLLOW-UP: at 24 months after trial termination. 74% was successfully followed up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: 77% received additional treatment, equally divided over four arms</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in FQ-Ag [imputed from mean&amp;SD]<BR/>REMISSION: panic-free<BR/>GLOBAL: Global outcome (1-9; the larger, the better)<BR/>PANIC ATTACK: panic frequency<BR/>AGORAPHOBIA: Agoraphobia composite, FQ-Ag, Multi-Task Behavioral Avoidence Test<BR/>GENERAL ANXIETY: Somatic Anxeity composite<BR/>DEPRESSION: Depression composite, BDI<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-de-Beurs-1995i">
<CHAR_METHODS>
<P>Same as (de Beurs 1995) but refers only to the comparison with psychotherapy + placebo.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-de-Beurs-1995ii">
<CHAR_METHODS>
<P>Same as (de Beurs 1995) but refers only to the comparison with psychotherapy alone.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fahy-1992">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (42% with moderate or severe agoraphobia)<BR/>AGE: mean=33.6 to 37.8 years<BR/>SEX: 65% women<BR/>HISTORY: mean duration of panic disorder=4.6 years<BR/>PSYCHIATRIC COMORBIDITY: Major depression was included if it preceded panic. Those with history of seizures, bipolar or melancholic depression, cyclothymic disorder, obsessive-compulsive disorder or current drug or alcohol dependence were excluded.<BR/>MEDICAL COMORBIDITY: "In good physical health."</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 6 weeks<BR/>1. clomipramine (100 mg/d) or lofepramine (140 mg/d) + CBT (6 one-hour sessions over eight weeks)<BR/>2. placebo + CBT</P>
<P>ACUTE PHASE CO-INTERVENTION: No psychotropic drug was allowed.</P>
<P>MAINTENANCE: None.</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: None (After 6 weeks, those on placebo received antidepressants and the double-blind was broken at 8 weeks)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=40% reduction in CGI [imputed from mean&amp;SD]<BR/>REMISSION: panic-free<BR/>GLOBAL: CGI Severity, CGI Change<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: Fear Inventory<BR/>GENERAL ANXIETY: HAM-A<BR/>DEPRESSION: HAM-D, MADRS, CGI Depression, BDI, Wakefield Self Assessment Depressiion Inventory<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fava-1997">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-IV panic disorder with agoraphobia<BR/>AGE: mean=29.8 years<BR/>SEX: 52% women<BR/>HISTORY: mean duration of illness=3.5 years before start of first exposure therapy; resistant to twelve 30-minute sessions for exposure<BR/>PSYCHIATRIC COMORBIDITY: Current major depression was excluded. 38% suffered from personality disorder.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 8 weeks<BR/>1. imipramine (mean=72 mg/d) + behaviour therapy (eight 45-minute sessions)<BR/>2. behaviour therapy alone<BR/>3. behaviour therapy plus congitive therapy (not used in the present meta-analysis)</P>
<P>ACUTE PHASE CO-INTERVENTION: not specifid</P>
<P>MAINTENANCE: None.</P>
<P>MODE OF DISCONTINUATION: naturalistic</P>
<P>FOLLOW-UP: at 24 months after acute phase treatment. 57% was successfully followed up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: Those who faild to respond received further 16 weeks of exposure with or without imipramine treatments.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: -<BR/>REMISSION: panic-free for a month and 1or 2 on CID-agoraphobia<BR/>GLOBAL: -<BR/>PANIC ATTACK: CID-panic<BR/>AGORAPHOBIA: FQ-Ag, CID-Agoraphobia<BR/>GENERAL ANXIETY: CID-generalized anxiety<BR/>DEPRESSION: CID-depression<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Johnston-1995">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III agoraphobia<BR/>AGE: mean=37 years<BR/>SEX: 100% women<BR/>HISTORY: mean duration of illness=9.5 years<BR/>PSYCHIATRIC COMORBIDITY: -<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 17 weeks<BR/>1. clomipramine (mean=95 mg/d) + behavior therapy (twice weekly for eight weeks)<BR/>2. clomipramine alone<BR/>3. placebo + behavior therapy<BR/>4. placebo alone</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: 12 weeks<BR/>On clomipraime or placebo only; no psychological intervention</P>
<P>MODE OF DISCONTINUATION: naturalistic</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in FQ-AG [imputed from mean&amp;SD]<BR/>REMISSION: -<BR/>GLOBAL: -<BR/>PANIC ATTACK: Number of days per week when panic was reported<BR/>AGORAPHOBIA: FQ-Ag, FSS-III-Ag, BAT<BR/>GENERAL ANXIETY: -<BR/>DEPRESSION: SCL-90-R Depression<BR/>FUNCTIONING: SAS-SR Social Leisure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kampman-2002">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-IV panic disorder with or without agoraphobia (% agoraphobic unspecified)<BR/>AGE: between 18 and 65<BR/>SEX: unspecified<BR/>HISTORY: unresponsive to initial 15 sessions of CBT (51% of the original sample)<BR/>PSYCHIATRIC COMORBIDITY: 16% suffered from mood disorders, 16% from additional anxiety disorders, and 9% suffered from somatoform disorders.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 8 weeks<BR/>1. paroxetine (40 mg/d) + CBT (4 sessions over 8 weeks)<BR/>2. placebo + CBT</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients who had been using benzo were asked either to discontinue their medication under supervision or to adhere to a fixed daily dose throughout the study.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: 30% improvement in panic frequency, ACQ and ADS<BR/>REMISSION: panic-free<BR/>GLOBAL: -<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: MI, (ACQ, BSQ, ADS)<BR/>GENERAL ANXIETY: FQ-general anxiety<BR/>DEPRESSION: -<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Loerch-1999">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with agoraphobia<BR/>AGE: mean=35.1 years<BR/>SEX: 75% women<BR/>HISTORY: mean duration of illness=6.1 years<BR/>PSYCHIATRIC COMORBIDITY: Depressed patients with 19-item HAM-D &gt;=17 were excluded. Patients with bipolar disorder, obsessive-compulsive disorder, organic mental disorder, schizophrenia, alcohol or drug dependence during the preceding 12 months, suicidality were excluded.<BR/>MEDICAL COMORBIDITY: Clinically relevant organic diseases, significant laboratory abnormalities, known allergic reactions to monoamine oxidase inhibitors, pregnancy, lactation period were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 8 weeks<BR/>1. moclobemide (mean=551 mg/d) + CBT (nine 50-minute individual sessions + two 6-hour therapist-aided exposure sessions)<BR/>2. moclobemide + clinical management<BR/>3. placebo + CBT<BR/>4. placebo + clinical management (not used in the present meta-analysis)</P>
<P>ACUTE PHASE CO-INTERVENTION: If patiens had been taing benzo, tapering lasted upt to 4 weeks and withdrawal symptoms had to end at least 1 week prior to treatment.</P>
<P>MAINTENANCE: - </P>
<P>MODE OF DISCONTINUATION: tapered off over two weeks (from week 8 to week 10). However, 70% of patients received treatment during follow-up, defined either as at least one intake of a drug such as benzodiazepine, antidepressant or beta-blocker or ast least one psychosocial treatmetn session.</P>
<P>FOLLOW-UP: at 6 months after treatment discontinuation. 67% was successfully followed-up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: 70% received at least some treatment after discontinuing moclobemide.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: "Much" or "very much improved" on CGI Improvement<BR/>REMISSION: "Normal" or "borderline mentally ill" on CGI Severity<BR/>GLOBAL: CGI Severity, CGI Improvement<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: FQ-Ag, MI<BR/>GENERAL ANXIETY: HAM-A<BR/>DEPRESSION: HAM-D<BR/>FUNCTIONING: Sheehan Disability Scale-work, -leisure, -home life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Marks-1983">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: approximately DSM-III agoraphobia (96% had spontaneous panic attacks)<BR/>AGE: mean=34 years<BR/>SEX: 84% women<BR/>HISTORY: mean duration of illness=8 years<BR/>PSYCHIATRIC COMORBIDITY: Moderate to severe depression was excluded.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 14 weeks<BR/>1. imipramine (mean=124-158 mg/d) + behavior therapy (six bi-weekly 1-hour sessions; self-exposure + therapist-guided exposure or + relaxation)<BR/>2. placebo + behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: 14 weeks</P>
<P>MODE OF DISCONTINUATION: tapered off over 2 weeks (from week 26 to 28)</P>
<P>FOLLOW-UP: at 6 months and at 18 months after treatment discontinuation. 63% and 56% were successfully followed up, respectively.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: 47% received some treatment (antidepressant, benzodiazepine, therapist-aided exposure)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;= 2 points reduction in total phobic targets<BR/>REMISSION: &gt;= 4 points reduction in total phobic targets<BR/>GLOBAL: -<BR/>PANIC ATTACK: spontaneous panics<BR/>AGORAPHOBIA: FQ-Ag, 4 phobic targets, FQ-Global<BR/>GENERAL ANXIETY: Non-phobic anxiety, FQ-Anxiety-Depression, <BR/>DEPRESSION: HAM-D<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mavissakalian-1983">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: not blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III agoraphobia (patients scored, on average, 5.5 on an 0-8 point scale of panic severity)<BR/>AGE: mean=33.5 years<BR/>SEX: 100% women<BR/>HISTORY: mean duration of illness=7 years<BR/>PSYCHIATRIC COMORBIDITY: Primary affective disorder, schizophrenia, organic brain syndrome and OCD were excluded.<BR/>MEDICAL COMORBIDITY: Physical illness precluding imipramine was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. imipramine (mean=125 mg/d) + programmd practice (self-directed in vivo graded exposure with behavioural diary, eight 1-hour sessions)<BR/>2. imipramine + anti-exposure instruction</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients had to be free of all psychotropic medications at least 2 weeks before starting treatment.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction on Self-Rated Severity<BR/>REMISSION: no spontaneous panic<BR/>GLOBAL: Self-Rated Panic Overall Severity [0-8]<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: FQ-Ag<BR/>GENERAL ANXIETY: Zung Anxiety Scale<BR/>DEPRESSION: HAM-D<BR/>FUNCTIONING: Clinician's Global Assessment [1-5]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mavissakalian-1986a">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: adequate<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III agoraphobia with panic<BR/>AGE: mean=36.5 years<BR/>SEX: 84% women<BR/>HISTORY: mean duration of illness=10.5 years<BR/>PSYCHIATRIC COMORBIDITY: Primary affective disorder or concurrent major depressive episode, schizophrenia, organic brain syndrome, OCD, somatization disorder, substance abuse, or severe personality disorder were excluded.<BR/>MEDICAL COMORBIDITY: Physical illness precluding imipramine was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. imipramine (mean=130 mg/d) + programmed practice (self-directed in vivo graded exposure, twelve 90-min group sessions)<BR/>2. placebo + programmed practice</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: naturalistic</P>
<P>FOLLOW-UP: at 6 months and 24 months after acute phase treatment. 50% and 63% were successfully followed up, respectively.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: 30% had interim treatment (individual therapy, group therapy, anxiolytics, antidepressants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in self-rated severity of phobia (imputed from mean &amp; SD)<BR/>REMISSION: High end-state functioning<BR/>GLOBAL: Self-rated Severity of Phobia [0-8]<BR/>PANIC ATTACK: Self-rated Panic Overall Severity [0-8]<BR/>AGORAPHOBIA: FQ-Ag [0-40], Individualized phobic anxiety-avoidance [0-8], Behavioral avoidance-anxiety index [0-8]<BR/>GENERAL ANXIETY: Zung Anxiety Scale [20-80]<BR/>DEPRESSION: Beck Depression Inventory [0-63]<BR/>FUNCTIONING: Clinician's Global Assessment [1-5]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mavissakalian-1986b">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: adequate<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III agoraphobia with panic<BR/>AGE: mean=36.5 years<BR/>SEX: 84% women<BR/>HISTORY: mean duration of illness=10.5 years<BR/>PSYCHIATRIC COMORBIDITY: Primary affective disorder or concurrent major depressive episode, schizophrenia, organic brain syndrome, OCD, somatization disorder, substance abuse, or severe personality disorder were excluded.<BR/>MEDICAL COMORBIDITY: Physical illness precluding imipramine was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. imipramine (mean=130 mg/d) + programmed practice (self-directed in vivo graded exposure) + flooding twelve 90-min group sessions (twelve 90-min group sessions)<BR/>2. placebo + programmed practice + flooding</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: naturalistic</P>
<P>FOLLOW-UP: at 6 months and 12 months after acute phase treatment. 63% and 55% were successfully followed up, respectively.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: 30% had interim treatment (individual therapy, group therapy, anxiolytics, antidepressants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in self-rated severity of phobia (imputed from mean &amp; SD)<BR/>REMISSION: High end-state functioning<BR/>GLOBAL: SElf-rated Severity of Phobia [0-8]<BR/>PANIC ATTACK: Self-rated Panic Overall Severity [0-8]<BR/>AGORAPHOBIA: FQ-Ag [0-40], Individualized phobic anxiety-avoidance [0-8], Behavioral avoidance-anxiety index [0-8]<BR/>GENERAL ANXIETY: Zung Anxiety Scale [20-80]<BR/>DEPRESSION: Beck Depression Inventory [0-63]<BR/>FUNCTIONING: Clinician's Global Assessment [1-5]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Oehrberg-1995">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (64% reported moderate to severe agoraphobia)<BR/>AGE: mean=37.4 years<BR/>SEX: 76% women<BR/>HISTORY: unspecified<BR/>PSYCHIATRIC COMORBIDITY: Primary diagnosis of major depression, generalized anxiety disorder, schizophrenia, dementia, organic brain disease, alcohol or drug abuse, or concomitant treatment with psychotropics and anticoagulants were excluded. The baseline 17-item HAM-D had to be 14 or less.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. paroxetine (40-60 mg/d) + CBT (details not given)<BR/>2. placebo + CBT</P>
<P>ACUTE PHASE CO-INTERVENTION: Concomitant use of benzo was prohibited. The urine was screened.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in panic frequency<BR/>REMISSION: "mildly ill" or less on CGI<BR/>GLOBAL: -<BR/>PANIC ATTACK: panic frequency<BR/>AGORAPHOBIA: -<BR/>GENERAL ANXIETY: Zung Anxiety Scale<BR/>DEPRESSION: -<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sharp-1996">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (% agoraphobia unclear; however, the average score for FQ-Ag was around 15, indicating most had at least some agoraphobia)<BR/>AGE: mean=33.2 to 38.8<BR/>SEX: 78% women<BR/>HISTORY: mean duration of panic disorder = 5.1 to 7.3 years<BR/>Patients who had received psychotherapy within 6 months were excluded.<BR/>Drugs were washed out over 4 weeks.<BR/>PSYCHIATRIC COMORBIDITY: Concurrent major depression (defined as MADRS&gt;=21) was excluded. OCD, paranoid personality disorder, schizophrenia, schizoaffective disorder, manic disorder, other unspecified psychosis, epilepsy, organic brain disease, alcohol dependence, drug dependence were excluded.<BR/>MEDICAL COMORBIDITY: Severe concurrent somatic disease and a physical disability that severely restricted mobility were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. fluvoxamine (100-150 mg/day) + CBT (12 sessions)<BR/>2. fluvoxamine alone<BR/>3. CBT alone<BR/>4. CBT + placebo<BR/>5. placebo alone [not included in the present meta-analysis]</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients were required to undergo a 4-week washout from psychotropics before entry into the study.</P>
<P>MAINTENANCE: No maintenance phase</P>
<P>MODE OF DISCONTINUATION: Abrupt</P>
<P>FOLLOW-UP: At 6 months after treatment discontinuation. 79% was successfully followed up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: Patients were required not to receive any psychotropic drugs or psychotherapies but at least 33% received further treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: "Very much" or "Much improved" on CGI Change<BR/>REMISSION: "Normal" or "borderline" on CGI Severity<BR/>GLOBAL: CGI Severity, CGI Change<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: FQ-Ag<BR/>GENERAL ANXIETY: HAM-A<BR/>DEPRESSION: MADRS<BR/>FUNCTIONING: Sheehan Disability Scale-work, -social, -home</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sharp-1996i">
<CHAR_METHODS>
<P>Same as (Sharp 1996) but refers only to the comparison with psychotherapy + placebo.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sharp-1996ii">
<CHAR_METHODS>
<P>Same as (Sharp 1996) but refers only to the comparison with psychotherapy alone.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sheehan-1980a">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: authors' own criteria, very similar to DSM-IV panic disorder with agoraphobia<BR/>AGE: mean=37.1 years<BR/>SEX: 82% women<BR/>HISTORY: mean duration of panic disorder = 11.5 to 13.5 years. On average, patients had received 4 years of psychoanalysis or behavior therapy.<BR/>PSYCHIATRIC COMORBIDITY: Psychosis was excluded.<BR/>MEDICAL COMORBIDITY: Physicall illness was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. imipramine (150 mg/d) + group behavior therapy (1-hour supportive group therapy every two weeks for three months; Patients were encouraged to gradually reapproach phobic situations and objects, and were rewarded emotionally when they did so)<BR/>2. placebo + group behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients were required to avoid all psychtropic drugs other than imipramine and phenelzine.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: Partial or marked improvement on Symptom Severity and Avoidance Scale<BR/>REMISSION: Marked improvement on Symptom Severity and Phobic Avoidance Scale<BR/>GLOBAL: Symptom Severity and Phobic Avoidacne Scale[1-5]<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: Wolpe-Lang FSS<BR/>GENERAL ANXIETY: SCL anxiety<BR/>DEPRESSION: Zung Depression Scale<BR/>FUNCTIONING: Work and Social Disability Scale [1-5]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sheehan-1980b">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: authors' own criteria, very similar to DSM-IV panic disorder with agoraphobia<BR/>AGE: mean=37.1 years<BR/>SEX: 82% women<BR/>HISTORY: mean duration of panci disorder = 13.0 to 13.5 years. On average, patients had received 4 years of psychoanalysis or behavior therapy.<BR/>PSYCHIATRIC COMORBIDITY: Psychosis was excluded.<BR/>MEDICAL COMORBIDITY: Physicall illness was excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12 weeks<BR/>1. phenelzine (45 mg/d) + group behavior therapy (1-hour supportive group therapy every two weeks for three months; Patients were encouraged to gradually reapproach phobic situations and objects, and were rewarded emotionally when they did so)<BR/>2. placebo + group behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: Patients were required to avoid all psychtropic drugs other than imipramine and phenelzine.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: Partial or marked improvement on Symptom Severity and Avoidance Scale<BR/>REMISSION: Marked improvement on Symptom Severity and Phobic Avoidance Scale<BR/>GLOBAL: Symptom Severity and Phobic Avoidacne Scale[1-5]<BR/>PANIC ATTACK: -<BR/>AGORAPHOBIA: Wolpe-Lang FSS<BR/>GENERAL ANXIETY: SCL anxiety<BR/>DEPRESSION: Zung Depression Scale<BR/>FUNCTIONING: Work and Social Disability Scale [1-5]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Spinhoven-1996">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: not blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (85% agoraphobic)<BR/>AGE: mean=35.6 years<BR/>SEX: 57% women<BR/>HISTORY: mean duration of illness=6.2 years<BR/>PSYCHIATRIC COMORBIDITY: Psychosis, major depression, alcohol abuse or dependence were excluded.<BR/>MEDICAL COMORBIDITY: Hyperthyroidism, pheochromocytome, bronchial asthma or angina were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 6 weeks<BR/>1. tranzodone (mean=178 mg/d) + CBT (breathing retraining, progressive relaxation, catastrophic cognitions, voluntary hyperventilation, BUT NO in vivo exposure; 6 sessions)<BR/>2. tranzodone alone<BR/>3. CBT alone</P>
<P>ACUTE PHASE CO-INTERVENTION: 25 out of 60 patients were taking low potency benzo at the start of the study. They were required to keep the dosage constant throughout the study.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in agoraphobic avoidance [imputed from mean&amp;SD]<BR/>REMISSION: -<BR/>GLOBAL: -<BR/>PANIC ATTACK: panic frequency for two weeks; panic intensity [0-10]<BR/>AGORAPHOBIA: agoraphobic avoidance [0-40]; agoraphobic anxiety [0-40]<BR/>GENERAL ANXIETY: -<BR/>DEPRESSION: Zung Depression Scale [20-80]<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Stein-2000">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-IV panic disorder with or without agoraphobia (percent agoraphobic not given; however, the average score for FQ-Ag was around 10.5 and 16.1, indicating most had at least some agoraphobia)<BR/>AGE: mean=33.8 years<BR/>SEX: 73% women<BR/>HISTORY: None of the enrolled subjects reported taking benzodiazepines.<BR/>PSYCHIATRIC COMORBIDITY: Major depressive disorder with melancholic features, schizophrenia, current substance abuse/dependence were excluded.<BR/>MEDICAL COMORBIDITY: Seizure disorder, thyroid disease were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 10 weeks<BR/>1. paroxetine (mean=32.4 mg/d) + CBT (2 sessions only, using self-help book, relaxation tape, cognitive restructuring, breathing control, graded exposure)<BR/>2. placebo + CBT</P>
<P>ACUTE PHASE CO-INTERVENTION: None of the subjected entrolled reported taking benzo.</P>
<P>MAINTENANCE: -</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: "Much" or "very much improved" on CGI Improvement<BR/>REMISSION: panic free<BR/>GLOBAL: -<BR/>PANIC ATTACK: frequency of panic attacks<BR/>AGORAPHOBIA: FQ-Ag<BR/>GENERAL ANXIETY: Beck Anxiety Inventory<BR/>DEPRESSION: Beck Depression Inventory<BR/>FUNCTIONING: Sheehan Disability Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Telch-1985">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III agoraphobia with panic attacks<BR/>AGE: mean=41.5 years<BR/>SEX: 92% women<BR/>HISTORY: mean duration of illness=12.2 years<BR/>PSYCHIATRIC COMORBIDITY: None met criteria for major affective disorder.<BR/>MEDICAL COMORBIDITY:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 8 weeks<BR/>1. imipramine (ca 180 mg/d) + behavior therapy (three 3-hour group sessions + three 1.5-hour individual sessions)<BR/>2. imipramine (with anti-exposure)<BR/>3. placebo + behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: 18 weeks</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=50% reduction in FQ-Ag [imputed from mean&amp;SD]<BR/>REMISSION: <BR/>GLOBAL: -<BR/>PANIC ATTACK: frequency of panic attacks<BR/>AGORAPHOBIA: FQ-Ag; BAT<BR/>GENERAL ANXIETY: -<BR/>DEPRESSION: Beck Depression Inventory<BR/>FUNCTIONING: -</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wiborg-1996">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: adequate [data provided by the original author]<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: DSM-III-R panic disorder with or without agoraphobia (80% agoraphobic)<BR/>AGE: mean=31.7 years<BR/>SEX: 58% women<BR/>HISTORY: mean duration of illness=3.2 years<BR/>PSYCHIATRIC COMORBIDITY: Personality disorder, primary major depression, psychosis, substance abuse, eating disorder, agoraphobia with or without panic attacks were excluded.<BR/>MEDICAL COMORBIDITY: Significant medical illness, pregnancy and lactation were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 12-15 weeks<BR/>1. clomipramine (mean=108-113 mg/d) + psychodynamic psychotherapy (15 weekly brief dynamic psychotherapy sessions, without encouraging exposure)<BR/>2. clomipramine alone</P>
<P>ACUTE PHASE CO-INTERVENTION: 11 out of 40 took benzo in the first month; 4 used benzo irregularly for six months.</P>
<P>MAINTENANCE: 33-36 weeks</P>
<P>MODE OF DISCONTINUATION: tapered off over 6 weeks</P>
<P>FOLLOW-UP: at 9 months after treatment discontinuation. 100% follow-up was achieved.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: <BR/>Of 20 patients in the first arm, 4 took effective medication. Of 20 patients in the second arm, 14 took effective medication and 4 received psychological treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: &gt;=40% reduction in Patient Status Scale [imputed from mean&amp;SD]<BR/>REMISSION: panic free<BR/>GLOBAL: Patient Status Scale<BR/>PANIC ATTACK: Panic Attack and Anxiety Scale<BR/>AGORAPHOBIA: Phobia Scale<BR/>GENERAL ANXIETY: HAM-A<BR/>DEPRESSION: HAM-D<BR/>FUNCTIONING: Sheehan Disability Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zitrin-1980">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: "agoraphobia" (the average severity being 5.9 to 6.3 on a scale between 1 through 7) with "spontaneous panic" (again the average severity being 4.1 to 4.9 on a scale between 1 through 7)<BR/>AGE: mean=35.6 years<BR/>SEX: 100% women<BR/>HISTORY: mean duration of illness=8.6 years<BR/>PSYCHIATRIC COMORBIDITY: Schizophrenia and significant current depression were excluded.<BR/>MEDICAL COMORBIDITY: -</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 14 weeks<BR/>1. imipramine (ca 200 mg/d) + behavior therapy (group in vivo exposure, ten 3-4-hour sessions)<BR/>2. placebo + behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE: 12 weeks</P>
<P>MODE OF DISCONTINUATION: -</P>
<P>FOLLOW-UP: -</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: "moderate" to "marked" improvement on CGI Change by an independent evaluator<BR/>REMISSION: "Marked" improvement on CGI Change by an independent evaluator<BR/>GLOBAL: CGI Change<BR/>PANIC ATTACK: spontaneous panic scale [1-7]<BR/>AGORAPHOBIA: primary phobia scale [1-7]<BR/>GENERAL ANXIETY: -<BR/>DEPRESSION: -<BR/>FUNCTIONING: functioning scale [1-7]</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zitrin-1983">
<CHAR_METHODS>
<P>ALLOCATION CONCEALMENT: unclear<BR/>BLINDING: at least one measure was assessed by an independent assessor blind to treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>DIAGNOSIS: authors' own criteria, similar to DSM-III agoraphobia with panic attacks or DSM-IV panic disorder with moderate to severe agoraphobia<BR/>AGE: mean=35.5 years<BR/>SEX: 65% women<BR/>HISTORY: mean duration of illness=10.6 years<BR/>PSYCHIATRIC COMORBIDITY: Patients rated as more than moderately depressed on BPRS were excluded.<BR/>MEDICAL COMORBIDITY: not specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ACUTE PHASE: 26 weeks<BR/>1. imipramine (mean=204 mg/d) + supportive therapy (dynamically oriented and non-directive) + behavior therapy (twenty-six 45-minute sessions including relaxation training, imaginary desensitization, in vivo desensitization, assertiveness training)<BR/>2. imipramine + supportive therapy<BR/>3. placebo + supportive therapy + behavior therapy</P>
<P>ACUTE PHASE CO-INTERVENTION: not specified</P>
<P>MAINTENANCE:-</P>
<P>MODE OF DISCONTINUATION: naturalisitc</P>
<P>FOLLOW-UP: At 24 months after treatment discontinuation. 59% was successfully followed up.</P>
<P>INTERVENTIONS AFTER TRIAL DISCONTINUATION: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>RESPONSE: "Moderate" to "marked" improvement on CGI Change by an independent evaluator<BR/>REMISSION: "Marked" improvement on CGI Change by an independent evaluator<BR/>GLOBAL: CGI Severity; CGI Improvement<BR/>PANIC ATTACK: spontaneous panic<BR/>AGORAPHOBIA: primary phobia<BR/>GENERAL ANXIETY: Taylor Manifest Anxiety<BR/>DEPRESSION: Self-rating Symptom Scale depression<BR/>FUNCTIONING: functioning scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ACQ: Agoraphobic Cognitiions Questionnaire<BR/>ADS: Anxiety Discomfort Scale<BR/>BAI: Beck Anxiety Inventory<BR/>BDI: Beck Depression Inventory<BR/>BAT: Behavioral Avoidance Test<BR/>BPRS: Bief Psychiatric Rating Scale<BR/>BSQ: Body Sensations Questionnaire<BR/>CGI: Clinical Global Impression<BR/>CID: Clinical Interview for Depression<BR/>FQ-Ag: Fear Questionnaire Agoraphobia Subscale<BR/>FSS: Fear Survey Schedule<BR/>HAM-A: Hamilton Rating Scale for Anxiety<BR/>HAM-D: Hamilton Rating Scale for Depression<BR/>IPT: Interpersonalty Therapy<BR/>MADRS: Montgomery-Asberg Depression Rating Scale<BR/>MI: Mobility Inventory<BR/>PDSS: Panic Disorder Severity Scale<BR/>SAS-SR: Social Adjustment Scale-Self Report<BR/>SCL-90-R: Symptom Checklist 90 Revised</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Agras-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization was flawed and the groups were not comparable (Personal communication from Dr Agras on Oct 14, 2003).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ba-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Although 3 arms had been planned (pharmacotherpay alone, pharmacotherapy plus CBT, pharmacotherapy plus CBT plus psychodynamic therapy), only the last two were successfully completed.<BR/>Moreover, pharmacotherapy always consisted of SSRI plus alprazolam.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chambless-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Flooding versus Flooding + barbiturate</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cox-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomized comparison between high serum level vs low serum level of imipramine, combined with behavior therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lipsedge-1973">
<CHAR_REASON_FOR_EXCLUSION>
<P>No operational diagnostic criteria used.<BR/>Iproniazid, though with MAO inhibiting effect, is not a widely recognized antidepressant.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Solyom-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Although the overall study design appears to satisfy the inclusion criteria of this systematic review, the authors did not separately report the results for agoraphobia and social phobia. The original author was contacted but could not provide separate data for patients with agoraphobia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azhar-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2000i">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2000ii">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Berger-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fahy-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fava-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Johnston-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kampman-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Loerch-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Marks-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mavissakalian-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Mavissakalian-1986a">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Mavissakalian-1986b">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oehrberg-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sharp-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sharp-1996i">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sharp-1996ii">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sheehan-1980a">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sheehan-1980b">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Spinhoven-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stein-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Telch-1985">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wiborg-1996">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zitrin-1980">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zitrin-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-de-Beurs-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-de-Beurs-1995i">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-de-Beurs-1995ii">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>PD+/-AGORAPHOBIA: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="17.937492093956926" CI_END="1.510772745135792" CI_START="1.0151015233600829" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2383810863535654" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="166" I2="44.250846508420416" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.17919914140310558" LOG_CI_START="0.006509479520321536" LOG_EFFECT_SIZE="0.09285431046171358" METHOD="MH" NO="1" P_CHI2="0.05602734666222542" P_Q="0.0" P_Z="0.035054838142680136" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.04204131170835254" TOTALS="YES" TOTAL_1="322" TOTAL_2="347" WEIGHT="100.00000000000001" Z="2.107724369022031">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8592539734267177" CI_END="1.3960782037129689" CI_START="0.8040457182397279" DF="3.0" EFFECT_SIZE="1.059486055605841" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="44" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.1449097467181801" LOG_CI_START="-0.09471925645709568" LOG_EFFECT_SIZE="0.025095245130542187" NO="1" P_CHI2="0.41383843588692293" P_Z="0.6814274289260617" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="26.67681007314212" Z="0.4105160559641447">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.5905355852063248" CI_START="0.47068186901227627" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5551592353055395" LOG_CI_START="-0.3272725306918659" LOG_EFFECT_SIZE="0.11394335230683678" ORDER="2015" O_E="0.0" SE="0.5183447874545656" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.2686813186813187" WEIGHT="3.3115780679786466"/>
<DICH_DATA CI_END="2.081852540666224" CI_START="0.6537980402183219" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.31844996482728344" LOG_CI_START="-0.18455638556605694" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2016" O_E="0.0" SE="0.29546842014263947" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.08730158730158732" WEIGHT="7.955459912368244"/>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="2017" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="0.9511893229809354"/>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="2018" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="14.458582769814296"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.973189893949896" CI_END="2.0203301078828795" CI_START="1.0510598677349974" DF="4.0" EFFECT_SIZE="1.4572192340112766" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="74" I2="42.637443396307134" ID="CMP-001.01.02" LOG_CI_END="0.30542233594117163" LOG_CI_START="0.021627453884056434" LOG_EFFECT_SIZE="0.16352489491261396" NO="2" P_CHI2="0.13731199479108092" P_Z="0.023902423353751714" STUDIES="5" TAU2="0.05359269251564066" TOTAL_1="159" TOTAL_2="177" WEIGHT="41.77632974373987" Z="2.2586940418461645">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.438919612627209" CI_START="1.2175955706334904" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.8088130031305857" LOG_CI_START="0.08550305955385278" LOG_EFFECT_SIZE="0.4471580313422192" ORDER="2019" O_E="0.0" SE="0.4248758412989382" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.18051948051948052" WEIGHT="4.623376101976276"/>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="2020" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="15.458233636122987"/>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="2021" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="5.170197871642358"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="2022" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="13.899844026634526"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="2023" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="2.6246781073637244"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.065916026918609" CI_END="1.8492207962635874" CI_START="0.6537283565358964" DF="1.0" EFFECT_SIZE="1.09949446202034" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="48" I2="83.51444372849348" ID="CMP-001.01.03" LOG_CI_END="0.2669887688519921" LOG_CI_START="-0.18460267639255165" LOG_EFFECT_SIZE="0.04119304622972021" NO="3" P_CHI2="0.013781586316294003" P_Z="0.7206680816779845" STUDIES="2" TAU2="0.1175354148526344" TOTAL_1="70" TOTAL_2="70" WEIGHT="31.54686018311802" Z="0.35756606053520273">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1547728590043567" CI_START="0.6300015148834446" EFFECT_SIZE="0.8529411764705882" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="34" LOG_CI_END="0.0624965679665984" LOG_CI_START="-0.20065840625319653" LOG_EFFECT_SIZE="-0.06908091914329904" ORDER="2024" O_E="0.0" SE="0.15457853449483858" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.023894523326571996" WEIGHT="15.605812036475236"/>
<DICH_DATA CI_END="1.8970926050149208" CI_START="1.053618012148746" EFFECT_SIZE="1.4137931034482758" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.2780885311339763" LOG_CI_START="0.022683186507582456" LOG_EFFECT_SIZE="0.1503858588207794" ORDER="2025" O_E="0.0" SE="0.15002636371038966" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.022507909808162127" WEIGHT="15.941048146642787"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.00358322846329" CI_END="1.4805304687080842" CI_START="0.8423625363091898" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1167557480057917" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="126" I2="62.50839631134198" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.1704173494190918" LOG_CI_START="-0.07450095644269307" LOG_EFFECT_SIZE="0.04795819648819936" METHOD="MH" NO="2" P_CHI2="0.01373477742217244" P_Q="0.0" P_Z="0.4427409220259202" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07924810137774652" TOTALS="YES" TOTAL_1="239" TOTAL_2="267" WEIGHT="100.00000000000001" Z="0.7675729876509202">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.01906103501001709" CI_END="1.5063413482788168" CI_START="0.6225630309871126" DF="1.0" EFFECT_SIZE="0.9683968378127192" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.1779233974130457" LOG_CI_START="-0.20581667214529703" LOG_EFFECT_SIZE="-0.013946637366125683" NO="1" P_CHI2="0.8901916562945521" P_Z="0.8867121369914315" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="62" WEIGHT="22.845657361925586" Z="0.14246574236830384">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9219135458330163" CI_START="0.5203147676273697" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.2837338477382853" LOG_CI_START="-0.28373384773828525" LOG_EFFECT_SIZE="0.0" ORDER="2026" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.1111111111111111" WEIGHT="10.872860047513717"/>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="2027" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="11.972797314411869"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.731825028495614" CI_END="2.1440031836100637" CI_START="0.9172907480911592" DF="2.0" EFFECT_SIZE="1.4023816471287343" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="62" I2="57.73301024539661" ID="CMP-001.02.02" LOG_CI_END="0.3312254259009827" LOG_CI_START="-0.037492986818599396" LOG_EFFECT_SIZE="0.1468662195411916" NO="2" P_CHI2="0.0938638290353434" P_Z="0.118437030093521" STUDIES="3" TAU2="0.07371307238040532" TOTAL_1="117" TOTAL_2="135" WEIGHT="42.00590007183017" Z="1.5613676503061216">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="2028" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="20.56897231919338"/>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="2029" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="3.7196892539963993"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="2030" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="17.717238498640388"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.637345853053072" CI_END="2.610017219986153" CI_START="0.28290896344282673" DF="1.0" EFFECT_SIZE="0.8593004516897513" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="41" I2="93.16816033426292" ID="CMP-001.02.03" LOG_CI_END="0.416643372671727" LOG_CI_START="-0.5483532925144117" LOG_EFFECT_SIZE="-0.06585495992134241" NO="3" P_CHI2="1.3030890879728307E-4" P_Z="0.7890761639182248" STUDIES="2" TAU2="0.5996929524601315" TOTAL_1="70" TOTAL_2="70" WEIGHT="35.148442566244256" Z="0.2675104574050787">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.9040336721887139" CI_START="0.3207190587275412" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.043815393226618926" LOG_CI_START="-0.49387523135854094" LOG_EFFECT_SIZE="-0.26884531229257996" ORDER="2031" O_E="0.0" SE="0.2643673767508198" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.06989010989010988" WEIGHT="13.878060213749965"/>
<DICH_DATA CI_END="1.7211088098619653" CI_START="1.0163329319635195" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" ORDER="2032" O_E="0.0" SE="0.13438199879091275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.01805852159904088" WEIGHT="21.270382352494295"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.6075855941056005" CI_END="-0.11286689727071392" CI_START="-0.5976288251007169" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.35524786118571544" ESTIMABLE="YES" I2="13.186637159445798" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="0.32998068041322637" P_Q="0.5215362414375495" P_Z="0.0040705894483380935" Q="1.3019531484070979" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.01061143340013638" TOTALS="YES" TOTAL_1="156" TOTAL_2="180" UNITS="" WEIGHT="99.99999999999997" Z="2.872639015302608">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.620882599825546" CI_END="0.4359807475729731" CI_START="-1.4472565047593395" DF="1.0" EFFECT_SIZE="-0.5056378785931832" ESTIMABLE="YES" I2="61.844914378592804" ID="CMP-001.03.01" NO="1" P_CHI2="0.10546581344978534" P_Z="0.2925807317412622" STUDIES="2" TAU2="0.30855631045333326" TOTAL_1="42" TOTAL_2="48" WEIGHT="28.22244618755819" Z="1.052477089686414">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.02125413161636569" CI_START="-2.262071319946162" EFFECT_SIZE="-1.141662725781264" ESTIMABLE="YES" MEAN_1="2.17" MEAN_2="3.67" ORDER="2033" SD_1="0.75" SD_2="1.63" SE="0.5716475419969643" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="4.5327901022290416"/>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="2034" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="23.68965608532915"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6847498458729566" CI_END="-0.01971823736066869" CI_START="-0.5725159594163156" DF="1.0" EFFECT_SIZE="-0.29611709838849215" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" NO="2" P_CHI2="0.4079562890803875" P_Z="0.03574754639855049" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="112" WEIGHT="58.72648559050569" Z="2.099787408275626">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="2035" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="40.01646601924858"/>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="2036" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="18.71001957125711"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" DF="0.0" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" NO="3" P_CHI2="1.0" P_Z="0.03499375510595159" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.0510682219361" Z="2.1084306554609964">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.0" ORDER="2037" SD_1="0.5" SD_2="1.1" SE="0.32644894275404324" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.0510682219361"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.39531887872953" CI_END="0.16096792940849983" CI_START="-0.5623515090792737" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2006917898353869" ESTIMABLE="YES" I2="57.30488652415629" I2_Q="0.0" ID="CMP-001.04" NO="4" P_CHI2="0.02174016561517489" P_Q="0.5907738386676757" P_Z="0.27676250399852365" Q="1.0526443311283753" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.14946761859618485" TOTALS="YES" TOTAL_1="161" TOTAL_2="194" UNITS="" WEIGHT="100.0" Z="1.0876209296755655">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2173992878339095" CI_END="0.18901180459510905" CI_START="-0.4855223464617978" DF="3.0" EFFECT_SIZE="-0.14825527093334437" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="0.5285294808445071" P_Z="0.3889310542111588" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="45.967543089631576" Z="0.8615575389097494">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.1030659113296144" CI_START="-0.40675425774589163" EFFECT_SIZE="0.34815582679186136" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="0.27" ORDER="2038" SD_1="0.93" SD_2="0.65" SE="0.38516528389928967" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="11.432740999180437"/>
<CONT_DATA CI_END="0.7980531175789702" CI_START="-1.2390075602204103" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" MEAN_1="1.71" MEAN_2="2.14" ORDER="2039" SD_1="1.89" SD_2="1.77" SE="0.5196678851926503" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="8.116130436155089"/>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="2040" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.726914929430057"/>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="2041" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="16.691756724865986"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.125275259767244" CI_END="0.5021175543559191" CI_START="-1.4230436158392366" DF="2.0" EFFECT_SIZE="-0.4604630307416587" ESTIMABLE="YES" I2="84.7622243311683" ID="CMP-001.04.02" NO="2" P_CHI2="0.0014121641345350433" P_Z="0.3484631613278639" STUDIES="3" TAU2="0.6105472502537721" TOTAL_1="57" TOTAL_2="68" WEIGHT="39.27508089417272" Z="0.937574443571729">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.8051814322011425" CI_START="-2.3712031782502496" EFFECT_SIZE="-1.588192305225696" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="9.07" ORDER="2042" SD_1="3.87" SD_2="1.98" SE="0.3995026843354487" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="11.016591062192662"/>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="2043" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="14.757376016195714"/>
<CONT_DATA CI_END="0.7096571108630692" CI_START="-0.5467164147484287" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.8" ORDER="2044" SD_1="2.5" SD_2="2.3" SE="0.32050933984542873" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="13.501113815784343"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5856257622309741" CI_START="-0.5317774780726351" DF="0.0" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.03" NO="3" P_CHI2="1.0" P_Z="0.9247503046351875" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="52" WEIGHT="14.757376016195714" Z="0.09445175543874984">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="2045" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="14.757376016195714"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.8" ORDER="2046" SD_1="0.0" SD_2="2.1" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="21.811288372710305" CI_END="0.050525171365235766" CI_START="-0.6829594554426515" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3162171420387078" ESTIMABLE="YES" I2="63.321744853874" I2_Q="29.387402700327943" ID="CMP-001.05" NO="5" P_CHI2="0.005277720575599387" P_Q="0.24263995526794913" P_Z="0.09103854474874701" Q="2.83235580687143" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.18987124509541392" TOTALS="YES" TOTAL_1="167" TOTAL_2="190" UNITS="" WEIGHT="100.0" Z="1.6899446478852627">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.731099367340444" CI_END="-0.056789718525092625" CI_START="-1.012359770540574" DF="3.0" EFFECT_SIZE="-0.5345747445328334" ESTIMABLE="YES" I2="36.58979093295962" ID="CMP-001.05.01" NO="1" P_CHI2="0.19258012153928394" P_Z="0.028312705021815526" STUDIES="4" TAU2="0.08750245792215271" TOTAL_1="64" TOTAL_2="74" WEIGHT="39.771168946287226" Z="2.192926084527561">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1660942883799188" CI_START="-1.3689479754433111" EFFECT_SIZE="-0.6014268435316962" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.9" ORDER="2047" SD_1="8.36" SD_2="8.97" SE="0.3915996099753484" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="10.20120262057349"/>
<CONT_DATA CI_END="0.039892566655316264" CI_START="-2.175482894859469" EFFECT_SIZE="-1.0677951641020764" ESTIMABLE="YES" MEAN_1="8.57" MEAN_2="19.43" ORDER="2048" SD_1="6.16" SD_2="12.42" SE="0.5651571863027546" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="6.875027618655569"/>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="2049" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="8.331091763527171"/>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="2050" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="14.363846943530998"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.103384502212562" CI_END="0.4419454999537956" CI_START="-0.9353727980340601" DF="2.0" EFFECT_SIZE="-0.24671364904013224" ESTIMABLE="YES" I2="71.84440741766069" ID="CMP-001.05.02" NO="2" P_CHI2="0.02867611589928787" P_Z="0.48257852481409924" STUDIES="3" TAU2="0.2643510660868033" TOTAL_1="63" TOTAL_2="64" WEIGHT="35.59582150252196" Z="0.7021613919157816">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="2051" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="10.154040001742171"/>
<CONT_DATA CI_END="0.41452271242937677" CI_START="-0.6155982943711397" EFFECT_SIZE="-0.10053779097088145" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.5" ORDER="2052" SD_1="7.8" SD_2="7.9" SE="0.2627907999651982" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="29" TOTAL_2="29" WEIGHT="13.522066526754081"/>
<CONT_DATA CI_END="0.9259489927372764" CI_START="-0.33737912447830304" EFFECT_SIZE="0.2942849341294867" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="18.7" ORDER="2053" SD_1="12.0" SD_2="13.3" SE="0.3222835029573376" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="11.919714974025705"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.144448696285867" CI_END="1.1331160192914684" CI_START="-1.1473798884999484" DF="1.0" EFFECT_SIZE="-0.007131934604240072" ESTIMABLE="YES" I2="86.00311874980834" ID="CMP-001.05.03" NO="3" P_CHI2="0.007519659688866032" P_Z="0.9902189534582193" STUDIES="2" TAU2="0.5822974907269153" TOTAL_1="40" TOTAL_2="52" WEIGHT="24.633009551190817" Z="0.012259030956072193">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="2054" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="12.757248716039634"/>
<CONT_DATA CI_END="0.03724050674962909" CI_START="-1.2326820263280838" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.6" ORDER="2055" SD_1="1.1" SD_2="3.3" SE="0.32396578281404653" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.875760835151185"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="29.201648787546603" CI_END="0.026681180708286345" CI_START="-0.8842102797094653" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4287645495005895" ESTIMABLE="YES" I2="76.0287508046969" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="1.3293443342399236E-4" P_Q="0.6974544063907264" P_Z="0.06501655628097354" Q="0.7206365967865338" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.3175796188233715" TOTALS="YES" TOTAL_1="162" TOTAL_2="194" UNITS="" WEIGHT="100.00000000000001" Z="1.8451442600708776">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.3924051889570751" CI_END="0.22860510417282892" CI_START="-0.6046012430484724" DF="1.0" EFFECT_SIZE="-0.18799806943782177" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.01" NO="1" P_CHI2="0.5310382132394685" P_Z="0.3764471754799724" STUDIES="2" TAU2="0.0" TOTAL_1="42" TOTAL_2="48" WEIGHT="23.59026061476014" Z="0.8844614458111532">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5440488746719574" CI_START="-1.5255257710292496" EFFECT_SIZE="-0.4907384481786461" ESTIMABLE="YES" MEAN_1="27.29" MEAN_2="32.29" ORDER="2056" SD_1="4.82" SD_2="13.12" SE="0.5279624171734143" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="9.055133306339906"/>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="2057" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="14.535127308420233"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.042629281981021" CI_END="0.17561847083039417" CI_START="-1.1977263848644588" DF="3.0" EFFECT_SIZE="-0.5110539570170324" ESTIMABLE="YES" I2="78.6364793959954" ID="CMP-001.06.02" NO="2" P_CHI2="0.0028477129411815794" P_Z="0.14464838606442806" STUDIES="4" TAU2="0.3821443065425785" TOTAL_1="80" TOTAL_2="94" WEIGHT="50.696666755768916" Z="1.4586974943060085">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.5404249278343514" CI_START="-2.0341743515424784" EFFECT_SIZE="-1.2872996396884149" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="28.71" ORDER="2058" SD_1="4.68" SD_2="4.18" SE="0.3810655286246665" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="11.667897358359443"/>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="2059" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="13.486296363316614"/>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="2060" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="11.649410401008772"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="2061" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="13.893062633084087"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.04597771982197" CI_END="1.2175195093439213" CI_START="-2.123103798736285" DF="1.0" EFFECT_SIZE="-0.45279214469618195" ESTIMABLE="YES" I2="92.8805240906172" ID="CMP-001.06.03" NO="3" P_CHI2="1.7839593308055512E-4" P_Z="0.595202730025378" STUDIES="2" TAU2="1.3494009453066427" TOTAL_1="40" TOTAL_2="52" WEIGHT="25.713072629470954" Z="0.531311802764838">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="2062" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="13.486296363316614"/>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="2063" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.22677626615434"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.77476056076418" CI_END="-0.2752166414513507" CI_START="-0.756461503926659" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5158390726890049" ESTIMABLE="YES" I2="0.0" I2_Q="0.1757744951506969" ID="CMP-001.07" NO="7" P_CHI2="0.4527026441377867" P_Q="0.36723234751878364" P_Z="2.649047510023516E-5" Q="2.003521680118463" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="135" TOTAL_2="146" UNITS="" WEIGHT="100.0" Z="4.201711366179468">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2759672774315742" CI_END="-0.008321257129870197" CI_START="-0.6887072791358819" DF="3.0" EFFECT_SIZE="-0.34851426813287606" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" NO="1" P_CHI2="0.5171406827628646" P_Z="0.0446533359428882" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="50.0289567744371" Z="2.0079054876078484">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.4847694472269716" CI_START="-1.0197910873796672" EFFECT_SIZE="-0.26751082007634774" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2064" SD_1="0.51" SD_2="0.85" SE="0.3838235157570292" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="10.23087740791353"/>
<CONT_DATA CI_END="-0.022765335912631635" CI_START="-2.264232881184172" EFFECT_SIZE="-1.1434991085484019" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="9.14" ORDER="2065" SD_1="1.99" SD_2="7.84" SE="0.5718134524287054" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="4.609643109370947"/>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="2066" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="7.520397458596585"/>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="2067" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="27.668038798556033"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.495271603214143" CI_END="-0.20363113883379635" CI_START="-1.1011784486237868" DF="2.0" EFFECT_SIZE="-0.6524047937287916" ESTIMABLE="YES" I2="19.848404581536805" ID="CMP-001.07.02" NO="2" P_CHI2="0.28718304382759297" P_Z="0.004381581266422712" STUDIES="3" TAU2="0.03140651077211375" TOTAL_1="51" TOTAL_2="52" WEIGHT="36.09813833235232" Z="2.8492980483645023">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17860078902451304" CI_START="-1.595980151651918" EFFECT_SIZE="-0.8872904703382155" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="12.2" ORDER="2068" SD_1="1.38" SD_2="4.46" SE="0.3615830121898954" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="11.528160184159558"/>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="2069" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="10.011165725698623"/>
<CONT_DATA CI_END="0.380172766114548" CI_START="-0.8810829019163788" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="46.0" ORDER="2070" SD_1="8.7" SD_2="10.8" SE="0.3217548072259364" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="14.558812422494135"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" DF="0.0" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.03" NO="3" P_CHI2="1.0" P_Z="0.01659699832819686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.872904893210588" Z="2.395515812805348">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="2071" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.872904893210588"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="11.856418152103739" CI_END="-0.05316045897337229" CI_START="-0.886652186087379" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4699063225303756" ESTIMABLE="YES" I2="57.82874780683383" I2_Q="58.738630746732" ID="CMP-001.08" NO="8" P_CHI2="0.03680907941079126" P_Q="0.08860438619822264" P_Z="0.0271066428372194" Q="4.847148885737948" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.14953911101073739" TOTALS="YES" TOTAL_1="117" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="2.209978667589637">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.339625354459889" CI_END="0.38861852175076217" CI_START="-0.8544889990941796" DF="2.0" EFFECT_SIZE="-0.23293523867170876" ESTIMABLE="YES" I2="53.91307228987926" ID="CMP-001.08.01" NO="1" P_CHI2="0.11419908537502266" P_Z="0.4626308906421045" STUDIES="3" TAU2="0.16210781936331775" TOTAL_1="54" TOTAL_2="64" WEIGHT="47.119557293291244" Z="0.7345216256377837">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.4719732474819971" CI_START="-1.0333537967547248" EFFECT_SIZE="-0.28069027463636387" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.3" ORDER="2072" SD_1="0.62" SD_2="0.74" SE="0.38401905752109466" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="15.222139972896835"/>
<CONT_DATA CI_END="0.0582778375411388" CI_START="-2.149781105514995" EFFECT_SIZE="-1.045751633986928" ESTIMABLE="YES" MEAN_1="1.86" MEAN_2="2.86" ORDER="2073" SD_1="0.9" SD_2="0.9" SE="0.5632906932150337" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="9.684618660872914"/>
<CONT_DATA CI_END="0.6222469115213249" CI_START="-0.2886432974821731" EFFECT_SIZE="0.16680180701957595" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.05" ORDER="2074" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="22.212798659521496"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-001.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="35.396476256026375" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="2075" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="14.784792168908833"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="2076" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="20.61168408711754"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" DF="0.0" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.03" NO="3" P_CHI2="1.0" P_Z="0.014437591269834836" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.48396645068238" Z="2.4461874573937834">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="3.0" ORDER="2077" SD_1="1.5" SD_2="2.7" SE="0.33022378325494234" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.48396645068238"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="6.6856673716272645" CI_END="1.230127561496337" CI_START="0.7520432321132788" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9618259235741836" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="98" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.08995014914791286" LOG_CI_START="-0.12375719274803536" LOG_EFFECT_SIZE="-0.016903521800061275" METHOD="MH" NO="9" P_CHI2="0.7547492466021903" P_Q="0.0" P_Z="0.7565207050887062" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="322" TOTAL_2="347" WEIGHT="100.0" Z="0.3100529316970169">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.633016983470406" CI_END="1.8784215501819799" CI_START="0.7845018955295239" DF="3.0" EFFECT_SIZE="1.213929679479528" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="26" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.2737930620374051" LOG_CI_START="-0.10540600272456782" LOG_EFFECT_SIZE="0.08419352965641862" NO="1" P_CHI2="0.6519268882653211" P_Z="0.38411397520199253" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="31.76174612351669" Z="0.8703412069935768">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.6601562747764063" CI_START="0.8297809266717024" EFFECT_SIZE="1.4857142857142858" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.42490715064590723" LOG_CI_START="-0.08103655207686013" LOG_EFFECT_SIZE="0.17193529928452353" ORDER="2078" O_E="0.0" SE="0.2971938354410734" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.08832417582417582" WEIGHT="17.84162863742308"/>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2079" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="1.2332716785089273"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2080" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="2.34125861507409"/>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="2081" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="10.345587192510592"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1916579856605614" CI_END="1.0788036449232927" CI_START="0.5498178381129171" DF="4.0" EFFECT_SIZE="0.7701593911652703" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="60" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.03294240512178687" LOG_CI_START="-0.2597811741536351" LOG_EFFECT_SIZE="-0.1134193845159241" NO="2" P_CHI2="0.8794701725135323" P_Z="0.12880661385765382" STUDIES="5" TAU2="0.0" TOTAL_1="159" TOTAL_2="177" WEIGHT="53.299541297103715" Z="1.5188247516661602">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9732644695315953" CI_START="0.33633065953179025" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.47323354107503623" LOG_CI_START="-0.47323354107503623" LOG_EFFECT_SIZE="0.0" ORDER="2082" O_E="0.0" SE="0.5559594491425693" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.3090909090909091" WEIGHT="5.098328997757493"/>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="2083" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="26.541590439610232"/>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="2084" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="4.604214266433328"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="2085" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="13.115789731399142"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2086" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="3.939617861903517"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2891052038056161" CI_END="2.4488813231295468" CI_START="0.6855624612458576" DF="1.0" EFFECT_SIZE="1.295708727756244" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" I2="0.0" ID="CMP-001.09.03" LOG_CI_END="0.38896773900024634" LOG_CI_START="-0.16395297072329848" LOG_EFFECT_SIZE="0.11250738413847393" NO="3" P_CHI2="0.5907945818087244" P_Z="0.4250908118289174" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="14.9387125793796" Z="0.7976204075136739">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="2.3945374130296906" CI_START="0.6525268686543702" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.3792216269895729" LOG_CI_START="-0.18540160097346" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="2087" O_E="0.0" SE="0.33166247903553997" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.11" WEIGHT="14.325883134194608"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2088" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.6128294451849915"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.486978126849342" CI_END="1.8738550891967392" CI_START="0.45470878393613845" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9230700779903948" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" I2="8.875160709433485" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.2727360025626468" LOG_CI_START="-0.34226665613545193" LOG_EFFECT_SIZE="-0.03476532678640257" METHOD="MH" NO="10" P_CHI2="0.3593759818274458" P_Q="0.0" P_Z="0.8246341595977508" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07089208829334732" TOTALS="YES" TOTAL_1="165" TOTAL_2="180" WEIGHT="100.00000000000001" Z="0.22158859786511462">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.533145101433542" CI_END="3.579967562941927" CI_START="0.265177618603538" DF="1.0" EFFECT_SIZE="0.9743342717049688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.5538790916441118" LOG_CI_START="-0.5764631338387787" LOG_EFFECT_SIZE="-0.011292021097333432" NO="1" P_CHI2="0.4652876652574288" P_Z="0.9687630306471365" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="21" WEIGHT="27.218424297396766" Z="0.039159741473844475">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2089" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="9.676616655592987"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2090" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="17.54180764180378"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.384594429417225" CI_END="2.6755611074468897" CI_START="0.24598168207620338" DF="2.0" EFFECT_SIZE="0.8112576789821194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" I2="54.385746910100686" ID="CMP-001.10.02" LOG_CI_END="0.42741487432500946" LOG_CI_START="-0.6090972330162566" LOG_EFFECT_SIZE="-0.09084117934562358" NO="2" P_CHI2="0.11166003559667514" P_Z="0.7311868047068162" STUDIES="3" TAU2="0.6047389436672939" TOTAL_1="123" TOTAL_2="139" WEIGHT="67.84252288897022" Z="0.34354724574759943">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="2091" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="20.572528336156093"/>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="2092" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="23.722606108205916"/>
<DICH_DATA CI_END="5.208499115067838" CI_START="0.34132246900739327" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7167125947102104" LOG_CI_START="-0.4668351214936106" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2093" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="23.54738844460821"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.10.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="4.939052813633023" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2094" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="4.939052813633023"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.911881033110566" CI_END="2.397593652978936" CI_START="0.75396326748392" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3445064316315882" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="91" I2="76.76558518230648" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.3797755802546249" LOG_CI_START="-0.12264981211117566" LOG_EFFECT_SIZE="0.12856288407172464" METHOD="MH" NO="11" P_CHI2="0.00483110703066203" P_Q="0.0" P_Z="0.3158372739952827" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.24049076356453972" TOTALS="YES" TOTAL_1="176" TOTAL_2="206" WEIGHT="100.0" Z="1.0030489157511393">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" DF="1.0" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" NO="1" P_CHI2="0.41779777973047816" P_Z="0.021254905136773212" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="37.62375500363581" Z="2.3034256644443234">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2095" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="12.045507728951174"/>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="2096" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="25.578247274684635"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="31.981738852076898" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="2097" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="31.981738852076898"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0175880523999328" CI_START="0.4386845857324744" DF="0.0" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" NO="3" P_CHI2="1.0" P_Z="0.06028032235338007" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="58" WEIGHT="30.394506144287288" Z="1.878737663869856">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.0175880523999328" CI_START="0.4386845857324744" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" ORDER="2098" O_E="0.0" SE="0.2146492963334045" STUDY_ID="STD-Berger-2004" TOTAL_1="35" TOTAL_2="38" VAR="0.04607432041642569" WEIGHT="30.394506144287288"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2099" O_E="0.0" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.188410692213075" CI_END="0.010998270772755503" CI_START="-0.9782980625331062" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4836498958801754" ESTIMABLE="YES" I2="69.67034092772263" I2_Q="52.42993776628748" ID="CMP-001.12" NO="12" P_CHI2="0.010390987548031916" P_Q="0.12219195835021601" P_Z="0.05531609577417425" Q="4.204324960043076" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.20897205658197623" TOTALS="YES" TOTAL_1="128" TOTAL_2="158" UNITS="" WEIGHT="100.0" Z="1.9163851014873143">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6964510583271646" CI_END="-0.2991250155371573" CI_START="-1.5113689966142019" DF="1.0" EFFECT_SIZE="-0.9052470060756796" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" NO="1" P_CHI2="0.4039791819030496" P_Z="0.0034200846498160646" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="31.416230546965366" Z="2.9272185413445753">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.07400266871028871" CI_START="-1.4743503608812065" EFFECT_SIZE="-0.700173846085459" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="11.3" ORDER="2100" SD_1="5.68" SD_2="9.61" SE="0.3949952758838189" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="17.45065384598793"/>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="2101" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.965576700977435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="26.87510144399297" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="2102" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="26.87510144399297"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.287634673842835" CI_END="1.0375944505760968" CI_START="-1.4473213765007107" DF="1.0" EFFECT_SIZE="-0.20486346296230684" ESTIMABLE="YES" I2="87.93383107056869" ID="CMP-001.12.03" NO="3" P_CHI2="0.003991634919482956" P_Z="0.7465665699207483" STUDIES="2" TAU2="0.7069141587221924" TOTAL_1="41" TOTAL_2="49" WEIGHT="41.70866800904166" Z="0.3231699076315359">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="2103" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="21.740056139546283"/>
<CONT_DATA CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="2.4" ORDER="2104" SD_1="1.1" SD_2="2.9" SE="0.3316581732834669" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.96861186949538"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.15508736788643443" CI_END="1.8971472761059518" CI_START="0.2676567200394752" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7125897959937005" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.2781010466068509" LOG_CI_START="-0.5724218483409831" LOG_EFFECT_SIZE="-0.14716040086706608" METHOD="MH" NO="13" P_CHI2="0.9253866208814989" P_Q="0.0" P_Z="0.49761989451149546" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="113" WEIGHT="100.0" Z="0.6782394392043192">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.866750975750852" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="2105" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="13.866750975750852"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.30456919828377" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="2106" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="68.30456919828377"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.083060192649951" CI_START="0.04918297059741634" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.13.03" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" NO="3" P_CHI2="1.0" P_Z="0.5579989793003175" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.82867982596538" Z="0.585816288803313">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2107" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="17.82867982596538"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" METHOD="MH" NO="14" P_CHI2="1.0" P_Q="0.0" P_Z="0.23602467635869728" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" DF="0.0" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-001.14.03" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" NO="3" P_CHI2="1.0" P_Z="0.23602467635869728" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1122988184661988" CI_START="0.6492757757564591" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" ORDER="2108" O_E="0.0" SE="0.13733074026524866" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" VAR="0.018859732221801193" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-001.15" NO="15" P_CHI2="0.0" P_Q="1.0" P_Z="0.14838783259194901" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" DF="0.0" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" ID="CMP-001.15.03" NO="3" P_CHI2="0.0" P_Z="0.14838783259194901" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="2109" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.3372115662738713" CI_END="2.112537130665279" CI_START="1.228637159305837" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6110684712788257" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="56" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.32480435099513794" LOG_CI_START="0.08942364612714793" LOG_EFFECT_SIZE="0.20711399856114296" METHOD="MH" NO="16" P_CHI2="0.5030583014087577" P_Q="0.0" P_Z="5.622781554360021E-4" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="174" TOTAL_2="202" WEIGHT="99.99999999999999" Z="3.4491865261562906">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="35.41073624915468" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="2110" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="35.41073624915468"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03616172698317163" CI_END="2.1135498083600237" CI_START="1.0026681360689822" DF="2.0" EFFECT_SIZE="1.4557434687599666" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="32" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.3250124869608847" LOG_CI_START="0.0011572136555768984" LOG_EFFECT_SIZE="0.16308485030823086" NO="2" P_CHI2="0.9820816189881668" P_Z="0.048385058681142824" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="129" WEIGHT="52.82503239392901" Z="1.9739708405297698">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="2111" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="19.265120840760126"/>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="2112" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="15.925463605478436"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="2113" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="17.63444794769045"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0514801901976165" CI_START="1.4521773760684742" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-001.16.03" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" NO="3" P_CHI2="1.0" P_Z="0.003908892607536905" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.764231356916302" Z="2.88542203962941">
<NAME>Other psychotherapies</NAME>
<DICH_DATA CI_END="7.0514801901976165" CI_START="1.4521773760684742" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" ORDER="2114" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.16250000000000003" WEIGHT="11.764231356916302"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="10.05578915203161" CI_END="0.6262294009688185" CI_START="-1.784480698893757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5791256489624692" ESTIMABLE="YES" I2="90.05547963584772" I2_Q="90.05547963584772" ID="CMP-001.17" NO="17" P_CHI2="0.0015187088582974129" P_Q="0.0015187088582974129" P_Z="0.3463536745706467" Q="10.05578915203161" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.6836610431139938" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="0.9416855345273837">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours AD</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="2115" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" DF="0.0" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.03" NO="3" P_CHI2="1.0" P_Z="3.97783813112423E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656" Z="3.5415497659113866">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="2.4" ORDER="2116" SD_1="1.1" SD_2="1.7" SE="0.34792608783334095" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>PD+/-AGORAPHOBIA: Psychotherapy+Antidepressant vs Psychotherapy alone</NAME>
<DICH_OUTCOME CHI2="8.959962032292406" CI_END="1.4972410874013082" CI_START="0.8511355509737796" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1288733843376295" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="95" I2="44.19619210461375" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.17529173654739566" LOG_CI_START="-0.07000126911403869" LOG_EFFECT_SIZE="0.052645233716678494" METHOD="MH" NO="1" P_CHI2="0.1106719679413668" P_Q="0.0" P_Z="0.40017871525457427" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.04770527694109163" TOTALS="YES" TOTAL_1="176" TOTAL_2="190" WEIGHT="100.0" Z="0.8413021134797585">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.46106295999088" CI_END="7.295120379776317" CI_START="0.10644109729102415" DF="1.0" EFFECT_SIZE="0.8811927247166218" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" I2="77.58381782618812" ID="CMP-002.01.01" LOG_CI_END="0.8630324627601402" LOG_CI_START="-0.9728906569975703" LOG_EFFECT_SIZE="-0.05492909711871504" NO="1" P_CHI2="0.034675955225937916" P_Z="0.9066377241998513" STUDIES="2" TAU2="1.863229797263998" TOTAL_1="31" TOTAL_2="28" WEIGHT="15.01890717213233" Z="0.11728056681392222">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.099466037545226" CI_START="1.1015154067977038" EFFECT_SIZE="2.125" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.6127272928052274" LOG_CI_START="0.041990575967433275" LOG_EFFECT_SIZE="0.32735893438633035" ORDER="2117" O_E="0.0" SE="0.3352535726628328" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="21" VAR="0.1123949579831933" WEIGHT="12.967419614751321"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2118" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="2.051487557381009"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.8715226094753405" CI_END="1.314270955547421" CI_START="0.8975299902887037" DF="3.0" EFFECT_SIZE="1.0860928127785405" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="84" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.11868491040498047" LOG_CI_START="-0.04695103088414084" LOG_EFFECT_SIZE="0.03586693976041977" NO="2" P_CHI2="0.41186107530489735" P_Z="0.3959790467336427" STUDIES="4" TAU2="0.0" TOTAL_1="145" TOTAL_2="162" WEIGHT="84.98109282786767" Z="0.8488243507897104">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.214830136893607" CI_START="0.5582679186538144" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.08451555713843212" LOG_CI_START="-0.253157328538504" LOG_EFFECT_SIZE="-0.08432088570003592" ORDER="2119" O_E="0.0" SE="0.19835072455437414" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.039343009931245204" WEIGHT="23.84983095334445"/>
<DICH_DATA CI_END="1.694804769298792" CI_START="0.9199428016816164" EFFECT_SIZE="1.2486486486486486" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="37" LOG_CI_END="0.22911967746562512" LOG_CI_START="-0.03623917448736417" LOG_EFFECT_SIZE="0.09644025148913046" ORDER="2120" O_E="0.0" SE="0.1558731031846877" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="0.024296424296424295" WEIGHT="28.833859353336198"/>
<DICH_DATA CI_END="1.5648004457663978" CI_START="0.8182966189661858" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="26" LOG_CI_END="0.19445896116148326" LOG_CI_START="-0.08708924323593059" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="2121" O_E="0.0" SE="0.16538280894912974" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="43" VAR="0.027351473495904347" WEIGHT="27.66022928778635"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2122" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="4.637173233400676"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.762819077892331" CI_END="1.4520891294295133" CI_START="0.9729986489023051" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1886466089720027" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="79" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.16199327423695675" LOG_CI_START="-0.011887762788873971" LOG_EFFECT_SIZE="0.07505275572404142" METHOD="MH" NO="2" P_CHI2="0.429657272261851" P_Q="0.0" P_Z="0.09065180553880957" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="134" TOTAL_2="148" WEIGHT="100.0" Z="1.6919694139821717">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.60221075246591" CI_END="3.15252818547001" CI_START="0.1566163347377253" DF="1.0" EFFECT_SIZE="0.7026645071196388" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" I2="61.57113719354288" ID="CMP-002.02.01" LOG_CI_END="0.4986589781124864" LOG_CI_START="-0.8051629439607332" LOG_EFFECT_SIZE="-0.15325198292412334" NO="1" P_CHI2="0.1067148080595296" P_Z="0.6449775482051185" STUDIES="2" TAU2="0.8177950715711421" TOTAL_1="31" TOTAL_2="28" WEIGHT="19.530548200590708" Z="0.4607506009915994">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.8593465034093077" CI_START="0.7320373629204512" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.2693603314049178" LOG_CI_START="-0.13546675214369133" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2123" O_E="0.0" SE="0.23779743280283544" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="21" VAR="0.05654761904761904" WEIGHT="18.44868109910026"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2124" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="1.0818671014904473"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.13082185597783427" CI_END="1.5238178784790524" CI_START="0.975205305798728" DF="1.0" EFFECT_SIZE="1.2190304672828047" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="63" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.18293306470834547" LOG_CI_START="-0.010903944517605988" LOG_EFFECT_SIZE="0.08601456009536974" NO="2" P_CHI2="0.7175815126763688" P_Z="0.08195464773292314" STUDIES="2" TAU2="0.0" TOTAL_1="103" TOTAL_2="120" WEIGHT="80.46945179940928" Z="1.7394556447831335">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.554779740661746" CI_START="0.9025803287545905" EFFECT_SIZE="1.1846153846153846" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="42" LOG_CI_END="0.19166887298306828" LOG_CI_START="-0.044514135923815666" LOG_EFFECT_SIZE="0.07357736852962629" ORDER="2125" O_E="0.0" SE="0.13873506855665313" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="0.019247419247419243" WEIGHT="54.200980261954385"/>
<DICH_DATA CI_END="1.911206661343043" CI_START="0.8750763797735941" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.28130765043975153" LOG_CI_START="-0.0579540385588253" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="2126" O_E="0.0" SE="0.19928399549020914" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="43" VAR="0.03971411085854169" WEIGHT="26.268471537454907"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.839151795143926" CI_END="0.021469103457126437" CI_START="-0.631606567659025" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.30506873210094926" ESTIMABLE="YES" I2="29.556425851523965" I2_Q="30.0405004666807" ID="CMP-002.03" NO="3" P_CHI2="0.24181687386356598" P_Q="0.23186289241784608" P_Z="0.06708548279131206" Q="1.429398447202634" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.025917616615997178" TOTALS="YES" TOTAL_1="113" TOTAL_2="125" UNITS="" WEIGHT="99.99999999999999" Z="1.8311009096549746">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.01418762002989482" CI_START="-1.3444624257271474" DF="0.0" EFFECT_SIZE="-0.679325022878521" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" NO="1" P_CHI2="1.0" P_Z="0.045309396265989156" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="18" WEIGHT="19.673987709199167" Z="2.001770721262183">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.01418762002989482" CI_START="-1.3444624257271474" EFFECT_SIZE="-0.679325022878521" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="2127" SD_1="0.84" SD_2="1.16" SE="0.3393620536372837" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="18" WEIGHT="19.673987709199167"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.409753347941292" CI_END="0.12880140950348462" CI_START="-0.5643200712962394" DF="1.0" EFFECT_SIZE="-0.2177593308963774" ESTIMABLE="YES" I2="29.065605592614336" ID="CMP-002.03.02" NO="2" P_CHI2="0.23509757198923165" P_Z="0.21812419055496202" STUDIES="2" TAU2="0.019797952696784662" TOTAL_1="94" TOTAL_2="107" WEIGHT="80.32601229080082" Z="1.2315314347551236">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.016768438737610747" CI_START="-0.682163050891553" EFFECT_SIZE="-0.3494657448145819" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="2128" SD_1="0.74" SD_2="0.74" SE="0.16974664264305112" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" WEIGHT="50.71461988438"/>
<CONT_DATA CI_END="0.5300445866468196" CI_START="-0.4907906844003461" EFFECT_SIZE="0.01962695112323673" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="2129" SD_1="1.06" SD_2="0.95" SE="0.26042194629579524" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="30" WEIGHT="29.61139240642082"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.870667688769815" CI_END="0.48542843744780995" CI_START="-0.4531293567003395" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.016149540373735203" ESTIMABLE="YES" I2="38.40680186585033" I2_Q="0.0" ID="CMP-002.04" NO="4" P_CHI2="0.18151630391315032" P_Q="0.35475502116297675" P_Z="0.9462240492768237" Q="0.8563756320915141" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0873002987853054" TOTALS="YES" TOTAL_1="62" TOTAL_2="60" UNITS="" WEIGHT="99.99999999999999" Z="0.0674492667297593">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.013755466304865" CI_END="1.2800046884622645" CI_START="-1.297107484278834" DF="1.0" EFFECT_SIZE="-0.00855139790828468" ESTIMABLE="YES" I2="75.08567703252193" ID="CMP-002.04.01" NO="1" P_CHI2="0.04513060156989601" P_Z="0.9896220948950488" STUDIES="2" TAU2="0.6566431789617644" TOTAL_1="25" TOTAL_2="23" WEIGHT="41.4946837686195" Z="0.01300714194359821">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.09139355228844903" CI_START="-1.289069085767136" EFFECT_SIZE="-0.5988377667393435" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="2130" SD_1="0.5" SD_2="3.46" SE="0.35216530735883367" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="18" TOTAL_2="16" WEIGHT="27.12837762053198"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="2131" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="14.366306148087522"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.365903734355071E-4" CI_END="0.5835808754287097" CI_START="-0.32882044586794" DF="1.0" EFFECT_SIZE="0.12738021478038483" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.02" NO="2" P_CHI2="0.9815191197328236" P_Z="0.5841997316203573" STUDIES="2" TAU2="0.0" TOTAL_1="37" TOTAL_2="37" WEIGHT="58.50531623138048" Z="0.5472605694119959">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.806334763281386" CI_START="-0.5398754786632862" EFFECT_SIZE="0.13322964230904988" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="3.64" ORDER="2132" SD_1="3.87" SD_2="2.21" SE="0.34342729064498295" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="27.931763384291877"/>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="2133" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="30.573552847088607"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.41931335933598" CI_END="0.3491068172730246" CI_START="-0.7285110783204399" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.18970213052370763" ESTIMABLE="YES" I2="59.56499133137441" I2_Q="46.63197812492272" ID="CMP-002.05" NO="5" P_CHI2="0.05966832302946545" P_Q="0.17104283735952963" P_Z="0.49015781360359145" Q="1.873781273626327" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.17461189970138022" TOTALS="YES" TOTAL_1="75" TOTAL_2="75" UNITS="" WEIGHT="100.0" Z="0.6900578491455379">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.541693101685297" CI_END="1.2231042992052874" CI_START="-1.7709289848949696" DF="1.0" EFFECT_SIZE="-0.2739123428448411" ESTIMABLE="YES" I2="81.95497329695345" ID="CMP-002.05.01" NO="1" P_CHI2="0.018568714413643495" P_Z="0.7198802738612617" STUDIES="2" TAU2="0.9617613465931318" TOTAL_1="26" TOTAL_2="25" WEIGHT="41.31141744754935" Z="0.3586188101166741">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.2950921114738162" CI_START="-1.6685578394190954" EFFECT_SIZE="-0.9818249754464557" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="2134" SD_1="2.0" SD_2="1.86" SE="0.35038034851124855" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="18" WEIGHT="25.413481159167578"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="2135" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="15.897936288381775"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0038389840243560846" CI_END="0.345306014621407" CI_START="-0.4428310936790839" DF="1.0" EFFECT_SIZE="-0.04876253952883846" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" NO="2" P_CHI2="0.9505951046514809" P_Z="0.8083707432922298" STUDIES="2" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="58.688582552450654" Z="0.24252841355820373">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.4515005408034355" CI_START="-0.5695464736221744" EFFECT_SIZE="-0.059022966409369465" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="2136" SD_1="7.8" SD_2="5.4" SE="0.26047596345634366" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="30" WEIGHT="31.169797683456547"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="2137" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="27.518784868994107"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.7190981949568656" CI_END="0.34700259715586645" CI_START="-0.6949277564319417" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17396257963803766" ESTIMABLE="YES" I2="55.35115110757421" I2_Q="76.11226061302224" ID="CMP-002.06" NO="6" P_CHI2="0.08141099298671994" P_Q="0.0407533316853218" P_Z="0.5128037227066745" Q="4.186247948372811" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.15265404809530003" TOTALS="YES" TOTAL_1="72" TOTAL_2="72" UNITS="" WEIGHT="100.0" Z="0.6544782759695281">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.086329330052174" CI_END="0.33559583455680186" CI_START="-1.4355658244822935" DF="1.0" EFFECT_SIZE="-0.5499849949627458" ESTIMABLE="YES" I2="52.068928639612594" ID="CMP-002.06.01" NO="1" P_CHI2="0.1486228463526753" P_Z="0.2235187907908729" STUDIES="2" TAU2="0.22092430790982984" TOTAL_1="26" TOTAL_2="25" WEIGHT="41.93273143069452" Z="1.2172246126299318">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.23935213879871098" CI_START="-1.6030202832286704" EFFECT_SIZE="-0.9211862110136907" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="2138" SD_1="1.28" SD_2="1.48" SE="0.3478809190338189" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="18" WEIGHT="25.81581210025226"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="2139" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="16.11691933044226"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.44652091653188036" CI_END="0.4927442120318758" CI_START="-0.32181089331543866" DF="1.0" EFFECT_SIZE="0.0854666593582186" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.02" NO="2" P_CHI2="0.5039917885610605" P_Z="0.6808556006920365" STUDIES="2" TAU2="0.0" TOTAL_1="46" TOTAL_2="47" WEIGHT="58.067268569305476" Z="0.4112958672075037">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.9449855770700366" CI_START="-0.4064133842298303" EFFECT_SIZE="0.26928609642010315" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="21.5" ORDER="2140" SD_1="4.68" SD_2="5.17" SE="0.34475096786459586" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="26.021943598211955"/>
<CONT_DATA CI_END="0.49099376822442625" CI_START="-0.5298409600890152" EFFECT_SIZE="-0.019423595932294438" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="2141" SD_1="5.7" SD_2="4.4" SE="0.2604218078407704" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="30" WEIGHT="32.04532497109352"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.411033111354965" CI_END="0.11788918912399293" CI_START="-1.1475980489806772" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5148544299283421" ESTIMABLE="YES" I2="63.03848158306345" I2_Q="58.704587320964684" ID="CMP-002.07" NO="7" P_CHI2="0.06683597746134096" P_Q="0.11967464841004194" P_Z="0.11075816330339401" Q="2.4215764781730242" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1970128607287347" TOTALS="YES" TOTAL_1="63" TOTAL_2="62" UNITS="" WEIGHT="100.0" Z="1.5947946522981655">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.2520991943264308" CI_START="-1.6179547163506973" DF="0.0" EFFECT_SIZE="-0.9350269553385641" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" NO="1" P_CHI2="1.0" P_Z="0.007286155536610047" STUDIES="2" TAU2="0.0" TOTAL_1="26" TOTAL_2="25" WEIGHT="32.730719224060344" Z="2.6834743902073828">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.2520991943264308" CI_START="-1.6179547163506973" EFFECT_SIZE="-0.9350269553385641" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="2142" SD_1="0.97" SD_2="1.5" SE="0.34843893377581436" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="18" WEIGHT="32.730719224060344"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="2143" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.9894566331819408" CI_END="0.4944855091406544" CI_START="-1.1182999646583915" DF="1.0" EFFECT_SIZE="-0.31190722775886853" ESTIMABLE="YES" I2="66.54910498114126" ID="CMP-002.07.02" NO="2" P_CHI2="0.08380847512158651" P_Z="0.44839068119365144" STUDIES="2" TAU2="0.22565277876707515" TOTAL_1="37" TOTAL_2="37" WEIGHT="67.26928077593966" Z="0.758100742915404">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.04205136398922227" CI_START="-1.437631644300558" EFFECT_SIZE="-0.73984150414489" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.0" ORDER="2144" SD_1="1.38" SD_2="0.57" SE="0.356021919616762" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="32.19068227695867"/>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="2145" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="35.078598498980995"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.33271972777479164" CI_START="-0.6902712867517654" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17877577948848689" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.49331966333185884" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.6850384492725426">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33271972777479164" CI_START="-0.6902712867517654" DF="0.0" EFFECT_SIZE="-0.17877577948848689" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" NO="2" P_CHI2="1.0" P_Z="0.49331966333185884" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="30" WEIGHT="100.0" Z="0.6850384492725426">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33271972777479164" CI_START="-0.6902712867517654" EFFECT_SIZE="-0.17877577948848689" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="2146" SD_1="2.77" SD_2="2.64" SE="0.2609718909622267" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6062086425986872" CI_END="1.593043993000184" CI_START="0.7221317634276267" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.072561265328471" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="37" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.20222776930609598" LOG_CI_START="-0.14138355186452894" LOG_EFFECT_SIZE="0.030422108720783526" METHOD="MH" NO="9" P_CHI2="0.4564021776650762" P_Q="0.0" P_Z="0.7285490211797154" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="154" TOTAL_2="168" WEIGHT="100.00000000000001" Z="0.3470563031704615">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.383579215282375" CI_START="0.3950412961462407" DF="0.0" EFFECT_SIZE="1.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.7310711077496366" LOG_CI_START="-0.40335750247229735" LOG_EFFECT_SIZE="0.16385680263866959" NO="1" P_CHI2="1.0" P_Z="0.5712617964369362" STUDIES="2" TAU2="0.0" TOTAL_1="31" TOTAL_2="28" WEIGHT="9.174461594628552" Z="0.5661941684119748">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="5.383579215282375" CI_START="0.3950412961462407" EFFECT_SIZE="1.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7310711077496366" LOG_CI_START="-0.40335750247229735" LOG_EFFECT_SIZE="0.16385680263866959" ORDER="2147" O_E="0.0" SE="0.6663689811565504" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="21" VAR="0.444047619047619" WEIGHT="9.174461594628552"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2148" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3731366664317903" CI_END="1.7155841465701245" CI_START="0.6488872693864889" DF="2.0" EFFECT_SIZE="1.0550927505535417" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="34" I2="15.723353471792779" ID="CMP-002.09.02" LOG_CI_END="0.23441202434196803" LOG_CI_START="-0.18783074624413448" LOG_EFFECT_SIZE="0.023290639048916796" NO="2" P_CHI2="0.30526709909427185" P_Z="0.8288157190506338" STUDIES="3" TAU2="0.03373354150642231" TOTAL_1="123" TOTAL_2="140" WEIGHT="90.82553840537146" Z="0.21622069999889132">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7355428025204642" CI_START="0.5940538692923457" EFFECT_SIZE="1.0153846153846153" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="0.23943532885112112" LOG_CI_START="-0.22617417105309495" LOG_EFFECT_SIZE="0.006630578899013076" ORDER="2149" O_E="0.0" SE="0.27350132504793245" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="0.07480297480297479" WEIGHT="54.46170874713151"/>
<DICH_DATA CI_END="1.8786859091541048" CI_START="0.48799368912291585" EFFECT_SIZE="0.9574898785425101" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.2738541780125363" LOG_CI_START="-0.311585794384207" LOG_EFFECT_SIZE="-0.018865808185835366" ORDER="2150" O_E="0.0" SE="0.34389033776044836" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="43" VAR="0.11826056440499526" WEIGHT="34.448489635032985"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2151" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="1.9153400232069675"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.28583489168790055" CI_END="32.256649275704284" CI_START="1.7261261970297332" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="7.461839407491515" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="1.5086192521834336" LOG_CI_START="0.23707254379526255" LOG_EFFECT_SIZE="0.8728458979893481" METHOD="MH" NO="10" P_CHI2="0.962670163592673" P_Q="0.0" P_Z="0.007127836556983948" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="147" TOTAL_2="161" WEIGHT="100.0" Z="2.6908119266514534">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="86.78391364245633" CI_START="0.22308281785679604" DF="0.0" EFFECT_SIZE="4.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.10.01" LOG_CI_END="1.9384392313543566" LOG_CI_START="-0.6515338783819817" LOG_EFFECT_SIZE="0.6434526764861874" NO="1" P_CHI2="1.0" P_Z="0.3301228231805431" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="21" WEIGHT="24.10316788835076" Z="0.97386653701375">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="86.78391364245633" CI_START="0.22308281785679604" EFFECT_SIZE="4.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9384392313543566" LOG_CI_START="-0.6515338783819817" LOG_EFFECT_SIZE="0.6434526764861874" ORDER="2152" O_E="0.0" SE="1.5213630252327859" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="21" VAR="2.3145454545454545" WEIGHT="24.10316788835076"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.12406236667200901" CI_END="47.366762023756124" CI_START="1.6440635546339424" DF="2.0" EFFECT_SIZE="8.82462277631608" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="0" I2="0.0" ID="CMP-002.10.02" LOG_CI_END="1.6754736975149729" LOG_CI_START="0.21591860206858082" LOG_EFFECT_SIZE="0.9456961497917769" NO="2" P_CHI2="0.9398535858325426" P_Z="0.011089789636548353" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="140" WEIGHT="75.89683211164923" Z="2.5398566997475256">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="120.91754437237343" CI_START="0.2887699676100813" EFFECT_SIZE="5.909090909090909" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.082489318820394" LOG_CI_START="-0.5394479758511329" LOG_EFFECT_SIZE="0.7715206714846305" ORDER="2153" O_E="0.0" SE="1.540138945688983" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="2.372027972027972" WEIGHT="23.519063996716792"/>
<DICH_DATA CI_END="217.30721475112554" CI_START="0.7087406846785915" EFFECT_SIZE="12.41025641025641" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.3370741454396557" LOG_CI_START="-0.14951263620382899" LOG_EFFECT_SIZE="1.0937807546179132" ORDER="2154" O_E="0.0" SE="1.460633384340466" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="43" VAR="2.133449883449883" WEIGHT="26.149139058245296"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2155" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="26.228629056687144"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.922334267153442" CI_START="0.975953938215326" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3697115384615384" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-002.11" LOG_CI_END="0.2838289076602769" LOG_CI_START="-0.010570679106846358" LOG_EFFECT_SIZE="0.13662911427671529" METHOD="MH" NO="11" P_CHI2="1.0" P_Q="0.0" P_Z="0.06887856159438178" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0" Z="1.8192154830284855">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>AD+PT</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.922334267153442" CI_START="0.975953938215326" DF="0.0" EFFECT_SIZE="1.3697115384615384" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" ID="CMP-002.11.02" LOG_CI_END="0.2838289076602769" LOG_CI_START="-0.010570679106846358" LOG_EFFECT_SIZE="0.13662911427671529" NO="2" P_CHI2="1.0" P_Z="0.06887856159438178" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0" Z="1.8192154830284855">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.922334267153442" CI_START="0.975953938215326" EFFECT_SIZE="1.3697115384615384" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" LOG_CI_END="0.2838289076602769" LOG_CI_START="-0.010570679106846358" LOG_EFFECT_SIZE="0.13662911427671529" ORDER="2156" O_E="0.0" SE="0.17293177456846576" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="0.029905398655398655" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.12800704946084174" CI_START="-0.7972332051466381" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4626201273037399" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.12" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.006733333258300856" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="77" UNITS="" WEIGHT="100.0" Z="2.709752989583905">
<NAME>GlobalAvoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.12800704946084174" CI_START="-0.7972332051466381" DF="0.0" EFFECT_SIZE="-0.4626201273037399" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.02" NO="2" P_CHI2="1.0" P_Z="0.006733333258300856" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0" Z="2.709752989583905">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.12800704946084174" CI_START="-0.7972332051466381" EFFECT_SIZE="-0.4626201273037399" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="2157" SD_1="0.86" SD_2="0.86" SE="0.17072409517842338" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.2102028106118836" CI_START="0.2073225361360158" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.676923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.13" LOG_CI_END="0.344432126847261" LOG_CI_START="-0.6833534871605973" LOG_EFFECT_SIZE="-0.16946068015666813" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.518075126991647" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0" Z="0.6463153898555959">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2102028106118836" CI_START="0.2073225361360158" DF="0.0" EFFECT_SIZE="0.676923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-002.13.02" LOG_CI_END="0.344432126847261" LOG_CI_START="-0.6833534871605973" LOG_EFFECT_SIZE="-0.16946068015666813" NO="2" P_CHI2="1.0" P_Z="0.518075126991647" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="77" WEIGHT="100.0" Z="0.6463153898555959">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.2102028106118836" CI_START="0.2073225361360158" EFFECT_SIZE="0.676923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.344432126847261" LOG_CI_START="-0.6833534871605973" LOG_EFFECT_SIZE="-0.16946068015666813" ORDER="2158" O_E="0.0" SE="0.6037263572890573" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="77" VAR="0.3644855144855145" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9798144720119972" CI_END="1.3264151504285588" CI_START="0.7077989996230976" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9689351456925559" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="53" I2="0.0" I2_Q="0.0" ID="CMP-002.14" LOG_CI_END="0.12267947378365927" LOG_CI_START="-0.15009005551381274" LOG_EFFECT_SIZE="-0.013705290865076694" METHOD="MH" NO="14" P_CHI2="0.5766068702117526" P_Q="0.0" P_Z="0.8438615182278495" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="144" WEIGHT="100.0" Z="0.19695657768211786">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9968029561422322" CI_END="1.6030784836684495" CI_START="0.5356391640085082" DF="1.0" EFFECT_SIZE="0.9266453576380747" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" I2="0.0" ID="CMP-002.14.01" LOG_CI_END="0.2049547851050772" LOG_CI_START="-0.27112767644912267" LOG_EFFECT_SIZE="-0.033086445672022735" NO="1" P_CHI2="0.3180855853586052" P_Z="0.7852957059164661" STUDIES="2" TAU2="0.0" TOTAL_1="31" TOTAL_2="28" WEIGHT="32.82670882996023" Z="0.2724244101826591">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9152648783628645" CI_START="0.5756383946968203" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.28222884475706933" LOG_CI_START="-0.2398502466171931" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="2159" O_E="0.0" SE="0.30667184260642366" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="21" VAR="0.09404761904761907" WEIGHT="27.2972632061503"/>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2160" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="5.529445623809933"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9518896278233768" CI_END="1.4526850786147891" CI_START="0.6750882923472418" DF="1.0" EFFECT_SIZE="0.9902982828624801" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="39" I2="0.0" ID="CMP-002.14.02" LOG_CI_END="0.16217147565830967" LOG_CI_START="-0.17063942365549614" LOG_EFFECT_SIZE="-0.004233973998593232" NO="2" P_CHI2="0.3292389537095787" P_Z="0.9602269572952239" STUDIES="2" TAU2="0.0" TOTAL_1="97" TOTAL_2="116" WEIGHT="67.17329117003976" Z="0.04986877873189643">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4033871339605217" CI_START="0.4848212960182729" EFFECT_SIZE="0.8248587570621468" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.1471774906653899" LOG_CI_START="-0.3144183118201291" LOG_EFFECT_SIZE="-0.08362041057736955" ORDER="2161" O_E="0.0" SE="0.27114365931606715" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="73" VAR="0.07351888398730748" WEIGHT="34.91949920646005"/>
<DICH_DATA CI_END="2.0982616546326707" CI_START="0.6943325433071542" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.3218596440470759" LOG_CI_START="-0.15843247892103612" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="2162" O_E="0.0" SE="0.2821259705158213" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="43" VAR="0.07959506323949407" WEIGHT="32.25379196357971"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.2270697525064634" CI_END="0.39671310538576765" CI_START="-0.21326299772060542" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09172505383258113" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.15" NO="15" P_CHI2="0.6337051466345583" P_Q="0.6337051466345583" P_Z="0.5555537406595485" Q="0.2270697525064634" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="77" TOTAL_2="90" UNITS="" WEIGHT="100.00000000000001" Z="0.5894585085426058">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6115874600766734" CI_START="-0.7143776839589334" DF="0.0" EFFECT_SIZE="-0.05139511194112999" ESTIMABLE="YES" I2="0.0" ID="CMP-002.15.01" NO="1" P_CHI2="1.0" P_Z="0.8792354530956208" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="17" WEIGHT="21.16222982338672" Z="0.15193848622511638">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.6115874600766733" CI_START="-0.7143776839589333" EFFECT_SIZE="-0.05139511194112999" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="2163" SD_1="2.39" SD_2="2.16" SE="0.3382626299500017" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="18" TOTAL_2="17" WEIGHT="21.16222982338672"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.47363368471154693" CI_START="-0.2133487849491587" DF="0.0" EFFECT_SIZE="0.1301424498811941" ESTIMABLE="YES" I2="0.0" ID="CMP-002.15.02" NO="2" P_CHI2="1.0" P_Z="0.4577275552106522" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="73" WEIGHT="78.83777017661329" Z="0.7425939551352118">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.47363368471154693" CI_START="-0.2133487849491587" EFFECT_SIZE="0.1301424498811941" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="2164" SD_1="0.9" SD_2="0.93" SE="0.1752538503461124" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="73" WEIGHT="78.83777017661329"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>PD+/-AGORAPHOBIA: Psychotherapy+Antidepressant vs Psychotherapy+Placebo</NAME>
<DICH_OUTCOME CHI2="18.1867182743175" CI_END="1.3209391368323398" CI_START="1.038562010539533" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1712716191169963" ESTIMABLE="YES" EVENTS_1="319" EVENTS_2="232" I2="12.023710057715519" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.1208828076623658" LOG_CI_START="0.01643243253325451" LOG_EFFECT_SIZE="0.06865762009781014" METHOD="MH" NO="1" P_CHI2="0.3130772027854677" P_Q="0.0" P_Z="0.009976051623593203" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0074874218284672325" TOTALS="YES" TOTAL_1="550" TOTAL_2="482" WEIGHT="100.0" Z="2.5766582932728297">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.275095031165535" CI_END="1.4796336678168895" CI_START="1.0343753885940568" DF="9.0" EFFECT_SIZE="1.237132430310088" ESTIMABLE="YES" EVENTS_1="150" EVENTS_2="105" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.17015420476064413" LOG_CI_START="0.014678178611556906" LOG_EFFECT_SIZE="0.0924161916861005" NO="1" P_CHI2="0.9523827840188018" P_Z="0.019804222479937513" STUDIES="10" TAU2="0.0" TOTAL_1="282" TOTAL_2="245" WEIGHT="40.26190055329612" Z="2.330036492178128">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.2788428320054854" CI_START="0.8806857657130492" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.3577143736461554" LOG_CI_START="-0.05517902298485715" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="2165" O_E="0.0" SE="0.242535625036333" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="0.05882352941176471" WEIGHT="5.676883139136611"/>
<DICH_DATA CI_END="2.3824152363315836" CI_START="0.3902959167635606" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3770174578735022" LOG_CI_START="-0.40860599223996596" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="2166" O_E="0.0" SE="0.46147910349544863" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="27" VAR="0.21296296296296297" WEIGHT="1.7075929415679403"/>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="2167" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="6.195985011595068"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="2168" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="3.825740471512613"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="2169" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="2.621471914299962"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="2170" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="2.7191567271421992"/>
<DICH_DATA CI_END="3.3551459414051803" CI_START="0.7112931338260449" EFFECT_SIZE="1.5448275862068965" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.5257114157623739" LOG_CI_START="-0.14795138356399803" LOG_EFFECT_SIZE="0.18888001609918792" ORDER="2171" O_E="0.0" SE="0.3957128630089486" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.15658866995073892" WEIGHT="2.2942984377172366"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="2172" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="0.6878987357722411"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="2173" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="6.601220068060696"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="2174" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="7.931653106491558"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.482644118336154" CI_END="1.4685763971679546" CI_START="0.9308737930972361" DF="6.0" EFFECT_SIZE="1.169213103452406" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="127" I2="58.57110102979377" ID="CMP-003.01.02" LOG_CI_END="0.16689654398476922" LOG_CI_START="-0.031109196222617857" LOG_EFFECT_SIZE="0.06789367388107563" NO="2" P_CHI2="0.02468574144928537" P_Z="0.1789180185548311" STUDIES="7" TAU2="0.051545316489113015" TOTAL_1="268" TOTAL_2="237" WEIGHT="59.738099446703885" Z="1.3440939181423952">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.405738419462645" CI_START="0.7842853156289488" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="36" LOG_CI_END="0.14790451445838393" LOG_CI_START="-0.10552591631850775" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="2175" O_E="0.0" SE="0.14886628953921086" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="0.02216117216117216" WEIGHT="12.696707343603823"/>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="2176" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="3.774563567118667"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="2177" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="1.9036405734503905"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="2178" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="9.683903868631448"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="2179" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="9.915798265319383"/>
<DICH_DATA CI_END="1.1613405535679442" CI_START="0.6663598931130817" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="28" LOG_CI_END="0.0649595917006089" LOG_CI_START="-0.1762911501424572" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="2180" O_E="0.0" SE="0.14171187996904913" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.02008225692436219" WEIGHT="13.654113434207112"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="2181" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="8.10937239437306"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.334791390926558" CI_END="1.5401574232759674" CI_START="1.1031350084621254" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3034575452075683" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="163" I2="19.237562862579743" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.18756511341173773" LOG_CI_START="0.04262866732868075" LOG_EFFECT_SIZE="0.11509689037020927" METHOD="MH" NO="2" P_CHI2="0.2387755588812276" P_Q="0.0" P_Z="0.0018526372940144535" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.01906644434167627" TOTALS="YES" TOTAL_1="509" TOTAL_2="443" WEIGHT="100.0" Z="3.1128921117451918">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.83574836545465" CI_END="1.9144938710532586" CI_START="1.1020308418952833" DF="7.0" EFFECT_SIZE="1.4525258319631298" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="48" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.28205398036142365" LOG_CI_START="0.04219374903255363" LOG_EFFECT_SIZE="0.1621238646969886" NO="1" P_CHI2="0.7984898333026074" P_Z="0.008060680625148791" STUDIES="8" TAU2="0.0" TOTAL_1="241" TOTAL_2="206" WEIGHT="30.211552879273242" Z="2.6495174634003327">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7760532777287243" CI_START="0.7354072455810021" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.24945598952622056" LOG_CI_START="-0.13347209557084708" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="2182" O_E="0.0" SE="0.22493385271060937" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="0.0505952380952381" WEIGHT="10.40486526666868"/>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="2183" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="6.859428818180267"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="2184" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="2.4648185263986933"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="2185" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="2.9697667860922943"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="2186" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="1.1753485844154041"/>
<DICH_DATA CI_END="10.324319187650293" CI_START="0.6478360451866196" EFFECT_SIZE="2.586206896551724" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0138614227695817" LOG_CI_START="-0.18853489178409377" LOG_EFFECT_SIZE="0.41266326549274396" ORDER="2187" O_E="0.0" SE="0.706293547126578" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="15" VAR="0.4988505747126437" WEIGHT="1.399491411440823"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="2188" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="2.0192125968598518"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="2189" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="2.9186208892172307"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.524540168114612" CI_END="1.603971627964789" CI_START="0.988334838735707" DF="6.0" EFFECT_SIZE="1.2590714992649263" ESTIMABLE="YES" EVENTS_1="163" EVENTS_2="115" I2="47.93718523711314" ID="CMP-003.02.02" LOG_CI_END="0.205196681948575" LOG_CI_START="-0.0050958955143766095" LOG_EFFECT_SIZE="0.10005039321709921" NO="2" P_CHI2="0.07345614759334718" P_Z="0.06218495183028897" STUDIES="7" TAU2="0.04650251837425562" TOTAL_1="268" TOTAL_2="237" WEIGHT="69.78844712072676" Z="1.8649746910742209">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3596367630862805" CI_START="0.8013105366748134" EFFECT_SIZE="1.0437869822485206" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="39" LOG_CI_END="0.13342289891606454" LOG_CI_START="-0.09619914655180982" LOG_EFFECT_SIZE="0.01861187618212735" ORDER="2190" O_E="0.0" SE="0.13488112615528605" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="0.01819291819291819" WEIGHT="19.453376834683496"/>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="2191" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="7.43777317450122"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="2192" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="6.678370020268442"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="2193" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="6.453149550072615"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="2194" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="12.286511213018361"/>
<DICH_DATA CI_END="1.2593122473288383" CI_START="0.6568207241896857" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.10013342707255969" LOG_CI_START="-0.1825531526924686" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="2195" O_E="0.0" SE="0.16605149627511545" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.02757309941520468" WEIGHT="15.54089859420243"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="2196" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="1.9383677339801897"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.856223319561412" CI_END="-0.26414750723237873" CI_START="-0.6316544584923258" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.44790098286235225" ESTIMABLE="YES" I2="0.0" I2_Q="58.23469555386895" ID="CMP-003.03" NO="3" P_CHI2="0.44400201098244385" P_Q="0.12177595421228415" P_Z="1.7754777240859676E-6" Q="2.394331882076429" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="228" UNITS="" WEIGHT="99.99999999999997" Z="4.777432329051989">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9415253363534641" CI_END="-0.33416496529208883" CI_START="-0.8763913119591002" DF="4.0" EFFECT_SIZE="-0.6052781386255945" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" NO="1" P_CHI2="0.9185292429318471" P_Z="1.2101588913552376E-5" STUDIES="5" TAU2="0.0" TOTAL_1="113" TOTAL_2="108" WEIGHT="45.937767351011956" Z="4.375749572582628">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.10324502923296297" CI_START="-1.1946894827465975" EFFECT_SIZE="-0.5457222267568173" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="2197" SD_1="0.84" SD_2="1.05" SE="0.3311118271094526" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" WEIGHT="8.017252378488276"/>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="2198" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="6.473798494775479"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="2199" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="6.530115639487869"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="2200" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="11.165275380633979"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="2201" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="13.751325457626358"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.5203661011315193" CI_END="-0.002359014224033007" CI_START="-0.6895730144915371" DF="2.0" EFFECT_SIZE="-0.345966014357785" ESTIMABLE="YES" I2="43.18772699926982" ID="CMP-003.03.02" NO="2" P_CHI2="0.17201342292147348" P_Z="0.04844773023423201" STUDIES="3" TAU2="0.0401903956016799" TOTAL_1="136" TOTAL_2="120" WEIGHT="54.06223264898802" Z="1.9734200052739819">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.19529107569046827" CI_START="-0.4987734411178169" EFFECT_SIZE="-0.15174118271367432" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="2202" SD_1="0.74" SD_2="0.7" SE="0.17706052822474735" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" WEIGHT="28.03699289880722"/>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="2203" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="12.572050220148109"/>
<CONT_DATA CI_END="0.24831608080499845" CI_START="-0.7536497876075283" EFFECT_SIZE="-0.25266685340126493" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="2204" SD_1="1.06" SD_2="1.33" SE="0.2556082347216341" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="33" WEIGHT="13.453189530032697"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.9164799883028" CI_END="0.1543925022406855" CI_START="-0.2746421989405618" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.06012484834993816" ESTIMABLE="YES" I2="10.278495432111063" I2_Q="63.986648781137546" ID="CMP-003.04" NO="4" P_CHI2="0.34939063181348307" P_Q="0.09564228047227474" P_Z="0.5827735003272174" Q="2.7767479730579403" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.01118161475821317" TOTALS="YES" TOTAL_1="198" TOTAL_2="195" UNITS="" WEIGHT="100.0" Z="0.5493380233223992">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.902936687389026" CI_END="0.3172229785640912" CI_START="-0.18637294584948805" DF="6.0" EFFECT_SIZE="0.0654250163573016" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.01" NO="1" P_CHI2="0.4341507578675896" P_Z="0.6105698668505753" STUDIES="7" TAU2="0.0" TOTAL_1="124" TOTAL_2="124" WEIGHT="65.36255320893079" Z="0.5092601807593079">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.36599518583474056" CI_START="-0.9304999416148811" EFFECT_SIZE="-0.2822523778900703" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="2205" SD_1="0.5" SD_2="1.57" SE="0.3307446304310206" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="18" TOTAL_2="19" WEIGHT="9.93519391080581"/>
<CONT_DATA CI_END="0.4017416085839796" CI_START="-1.088391349315334" EFFECT_SIZE="-0.3433248703656772" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="1.07" ORDER="2206" SD_1="0.93" SD_2="1.75" SE="0.38014294386358427" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="7.694265856226854"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="2207" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.446659085548545"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="2208" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.459499733999076"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="2209" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.362581397314612"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="2210" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="8.71156900507164"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="2211" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="16.752784219964255"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2367953278558337" CI_END="0.04169948370716947" CI_START="-0.6132904782918016" DF="1.0" EFFECT_SIZE="-0.28579549729231607" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.02" NO="2" P_CHI2="0.6265303649209744" P_Z="0.08719110375743694" STUDIES="2" TAU2="0.0" TOTAL_1="74" TOTAL_2="71" WEIGHT="34.63744679106921" Z="1.710404476817109">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="2212" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="10.258306137310793"/>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="2213" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="24.379140653758412"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.775768904915754" CI_END="-0.15039559146963544" CI_START="-0.5427269961063664" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.34656129378800093" ESTIMABLE="YES" I2="25.435810001183984" I2_Q="0.0" ID="CMP-003.05" NO="5" P_CHI2="0.17369544794685987" P_Q="0.48191163727427977" P_Z="5.349395625166044E-4" Q="0.4945343244238103" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03744293867561475" TOTALS="YES" TOTAL_1="305" TOTAL_2="277" UNITS="" WEIGHT="100.0" Z="3.4626218866624674">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="17.726487724868694" CI_END="-0.11239590132679006" CI_START="-0.719877481230885" DF="9.0" EFFECT_SIZE="-0.41613669127883757" ESTIMABLE="YES" I2="49.228520958645426" ID="CMP-003.05.01" NO="1" P_CHI2="0.03848271474586207" P_Z="0.007248059071902113" STUDIES="10" TAU2="0.11524947587392698" TOTAL_1="189" TOTAL_2="175" WEIGHT="63.25052295048411" Z="2.685226859655393">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.2487905121670344" CI_START="-1.5937461474749637" EFFECT_SIZE="-0.921268329820999" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="2214" SD_1="2.0" SD_2="1.28" SE="0.34310723205037635" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.455869990579941"/>
<CONT_DATA CI_END="0.21869047113718676" CI_START="-1.2886598659887283" EFFECT_SIZE="-0.5349846974257708" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.5" ORDER="2215" SD_1="8.36" SD_2="9.55" SE="0.3845352131507778" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="5.405681912288682"/>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="2216" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="7.914028637637071"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="2217" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.932178017879898"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="2218" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.966463282655497"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="2219" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="5.1017310100870015"/>
<CONT_DATA CI_END="-0.36766554192815826" CI_START="-2.0287561923899347" EFFECT_SIZE="-1.1982108671590466" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.9" ORDER="2220" SD_1="1.18" SD_2="1.27" SE="0.4237554015186625" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="4.616013454311197"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="2221" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="3.8319424184770736"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="2222" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="7.8317290726994395"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="2223" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="10.194885153868304"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.5547468556232514" CI_END="0.008692373918626817" CI_START="-0.5315121056963064" DF="4.0" EFFECT_SIZE="-0.26140986588883974" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.02" NO="2" P_CHI2="0.9679571614973909" P_Z="0.05784261165065085" STUDIES="5" TAU2="0.0" TOTAL_1="116" TOTAL_2="102" WEIGHT="36.74947704951589" Z="1.8968888325797895">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="2224" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="9.664687330185641"/>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="2225" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.929910867112814"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="2226" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="5.50489820439615"/>
<CONT_DATA CI_END="0.2384708261460381" CI_START="-0.7638358214027273" EFFECT_SIZE="-0.2626824976283446" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="2227" SD_1="7.8" SD_2="10.6" SE="0.25569516977220813" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="33" WEIGHT="9.742263622656534"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="2228" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.907717025164753"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.45598267754362" CI_END="-0.29286381274468115" CI_START="-0.648009215464223" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.47043651410445203" ESTIMABLE="YES" I2="10.820337038434776" I2_Q="75.39371569826173" ID="CMP-003.06" NO="6" P_CHI2="0.33678690024140234" P_Q="0.04380664626478836" P_Z="2.075367598848427E-7" Q="4.064002462693471" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.011489455583603411" TOTALS="YES" TOTAL_1="313" TOTAL_2="282" UNITS="" WEIGHT="100.0" Z="5.192457047714786">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.08789258168987" CI_END="-0.3759488573339074" CI_START="-0.9646745339400615" DF="6.0" EFFECT_SIZE="-0.6703116956369845" ESTIMABLE="YES" I2="25.81503847388672" ID="CMP-003.06.01" NO="1" P_CHI2="0.23173461457446054" P_Z="8.076183267395167E-6" STUDIES="7" TAU2="0.04042621745158504" TOTAL_1="142" TOTAL_2="128" WEIGHT="45.504892824466474" Z="4.463154348687808">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.21268043942573156" CI_START="-1.551714140417673" EFFECT_SIZE="-0.8821972899217023" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="2229" SD_1="1.28" SD_2="1.36" SE="0.3415965067608559" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.40389182432901"/>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="2230" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="8.017271891833225"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="2231" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.510156527577647"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="2232" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.7909756058257615"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="2233" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="4.449597804624933"/>
<CONT_DATA CI_END="-0.466210138361711" CI_START="-2.154071253344198" EFFECT_SIZE="-1.3101406958529547" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="2.02" ORDER="2234" SD_1="0.56" SD_2="1.05" SE="0.43058472714195783" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="4.168950019291961"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="2235" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.164049150983933"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.3040876331602789" CI_END="-0.0946801393750917" CI_START="-0.5364277517513072" DF="5.0" EFFECT_SIZE="-0.31555394556319943" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.02" NO="2" P_CHI2="0.9345105113806913" P_Z="0.005108274840850469" STUDIES="6" TAU2="0.0" TOTAL_1="171" TOTAL_2="154" WEIGHT="54.49510717553353" Z="2.8001254614893467">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="2236" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="10.46962608978393"/>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="2237" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="7.015786255061215"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="2238" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="5.316838471048737"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="2239" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="16.52671059163544"/>
<CONT_DATA CI_END="0.23280883724610318" CI_START="-0.7696998436263476" EFFECT_SIZE="-0.2684455031901222" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="2240" SD_1="5.7" SD_2="6.7" SE="0.2557467098324539" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="33" WEIGHT="10.674644064342472"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="2241" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.4915017036617435"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.424593963129896" CI_END="-0.18839994503781374" CI_START="-0.6032024142297466" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3958011796337802" ESTIMABLE="YES" I2="11.465919669949715" I2_Q="0.0" ID="CMP-003.07" NO="7" P_CHI2="0.33258831237946407" P_Q="0.9358459913816415" P_Z="1.837541427859952E-4" Q="0.006478955475422765" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.015361279180293771" TOTALS="YES" TOTAL_1="232" TOTAL_2="204" UNITS="" WEIGHT="100.0" Z="3.7403637381036328">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="11.397669445812157" CI_END="-0.13045888278110546" CI_START="-0.6803408291053878" DF="8.0" EFFECT_SIZE="-0.4053998559432467" ESTIMABLE="YES" I2="29.81021218386503" ID="CMP-003.07.01" NO="1" P_CHI2="0.1801686185841075" P_Z="0.003852877181203042" STUDIES="9" TAU2="0.05193875917002589" TOTAL_1="164" TOTAL_2="154" WEIGHT="73.40433733415222" Z="2.889962553954836">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.059248723983806206" CI_START="-1.3759140534601089" EFFECT_SIZE="-0.7175813887219575" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="2242" SD_1="0.97" SD_2="1.37" SE="0.3358901846824714" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" WEIGHT="8.735633048431138"/>
<CONT_DATA CI_END="0.4639401327102852" CI_START="-1.0220729437718097" EFFECT_SIZE="-0.27906640553076223" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2243" SD_1="0.51" SD_2="0.8" SE="0.37909193439358485" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="7.039354266745989"/>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="2244" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="10.736600956757325"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="2245" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.399055741764769"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="2246" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.649529371942707"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="2247" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="6.564500195093578"/>
<CONT_DATA CI_END="-0.42277473134623855" CI_START="-2.098561793622174" EFFECT_SIZE="-1.2606682624842063" ESTIMABLE="YES" MEAN_1="45.41" MEAN_2="57.68" ORDER="2248" SD_1="9.04" SD_2="10.07" SE="0.42750455505670765" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="5.651907587162656"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="2249" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.943111182875814"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="2250" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="14.684644983378243"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0204455618423156" CI_END="-0.012049880723555617" CI_START="-0.7577513683968898" DF="2.0" EFFECT_SIZE="-0.3849006245602227" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.02" NO="2" P_CHI2="0.6003618872256332" P_Z="0.043041549362263634" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="50" WEIGHT="26.595662665847783" Z="2.0233065757151394">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="2251" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="13.425244019005495"/>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="2252" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="7.052795364266228"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="2253" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="6.1176232825760595"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.707488942936381" CI_END="-0.10216076988835637" CI_START="-0.6466321224648801" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3743964461766182" ESTIMABLE="YES" I2="38.80668525457256" I2_Q="80.16774609823524" ID="CMP-003.08" NO="8" P_CHI2="0.09929056135109748" P_Q="0.02473578323187875" P_Z="0.007028905661368686" Q="5.042291234033746" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.07306829797174691" TOTALS="YES" TOTAL_1="192" TOTAL_2="182" UNITS="" WEIGHT="100.00000000000001" Z="2.695471660624521">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.703334404582302" CI_END="-0.25598904826503266" CI_START="-0.8365255246944099" DF="6.0" EFFECT_SIZE="-0.5462572864797213" ESTIMABLE="YES" I2="22.111650814082264" ID="CMP-003.08.01" NO="1" P_CHI2="0.26065348458644555" P_Z="2.256099215856378E-4" STUDIES="7" TAU2="0.0337989427769667" TOTAL_1="137" TOTAL_2="123" WEIGHT="69.21172713289926" Z="3.6884662764961584">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8873607300917461" CI_START="-0.6116126107138591" EFFECT_SIZE="0.13787405968894345" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.0" ORDER="2254" SD_1="0.62" SD_2="0.76" SE="0.3823981850251626" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="8.797552320500266"/>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="2255" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="9.28898356084621"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="2256" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="9.362792410426371"/>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="2257" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="8.305491078682136"/>
<CONT_DATA CI_END="-0.38927353848264634" CI_START="-2.056043178938999" EFFECT_SIZE="-1.2226583587108226" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.0" ORDER="2258" SD_1="1.4" SD_2="1.03" SE="0.42520415007714907" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="7.599549906487745"/>
<CONT_DATA CI_END="0.26110133948943387" CI_START="-0.9235736714263485" EFFECT_SIZE="-0.33123616596845734" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.4" ORDER="2259" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="11.734931660593809"/>
<CONT_DATA CI_END="-0.2834851042937671" CI_START="-1.2716052532915705" EFFECT_SIZE="-0.7775451787926688" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.9" ORDER="2260" SD_1="0.89" SD_2="0.89" SE="0.2520760985385367" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="14.12242619536271"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9618633043203326" CI_END="0.33101702389252075" CI_START="-0.40774746793583516" DF="2.0" EFFECT_SIZE="-0.0383652220216572" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.02" NO="2" P_CHI2="0.3749616957914771" P_Z="0.8386909995340543" STUDIES="3" TAU2="0.0" TOTAL_1="55" TOTAL_2="59" WEIGHT="30.788272867100755" Z="0.20356813098916973">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="2261" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.924215979177543"/>
<CONT_DATA CI_END="0.23497230444474243" CI_START="-0.7674586568133865" EFFECT_SIZE="-0.2662431761843221" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="2262" SD_1="2.77" SD_2="2.58" SE="0.2557268830359069" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="33" WEIGHT="13.933343318610032"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="2263" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.93071356931318"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.997265050536276" CI_END="1.5048249889236498" CI_START="0.9421136497504158" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1906788662567622" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="92" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="0.17748599443861518" LOG_CI_START="-0.02589670391381821" LOG_EFFECT_SIZE="0.07579464526239849" METHOD="MH" NO="9" P_CHI2="0.8312258066880076" P_Q="0.0" P_Z="0.14405939777315235" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="508" TOTAL_2="442" WEIGHT="100.00000000000001" Z="1.4608398466408985">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.4162249363033186" CI_END="1.5835948168456255" CI_START="0.8834926835725843" DF="7.0" EFFECT_SIZE="1.1828332234201815" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="55" I2="0.0" ID="CMP-003.09.01" LOG_CI_END="0.19964407162334238" LOG_CI_START="-0.05379704264528802" LOG_EFFECT_SIZE="0.07292351448902722" NO="1" P_CHI2="0.8440176583856283" P_Z="0.2593643534895742" STUDIES="8" TAU2="0.0" TOTAL_1="240" TOTAL_2="205" WEIGHT="64.39822117557124" Z="1.1278948361400012">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.0129912117180666" CI_START="0.3318960892122153" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4789978649266212" LOG_CI_START="-0.47899786492662116" LOG_EFFECT_SIZE="0.0" ORDER="2264" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="0.31666666666666665" WEIGHT="4.507138081724489"/>
<DICH_DATA CI_END="2.9619712520075643" CI_START="0.9320516049237294" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.47158083907544335" LOG_CI_START="-0.030560041387254936" LOG_EFFECT_SIZE="0.22051039884409415" ORDER="2265" O_E="0.0" SE="0.29496003882123506" STUDY_ID="STD-Johnston-1995" TOTAL_1="26" TOTAL_2="27" VAR="0.0870014245014245" WEIGHT="16.405023259391793"/>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="2266" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="15.380608703884816"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2267" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="3.7760589913030365"/>
<DICH_DATA CI_END="8.748921872143878" CI_START="0.5394243722180654" EFFECT_SIZE="2.1724137931034484" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9419545382992105" LOG_CI_START="-0.2680694351899591" LOG_EFFECT_SIZE="0.33694255155462566" ORDER="2268" O_E="0.0" SE="0.7107740717428078" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.5051997810618502" WEIGHT="2.8251405603268713"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="2269" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="2.8183876105973393"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="2270" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="11.768235039223434"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="2271" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="6.917628929119455"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.596667181863762" CI_END="1.78409886180577" CI_START="0.8138741505268707" DF="6.0" EFFECT_SIZE="1.2050028819916274" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="37" I2="0.0" ID="CMP-003.09.02" LOG_CI_END="0.2514189161539597" LOG_CI_START="-0.08944274493539874" LOG_EFFECT_SIZE="0.08098808560928049" NO="2" P_CHI2="0.46985105817119044" P_Z="0.3516635244645091" STUDIES="7" TAU2="0.0" TOTAL_1="268" TOTAL_2="237" WEIGHT="35.60177882442878" Z="0.9313674671638921">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6864084609185699" CI_START="0.5570467094976399" EFFECT_SIZE="0.9692307692307692" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="0.22696277244672497" LOG_CI_START="-0.2541083868252727" LOG_EFFECT_SIZE="-0.01357280718927387" ORDER="2272" O_E="0.0" SE="0.2825835802970156" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="0.07985347985347985" WEIGHT="17.87349023693037"/>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="2273" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="3.971924916045458"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2274" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="1.928053512737698"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2275" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="1.198898729738714"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2276" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="4.893464203015159"/>
<DICH_DATA CI_END="7.442416182256396" CI_START="0.911988251619899" EFFECT_SIZE="2.6052631578947367" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.8717139522487574" LOG_CI_START="-0.04001075628727795" LOG_EFFECT_SIZE="0.41585159798073973" ORDER="2277" O_E="0.0" SE="0.5355516069041609" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.28681552365762897" WEIGHT="4.976231322296925"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="2278" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="0.7597159036644539"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.641968342758994" CI_END="4.814791107726219" CI_START="1.2265295674757777" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.4301200906222022" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-003.10" LOG_CI_END="0.6825774497721273" LOG_CI_START="0.08867802203836571" LOG_EFFECT_SIZE="0.38562773590524657" METHOD="MH" NO="10" P_CHI2="0.6872654804153506" P_Q="0.0" P_Z="0.01091940342560472" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="352" TOTAL_2="313" WEIGHT="100.00000000000001" Z="2.545267560529897">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.014795456855614" CI_END="4.406014788477034" CI_START="0.7681397830834091" DF="3.0" EFFECT_SIZE="1.839683462958517" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" I2="0.0" ID="CMP-003.10.01" LOG_CI_END="0.6440459504959093" LOG_CI_START="-0.11455974155984303" LOG_EFFECT_SIZE="0.2647431044680331" NO="1" P_CHI2="0.5693415745029891" P_Z="0.1713115343070701" STUDIES="4" TAU2="0.0" TOTAL_1="114" TOTAL_2="107" WEIGHT="61.29056425028833" Z="1.3680017309296313">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="98.96498619891642" CI_START="0.25261459593144187" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9954815684331297" LOG_CI_START="-0.5975415597610922" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="2279" O_E="0.0" SE="1.5231546211727816" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="2.32" WEIGHT="5.245815750574365"/>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="2280" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="15.647518981713247"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="2281" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="10.374675609004775"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="2282" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="30.022553908995935"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.5307154973035906" CI_END="11.3321347715311" CI_START="1.2581979496086126" DF="4.0" EFFECT_SIZE="3.775985796348934" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="2" I2="0.0" ID="CMP-003.10.02" LOG_CI_END="1.0543117308840708" LOG_CI_START="0.09974897311222794" LOG_EFFECT_SIZE="0.5770303519981492" NO="2" P_CHI2="0.639144387674487" P_Z="0.017808070116389695" STUDIES="5" TAU2="0.0" TOTAL_1="238" TOTAL_2="206" WEIGHT="38.70943574971169" Z="2.3695848150261942">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="99.03745489683193" CI_START="0.23736277704708192" EFFECT_SIZE="4.848484848484849" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9957994711503544" LOG_CI_START="-0.6245873855942797" LOG_EFFECT_SIZE="0.6856060427780373" ORDER="2283" O_E="0.0" SE="1.5392282107759345" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="2.3692234848484848" WEIGHT="5.13682758049768"/>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="2284" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="5.857360046630628"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2285" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="16.440570626010608"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2286" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="5.5586444302758355"/>
<DICH_DATA CI_END="182.20894542331035" CI_START="0.5977091576901139" EFFECT_SIZE="10.435897435897436" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.260569694550349" LOG_CI_START="-0.2235100901529073" LOG_EFFECT_SIZE="1.0185298021987208" ORDER="2287" O_E="0.0" SE="1.4591607619279408" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="2.129150129150129" WEIGHT="5.7160330662969345"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.3954905030385807" CI_END="1.6731660991685746" CI_START="0.9310055691179692" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.24808932227839" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="51" I2="16.509792150581156" I2_Q="0.0" ID="CMP-003.11" LOG_CI_END="0.22353905654618927" LOG_CI_START="-0.03104772113469484" LOG_EFFECT_SIZE="0.09624566770574715" METHOD="MH" NO="11" P_CHI2="0.30187415638584403" P_Q="0.0" P_Z="0.13836278776313962" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.012718270331925446" TOTALS="YES" TOTAL_1="119" TOTAL_2="110" WEIGHT="100.0" Z="1.4819154717274883">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6579743283184165" CI_END="3.613872802581938" CI_START="0.7408556822095642" DF="1.0" EFFECT_SIZE="1.636263487515208" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="19" I2="39.6854352374539" ID="CMP-003.11.01" LOG_CI_END="0.5579728626386027" LOG_CI_START="-0.1302663838213139" LOG_EFFECT_SIZE="0.2138532394086443" NO="1" P_CHI2="0.1978771184070084" P_Z="0.22321632491894905" STUDIES="2" TAU2="0.17335127459783908" TOTAL_1="54" TOTAL_2="47" WEIGHT="43.72123789750419" Z="1.2180201852019086">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2288" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="4.515043121268499"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="2289" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="39.20619477623569"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5466635576573329" CI_START="0.812011208981033" DF="0.0" EFFECT_SIZE="1.1206730769230768" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" ID="CMP-003.11.02" LOG_CI_END="0.18939585284365273" LOG_CI_START="-0.09043797572802253" LOG_EFFECT_SIZE="0.049478938557815114" NO="2" P_CHI2="1.0" P_Z="0.48824445113570736" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="63" WEIGHT="56.278762102495804" Z="0.6931037470457123">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.5466635576573329" CI_START="0.812011208981033" EFFECT_SIZE="1.1206730769230768" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" LOG_CI_END="0.18939585284365273" LOG_CI_START="-0.09043797572802253" LOG_EFFECT_SIZE="0.049478938557815114" ORDER="2290" O_E="0.0" SE="0.16437577610279372" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="0.02701939576939577" WEIGHT="56.278762102495804"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.339050209148512" CI_END="-0.31011345714060096" CI_START="-1.2185636980499446" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.7643385775952728" ESTIMABLE="YES" I2="52.67429818318204" I2_Q="77.78206171167668" ID="CMP-003.12" NO="12" P_CHI2="0.09623083299933866" P_Q="0.03387770660337219" P_Z="9.734435007984462E-4" Q="4.500867663880188" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.10799597807374146" TOTALS="YES" TOTAL_1="116" TOTAL_2="113" UNITS="" WEIGHT="100.0" Z="3.2980916656079233">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" DF="2.0" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.01" NO="1" P_CHI2="0.398881402393063" P_Z="8.814533869822001E-6" STUDIES="3" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="61.57573436047913" Z="4.444380855933662">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.32992271565191034" CI_START="-1.9354422337814112" EFFECT_SIZE="-1.1326824747166608" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="14.6" ORDER="2291" SD_1="5.68" SD_2="9.11" SE="0.4095788317524286" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="19.477326227167737"/>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="2292" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="13.735030845408584"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="2293" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="28.363377287902807"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.011484324653000477" CI_START="-0.7103160689098049" DF="0.0" EFFECT_SIZE="-0.3609001967814027" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.02" NO="2" P_CHI2="1.0" P_Z="0.042930807725127494" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="63" WEIGHT="38.424265639520875" Z="2.024382531326546">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.011484324653000477" CI_START="-0.7103160689098049" EFFECT_SIZE="-0.3609001967814027" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="2294" SD_1="0.86" SD_2="0.79" SE="0.17827668002297495" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" WEIGHT="38.424265639520875"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.7280467536354603" CI_END="2.432975235186042" CI_START="0.252941028426843" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7844738734495864" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-003.13" LOG_CI_END="0.3861376883484984" LOG_CI_START="-0.5969807199866426" LOG_EFFECT_SIZE="-0.10542151581907215" METHOD="MH" NO="13" P_CHI2="0.3935170716581805" P_Q="0.0" P_Z="0.6742365317830631" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="72" WEIGHT="100.0" Z="0.4203407696350739">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.57376743870334" CI_START="0.12485388869486465" DF="0.0" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.13.01" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" NO="1" P_CHI2="1.0" P_Z="0.523706034306008" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="13.47034576402696" Z="0.6376431033323103">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="2295" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="13.47034576402696"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.18158978712101" CI_START="0.19138098067941195" DF="0.0" EFFECT_SIZE="0.6461538461538462" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" ID="CMP-003.13.02" LOG_CI_END="0.3387730918352183" LOG_CI_START="-0.7181012243251284" LOG_EFFECT_SIZE="-0.18966406624495508" NO="2" P_CHI2="1.0" P_Z="0.4817687352865989" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="63" WEIGHT="86.52965423597304" Z="0.7034606354179433">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.18158978712101" CI_START="0.19138098067941195" EFFECT_SIZE="0.6461538461538462" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3387730918352183" LOG_CI_START="-0.7181012243251284" LOG_EFFECT_SIZE="-0.18966406624495508" ORDER="2296" O_E="0.0" SE="0.6208132049248271" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="63" VAR="0.38540903540903537" WEIGHT="86.52965423597304"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.676659341897083" CI_END="1.1487107801389485" CI_START="0.7608838587531431" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9348986527872722" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="105" I2="0.0" I2_Q="0.0" ID="CMP-003.14" LOG_CI_END="0.06021069674671915" LOG_CI_START="-0.11868162884306203" LOG_EFFECT_SIZE="-0.02923546604817141" METHOD="MH" NO="14" P_CHI2="0.9132178248391774" P_Q="0.0" P_Z="0.5217735313998452" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="254" TOTAL_2="253" WEIGHT="100.0" Z="0.6406139596737699">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5531351611220652" CI_END="1.3608393469714382" CI_START="0.7759137452561577" DF="4.0" EFFECT_SIZE="1.0275670072557568" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="54" I2="0.0" ID="CMP-003.14.01" LOG_CI_END="0.13380685786901234" LOG_CI_START="-0.11018655456827647" LOG_EFFECT_SIZE="0.011810151650367926" NO="1" P_CHI2="0.9681263607468403" P_Z="0.8495140512429632" STUDIES="5" TAU2="0.0" TOTAL_1="143" TOTAL_2="141" WEIGHT="53.75603373296787" Z="0.18973849871972942">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7608433440481477" CI_START="0.5679096913306425" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.24572072005486098" LOG_CI_START="-0.24572072005486104" LOG_EFFECT_SIZE="0.0" ORDER="2297" O_E="0.0" SE="0.2886751345948129" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="0.08333333333333334" WEIGHT="13.250731986472184"/>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="2298" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="7.539209578510037"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2299" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="4.140853745772557"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="2300" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="4.732404280882923"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="2301" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="24.09283414133017"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2107458839744656" CI_END="1.1339244620733953" CI_START="0.6187546234439271" DF="2.0" EFFECT_SIZE="0.837628201258817" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="51" I2="0.0" ID="CMP-003.14.02" LOG_CI_END="0.05458412440047419" LOG_CI_START="-0.2084815429211093" LOG_EFFECT_SIZE="-0.07694870926031756" NO="2" P_CHI2="0.5458710722111577" P_Z="0.2515433753033247" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="112" WEIGHT="46.24396626703213" Z="1.1466087562289222">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.1271829313278217" CI_START="0.40127758392159096" EFFECT_SIZE="0.672542372881356" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="25" LOG_CI_END="0.051994403729524304" LOG_CI_START="-0.39655510004953054" LOG_EFFECT_SIZE="-0.17228034816000312" ORDER="2302" O_E="0.0" SE="0.26348019887567" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="62" VAR="0.06942181519956261" WEIGHT="15.90606155089857"/>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="2303" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="13.913268585795796"/>
<DICH_DATA CI_END="1.482162465341443" CI_START="0.5363942577610766" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" LOG_CI_END="0.17089581088628936" LOG_CI_START="-0.2705158800300335" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="2304" O_E="0.0" SE="0.2592874122673577" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.06722996216030272" WEIGHT="16.424636130337763"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.363047798582625" CI_END="0.47558328013608797" CI_START="-0.1539106951299003" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.16083629250309384" ESTIMABLE="YES" I2="25.41554447720676" I2_Q="0.0" ID="CMP-003.15" NO="15" P_CHI2="0.2520326928872335" P_Q="0.3973254311862773" P_Z="0.31656330346576367" Q="0.716405802800951" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03322599807840057" TOTALS="YES" TOTAL_1="124" TOTAL_2="121" UNITS="" WEIGHT="100.0" Z="1.0015452191732694">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.646641995781674" CI_END="0.5277647866493228" CI_START="-0.3736638321847924" DF="3.0" EFFECT_SIZE="0.07705047723226524" ESTIMABLE="YES" I2="35.437246882297636" ID="CMP-003.15.01" NO="1" P_CHI2="0.1995772908217197" P_Z="0.7375801212787989" STUDIES="4" TAU2="0.07485547799263068" TOTAL_1="65" TOTAL_2="59" WEIGHT="61.32212852352673" Z="0.3350596091838836">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7178462297320494" CI_START="-0.571968500445488" EFFECT_SIZE="0.07293886464328074" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="2305" SD_1="2.39" SD_2="2.69" SE="0.3290404161381105" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="18" TOTAL_2="19" WEIGHT="18.2259513188383"/>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="2306" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="19.170950954503283"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="2307" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="12.664447944983424"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="2308" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="11.260778305201717"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6531902491990114" CI_START="-0.0637303448426898" DF="0.0" EFFECT_SIZE="0.2947299521781608" ESTIMABLE="YES" I2="0.0" ID="CMP-003.15.02" NO="2" P_CHI2="1.0" P_Z="0.1070699835558656" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="62" WEIGHT="38.677871476473264" Z="1.611503690186383">
<NAME>Cognitive-behviour therapy</NAME>
<CONT_DATA CI_END="0.6531902491990114" CI_START="-0.0637303448426898" EFFECT_SIZE="0.2947299521781608" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="2309" SD_1="0.9" SD_2="0.92" SE="0.1828912673132464" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="62" WEIGHT="38.677871476473264"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>PD+/-AGORAPHOBIA: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="25.16436564014697" CI_END="1.3062936518764545" CI_START="1.0456416803489545" CI_STUDY="95" CI_TOTAL="95" DF="22.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1687237009564186" ESTIMABLE="YES" EVENTS_1="338" EVENTS_2="327" I2="12.574788037170197" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.11604081633728303" LOG_CI_START="0.019382886340637166" LOG_EFFECT_SIZE="0.06771185133896011" METHOD="MH" NO="1" P_CHI2="0.2892794363643716" P_Q="0.0" P_Z="0.006032123905037874" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.00901828214927423" TOTALS="YES" TOTAL_1="599" TOTAL_2="672" WEIGHT="100.0" Z="2.7460300454499156">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.57732324629805" CI_END="1.496701232626832" CI_START="1.0526691720122112" DF="11.0" EFFECT_SIZE="1.2552016759465163" ESTIMABLE="YES" EVENTS_1="151" EVENTS_2="116" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.17513511632758935" LOG_CI_START="0.022291904571786966" LOG_EFFECT_SIZE="0.09871351044968817" NO="1" P_CHI2="0.6608432973855476" P_Z="0.011351806970308017" STUDIES="12" TAU2="0.0" TOTAL_1="289" TOTAL_2="273" WEIGHT="35.26085475206225" Z="2.5316783525593807">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3477911253975297" CI_START="0.7572129217741901" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.3706594566631608" LOG_CI_START="-0.12078198344656102" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2310" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.08333333333333331" WEIGHT="3.4906450350522937"/>
<DICH_DATA CI_END="4.474347411298529" CI_START="1.1314499154035917" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6507297019224901" LOG_CI_START="0.05363533430023487" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="2311" O_E="0.0" SE="0.35073618720610084" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.12301587301587302" WEIGHT="2.441540279181617"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2312" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.3312086555117262"/>
<DICH_DATA CI_END="2.3824152363315836" CI_START="0.3902959167635606" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3770174578735022" LOG_CI_START="-0.40860599223996596" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="2313" O_E="0.0" SE="0.46147910349544863" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="27" VAR="0.21296296296296297" WEIGHT="1.4522249746839146"/>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="2314" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="5.175567271775701"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="2315" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="3.2260100330580688"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="2316" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="2.221236517436858"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="2317" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="2.3031019566528763"/>
<DICH_DATA CI_END="3.3551459414051803" CI_START="0.7112931338260449" EFFECT_SIZE="1.5448275862068965" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.5257114157623739" LOG_CI_START="-0.14795138356399803" LOG_EFFECT_SIZE="0.18888001609918792" ORDER="2318" O_E="0.0" SE="0.3957128630089486" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.15658866995073892" WEIGHT="1.946577145316576"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="2319" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="0.5874437065962173"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="2320" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="5.5052146948120555"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="2321" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="6.5800844819843505"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.89591115663086" CI_END="1.3277395972766124" CI_START="0.9601493934072616" DF="10.0" EFFECT_SIZE="1.129082976989708" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="211" I2="37.090740496315775" ID="CMP-004.01.02" LOG_CI_END="0.12311290744529838" LOG_CI_START="-0.01766118812228482" LOG_EFFECT_SIZE="0.05272585966150681" NO="2" P_CHI2="0.10265117530656642" P_Z="0.1420556048145521" STUDIES="11" TAU2="0.026473056395386274" TOTAL_1="310" TOTAL_2="399" WEIGHT="64.73914524793774" Z="1.4681790079887873">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.214830136893607" CI_START="0.5582679186538144" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.08451555713843212" LOG_CI_START="-0.253157328538504" LOG_EFFECT_SIZE="-0.08432088570003592" ORDER="2322" O_E="0.0" SE="0.19835072455437414" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.039343009931245204" WEIGHT="6.6658001512179625"/>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="2323" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="7.620129555408629"/>
<DICH_DATA CI_END="1.8078009413055642" CI_START="0.8799530594388961" EFFECT_SIZE="1.2612612612612613" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="37" LOG_CI_END="0.2571506081902599" LOG_CI_START="-0.055540494407098746" LOG_EFFECT_SIZE="0.10080505689158058" ORDER="2324" O_E="0.0" SE="0.18367630151160966" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.033736983736983736" WEIGHT="7.539812965285169"/>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="2325" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="3.1835081211031717"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="2326" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="1.6176731591694082"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="2327" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="7.978670192982223"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="2328" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="8.16232466554247"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="2329" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="7.815653800963439"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="2330" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="6.644612078175358"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2331" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="0.7881474304020778"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="2332" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="6.722813127687827"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.920111262515345" CI_END="1.4386182880918341" CI_START="1.0970808159451306" CI_STUDY="95" CI_TOTAL="95" DF="18.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2562963525113715" ESTIMABLE="YES" EVENTS_1="245" EVENTS_2="242" I2="4.863138750871279" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.1579455768648681" LOG_CI_START="0.0402386208529722" LOG_EFFECT_SIZE="0.09909209885892013" METHOD="MH" NO="2" P_CHI2="0.3967585522674615" P_Q="0.0" P_Z="9.668209190679804E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.004437237982257088" TOTALS="YES" TOTAL_1="516" TOTAL_2="591" WEIGHT="100.0" Z="3.300007943393554">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.019033483212007" CI_END="1.7744568280013024" CI_START="1.063208961983429" DF="9.0" EFFECT_SIZE="1.3735422826340924" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="64" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="0.24906543755856883" LOG_CI_START="0.026618628697981008" LOG_EFFECT_SIZE="0.13784203312827492" NO="1" P_CHI2="0.6351377392588502" P_Z="0.015139116478610368" STUDIES="10" TAU2="0.0" TOTAL_1="248" TOTAL_2="234" WEIGHT="26.861030089376463" Z="2.429033905867486">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="2333" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="6.301346563158402"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2334" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="5.842915313452332"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2335" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.49349172152154497"/>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="2336" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="5.251146714724076"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="2337" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="1.7107840058972703"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="2338" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="2.083605789523686"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="2339" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="0.7940399740444446"/>
<DICH_DATA CI_END="10.324319187650293" CI_START="0.6478360451866196" EFFECT_SIZE="2.586206896551724" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0138614227695817" LOG_CI_START="-0.18853489178409377" LOG_EFFECT_SIZE="0.41266326549274396" ORDER="2340" O_E="0.0" SE="0.706293547126578" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="15" VAR="0.4988505747126437" WEIGHT="0.9498675416604186"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="2341" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="1.3883570912022256"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="2342" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="2.045475374192061"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.012624748255668" CI_END="1.4739129123687569" CI_START="1.022243072663864" DF="8.0" EFFECT_SIZE="1.2274759730352292" ESTIMABLE="YES" EVENTS_1="160" EVENTS_2="178" I2="27.356100994296103" ID="CMP-004.02.02" LOG_CI_END="0.16847182355353815" LOG_CI_START="0.009554176194774841" LOG_EFFECT_SIZE="0.0890129998741565" NO="2" P_CHI2="0.2009849829165148" P_Z="0.02811834982893009" STUDIES="9" TAU2="0.02075662875825776" TOTAL_1="268" TOTAL_2="357" WEIGHT="73.13896991062354" Z="2.195631219173025">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="2343" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="14.101046875065746"/>
<DICH_DATA CI_END="1.5473815458642357" CI_START="0.7657600436275381" EFFECT_SIZE="1.0885416666666667" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="42" LOG_CI_END="0.189597413138667" LOG_CI_START="-0.11590729832365816" LOG_EFFECT_SIZE="0.03684505740750443" ORDER="2344" O_E="0.0" SE="0.17945497978568117" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.032204089769879235" WEIGHT="13.046927792191758"/>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="2345" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="5.772094455426504"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="2346" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="5.090945873617945"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="2347" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="4.893549540540775"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="2348" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="10.775786571095662"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="2349" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="10.093844964200079"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="2350" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="8.034266770469179"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="2351" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="1.3305070680158866"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="8.209594248327612" CI_END="-0.262613762940457" CI_START="-0.6023002676448749" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.43245701529266595" ESTIMABLE="YES" I2="0.0" I2_Q="65.8634765816895" ID="CMP-004.03" NO="3" P_CHI2="0.6083723755500532" P_Q="0.08697922751555531" P_Z="6.022792979780575E-7" Q="2.9294137183976083" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="353" UNITS="" WEIGHT="100.0" Z="4.990484832907105">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9565276218682941" CI_END="-0.3449357808799324" CI_START="-0.8726936665566979" DF="5.0" EFFECT_SIZE="-0.6088147237183151" ESTIMABLE="YES" I2="0.0" ID="CMP-004.03.01" NO="1" P_CHI2="0.965995370561355" P_Z="6.126425556268476E-6" STUDIES="6" TAU2="0.0" TOTAL_1="113" TOTAL_2="126" WEIGHT="41.427347201234056" Z="4.521978597119176">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="2352" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.750059713228182"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="2353" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="4.28066784283948"/>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="2354" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.530757893099731"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="2355" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.578871298681673"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="2356" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="9.538825619906039"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="2357" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.748164833478953"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.323652908061709" CI_END="-0.07562575115665177" CI_START="-0.5396231477342819" DF="4.0" EFFECT_SIZE="-0.30762444944546685" ESTIMABLE="YES" I2="7.485635756243043" ID="CMP-004.03.02" NO="2" P_CHI2="0.36397270676829907" P_Z="0.009353308397099119" STUDIES="5" TAU2="0.005349509762461575" TOTAL_1="136" TOTAL_2="227" WEIGHT="58.57265279876594" Z="2.598863037267937">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="2358" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="16.217793338609805"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="2359" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="16.755771912534925"/>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="2360" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="10.740675052466532"/>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="2361" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="7.6907677764756945"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="2362" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="7.1676447186789805"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.278916641529964" CI_END="0.155346589340001" CI_START="-0.2075281861796615" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.026090798419830266" ESTIMABLE="YES" I2="2.2715085513864253" I2_Q="26.794904154403476" ID="CMP-004.04" NO="4" P_CHI2="0.42354767000534976" P_Q="0.2424961769007664" P_Z="0.7780631898742488" Q="1.3660251222253574" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.002591444620593326" TOTALS="YES" TOTAL_1="242" TOTAL_2="255" UNITS="" WEIGHT="100.00000000000001" Z="0.2818439234721125">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.596137714017445" CI_END="0.3119827220159218" CI_START="-0.1913762995562834" DF="8.0" EFFECT_SIZE="0.06030321122981921" ESTIMABLE="YES" I2="6.934948390197871" ID="CMP-004.04.01" NO="1" P_CHI2="0.37750139989467724" P_Z="0.6386311049138407" STUDIES="9" TAU2="0.010424928009632389" TOTAL_1="131" TOTAL_2="147" WEIGHT="55.498195570873705" Z="0.46961360419603687">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="2363" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="5.112971385841934"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="2364" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="4.701310825003589"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="2365" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.7262425290154377"/>
<CONT_DATA CI_END="0.4017416085839796" CI_START="-1.088391349315334" EFFECT_SIZE="-0.3433248703656772" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="1.07" ORDER="2366" SD_1="0.93" SD_2="1.75" SE="0.38014294386358427" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="5.825650307551399"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="2367" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="6.43204823630264"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="2368" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="6.442457726467931"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="2369" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="3.989631375121745"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="2370" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="6.647216016154601"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="2371" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="13.620667169414427"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.316753805287162" CI_END="0.12076019331675297" CI_START="-0.4113223176575623" DF="3.0" EFFECT_SIZE="-0.14528106217040465" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.02" NO="2" P_CHI2="0.5093190603142691" P_Z="0.2844814457865015" STUDIES="4" TAU2="0.0" TOTAL_1="111" TOTAL_2="108" WEIGHT="44.50180442912631" Z="1.0703063664630124">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.806334763281386" CI_START="-0.5398754786632862" EFFECT_SIZE="0.13322964230904988" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="3.64" ORDER="2372" SD_1="3.87" SD_2="2.21" SE="0.34342729064498295" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="7.109658222876254"/>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="2373" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="7.921139030626722"/>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="2374" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="21.134817359729826"/>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="2375" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="8.33618981589351"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="24.59561373727878" CI_END="-0.12347259450814585" CI_START="-0.49324624626677105" CI_STUDY="95" CI_TOTAL="95" DF="18.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.30835942038745845" ESTIMABLE="YES" I2="26.81621937850658" I2_Q="17.40196386964367" ID="CMP-004.05" NO="5" P_CHI2="0.13646653900734984" P_Q="0.2711970576807594" P_Z="0.0010797302892962075" Q="1.2106825378048924" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.04427229751724764" TOTALS="YES" TOTAL_1="332" TOTAL_2="352" UNITS="" WEIGHT="99.99999999999999" Z="3.268882763164411">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="22.21054402063583" CI_END="-0.10579682258472634" CI_START="-0.7043732920577611" DF="11.0" EFFECT_SIZE="-0.4050850573212437" ESTIMABLE="YES" I2="50.47397312834889" ID="CMP-004.05.01" NO="1" P_CHI2="0.022791949175259174" P_Z="0.007982692261717224" STUDIES="12" TAU2="0.13618603367370316" TOTAL_1="196" TOTAL_2="200" WEIGHT="58.73100142381942" Z="2.652800982049789">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="2376" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.113894250151747"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="2377" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="3.834509472324039"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="2378" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.5790345532149743"/>
<CONT_DATA CI_END="0.21869047113718676" CI_START="-1.2886598659887283" EFFECT_SIZE="-0.5349846974257708" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.5" ORDER="2379" SD_1="8.36" SD_2="9.55" SE="0.3845352131507778" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="4.631256195908268"/>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="2380" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="6.670241192555541"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="2381" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.064792189609579"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="2382" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.092920204577494"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="2383" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="4.379602607688341"/>
<CONT_DATA CI_END="-0.36766554192815826" CI_START="-2.0287561923899347" EFFECT_SIZE="-1.1982108671590466" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.9" ORDER="2384" SD_1="1.18" SD_2="1.27" SE="0.4237554015186625" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="3.975357902533804"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="2385" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="3.3172994100373265"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="2386" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="6.604391937670535"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="2387" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="8.467701507547782"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1743871788380567" CI_END="0.04193810411451862" CI_START="-0.4364692251962311" DF="6.0" EFFECT_SIZE="-0.19726556054085623" ESTIMABLE="YES" I2="0.0" ID="CMP-004.05.02" NO="2" P_CHI2="0.9781309164960221" P_Z="0.10602177814221503" STUDIES="7" TAU2="0.0" TOTAL_1="136" TOTAL_2="152" WEIGHT="41.268998576180564" Z="1.6163355800054893">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="2388" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="8.05455045534024"/>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="2389" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="5.878209390491181"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="2390" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="4.713183869741572"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="2391" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="6.268663901459267"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="2392" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="5.968783120766269"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="2393" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.167165151766299"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="2394" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.2184426866157425"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="20.31582227924571" CI_END="-0.2268966483056455" CI_START="-0.5853297498549821" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4061131990803138" ESTIMABLE="YES" I2="21.243650490360313" I2_Q="84.00753401564056" ID="CMP-004.06" NO="6" P_CHI2="0.2063318799679864" P_Q="0.012398796105536292" P_Z="8.93874058422882E-6" Q="6.252944361288593" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.029280390229665818" TOTALS="YES" TOTAL_1="337" TOTAL_2="354" UNITS="" WEIGHT="100.0" Z="4.441371293014907">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.678889889886424" CI_END="-0.373065145370958" CI_START="-0.9046901677321064" DF="8.0" EFFECT_SIZE="-0.6388776565515322" ESTIMABLE="YES" I2="17.345893061979286" ID="CMP-004.06.01" NO="1" P_CHI2="0.28829092888833385" P_Z="2.4680269208885644E-6" STUDIES="9" TAU2="0.028518214242611698" TOTAL_1="149" TOTAL_2="153" WEIGHT="45.2212936368009" Z="4.710753424686293">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="2395" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.246028523690619"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="2396" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="3.9243088420733456"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="2397" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.6543417232232858"/>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="2398" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="6.957420760287285"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="2399" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.013852602765121"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="2400" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.240882524409107"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="2401" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="4.133702104289982"/>
<CONT_DATA CI_END="-0.466210138361711" CI_START="-2.154071253344198" EFFECT_SIZE="-1.3101406958529547" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="2.02" ORDER="2402" SD_1="0.56" SD_2="1.05" SE="0.43058472714195783" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="3.894584964920503"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="2403" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="9.156171591141655"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.383988028070695" CI_END="-0.028112554841239673" CI_START="-0.4375885137131078" DF="7.0" EFFECT_SIZE="-0.23285053427717373" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.02" NO="2" P_CHI2="0.7346382905347938" P_Z="0.025808151609731707" STUDIES="8" TAU2="0.0" TOTAL_1="188" TOTAL_2="201" WEIGHT="54.7787063631991" Z="2.2290864754137054">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.9449855770700366" CI_START="-0.4064133842298303" EFFECT_SIZE="0.26928609642010315" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="21.5" ORDER="2404" SD_1="4.68" SD_2="5.17" SE="0.34475096786459586" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="5.644252199722356"/>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="2405" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="8.691977189638179"/>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="2406" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.2030397144641345"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="2407" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="4.856123273273988"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="2408" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="12.394403472421425"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="2409" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="6.582362445638367"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="2410" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="6.237370518989841"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="2411" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.16917754905081"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.400600981026596" CI_END="-0.2001946053171659" CI_START="-0.5861166478223753" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3931556265697706" ESTIMABLE="YES" I2="14.63727447429387" I2_Q="0.0" ID="CMP-004.07" NO="7" P_CHI2="0.28952711215522664" P_Q="0.6789788316514591" P_Z="6.513209024264433E-5" Q="0.1712779391047512" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02108369705028358" TOTALS="YES" TOTAL_1="276" TOTAL_2="266" UNITS="" WEIGHT="100.00000000000001" Z="3.9934016901127256">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.099303521988126" CI_END="-0.16664596299925666" CI_START="-0.6909714964287412" DF="9.0" EFFECT_SIZE="-0.42880872971399897" ESTIMABLE="YES" I2="25.615553129614003" ID="CMP-004.07.01" NO="1" P_CHI2="0.20776883651035627" P_Z="0.0013467280484533572" STUDIES="11" TAU2="0.045119918890346014" TOTAL_1="171" TOTAL_2="179" WEIGHT="63.5429388391579" Z="3.205831541327517">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="2412" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="5.301401878462082"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="2413" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="4.7563367646643435"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="2414" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.4639401327102852" CI_START="-1.0220729437718097" EFFECT_SIZE="-0.27906640553076223" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2415" SD_1="0.51" SD_2="0.8" SE="0.37909193439358485" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="5.881668834949233"/>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="2416" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="8.810187640344825"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="2417" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="6.171263986420632"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="2418" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="6.372314801450123"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="2419" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="5.497786924826947"/>
<CONT_DATA CI_END="-0.42277473134623855" CI_START="-2.098561793622174" EFFECT_SIZE="-1.2606682624842063" ESTIMABLE="YES" MEAN_1="45.41" MEAN_2="57.68" ORDER="2420" SD_1="9.04" SD_2="10.07" SE="0.42750455505670765" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="4.754943933765456"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="2421" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.173326595397565"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="2422" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.823707478876694"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.130019519933718" CI_END="-0.04647121023388057" CI_START="-0.6382275298797727" DF="4.0" EFFECT_SIZE="-0.34234937005682664" ESTIMABLE="YES" I2="3.1481575161127773" ID="CMP-004.07.02" NO="2" P_CHI2="0.3886958007077529" P_Z="0.02334141083627799" STUDIES="5" TAU2="0.0036773392906802402" TOTAL_1="105" TOTAL_2="87" WEIGHT="36.457061160842116" Z="2.267799812743456">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.04205136398922227" CI_START="-1.437631644300558" EFFECT_SIZE="-0.73984150414489" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.0" ORDER="2423" SD_1="1.38" SD_2="0.57" SE="0.356021919616762" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="6.556390862564023"/>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="2424" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="10.874773947325158"/>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="2425" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="5.8925087262122835"/>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="2426" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="7.998515403224795"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="2427" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.134872221515855"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.020593955322328" CI_END="-0.10649416240294557" CI_START="-0.6117411145150342" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3591176384589899" ESTIMABLE="YES" I2="33.42473653342685" I2_Q="81.55187076817478" ID="CMP-004.08" NO="8" P_CHI2="0.13131294921383196" P_Q="0.019900555230329853" P_Z="0.005333118836415128" Q="5.4206038316063" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.06015014973304875" TOTALS="YES" TOTAL_1="192" TOTAL_2="212" UNITS="" WEIGHT="100.0" Z="2.786192512989355">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.703334404582302" CI_END="-0.25598904826503266" CI_START="-0.8365255246944099" DF="6.0" EFFECT_SIZE="-0.5462572864797213" ESTIMABLE="YES" I2="22.111650814082264" ID="CMP-004.08.01" NO="1" P_CHI2="0.26065348458644555" P_Z="2.256099215856378E-4" STUDIES="7" TAU2="0.033798942776966705" TOTAL_1="137" TOTAL_2="123" WEIGHT="64.04646409996352" Z="3.6884662764961584">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8873607300917461" CI_START="-0.6116126107138591" EFFECT_SIZE="0.13787405968894345" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.0" ORDER="2428" SD_1="0.62" SD_2="0.76" SE="0.3823981850251626" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="8.049830469187775"/>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="2429" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.529316941765847"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="2430" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.601622577129412"/>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="2431" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="7.57307711102102"/>
<CONT_DATA CI_END="-0.38927353848264634" CI_START="-2.056043178938999" EFFECT_SIZE="-1.2226583587108226" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.0" ORDER="2432" SD_1="1.4" SD_2="1.03" SE="0.42520415007714907" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="6.894878374011132"/>
<CONT_DATA CI_END="0.26110133948943387" CI_START="-0.9235736714263485" EFFECT_SIZE="-0.33123616596845734" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.4" ORDER="2433" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="10.966754627690218"/>
<CONT_DATA CI_END="-0.2834851042937671" CI_START="-1.2716052532915705" EFFECT_SIZE="-0.7775451787926688" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.9" ORDER="2434" SD_1="0.89" SD_2="0.89" SE="0.2520760985385367" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="13.43098399915811"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8966557191337254" CI_END="0.2985034934444692" CI_START="-0.38806142026940765" DF="3.0" EFFECT_SIZE="-0.044778963412469217" ESTIMABLE="YES" I2="0.0" ID="CMP-004.08.02" NO="2" P_CHI2="0.5941309163838325" P_Z="0.7982098692592872" STUDIES="4" TAU2="0.0" TOTAL_1="55" TOTAL_2="89" WEIGHT="35.953535900036485" Z="0.2556645520340477">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="2435" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.17309439938796"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="2436" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="10.518832759973161"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="2437" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="10.04942409851646"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="2438" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.212184642158901"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="11.508349756260092" CI_END="1.4686631403383519" CI_START="0.9480923767657127" CI_STUDY="95" CI_TOTAL="95" DF="18.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1800120030709786" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="129" I2="0.0" I2_Q="0.0" ID="CMP-004.09" LOG_CI_END="0.16692219533514513" LOG_CI_START="-0.023149345399200733" LOG_EFFECT_SIZE="0.07188642496797218" METHOD="MH" NO="9" P_CHI2="0.8715543055171748" P_Q="0.0" P_Z="0.13819534553852728" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="535" TOTAL_2="610" WEIGHT="99.99999999999999" Z="1.4825449761728247">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.321544042577681" CI_END="1.598913539245522" CI_START="0.8961235408338613" DF="8.0" EFFECT_SIZE="1.1970062916609496" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="58" I2="0.0" ID="CMP-004.09.01" LOG_CI_END="0.20382498004155084" LOG_CI_START="-0.04763211377099963" LOG_EFFECT_SIZE="0.07809643313527563" NO="1" P_CHI2="0.9125899157833237" P_Z="0.22343919095719578" STUDIES="10" TAU2="0.0" TOTAL_1="247" TOTAL_2="233" WEIGHT="57.13554922121906" Z="1.217433908468571">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2439" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="3.0527733402114348"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2440" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="1.7747478910042749"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2441" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9619712520075643" CI_START="0.9320516049237294" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.47158083907544335" LOG_CI_START="-0.030560041387254936" LOG_EFFECT_SIZE="0.22051039884409415" ORDER="2442" O_E="0.0" SE="0.29496003882123506" STUDY_ID="STD-Johnston-1995" TOTAL_1="26" TOTAL_2="27" VAR="0.0870014245014245" WEIGHT="14.327916135433611"/>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="2443" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="13.43320689868696"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2444" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="3.2979567108425893"/>
<DICH_DATA CI_END="8.748921872143878" CI_START="0.5394243722180654" EFFECT_SIZE="2.1724137931034484" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9419545382992105" LOG_CI_START="-0.2680694351899591" LOG_EFFECT_SIZE="0.33694255155462566" ORDER="2445" O_E="0.0" SE="0.7107740717428078" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.5051997810618502" WEIGHT="2.4674379535549673"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="2446" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="2.461540022423651"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="2447" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="10.278210645482249"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="2448" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="6.0417596235793205"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.220612138027676" CI_END="1.6172086149448124" CI_START="0.82880377929573" DF="9.0" EFFECT_SIZE="1.157734257926176" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="71" I2="0.0" ID="CMP-004.09.02" LOG_CI_END="0.20876604617451605" LOG_CI_START="-0.0815482772374295" LOG_EFFECT_SIZE="0.06360888446854326" NO="2" P_CHI2="0.5120761394772575" P_Z="0.3904122847042001" STUDIES="10" TAU2="0.0" TOTAL_1="288" TOTAL_2="377" WEIGHT="42.86445077878093" Z="0.8588699392431302">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="2449" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="10.345611208938093"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="2450" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="10.887543580260965"/>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="2451" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="3.469023249373216"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2452" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="1.6839347679265708"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2453" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="1.047101255692522"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2454" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="4.273882676296008"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="2455" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="3.7071286692219734"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="2456" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="6.200636071066318"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2457" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="0.5860641356487996"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="2458" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="0.6635251643564579"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.963673724787399" CI_END="5.62905522401201" CI_START="1.6086692206114976" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.009200538347433" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-004.10" LOG_CI_END="0.7504355093399036" LOG_CI_START="0.20646675234539635" LOG_EFFECT_SIZE="0.47845113084265" METHOD="MH" NO="10" P_CHI2="0.7879627305125708" P_Q="0.0" P_Z="5.65178179902445E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="372" TOTAL_2="474" WEIGHT="99.99999999999997" Z="3.447797222749409">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.465532261825362" CI_END="4.622860472923856" CI_START="0.8543834433357309" DF="4.0" EFFECT_SIZE="1.9873840718183613" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" I2="0.0" ID="CMP-004.10.01" LOG_CI_END="0.6649107857691032" LOG_CI_START="-0.06834717620690522" LOG_EFFECT_SIZE="0.298281804781099" NO="1" P_CHI2="0.6508183084335022" P_Z="0.11080475113355209" STUDIES="5" TAU2="0.0" TOTAL_1="114" TOTAL_2="128" WEIGHT="55.034412966260774" Z="1.5945864209618763">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="2459" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="4.004300013416606"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="2460" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="4.0128845869680445"/>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="2461" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="13.127063516510349"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="2462" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="8.703553952658956"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="2463" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="25.18661089670682"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.33186524099875" CI_END="12.722427723704758" CI_START="1.964983951519963" DF="7.0" EFFECT_SIZE="4.999936629743672" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="2" I2="0.0" ID="CMP-004.10.02" LOG_CI_END="1.1045699923191301" LOG_CI_START="0.29335900774208934" LOG_EFFECT_SIZE="0.6989645000306098" NO="2" P_CHI2="0.8527001517280022" P_Z="7.313962812380342E-4" STUDIES="8" TAU2="0.0" TOTAL_1="258" TOTAL_2="346" WEIGHT="44.965587033739205" Z="3.3775313021588826">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="2464" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="3.8945002431437348"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="2465" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="3.8916601747451085"/>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="2466" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="4.9138740436135"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2467" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="13.792372778555709"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2468" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="4.663274643552344"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="2469" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="4.62262742290073"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="2470" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="4.3870828592504205"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2471" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="4.800194867977664"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.304261683165066" CI_END="1.615741246775959" CI_START="1.026431985246888" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.287807631431624" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="83" I2="0.0" I2_Q="0.0" ID="CMP-004.11" LOG_CI_END="0.20837181182528627" LOG_CI_START="0.011330176881866693" LOG_EFFECT_SIZE="0.1098509943535765" METHOD="MH" NO="11" P_CHI2="0.5117051037052454" P_Q="0.0" P_Z="0.028862060530283846" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="187" WEIGHT="100.00000000000001" Z="2.1853654702037693">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6579743283184165" CI_END="3.613872802581938" CI_START="0.7408556822095642" DF="1.0" EFFECT_SIZE="1.636263487515208" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="19" I2="39.6854352374539" ID="CMP-004.11.01" LOG_CI_END="0.5579728626386027" LOG_CI_START="-0.1302663838213139" LOG_EFFECT_SIZE="0.2138532394086443" NO="1" P_CHI2="0.1978771184070084" P_Z="0.22321632491894905" STUDIES="2" TAU2="0.17335127459783908" TOTAL_1="54" TOTAL_2="47" WEIGHT="33.00033094712383" Z="1.2180201852019086">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2472" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="2.775896261256673"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="2473" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="30.224434685867156"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-004.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="66.99966905287619" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="2474" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="35.529257136634456"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="2475" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="31.470411916241726"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.133972258048254" CI_END="-0.3334892460847304" CI_START="-0.9718365394537506" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6526628927692405" ESTIMABLE="YES" I2="34.78940184720129" I2_Q="76.16092516404896" ID="CMP-004.12" NO="12" P_CHI2="0.189364218538703" P_Q="0.04054842406948567" P_Z="6.127753920015621E-5" Q="4.1947936607503244" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.044746681824347254" TOTALS="YES" TOTAL_1="116" TOTAL_2="190" UNITS="" WEIGHT="100.0" Z="4.007836414946472">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" DF="2.0" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" ID="CMP-004.12.01" NO="1" P_CHI2="0.398881402393063" P_Z="8.814533869822001E-6" STUDIES="3" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="41.598193787798095" Z="4.444380855933662">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.32992271565191034" CI_START="-1.9354422337814112" EFFECT_SIZE="-1.1326824747166608" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="14.6" ORDER="2476" SD_1="5.68" SD_2="9.11" SE="0.4095788317524286" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="12.479462107116134"/>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="2477" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="8.090341478248416"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="2478" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="21.02839020243355"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-004.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="58.401806212201905" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="2479" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="28.935824294395545"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="2480" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="29.465981917806364"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.7269122710222943" CI_END="2.1455069060541696" CI_START="0.2784966187870194" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.772991862130699" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-004.13" LOG_CI_END="0.3315299167975606" LOG_CI_START="-0.5551800732049874" LOG_EFFECT_SIZE="-0.11182507820371332" METHOD="MH" NO="13" P_CHI2="0.6952693452285448" P_Q="0.0" P_Z="0.6210580907158085" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="149" WEIGHT="100.0" Z="0.4943513173839924">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.57376743870334" CI_START="0.12485388869486465" DF="0.0" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.13.01" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" NO="1" P_CHI2="1.0" P_Z="0.523706034306008" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="10.957974619597316" Z="0.6376431033323103">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="2481" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="10.957974619597316"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-004.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="89.04202538040269" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="2482" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="43.722318732193294"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="2483" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="45.31970664820939"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.6794833961023747" CI_END="1.1633190760221364" CI_START="0.7894162280098307" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9583021219663851" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="158" I2="0.0" I2_Q="0.0" ID="CMP-004.14" LOG_CI_END="0.06569884968118876" LOG_CI_START="-0.10269395006783918" LOG_EFFECT_SIZE="-0.0184975501933252" METHOD="MH" NO="14" P_CHI2="0.9783731315906626" P_Q="0.0" P_Z="0.6667630221798309" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="261" TOTAL_2="397" WEIGHT="100.00000000000003" Z="0.43059480257080995">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6475226805935062" CI_END="1.30960736276641" CI_START="0.7689717115632353" DF="6.0" EFFECT_SIZE="1.0035193148227397" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="68" I2="0.0" ID="CMP-004.14.01" LOG_CI_END="0.11714110806533486" LOG_CI_START="-0.11408963645079466" LOG_EFFECT_SIZE="0.0015257358072700805" NO="1" P_CHI2="0.9491002927305745" P_Z="0.9793650468101106" STUDIES="7" TAU2="0.0" TOTAL_1="150" TOTAL_2="169" WEIGHT="53.034182695191454" Z="0.025864962191167445">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="2484" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="7.8273044503751565"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="2485" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="7.209359362187644"/>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2486" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="2.1073511981779265"/>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="2487" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="6.680199487820178"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2488" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="3.6690489611133548"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="2489" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="4.193198812700977"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="2490" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="21.34772042281621"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7895557447682486" CI_END="1.2071180634987027" CI_START="0.6855422667382742" DF="4.0" EFFECT_SIZE="0.909687008520852" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="90" I2="0.0" ID="CMP-004.14.02" LOG_CI_END="0.081749748820173" LOG_CI_START="-0.16396576385722889" LOG_EFFECT_SIZE="-0.041108007518527924" NO="2" P_CHI2="0.7743926715839039" P_Z="0.5119523092847125" STUDIES="5" TAU2="0.0" TOTAL_1="111" TOTAL_2="228" WEIGHT="46.96581730480857" Z="0.6558007944601899">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="2491" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="8.468349393728358"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="2492" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="8.257676173477181"/>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="2493" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="12.328004509340875"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="2494" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="9.4611118657965"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="2495" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="8.450675362465649"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.444940660489291" CI_END="0.36835221203552704" CI_START="-0.08865228724814178" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.13984996239369263" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.15" NO="15" P_CHI2="0.4881363973992512" P_Q="0.5043245973472998" P_Z="0.23031244916805782" Q="0.44582441569009745" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="211" UNITS="" WEIGHT="100.0" Z="1.1995544462278058">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.7257800652650825" CI_END="0.4264621044602518" CI_START="-0.3211552971290882" DF="4.0" EFFECT_SIZE="0.05265340366558182" ESTIMABLE="YES" I2="15.357889178966087" ID="CMP-004.15.01" NO="1" P_CHI2="0.31660871145154845" P_Z="0.7824914118980268" STUDIES="5" TAU2="0.028093961755684366" TOTAL_1="65" TOTAL_2="76" WEIGHT="44.62831664206247" Z="0.2760737634747455">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="2496" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="8.295561571930895"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="2497" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="7.995523148733882"/>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="2498" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="13.418554658271567"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="2499" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="7.976387302368537"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="2500" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="6.94228996075759"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-004.15.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="55.37168335793752" Z="1.3386680075530792">
<NAME>Cognitive-behviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="2501" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="27.211287332306316"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="2502" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="28.160396025631204"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>SUBGROUP2: TCA: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="5.346422208356168" CI_END="1.4529900257653605" CI_START="1.0414152615535197" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2301081203362119" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="101" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.16226263303860444" LOG_CI_START="0.017623937810494702" LOG_EFFECT_SIZE="0.08994328542454956" METHOD="MH" NO="1" P_CHI2="0.5002095933726776" P_Q="0.0" P_Z="0.014785147743462037" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="223" WEIGHT="99.99999999999999" Z="2.4375994239342855">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8592539734267177" CI_END="1.3960782037129689" CI_START="0.8040457182397279" DF="3.0" EFFECT_SIZE="1.059486055605841" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="44" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.1449097467181801" LOG_CI_START="-0.09471925645709568" LOG_EFFECT_SIZE="0.025095245130542187" NO="1" P_CHI2="0.41383843588692293" P_Z="0.6814274289260617" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="36.43260527802801" Z="0.4105160559641447">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.5905355852063248" CI_START="0.47068186901227627" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5551592353055395" LOG_CI_START="-0.3272725306918659" LOG_EFFECT_SIZE="0.11394335230683678" ORDER="2503" O_E="0.0" SE="0.5183447874545656" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.2686813186813187" WEIGHT="2.6866229711482985"/>
<DICH_DATA CI_END="2.081852540666224" CI_START="0.6537980402183219" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.31844996482728344" LOG_CI_START="-0.18455638556605694" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2504" O_E="0.0" SE="0.29546842014263947" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.08730158730158732" WEIGHT="8.268410976240322"/>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="2505" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="0.694253284952361"/>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="2506" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="24.78331804568703"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6675098058887675" CI_END="1.707146813691322" CI_START="0.9430796854276406" DF="1.0" EFFECT_SIZE="1.2688480917883003" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="43" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.23227087180849554" LOG_CI_START="-0.025451610041657684" LOG_EFFECT_SIZE="0.10340963088341892" NO="2" P_CHI2="0.41392147128779655" P_Z="0.11575400534626379" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="103" WEIGHT="31.496651199360134" Z="1.572848055249795">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="2507" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="29.43423576310971"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="2508" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="2.062415436250421"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8970926050149208" CI_START="1.053618012148746" DF="0.0" EFFECT_SIZE="1.4137931034482758" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="0.2780885311339763" LOG_CI_START="0.022683186507582456" LOG_EFFECT_SIZE="0.1503858588207794" NO="3" P_CHI2="1.0" P_Z="0.020993431887657236" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.07074352261185" Z="2.3081025771329373">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.8970926050149208" CI_START="1.053618012148746" EFFECT_SIZE="1.4137931034482758" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.2780885311339763" LOG_CI_START="0.022683186507582456" LOG_EFFECT_SIZE="0.1503858588207794" ORDER="2509" O_E="0.0" SE="0.15002636371038966" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.022507909808162127" WEIGHT="32.07074352261185"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.8175810772872603" CI_END="1.5099009885461157" CI_START="1.058563168698936" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2642490161582218" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="78" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.17894846945350137" LOG_CI_START="0.02471677921780004" LOG_EFFECT_SIZE="0.10183262433565066" METHOD="MH" NO="2" P_CHI2="0.6111167469608788" P_Q="0.0" P_Z="0.009648967631134523" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="137" TOTAL_2="165" WEIGHT="100.0" Z="2.588161691596011">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.01906103501001709" CI_END="1.5063413482788168" CI_START="0.6225630309871126" DF="1.0" EFFECT_SIZE="0.9683968378127192" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="0.1779233974130457" LOG_CI_START="-0.20581667214529703" LOG_EFFECT_SIZE="-0.013946637366125683" NO="1" P_CHI2="0.8901916562945521" P_Z="0.8867121369914315" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="62" WEIGHT="16.15373433848118" Z="0.14246574236830384">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9219135458330163" CI_START="0.5203147676273697" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.2837338477382853" LOG_CI_START="-0.28373384773828525" LOG_EFFECT_SIZE="0.0" ORDER="2510" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.1111111111111111" WEIGHT="7.386946431445323"/>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="2511" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="8.766787907035857"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.785691062136034" CI_START="1.0067038852886236" DF="0.0" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" NO="2" P_CHI2="1.0" P_Z="0.04489224275826041" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="38.39560010095933" Z="2.0056627432757965">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="2512" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="38.39560010095933"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7211088098619653" CI_START="1.0163329319635195" DF="0.0" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" I2="0.0" ID="CMP-005.02.03" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" NO="3" P_CHI2="1.0" P_Z="0.037477572623570855" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="45.45066556055949" Z="2.080523170772094">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.7211088098619653" CI_START="1.0163329319635195" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" ORDER="2513" O_E="0.0" SE="0.13438199879091275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.01805852159904088" WEIGHT="45.45066556055949"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.2492882823729135" CI_END="-0.038149991366068337" CI_START="-0.6642020163911002" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3511760038785843" ESTIMABLE="YES" I2="29.399941810379556" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.23577344754535512" P_Q="0.44299253067907474" P_Z="0.027889709630648407" Q="1.6284056825473674" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.030383521732246937" TOTALS="YES" TOTAL_1="127" TOTAL_2="151" UNITS="" WEIGHT="100.0" Z="2.1988342576136644">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.620882599825546" CI_END="0.4359807475729731" CI_START="-1.4472565047593395" DF="1.0" EFFECT_SIZE="-0.5056378785931832" ESTIMABLE="YES" I2="61.844914378592804" ID="CMP-005.03.01" NO="1" P_CHI2="0.10546581344978534" P_Z="0.2925807317412622" STUDIES="2" TAU2="0.30855631045333326" TOTAL_1="42" TOTAL_2="48" WEIGHT="37.389028613506476" Z="1.052477089686414">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.02125413161636569" CI_START="-2.262071319946162" EFFECT_SIZE="-1.141662725781264" ESTIMABLE="YES" MEAN_1="2.17" MEAN_2="3.67" ORDER="2514" SD_1="0.75" SD_2="1.63" SE="0.5716475419969643" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="7.141615594206502"/>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="2515" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="30.247413019299977"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1022330143445232" CI_START="-0.5490657188353458" DF="0.0" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.02" NO="2" P_CHI2="1.0" P_Z="0.17873473351770594" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="43.98602973436713" Z="1.3446610031633186">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="2516" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="43.98602973436713"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" DF="0.0" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.03" NO="3" P_CHI2="1.0" P_Z="0.03499375510595159" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.624941652126395" Z="2.1084306554609964">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.0" ORDER="2517" SD_1="0.5" SD_2="1.1" SE="0.32644894275404324" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.624941652126395"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.6161827164138294" CI_END="0.2002953014278121" CI_START="-0.3940019931605547" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.09685334586637129" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.04" NO="4" P_CHI2="0.6239592647557819" P_Q="0.5277186277594306" P_Z="0.5229300318112935" Q="0.3987834285799199" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="113" UNITS="" WEIGHT="99.99999999999999" Z="0.6388353822534966">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2173992878339095" CI_END="0.18901180459510902" CI_START="-0.4855223464617977" DF="3.0" EFFECT_SIZE="-0.14825527093334434" ESTIMABLE="YES" I2="0.0" ID="CMP-005.04.01" NO="1" P_CHI2="0.5285294808445071" P_Z="0.3889310542111588" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="77.62464400234703" Z="0.8615575389097494">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.1030659113296144" CI_START="-0.40675425774589163" EFFECT_SIZE="0.34815582679186136" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="0.27" ORDER="2518" SD_1="0.93" SD_2="0.65" SE="0.38516528389928967" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="15.493768446881667"/>
<CONT_DATA CI_END="0.7980531175789702" CI_START="-1.2390075602204103" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" MEAN_1="1.71" MEAN_2="2.14" ORDER="2519" SD_1="1.89" SD_2="1.77" SE="0.5196678851926503" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="8.51137206198441"/>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="2520" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="11.459362808714056"/>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="2521" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="42.16014068476689"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.709657110863069" CI_START="-0.5467164147484286" DF="0.0" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" I2="0.0" ID="CMP-005.04.02" NO="2" P_CHI2="1.0" P_Z="0.7993485857195068" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="22.375355997652964" Z="0.2541902463641487">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7096571108630692" CI_START="-0.5467164147484287" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.8" ORDER="2522" SD_1="2.5" SD_2="2.3" SE="0.32050933984542873" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="22.375355997652964"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.8" ORDER="2523" SD_1="0.0" SD_2="2.1" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.936638396452304" CI_END="-0.0016028191983878948" CI_START="-0.6507179091185736" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.32616036415848076" ESTIMABLE="YES" I2="39.61740620306571" I2_Q="53.53248807262629" ID="CMP-005.05" NO="5" P_CHI2="0.12734587236452577" P_Q="0.11624670415857441" P_Z="0.048879274977969095" Q="4.304082394439142" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0729444818200496" TOTALS="YES" TOTAL_1="133" TOTAL_2="142" UNITS="" WEIGHT="100.0" Z="1.9696432169330522">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.731099367340445" CI_END="-0.05678971852509268" CI_START="-1.0123597705405742" DF="3.0" EFFECT_SIZE="-0.5345747445328335" ESTIMABLE="YES" I2="36.58979093295964" ID="CMP-005.05.01" NO="1" P_CHI2="0.19258012153928383" P_Z="0.028312705021815526" STUDIES="4" TAU2="0.08750245792215275" TOTAL_1="64" TOTAL_2="74" WEIGHT="49.76695368625196" Z="2.192926084527561">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1660942883799188" CI_START="-1.3689479754433111" EFFECT_SIZE="-0.6014268435316962" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.9" ORDER="2524" SD_1="8.36" SD_2="8.97" SE="0.3915996099753484" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="12.117493203778189"/>
<CONT_DATA CI_END="0.039892566655316264" CI_START="-2.175482894859469" EFFECT_SIZE="-1.0677951641020764" ESTIMABLE="YES" MEAN_1="8.57" MEAN_2="19.43" ORDER="2525" SD_1="6.16" SD_2="12.42" SE="0.5651571863027546" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="6.989027676656466"/>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="2526" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.03980548627926"/>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="2527" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="21.62062731953804"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9014566346727172" CI_END="0.45631527469504923" CI_START="-0.34204073176052024" DF="1.0" EFFECT_SIZE="0.05713727146726451" ESTIMABLE="YES" I2="0.0" ID="CMP-005.05.02" NO="2" P_CHI2="0.3423915555337512" P_Z="0.7790601723976334" STUDIES="2" TAU2="0.0" TOTAL_1="49" TOTAL_2="48" WEIGHT="34.81904420273218" Z="0.28054400128561907">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.41452271242937677" CI_START="-0.6155982943711397" EFFECT_SIZE="-0.10053779097088145" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.5" ORDER="2528" SD_1="7.8" SD_2="7.9" SE="0.2627907999651982" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="29" TOTAL_2="29" WEIGHT="19.31026483907392"/>
<CONT_DATA CI_END="0.9259489927372764" CI_START="-0.33737912447830304" EFFECT_SIZE="0.2942849341294867" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="18.7" ORDER="2529" SD_1="12.0" SD_2="13.3" SE="0.3222835029573376" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="15.508779363658261"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.03724050674962909" CI_START="-1.2326820263280838" DF="0.0" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" I2="0.0" ID="CMP-005.05.03" NO="3" P_CHI2="1.0" P_Z="0.06503579171955816" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.414002111015858" Z="1.8450120089760027">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.03724050674962909" CI_START="-1.2326820263280838" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.6" ORDER="2530" SD_1="1.1" SD_2="3.3" SE="0.32396578281404653" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.414002111015858"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.926667657629532" CI_END="0.17237356611400878" CI_START="-1.4303689545174971" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6289976942017441" ESTIMABLE="YES" I2="74.7687163586962" I2_Q="86.72730072574441" ID="CMP-005.06" NO="6" P_CHI2="0.018999711776593986" P_Q="0.006053698063111623" P_Z="0.1239559406034685" Q="7.534262468672457" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.36528480105503836" TOTALS="YES" TOTAL_1="62" TOTAL_2="68" UNITS="" WEIGHT="99.99999999999999" Z="1.538379135918113">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.3924051889570751" CI_END="0.22860510417282892" CI_START="-0.6046012430484724" DF="1.0" EFFECT_SIZE="-0.18799806943782177" ESTIMABLE="YES" I2="0.0" ID="CMP-005.06.01" NO="1" P_CHI2="0.5310382132394685" P_Z="0.3764471754799724" STUDIES="2" TAU2="0.0" TOTAL_1="42" TOTAL_2="48" WEIGHT="65.8367651461322" Z="0.8844614458111532">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5440488746719574" CI_START="-1.5255257710292496" EFFECT_SIZE="-0.4907384481786461" ESTIMABLE="YES" MEAN_1="27.29" MEAN_2="32.29" ORDER="2531" SD_1="4.82" SD_2="13.12" SE="0.5279624171734143" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="25.95767814284814"/>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="2532" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="39.87908700328406"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.626858518947859" CI_START="-2.0075250794135924" DF="0.0" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" I2="0.0" ID="CMP-005.06.03" NO="3" P_CHI2="1.0" P_Z="1.8423032726965448E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="34.16323485386779" Z="3.7397132096179453">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="2533" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="34.16323485386779"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.973437784889416" CI_END="-0.136657288303407" CI_START="-0.6799577682964799" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4083075282999435" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.07" NO="7" P_CHI2="0.5532466567459406" P_Q="0.42795613966742774" P_Z="0.00321964342449816" Q="1.6974705074578416" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="113" UNITS="" WEIGHT="100.0" Z="2.945950094116102">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2759672774315742" CI_END="-0.008321257129870197" CI_START="-0.6887072791358819" DF="3.0" EFFECT_SIZE="-0.34851426813287606" ESTIMABLE="YES" I2="0.0" ID="CMP-005.07.01" NO="1" P_CHI2="0.5171406827628646" P_Z="0.0446533359428882" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="63.76309833504601" Z="2.0079054876078484">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.4847694472269716" CI_START="-1.0197910873796672" EFFECT_SIZE="-0.26751082007634774" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2534" SD_1="0.51" SD_2="0.85" SE="0.3838235157570292" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="13.039497208702908"/>
<CONT_DATA CI_END="-0.022765335912631635" CI_START="-2.264232881184172" EFFECT_SIZE="-1.1434991085484019" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="9.14" ORDER="2535" SD_1="1.99" SD_2="7.84" SE="0.5718134524287054" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="5.8751000585019515"/>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="2536" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.584925882686859"/>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="2537" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="35.26357518515429"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.380172766114548" CI_START="-0.8810829019163788" DF="0.0" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" I2="0.0" ID="CMP-005.07.02" NO="2" P_CHI2="1.0" P_Z="0.4363311830916393" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="18.555553583146406" Z="0.7784034994232293">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.380172766114548" CI_START="-0.8810829019163788" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="46.0" ORDER="2538" SD_1="8.7" SD_2="10.8" SE="0.3217548072259364" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="18.555553583146406"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" DF="0.0" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" I2="0.0" ID="CMP-005.07.03" NO="3" P_CHI2="1.0" P_Z="0.01659699832819686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.68134808180758" Z="2.395515812805348">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="2539" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.68134808180758"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.931664549354908" CI_END="-0.06962130751815182" CI_START="-0.838983198969701" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.45430225324392637" ESTIMABLE="YES" I2="23.6964404683958" I2_Q="45.94473243727725" ID="CMP-005.08" NO="8" P_CHI2="0.26893836288170114" P_Q="0.1737884075578816" P_Z="0.020630057729464885" Q="1.8499584685981905" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03759019868471252" TOTALS="YES" TOTAL_1="74" TOTAL_2="84" UNITS="" WEIGHT="100.0" Z="2.3146871825781483">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.0817060807567174" CI_END="0.08342024519488622" CI_START="-0.6796591376748391" DF="2.0" EFFECT_SIZE="-0.29811944623997644" ESTIMABLE="YES" I2="3.924957587048818" ID="CMP-005.08.01" NO="1" P_CHI2="0.353153459688324" P_Z="0.12566182861770742" STUDIES="3" TAU2="0.005661245957582937" TOTAL_1="54" TOTAL_2="64" WEIGHT="73.73007697401994" Z="1.5314353679009889">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.4719732474819971" CI_START="-1.0333537967547248" EFFECT_SIZE="-0.28069027463636387" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.3" ORDER="2540" SD_1="0.62" SD_2="0.74" SE="0.38401905752109466" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="20.81568226942848"/>
<CONT_DATA CI_END="0.0582778375411388" CI_START="-2.149781105514995" EFFECT_SIZE="-1.045751633986928" ESTIMABLE="YES" MEAN_1="1.86" MEAN_2="2.86" ORDER="2541" SD_1="0.9" SD_2="0.9" SE="0.5632906932150337" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="10.85464344346458"/>
<CONT_DATA CI_END="0.2886432974821726" CI_START="-0.6222469115213254" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.95" ORDER="2542" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="42.059751261126884"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" DF="0.0" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" ID="CMP-005.08.03" NO="3" P_CHI2="1.0" P_Z="0.014437591269834836" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="26.26992302598006" Z="2.4461874573937834">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="3.0" ORDER="2543" SD_1="1.5" SD_2="2.7" SE="0.33022378325494234" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="26.26992302598006"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.640070173240802" CI_END="1.322174303202925" CI_START="0.710778148564183" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9694186935012723" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="0.12128871228219874" LOG_CI_START="-0.1482659321664973" LOG_EFFECT_SIZE="-0.013488609942149272" METHOD="MH" NO="9" P_CHI2="0.5907330725104958" P_Q="0.0" P_Z="0.8444891735973985" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="223" WEIGHT="100.0" Z="0.1961545848500731">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6330169834704058" CI_END="1.8784215501819799" CI_START="0.7845018955295239" DF="3.0" EFFECT_SIZE="1.213929679479528" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="26" I2="0.0" ID="CMP-005.09.01" LOG_CI_END="0.2737930620374051" LOG_CI_START="-0.10540600272456782" LOG_EFFECT_SIZE="0.08419352965641862" NO="1" P_CHI2="0.6519268882653212" P_Z="0.38411397520199253" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="50.53114314682371" Z="0.8703412069935768">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.6601562747764063" CI_START="0.8297809266717024" EFFECT_SIZE="1.4857142857142858" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.42490715064590723" LOG_CI_START="-0.08103655207686013" LOG_EFFECT_SIZE="0.17193529928452353" ORDER="2544" O_E="0.0" SE="0.2971938354410734" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.08832417582417582" WEIGHT="28.38502288709415"/>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2545" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="1.9620655452414457"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2546" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="3.7248101462043954"/>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="2547" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="16.459244568283726"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.23884456260922093" CI_END="1.1705849402463695" CI_START="0.4800877191606528" DF="1.0" EFFECT_SIZE="0.74965555693711" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="36" I2="0.0" ID="CMP-005.09.02" LOG_CI_END="0.06840293254941424" LOG_CI_START="-0.318679403318436" LOG_EFFECT_SIZE="-0.1251382353845109" NO="2" P_CHI2="0.6250419070983673" P_Z="0.20506337170402378" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="103" WEIGHT="48.493879838411246" Z="1.2672571787221576">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="2548" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="42.22617045777885"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2549" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="6.267709380632396"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.09.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.9749770147650392" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2550" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.9749770147650392"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.685283991380386" CI_END="1.8319340246736282" CI_START="0.3354170945131739" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7838762580253681" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" I2="14.62630638059757" I2_Q="0.0" ID="CMP-005.10" LOG_CI_END="0.26290982891909753" LOG_CI_START="-0.47441480737228303" LOG_EFFECT_SIZE="-0.10575248922659274" METHOD="MH" NO="10" P_CHI2="0.321139434030409" P_Q="0.0" P_Z="0.5739629207709848" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1398281510928951" TOTALS="YES" TOTAL_1="127" TOTAL_2="144" WEIGHT="99.99999999999999" Z="0.562224724246624">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.533145101433542" CI_END="3.579967562941927" CI_START="0.265177618603538" DF="1.0" EFFECT_SIZE="0.9743342717049688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-005.10.01" LOG_CI_END="0.5538790916441118" LOG_CI_START="-0.5764631338387787" LOG_EFFECT_SIZE="-0.011292021097333432" NO="1" P_CHI2="0.4652876652574288" P_Z="0.9687630306471365" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="21" WEIGHT="36.30794836658048" Z="0.039159741473844475">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2551" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="13.232355912907927"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2552" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="23.075592453672556"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.054247053987038" CI_END="3.2783262541128084" CI_START="0.09865463639829597" DF="1.0" EFFECT_SIZE="0.5687021053191967" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="67.258706243341" ID="CMP-005.10.02" LOG_CI_END="0.5156521717208289" LOG_CI_START="-1.0058824997186306" LOG_EFFECT_SIZE="-0.24511516399890093" NO="2" P_CHI2="0.08052654581251328" P_Z="0.527720250681456" STUDIES="2" TAU2="1.0752027849657277" TOTAL_1="85" TOTAL_2="103" WEIGHT="56.77339061572731" Z="0.6314899062378546">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="2553" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="26.671616575027848"/>
<DICH_DATA CI_END="5.208499115067838" CI_START="0.34132246900739327" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7167125947102104" LOG_CI_START="-0.4668351214936106" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2554" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="30.101774040699464"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.10.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.918661017692197" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2555" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="6.918661017692197"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1876473359458186" CI_END="2.1941175695135633" CI_START="1.2106942927536184" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6298483423437014" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-005.11" LOG_CI_END="0.3412598950814285" LOG_CI_START="0.0830344951405906" LOG_EFFECT_SIZE="0.2121471951110095" METHOD="MH" NO="11" P_CHI2="0.5522119949524318" P_Q="0.0" P_Z="0.0012798997611695115" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="168" WEIGHT="100.0" Z="3.2204489715886564">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" DF="1.0" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" ID="CMP-005.11.01" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" NO="1" P_CHI2="0.41779777973047816" P_Z="0.021254905136773212" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="27.76751591866951" Z="2.3034256644443234">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2556" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="4.76743899732525"/>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="2557" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="23.00007692134426"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-005.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="72.2324840813305" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="2558" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="72.2324840813305"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" I2="0.0" ID="CMP-005.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2559" O_E="0.0" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.4471015958559326" CI_END="-0.30948805809425706" CI_START="-0.9228109539735939" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6161495060339255" ESTIMABLE="YES" I2="12.970363171002363" I2_Q="27.289927502137925" ID="CMP-005.12" NO="12" P_CHI2="0.32768805829615577" P_Q="0.25275760622279575" P_Z="8.216576146918974E-5" Q="2.750650537528768" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0150848016661147" TOTALS="YES" TOTAL_1="107" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="3.9379936703234506">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6964510583271646" CI_END="-0.2991250155371573" CI_START="-1.5113689966142019" DF="1.0" EFFECT_SIZE="-0.9052470060756796" ESTIMABLE="YES" I2="0.0" ID="CMP-005.12.01" NO="1" P_CHI2="0.4039791819030496" P_Z="0.0034200846498160646" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="23.644266607617364" Z="2.9272185413445753">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.07400266871028871" CI_START="-1.4743503608812065" EFFECT_SIZE="-0.700173846085459" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="11.3" ORDER="2560" SD_1="5.68" SD_2="9.61" SE="0.3949952758838189" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="14.307269777527317"/>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="2561" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.336996830090047"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-005.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="56.784078285228375" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="2562" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="56.784078285228375"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" DF="0.0" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" I2="0.0" ID="CMP-005.12.03" NO="3" P_CHI2="1.0" P_Z="0.01046097516817652" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.571655107154264" Z="2.5602072700386764">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="2.4" ORDER="2563" SD_1="1.1" SD_2="2.9" SE="0.3316581732834669" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.571655107154264"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.15508736788643443" CI_END="1.8971472761059518" CI_START="0.2676567200394752" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7125897959937005" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-005.13" LOG_CI_END="0.2781010466068509" LOG_CI_START="-0.5724218483409831" LOG_EFFECT_SIZE="-0.14716040086706608" METHOD="MH" NO="13" P_CHI2="0.9253866208814989" P_Q="0.0" P_Z="0.49761989451149546" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="113" WEIGHT="100.0" Z="0.6782394392043192">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-005.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.866750975750852" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="2564" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="13.866750975750852"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-005.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.30456919828377" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="2565" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="68.30456919828377"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.083060192649951" CI_START="0.04918297059741634" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-005.13.03" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" NO="3" P_CHI2="1.0" P_Z="0.5579989793003175" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.82867982596538" Z="0.585816288803313">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2566" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="17.82867982596538"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.15" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.15.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.1789822846393054" CI_END="2.6901982696444353" CI_START="1.1207126654994066" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7363580487604238" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="39" I2="37.08678372748703" I2_Q="0.0" ID="CMP-005.16" LOG_CI_END="0.4297842890133145" LOG_CI_START="0.0494942800493958" LOG_EFFECT_SIZE="0.23963928453135513" METHOD="MH" NO="16" P_CHI2="0.20402953329545226" P_Q="0.0" P_Z="0.013506100623285153" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.05649027104528802" TOTALS="YES" TOTAL_1="122" TOTAL_2="150" WEIGHT="100.0" Z="2.470137820565071">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-005.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="45.168496036319404" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="2567" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="45.168496036319404"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5810912337081713" CI_START="0.7508125415637287" DF="0.0" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" I2="0.0" ID="CMP-005.16.02" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" NO="2" P_CHI2="1.0" P_Z="0.2936490530586643" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="32.04486799052132" Z="1.050150251868255">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="2568" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="32.04486799052132"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0514801901976165" CI_START="1.4521773760684742" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-005.16.03" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" NO="3" P_CHI2="1.0" P_Z="0.003908892607536905" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="22.786635973159278" Z="2.88542203962941">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="7.0514801901976165" CI_START="1.4521773760684742" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" ORDER="2569" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.16250000000000003" WEIGHT="22.786635973159278"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="10.05578915203161" CI_END="0.6262294009688185" CI_START="-1.784480698893757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5791256489624692" ESTIMABLE="YES" I2="90.05547963584772" I2_Q="90.05547963584772" ID="CMP-005.17" NO="17" P_CHI2="0.0015187088582974129" P_Q="0.0015187088582974129" P_Z="0.3463536745706467" Q="10.05578915203161" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.6836610431139938" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="0.9416855345273837">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="2570" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" DF="0.0" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" I2="0.0" ID="CMP-005.17.03" NO="3" P_CHI2="1.0" P_Z="3.97783813112423E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656" Z="3.5415497659113866">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="2.4" ORDER="2571" SD_1="1.1" SD_2="1.7" SE="0.34792608783334095" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>SUBGROUP2: TCA: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="3.9640756962755814" CI_END="1.3642010569915766" CI_START="1.0058179475932831" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1713829037713737" ESTIMABLE="YES" EVENTS_1="183" EVENTS_2="174" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.13487838168936128" LOG_CI_START="0.0025193808088532837" LOG_EFFECT_SIZE="0.06869888124910734" METHOD="MH" NO="1" P_CHI2="0.9709561277394684" P_Q="0.0" P_Z="0.04189338729611386" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="367" TOTAL_2="393" WEIGHT="99.99999999999997" Z="2.0345776581979815">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8019291395571133" CI_END="1.5017503147788205" CI_START="0.991810533130172" DF="7.0" EFFECT_SIZE="1.2204309813869794" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="83" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.17659773165098294" LOG_CI_START="-0.003571283768219985" LOG_EFFECT_SIZE="0.08651322394138149" NO="1" P_CHI2="0.9027009298808203" P_Z="0.05980021405000692" STUDIES="8" TAU2="0.0" TOTAL_1="229" TOTAL_2="207" WEIGHT="53.969295623016194" Z="1.8822637479261444">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3824152363315836" CI_START="0.3902959167635606" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3770174578735022" LOG_CI_START="-0.40860599223996596" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="2572" O_E="0.0" SE="0.46147910349544863" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="27" VAR="0.21296296296296297" WEIGHT="2.8384293175117863"/>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="2573" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="6.980036875139048"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="2574" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="6.649283493800758"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="2575" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="4.44107988454225"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="2576" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="4.616031516357553"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="2577" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="1.1199397808604172"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="2578" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="12.20227544620629"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="2579" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="15.1222193085981"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8217050057655444" CI_END="1.397513543105219" CI_START="0.8918019620914295" DF="3.0" EFFECT_SIZE="1.1163804547691525" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="91" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.14535602526498329" LOG_CI_START="-0.049731576475598116" LOG_EFFECT_SIZE="0.047812224394692564" NO="2" P_CHI2="0.8442688104846571" P_Z="0.33670351586201397" STUDIES="4" TAU2="0.0" TOTAL_1="138" TOTAL_2="186" WEIGHT="46.030704376983785" Z="0.9606990603017046">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="2580" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="18.160011047881948"/>
<DICH_DATA CI_END="1.5648074868854178" CI_START="0.7889583297507372" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="42" LOG_CI_END="0.1944609153482074" LOG_CI_START="-0.10294593422685715" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="2581" O_E="0.0" SE="0.17469825562804145" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.03051948051948052" WEIGHT="19.8063763645129"/>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="2582" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="6.55311617054331"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2583" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="1.5112007940456271"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.195244608502385" CI_END="1.454417333533169" CI_START="1.003875541244918" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2083269375035055" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="127" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.16268904176688356" LOG_CI_START="0.0016798730669293218" LOG_EFFECT_SIZE="0.08218445741690646" METHOD="MH" NO="2" P_CHI2="0.5145966328263348" P_Q="0.0" P_Z="0.04540724629971675" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="313" TOTAL_2="340" WEIGHT="100.0" Z="2.0008621611639694">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.6481748153335305" CI_END="1.9046049560250762" CI_START="0.9986887055248483" DF="6.0" EFFECT_SIZE="1.3791691187337738" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="41" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="0.2798049100852211" LOG_CI_START="-5.698616646444976E-4" LOG_EFFECT_SIZE="0.13961752421028834" NO="1" P_CHI2="0.4637317456027993" P_Z="0.050938592637404384" STUDIES="7" TAU2="0.0" TOTAL_1="195" TOTAL_2="174" WEIGHT="32.977926776604214" Z="1.9519967317669007">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2584" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.9276212451712538"/>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="2585" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="16.792302207723267"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="2586" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="3.2526978726784224"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="2587" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="3.975519622162516"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="2588" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="1.4967593796587961"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="2589" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="2.6316676535227526"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="2590" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="3.9013587956872016"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.437826946379682" CI_END="1.4199091795711976" CI_START="0.9027946032476373" DF="2.0" EFFECT_SIZE="1.1322041973154213" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="86" I2="0.0" ID="CMP-006.02.02" LOG_CI_END="0.15226056686723297" LOG_CI_START="-0.04441104572495422" LOG_EFFECT_SIZE="0.05392476057113939" NO="2" P_CHI2="0.48728148693373907" P_Z="0.28246764847782013" STUDIES="3" TAU2="0.0" TOTAL_1="118" TOTAL_2="166" WEIGHT="67.02207322339578" Z="1.074792515313695">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="2591" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="30.357798689448003"/>
<DICH_DATA CI_END="1.7868745988134767" CI_START="0.8544588892874796" EFFECT_SIZE="1.2356418918918919" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="0.2520940751949005" LOG_CI_START="-0.06830882771808076" LOG_EFFECT_SIZE="0.09189262373840987" ORDER="2592" O_E="0.0" SE="0.18820625119103365" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.035421592987382455" WEIGHT="25.252729748918792"/>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="2593" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="11.411544785028985"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.4000841075350206" CI_END="-0.2824357250322107" CI_START="-0.6717989934343571" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4771173592332839" ESTIMABLE="YES" I2="0.0" I2_Q="32.8004484195491" ID="CMP-006.03" NO="3" P_CHI2="0.4936143717349212" P_Q="0.22251103653715731" P_Z="1.5599750177763593E-6" Q="1.488105168087031" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="201" TOTAL_2="253" UNITS="" WEIGHT="100.0" Z="4.803395268041882">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9023334626406148" CI_END="-0.3194698560529654" CI_START="-0.9162693479822595" DF="3.0" EFFECT_SIZE="-0.6178696020176124" ESTIMABLE="YES" I2="0.0" ID="CMP-006.03.01" NO="1" P_CHI2="0.8248647769804303" P_Z="4.942664744947924E-5" STUDIES="4" TAU2="0.0" TOTAL_1="94" TOTAL_2="89" WEIGHT="42.56504218579216" Z="4.058321709295593">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="2594" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.266713182352574"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="2595" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.329928084423477"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="2596" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="12.53280494574051"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="2597" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="15.435595973275596"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.009645476807375" CI_END="-0.0678989028686352" CI_START="-0.7026163081770123" DF="2.0" EFFECT_SIZE="-0.38525760552282373" ESTIMABLE="YES" I2="33.546990321212334" ID="CMP-006.03.02" NO="2" P_CHI2="0.2220567230701066" P_Z="0.017345631375453644" STUDIES="3" TAU2="0.026476300901589523" TOTAL_1="107" TOTAL_2="164" WEIGHT="57.43495781420785" Z="2.3792983311305718">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="2598" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="21.30811995755182"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="2599" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="22.014955452890035"/>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="2600" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="14.111882403765993"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.689235829589398" CI_END="0.3998555472569722" CI_START="-0.0877251699275044" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1560651886647339" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.04" NO="4" P_CHI2="0.5764674624996835" P_Q="0.9079578553079496" P_Z="0.2095901143755018" Q="0.013366776040224515" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="133" TOTAL_2="132" UNITS="" WEIGHT="99.99999999999999" Z="1.2546933799582414">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.675869053549174" CI_END="0.4273242863125044" CI_START="-0.10290407717956954" DF="6.0" EFFECT_SIZE="0.16221010456646742" ESTIMABLE="YES" I2="0.0" ID="CMP-006.04.01" NO="1" P_CHI2="0.46046045572960914" P_Z="0.23044868976451782" STUDIES="7" TAU2="0.0" TOTAL_1="113" TOTAL_2="112" WEIGHT="84.56042016228848" Z="1.199203908236436">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="2601" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="4.962942311305622"/>
<CONT_DATA CI_END="0.4017416085839796" CI_START="-1.088391349315334" EFFECT_SIZE="-0.3433248703656772" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="1.07" ORDER="2602" SD_1="0.93" SD_2="1.75" SE="0.38014294386358427" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="10.70638861353468"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="2603" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="11.842934144536672"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="2604" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.862481317752595"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="2605" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="7.290943957502781"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="2606" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="12.247236324284746"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="2607" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="25.64749349337139"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7428489122247686" CI_START="-0.49802822544055" DF="0.0" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" I2="0.0" ID="CMP-006.04.02" NO="2" P_CHI2="1.0" P_Z="0.6989827684727183" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.439579837711511" Z="0.38669398782722103">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="2608" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.439579837711511"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.953653154966196" CI_END="0.015378539127478746" CI_START="-0.43939505534521905" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.21200825810887017" ESTIMABLE="YES" I2="22.80170018164967" I2_Q="0.0" ID="CMP-006.05" NO="5" P_CHI2="0.2262747791696601" P_Q="0.9062167981550551" P_Z="0.06763838267798818" Q="0.013879615414413848" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03313571613465839" TOTALS="YES" TOTAL_1="222" TOTAL_2="196" UNITS="" WEIGHT="100.0" Z="1.827408430783039">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.510244926861487" CI_END="0.07162895944129286" CI_START="-0.5109874487076291" DF="8.0" EFFECT_SIZE="-0.21967924463316815" ESTIMABLE="YES" I2="36.052411069724734" ID="CMP-006.05.01" NO="1" P_CHI2="0.12984857176159548" P_Z="0.13939869863271598" STUDIES="9" TAU2="0.06960670231162103" TOTAL_1="160" TOTAL_2="152" WEIGHT="76.34251279976415" Z="1.4780339228685702">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="2609" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="4.031110085782648"/>
<CONT_DATA CI_END="0.21869047113718676" CI_START="-1.2886598659887283" EFFECT_SIZE="-0.5349846974257708" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.5" ORDER="2610" SD_1="8.36" SD_2="9.55" SE="0.3845352131507778" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="7.436154819095271"/>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="2611" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="11.008235562001754"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="2612" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.179369759363468"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="2613" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.22788745996798"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="2614" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="7.008656642770334"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="2615" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.235022951798267"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="2616" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="10.889769396945741"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="2617" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="14.32630612203869"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4295286126902952" CI_END="0.19677475033121905" CI_START="-0.5856015964655856" DF="1.0" EFFECT_SIZE="-0.1944134230671833" ESTIMABLE="YES" I2="0.0" ID="CMP-006.05.02" NO="2" P_CHI2="0.5122203616640323" P_Z="0.3300235183509008" STUDIES="2" TAU2="0.0" TOTAL_1="62" TOTAL_2="44" WEIGHT="23.65748720023585" Z="0.9740665317475165">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="2618" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="13.548944406933359"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="2619" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="10.108542793302489"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.797922264953548" CI_END="-0.247474075177682" CI_START="-0.7288959576331608" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4881850164054214" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.06" NO="6" P_CHI2="0.44620368161228263" P_Q="0.7718606598390522" P_Z="7.0380412711671E-5" Q="0.08406633428808874" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="155" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="3.974996088945779">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.713855930665459" CI_END="-0.20652280388525146" CI_START="-0.8003207934037208" DF="5.0" EFFECT_SIZE="-0.5034217986444861" ESTIMABLE="YES" I2="12.493418443301922" ID="CMP-006.06.01" NO="1" P_CHI2="0.335065096520343" P_Z="8.895471359427269E-4" STUDIES="6" TAU2="0.017466773551999357" TOTAL_1="113" TOTAL_2="105" WEIGHT="77.45810685653153" Z="3.323314028650406">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="2620" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="5.279144193896651"/>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="2621" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="16.594358217837037"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="2622" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="10.971381471490771"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="2623" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.579846758421494"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="2624" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="8.719425254217962"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="2625" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="24.31395096066761"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.08481450726307865" CI_START="-0.9291683981481176" DF="0.0" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" I2="0.0" ID="CMP-006.06.02" NO="2" P_CHI2="1.0" P_Z="0.10266221973456985" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="24" WEIGHT="22.54189314346847" Z="1.6320819685513661">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="2626" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="22.54189314346847"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.081080543778702" CI_END="-0.07245466985981863" CI_START="-0.4989612720926001" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.28570797097620937" ESTIMABLE="YES" I2="1.0033378994238926" I2_Q="0.0" ID="CMP-006.07" NO="7" P_CHI2="0.42559035912722154" P_Q="0.9243488668745521" P_Z="0.008642557199175848" Q="0.009016859395286403" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0010880578617409862" TOTALS="YES" TOTAL_1="197" TOTAL_2="175" UNITS="" WEIGHT="99.99999999999999" Z="2.6258788505400794">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.571395209636752" CI_END="-0.028316562554770164" CI_START="-0.5310790872163522" DF="6.0" EFFECT_SIZE="-0.27969782488556116" ESTIMABLE="YES" I2="0.0" ID="CMP-006.07.01" NO="1" P_CHI2="0.47287001520507776" P_Z="0.02920250861758008" STUDIES="8" TAU2="0.0" TOTAL_1="135" TOTAL_2="131" WEIGHT="71.17628379055986" Z="2.180741946504036">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="2627" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.4639401327102852" CI_START="-1.0220729437718097" EFFECT_SIZE="-0.27906640553076223" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2628" SD_1="0.51" SD_2="0.8" SE="0.37909193439358485" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="8.17580496603268"/>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="2629" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="13.150799774678864"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="2630" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.637081977045725"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="2631" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.961054597498698"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="2632" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="7.573926973512223"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="2633" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.577420128956208"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="2634" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="19.100195372835472"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.5006684747466643" CI_END="0.36833475509192853" CI_START="-0.898880178722522" DF="1.0" EFFECT_SIZE="-0.2652727118152967" ESTIMABLE="YES" I2="60.01069273681681" ID="CMP-006.07.02" NO="2" P_CHI2="0.11379826762838186" P_Z="0.4118861394790443" STUDIES="2" TAU2="0.12616353446684542" TOTAL_1="62" TOTAL_2="44" WEIGHT="28.82371620944012" Z="0.8205789678854645">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="2635" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="17.123907466761448"/>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="2636" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.699808742678675"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.955644417182201" CI_END="-0.21821181690695335" CI_START="-0.7479672084346506" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.48308951267080197" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.08" NO="8" P_CHI2="0.42131753804263805" P_Q="1.0" P_Z="3.5073218021363696E-4" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="112" UNITS="" WEIGHT="100.0" Z="3.5746235386611427">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.955644417182201" CI_END="-0.21821181690695335" CI_START="-0.7479672084346506" DF="5.0" EFFECT_SIZE="-0.48308951267080197" ESTIMABLE="YES" I2="0.0" ID="CMP-006.08.01" NO="1" P_CHI2="0.42131753804263805" P_Z="3.5073218021363696E-4" STUDIES="6" TAU2="0.0" TOTAL_1="120" TOTAL_2="112" WEIGHT="100.0" Z="3.5746235386611427">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8873607300917461" CI_START="-0.6116126107138591" EFFECT_SIZE="0.13787405968894345" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.0" ORDER="2637" SD_1="0.62" SD_2="0.76" SE="0.3823981850251626" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="12.490014793780352"/>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="2638" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="13.566378078055463"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="2639" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="13.73340103327467"/>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="2640" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="11.470838313940844"/>
<CONT_DATA CI_END="0.26110133948943387" CI_START="-0.9235736714263485" EFFECT_SIZE="-0.33123616596845734" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.4" ORDER="2641" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="19.996423009698404"/>
<CONT_DATA CI_END="-0.2834851042937671" CI_START="-1.2716052532915705" EFFECT_SIZE="-0.7775451787926688" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.9" ORDER="2642" SD_1="0.89" SD_2="0.89" SE="0.2520760985385367" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="28.742944771250272"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.808809935739647" CI_END="1.4903470444047011" CI_START="0.8994975014259563" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1578270348802482" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="90" I2="0.0" I2_Q="0.0" ID="CMP-006.09" LOG_CI_END="0.17328741064059355" LOG_CI_START="-0.046000038675769336" LOG_EFFECT_SIZE="0.06364368598241212" METHOD="MH" NO="9" P_CHI2="0.7588904779511283" P_Q="0.0" P_Z="0.2552546811675791" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="332" TOTAL_2="360" WEIGHT="99.99999999999999" Z="1.1376787203990388">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.5919102795044884" CI_END="1.5857256699144284" CI_START="0.8530937924731196" DF="5.0" EFFECT_SIZE="1.1630875829314307" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="48" I2="0.0" ID="CMP-006.09.01" LOG_CI_END="0.20022805665914734" LOG_CI_START="-0.06900321817100614" LOG_EFFECT_SIZE="0.06561241924407056" NO="1" P_CHI2="0.7625940612727905" P_Z="0.33942729534829186" STUDIES="7" TAU2="0.0" TOTAL_1="194" TOTAL_2="174" WEIGHT="66.34016338320009" Z="0.9552974760309558">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2643" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9619712520075643" CI_START="0.9320516049237294" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.47158083907544335" LOG_CI_START="-0.030560041387254936" LOG_EFFECT_SIZE="0.22051039884409415" ORDER="2644" O_E="0.0" SE="0.29496003882123506" STUDY_ID="STD-Johnston-1995" TOTAL_1="26" TOTAL_2="27" VAR="0.0870014245014245" WEIGHT="19.07112850530748"/>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="2645" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="17.880228539981534"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2646" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="4.389735090776812"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="2647" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="3.2764252418049358"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="2648" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="13.680780524660657"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="2649" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="8.041865480668681"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.363829673831808" CI_END="1.8925376710444903" CI_START="0.7260601907655041" DF="3.0" EFFECT_SIZE="1.1722185216372694" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="42" I2="10.815936272342892" ID="CMP-006.09.02" LOG_CI_END="0.277044532908661" LOG_CI_START="-0.13902737457021094" LOG_EFFECT_SIZE="0.069008579169225" NO="2" P_CHI2="0.3388571715983121" P_Z="0.5155961008978444" STUDIES="4" TAU2="0.028562052898767492" TOTAL_1="138" TOTAL_2="186" WEIGHT="33.65983661679989" Z="0.6501488197822164">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="2650" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="13.77049383641139"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="2651" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="14.491831244935502"/>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="2652" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="4.6174326783699975"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2653" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="0.7800788570830061"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.400815330421236" CI_END="5.448393104392884" CI_START="1.1456178378119546" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.4983547241743196" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-006.10" LOG_CI_END="0.7362684346076682" LOG_CI_START="0.059039767187060395" LOG_EFFECT_SIZE="0.39765410089736436" METHOD="MH" NO="10" P_CHI2="0.6226045319006235" P_Q="0.0" P_Z="0.021352245504930607" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="228" TOTAL_2="269" WEIGHT="99.99999999999997" Z="2.3016973544016706">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.539012290225242" CI_END="4.175962142493917" CI_START="0.6721124767658356" DF="2.0" EFFECT_SIZE="1.6753257171284492" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" I2="0.0" ID="CMP-006.10.01" LOG_CI_END="0.6207565528820135" LOG_CI_START="-0.17255804249498016" LOG_EFFECT_SIZE="0.22409925519351667" NO="1" P_CHI2="0.46324191680604476" P_Z="0.26815571570214936" STUDIES="3" TAU2="0.0" TOTAL_1="90" TOTAL_2="83" WEIGHT="72.87520315491344" Z="1.1073197737722626">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="2654" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="20.346529428507246"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="2655" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="13.490230805057625"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="2656" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="39.03844292134857"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04745113804511666" CI_END="32.66632967819113" CI_START="1.6359680544472819" DF="3.0" EFFECT_SIZE="7.310340061143795" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" I2="0.0" ID="CMP-006.10.02" LOG_CI_END="1.5141003407792526" LOG_CI_START="0.21377481894855446" LOG_EFFECT_SIZE="0.8639375798639035" NO="2" P_CHI2="0.9972897168395763" P_Z="0.009203418076377869" STUDIES="4" TAU2="0.0" TOTAL_1="138" TOTAL_2="186" WEIGHT="27.124796845086543" Z="2.6044040711282954">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="2657" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="6.036351062580779"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="2658" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="6.0319490472192365"/>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="2659" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="7.616347914414478"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2660" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="7.44014882087205"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3432988163666737" CI_END="1.510581734881255" CI_START="0.9968292684519512" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2271072022111844" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="100" I2="0.0" I2_Q="0.0" ID="CMP-006.11" LOG_CI_END="0.1791442291442551" LOG_CI_START="-0.001379218938752684" LOG_EFFECT_SIZE="0.08888250510275121" METHOD="MH" NO="11" P_CHI2="0.5021015221936571" P_Q="0.0" P_Z="0.05360494141861328" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="162" TOTAL_2="228" WEIGHT="100.0" Z="1.930015305014413">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" DF="2.0" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" ID="CMP-006.11.01" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" NO="1" P_CHI2="0.227899780136411" P_Z="0.3063895529035281" STUDIES="3" TAU2="0.04674841377412624" TOTAL_1="97" TOTAL_2="88" WEIGHT="43.762773632369715" Z="1.0228272347262604">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2661" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="2.3299922018144454"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="2662" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="25.36935479369806"/>
<DICH_DATA CI_END="1.6014883037625876" CI_START="0.5676844929685975" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" ORDER="2663" O_E="0.0" SE="0.26457702275065764" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.070001000967602" WEIGHT="16.06342663685721"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-006.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="56.23722636763029" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="2664" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="29.822040981870824"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="2665" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="26.415185385759468"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.133972258048254" CI_END="-0.3334892460847304" CI_START="-0.9718365394537506" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6526628927692405" ESTIMABLE="YES" I2="34.78940184720129" I2_Q="76.16092516404896" ID="CMP-006.12" NO="12" P_CHI2="0.189364218538703" P_Q="0.04054842406948567" P_Z="6.127753920015621E-5" Q="4.1947936607503244" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.044746681824347254" TOTALS="YES" TOTAL_1="116" TOTAL_2="190" UNITS="" WEIGHT="100.0" Z="4.007836414946472">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" DF="2.0" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" ID="CMP-006.12.01" NO="1" P_CHI2="0.398881402393063" P_Z="8.814533869822001E-6" STUDIES="3" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="41.598193787798095" Z="4.444380855933662">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.32992271565191034" CI_START="-1.9354422337814112" EFFECT_SIZE="-1.1326824747166608" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="14.6" ORDER="2666" SD_1="5.68" SD_2="9.11" SE="0.4095788317524286" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="12.479462107116134"/>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="2667" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="8.090341478248416"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="2668" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="21.02839020243355"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-006.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="58.401806212201905" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="2669" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="28.935824294395545"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="2670" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="29.465981917806364"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.7269122710222943" CI_END="2.1455069060541696" CI_START="0.2784966187870194" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.772991862130699" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-006.13" LOG_CI_END="0.3315299167975606" LOG_CI_START="-0.5551800732049874" LOG_EFFECT_SIZE="-0.11182507820371332" METHOD="MH" NO="13" P_CHI2="0.6952693452285448" P_Q="0.0" P_Z="0.6210580907158085" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="149" WEIGHT="100.0" Z="0.4943513173839924">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.57376743870334" CI_START="0.12485388869486465" DF="0.0" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-006.13.01" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" NO="1" P_CHI2="1.0" P_Z="0.523706034306008" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="10.957974619597316" Z="0.6376431033323103">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="2671" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="10.957974619597316"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-006.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="89.04202538040269" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="2672" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="43.722318732193294"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="2673" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="45.31970664820939"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.9142607436753707" CI_END="1.1836314592076687" CI_START="0.7007819025749966" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9107510669393529" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="95" I2="0.0" I2_Q="0.0" ID="CMP-006.18" LOG_CI_END="0.07321649955950485" LOG_CI_START="-0.15441712218429715" LOG_EFFECT_SIZE="-0.0406003113123961" METHOD="MH" NO="18" P_CHI2="0.8195286128036632" P_Q="0.0" P_Z="0.48445761478931393" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="185" TOTAL_2="259" WEIGHT="100.0" Z="0.6991510948498731">
<NAME>Response 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6313628152497521" CI_END="1.3636354129050896" CI_START="0.7269761445402245" DF="4.0" EFFECT_SIZE="0.995655771354869" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="46" I2="0.0" ID="CMP-006.18.01" LOG_CI_END="0.13469827110596352" LOG_CI_START="-0.13847984012380476" LOG_EFFECT_SIZE="-0.0018907845089205925" NO="1" P_CHI2="0.8031445588166823" P_Z="0.9783548297434249" STUDIES="5" TAU2="0.0" TOTAL_1="126" TOTAL_2="124" WEIGHT="69.43541260829969" Z="0.027131526192401837">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2674" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="3.8509040658171623"/>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="2675" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="12.207176188932731"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2676" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="6.70469904316381"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="2677" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="7.6625131921872125"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="2678" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="39.01012011819876"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2422119208092252" CI_END="1.1949035758859248" CI_START="0.46300853125965286" DF="1.0" EFFECT_SIZE="0.7438081403613765" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="49" I2="0.0" ID="CMP-006.18.02" LOG_CI_END="0.07733286080695621" LOG_CI_START="-0.3344110067253377" LOG_EFFECT_SIZE="-0.1285390729591907" NO="2" P_CHI2="0.6226131221215001" P_Z="0.22105358613984316" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="30.56458739170032" Z="1.2237314188361075">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="2679" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="15.47478234252792"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="2680" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="15.0898050491724"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.1607104738682485" CI_END="0.4522549475416378" CI_START="-0.1365108977410016" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1578720249003181" ESTIMABLE="YES" I2="22.49129223089761" I2_Q="0.0" ID="CMP-006.19" NO="19" P_CHI2="0.2712015973910762" P_Q="0.6235785285123929" P_Z="0.2932164343637472" Q="0.24086994309802545" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.025485667010159252" TOTALS="YES" TOTAL_1="106" TOTAL_2="175" UNITS="" WEIGHT="100.00000000000001" Z="1.0510918235159994">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.646504351236112" CI_END="0.7512481843951335" CI_START="-0.5885937586681784" DF="2.0" EFFECT_SIZE="0.0813272128634776" ESTIMABLE="YES" I2="56.95688954928153" ID="CMP-006.19.01" NO="1" P_CHI2="0.09795467886811837" P_Z="0.8119306270395139" STUDIES="3" TAU2="0.19942951145512536" TOTAL_1="47" TOTAL_2="40" WEIGHT="39.50620965843923" Z="0.23793613717003428">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="2681" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="17.7943929954717"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="2682" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="11.516449146883243"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="2683" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="10.19536751608429"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-006.19.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="60.49379034156078" Z="1.3386680075530792">
<NAME>Cognitive-behviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="2684" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="29.905576425231686"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="2685" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="30.588213916329092"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>SUBGROUP2: SSRI: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="7.892674887779147" CI_END="2.0285474849689478" CI_START="0.7478116402612651" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2316539376312217" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="60" I2="74.66004835576392" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.3071851782807278" LOG_CI_START="-0.12620777900275354" LOG_EFFECT_SIZE="0.09048869963898717" METHOD="MH" NO="1" P_CHI2="0.019325394477972546" P_Q="0.0" P_Z="0.4131019765091498" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1352520264439343" TOTALS="YES" TOTAL_1="110" TOTAL_2="108" WEIGHT="100.0" Z="0.8184470435880672">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.938011413543596" CI_END="4.053561554617282" CI_START="0.6942624185927817" DF="1.0" EFFECT_SIZE="1.6775683142046138" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="26" I2="74.606472785711" ID="CMP-007.01.02" LOG_CI_END="0.607836772302758" LOG_CI_START="-0.15847634308208888" LOG_EFFECT_SIZE="0.2246802146103345" NO="2" P_CHI2="0.04720661513344604" P_Z="0.2504287707384345" STUDIES="2" TAU2="0.31217326026919745" TOTAL_1="60" TOTAL_2="58" WEIGHT="59.276820777205074" Z="1.1493086046265355">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.438919612627209" CI_START="1.2175955706334904" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.8088130031305857" LOG_CI_START="0.08550305955385278" LOG_EFFECT_SIZE="0.4471580313422192" ORDER="2686" O_E="0.0" SE="0.4248758412989382" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.18051948051948052" WEIGHT="20.524187034217313"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="2687" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="38.75263374298776"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1547728590043567" CI_START="0.6300015148834446" DF="0.0" EFFECT_SIZE="0.8529411764705882" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="34" I2="0.0" ID="CMP-007.01.03" LOG_CI_END="0.0624965679665984" LOG_CI_START="-0.20065840625319653" LOG_EFFECT_SIZE="-0.06908091914329904" NO="3" P_CHI2="1.0" P_Z="0.30346940642088005" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="40.723179222794926" Z="1.029021882951016">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1547728590043567" CI_START="0.6300015148834446" EFFECT_SIZE="0.8529411764705882" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="34" LOG_CI_END="0.0624965679665984" LOG_CI_START="-0.20065840625319653" LOG_EFFECT_SIZE="-0.06908091914329904" ORDER="2688" O_E="0.0" SE="0.15457853449483858" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.023894523326571996" WEIGHT="40.723179222794926"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.505871175610993" CI_END="1.6950277179104385" CI_START="0.3761875745399713" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7985288761082787" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="46" I2="81.83756996659064" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="0.22917680438991475" LOG_CI_START="-0.42459555327751797" LOG_EFFECT_SIZE="-0.09770937444380154" METHOD="MH" NO="2" P_CHI2="0.018952833256170476" P_Q="0.0" P_Z="0.5579751161597482" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.242107688623734" TOTALS="YES" TOTAL_1="88" TOTAL_2="86" WEIGHT="100.0" Z="0.585851795707787">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6622456282399865" CI_START="0.7775084201410078" DF="0.0" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" NO="2" P_CHI2="1.0" P_Z="0.5081904547197454" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="36" WEIGHT="52.730959951009" Z="0.6616579639147724">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="2689" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="52.730959951009"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9040336721887139" CI_START="0.3207190587275412" DF="0.0" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" I2="0.0" ID="CMP-007.02.03" LOG_CI_END="-0.043815393226618926" LOG_CI_START="-0.49387523135854094" LOG_EFFECT_SIZE="-0.26884531229257996" NO="3" P_CHI2="1.0" P_Z="0.019201950895338257" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="47.26904004899101" Z="2.341586984046449">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.9040336721887139" CI_START="0.3207190587275412" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.043815393226618926" LOG_CI_START="-0.49387523135854094" LOG_EFFECT_SIZE="-0.26884531229257996" ORDER="2690" O_E="0.0" SE="0.2643673767508198" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.06989010989010988" WEIGHT="47.26904004899101"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.332371116245477E-32" CI_END="0.0392849124643212" CI_START="-1.0061463786555822" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.48343073309563045" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-007.03" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.06988395750165902" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.8126620734151322">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.332371116245477E-32" CI_END="0.0392849124643212" CI_START="-1.0061463786555822" DF="0.0" EFFECT_SIZE="-0.48343073309563045" ESTIMABLE="YES" I2="100.0" ID="CMP-007.03.02" NO="2" P_CHI2="0.0" P_Z="0.06988395750165902" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="100.0" Z="1.8126620734151322">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="2691" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.027947622029414" CI_END="0.4502649397898825" CI_START="-1.3917168933388029" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4707259767744602" ESTIMABLE="YES" I2="84.6483877735421" I2_Q="54.49544413772159" ID="CMP-007.04" NO="4" P_CHI2="0.0014825835020485512" P_Q="0.13822748385713524" P_Z="0.31646262839923345" Q="2.197582156447247" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.5570263750215511" TOTALS="YES" TOTAL_1="57" TOTAL_2="81" UNITS="" WEIGHT="100.0" Z="1.0017535943862097">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.830365465582167" CI_END="0.8256905803797603" CI_START="-2.3384514961329224" DF="1.0" EFFECT_SIZE="-0.7563804578765811" ESTIMABLE="YES" I2="90.76670124218892" ID="CMP-007.04.02" NO="2" P_CHI2="9.984971272440912E-4" P_Z="0.3487332438047136" STUDIES="2" TAU2="1.1838706009253708" TOTAL_1="37" TOTAL_2="49" WEIGHT="65.40601359375837" Z="0.9370492349584432">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.8051814322011425" CI_START="-2.3712031782502496" EFFECT_SIZE="-1.588192305225696" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="9.07" ORDER="2692" SD_1="3.87" SD_2="1.98" SE="0.3995026843354487" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="30.812027187516737"/>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="2693" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="34.59398640624163"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5856257622309741" CI_START="-0.5317774780726351" DF="0.0" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" I2="0.0" ID="CMP-007.04.03" NO="3" P_CHI2="1.0" P_Z="0.9247503046351875" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="32" WEIGHT="34.59398640624163" Z="0.09445175543874984">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="2694" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="34.59398640624163"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.9690135286113024" CI_START="0.16288773194486145" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.005922634815298484" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="64" UNITS="" WEIGHT="100.0" Z="2.7520341290647656">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1359676475903302" CI_START="-0.004066387034166508" DF="0.0" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" I2="0.0" ID="CMP-007.05.02" NO="2" P_CHI2="1.0" P_Z="0.05165690247763168" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="32" WEIGHT="50.0" Z="1.94598199471851">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="2695" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="50.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1359676475903302" CI_START="-0.004066387034166508" DF="0.0" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" I2="0.0" ID="CMP-007.05.03" NO="3" P_CHI2="1.0" P_Z="0.05165690247763168" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="32" WEIGHT="50.0" Z="1.94598199471851">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="2696" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="50.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.4002991971985" CI_END="0.49123386513132794" CI_START="-0.9325511372511288" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.22065863605990044" ESTIMABLE="YES" I2="82.75891715423485" I2_Q="78.07733300084216" ID="CMP-007.06" NO="6" P_CHI2="5.846392083314056E-4" P_Q="0.032698692556863085" P_Z="0.5435114247793619" Q="4.561488800785119" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.4337397063259803" TOTALS="YES" TOTAL_1="86" TOTAL_2="110" UNITS="" WEIGHT="100.0" Z="0.6075116381075106">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="12.83881039641338" CI_END="0.4505856663740015" CI_START="-1.3164278786544963" DF="2.0" EFFECT_SIZE="-0.4329211061402474" ESTIMABLE="YES" I2="84.42223275951862" ID="CMP-007.06.02" NO="2" P_CHI2="0.0016296304721709065" P_Z="0.3368597174119763" STUDIES="3" TAU2="0.5115710475994826" TOTAL_1="66" TOTAL_2="78" WEIGHT="74.46009303975532" Z="0.9603885364313295">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.5404249278343514" CI_START="-2.0341743515424784" EFFECT_SIZE="-1.2872996396884149" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="28.71" ORDER="2697" SD_1="4.68" SD_2="4.18" SE="0.3810655286246665" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="22.7872078426165"/>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="2698" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="25.539906960244675"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="2699" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="26.132978236894154"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9514293494058191" CI_START="-0.17660753046268896" DF="0.0" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" I2="0.0" ID="CMP-007.06.03" NO="3" P_CHI2="1.0" P_Z="0.1782209875021376" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="32" WEIGHT="25.539906960244675" Z="1.3462528456883176">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="2700" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="25.539906960244675"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.17860078902451304" CI_START="-1.595980151651918" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.8872904703382155" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.01413141906564501" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="2.453905300927772">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.07.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17860078902451304" CI_START="-1.595980151651918" DF="0.0" EFFECT_SIZE="-0.8872904703382155" ESTIMABLE="YES" I2="0.0" ID="CMP-007.07.02" NO="2" P_CHI2="1.0" P_Z="0.01413141906564501" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="2.453905300927772">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17860078902451304" CI_START="-1.595980151651918" EFFECT_SIZE="-0.8872904703382155" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="12.2" ORDER="2701" SD_1="1.38" SD_2="4.46" SE="0.3615830121898954" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.21594600718033197" CI_START="-0.8197499551427975" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.25318556028922157" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.1426461382305813">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behavour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.21594600718033197" CI_START="-0.8197499551427975" DF="0.0" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" I2="0.0" ID="CMP-007.08.02" NO="2" P_CHI2="1.0" P_Z="0.25318556028922157" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="100.0" Z="1.1426461382305813">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="2702" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.5833965042963957" CI_END="1.6043082302010372" CI_START="0.6770968933165331" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0422437903826858" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-007.09" LOG_CI_END="0.20528781146395264" LOG_CI_START="-0.16934917884558534" LOG_EFFECT_SIZE="0.017969316309183667" METHOD="MH" NO="9" P_CHI2="0.7469939334123195" P_Q="0.0" P_Z="0.8508626917295227" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="108" WEIGHT="100.00000000000001" Z="0.1880178076580683">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04649509263246239" CI_END="1.607874533761196" CI_START="0.5075848020735368" DF="1.0" EFFECT_SIZE="0.903400618207812" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" I2="0.0" ID="CMP-007.09.02" LOG_CI_END="0.20625215671275177" LOG_CI_START="-0.2944913898760157" LOG_EFFECT_SIZE="-0.04411961658163194" NO="2" P_CHI2="0.8292785078513314" P_Z="0.7298103433813948" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="58" WEIGHT="55.9745472838175" Z="0.3453778290336315">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9732644695315953" CI_START="0.33633065953179025" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.47323354107503623" LOG_CI_START="-0.47323354107503623" LOG_EFFECT_SIZE="0.0" ORDER="2703" O_E="0.0" SE="0.5559594491425693" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.3090909090909091" WEIGHT="15.66788170193554"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="2704" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="40.30666558188196"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3945374130296906" CI_START="0.6525268686543702" DF="0.0" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" I2="0.0" ID="CMP-007.09.03" LOG_CI_END="0.3792216269895729" LOG_CI_START="-0.18540160097346" LOG_EFFECT_SIZE="0.09691001300805642" NO="3" P_CHI2="1.0" P_Z="0.5010725557673679" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="44.025452716182514" Z="0.6728031219060459">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="2.3945374130296906" CI_START="0.6525268686543702" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.3792216269895729" LOG_CI_START="-0.18540160097346" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="2705" O_E="0.0" SE="0.33166247903553997" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.11" WEIGHT="44.025452716182514"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.132395888163894" CI_START="0.4065417232856148" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-007.10" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" METHOD="MH" NO="10" P_CHI2="1.0" P_Q="0.0" P_Z="0.509384322524731" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="36" WEIGHT="100.0" Z="0.659796673441616">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.10.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.132395888163894" CI_START="0.4065417232856148" DF="0.0" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-007.10.02" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" NO="2" P_CHI2="1.0" P_Z="0.509384322524731" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="36" WEIGHT="100.0" Z="0.659796673441616">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="2706" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0175880523999328" CI_START="0.4386845857324744" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-007.11" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" METHOD="MH" NO="11" P_CHI2="1.0" P_Q="0.0" P_Z="0.06028032235338007" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="38" WEIGHT="100.0" Z="1.878737663869856">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0175880523999328" CI_START="0.4386845857324744" DF="0.0" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-007.11.03" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" NO="3" P_CHI2="1.0" P_Z="0.06028032235338007" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="38" WEIGHT="100.0" Z="1.878737663869856">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.0175880523999328" CI_START="0.4386845857324744" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" ORDER="2707" O_E="0.0" SE="0.2146492963334045" STUDY_ID="STD-Berger-2004" TOTAL_1="35" TOTAL_2="38" VAR="0.04607432041642569" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-007.12" NO="12" P_CHI2="0.0" P_Q="1.0" P_Z="0.14838783259194901" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" DF="0.0" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" ID="CMP-007.12.03" NO="3" P_CHI2="0.0" P_Z="0.14838783259194901" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="2708" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-007.14" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" METHOD="MH" NO="14" P_CHI2="1.0" P_Q="0.0" P_Z="0.23602467635869728" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" DF="0.0" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-007.14.03" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" NO="3" P_CHI2="1.0" P_Z="0.23602467635869728" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1122988184661988" CI_START="0.6492757757564591" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" ORDER="2709" O_E="0.0" SE="0.13733074026524866" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" VAR="0.018859732221801193" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-007.15" NO="15" P_CHI2="0.0" P_Q="1.0" P_Z="0.14838783259194901" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" DF="0.0" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" ID="CMP-007.15.03" NO="3" P_CHI2="0.0" P_Z="0.14838783259194901" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="2710" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.8900018437325614" CI_START="0.7950229282775766" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-007.16" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" METHOD="MH" NO="16" P_CHI2="1.0" P_Q="0.0" P_Z="0.2064888160306677" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="36" WEIGHT="99.99999999999999" Z="1.263279387932728">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.16.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8900018437325614" CI_START="0.7950229282775766" DF="0.0" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" I2="0.0" ID="CMP-007.16.02" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" NO="2" P_CHI2="1.0" P_Z="0.2064888160306677" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="36" WEIGHT="99.99999999999999" Z="1.263279387932728">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="2711" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.17" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.17.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.17.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>SUBGROUP2: SSRI: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="17.46439471218255" CI_END="1.650078988329029" CI_START="0.937418787691115" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2437101932660921" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="118" I2="59.91845056549801" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="0.2175047341377596" LOG_CI_START="-0.028066346624627307" LOG_EFFECT_SIZE="0.09471919375656618" METHOD="MH" NO="1" P_CHI2="0.01463504559836204" P_Q="0.0" P_Z="0.1305453175807199" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.08549371350407711" TOTALS="YES" TOTAL_1="182" TOTAL_2="244" WEIGHT="100.00000000000003" Z="1.5119549731278898">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2703391090529212" CI_END="7.985819868443031" CI_START="1.0720430427610872" DF="1.0" EFFECT_SIZE="2.925943032717419" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" ID="CMP-008.01.01" LOG_CI_END="0.9023195098373449" LOG_CI_START="0.030212222724617196" LOG_EFFECT_SIZE="0.4662658662809809" NO="1" P_CHI2="0.6031044371861549" P_Z="0.036103380280355056" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="6.797216107362184" Z="2.095761195062613">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="18.836226212300094" CI_START="0.8494270465679568" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.2749938974302595" LOG_CI_START="-0.07087391477433472" LOG_EFFECT_SIZE="0.6020599913279624" ORDER="2712" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.625" WEIGHT="2.928663047749476"/>
<DICH_DATA CI_END="8.719442885088323" CI_START="0.6244027876775635" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.9404887372649836" LOG_CI_START="-0.20453516667579466" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="2713" O_E="0.0" SE="0.6725927091345493" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.45238095238095233" WEIGHT="3.868553059612708"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.18622422562071" CI_END="1.5297841352146984" CI_START="0.885035281181161" DF="5.0" EFFECT_SIZE="1.1635776434154361" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="113" I2="62.081639789766" ID="CMP-008.01.02" LOG_CI_END="0.18463015271358463" LOG_CI_START="-0.05303941617575477" LOG_EFFECT_SIZE="0.06579536826891494" NO="2" P_CHI2="0.021694778936819592" P_Z="0.2778441155674627" STUDIES="6" TAU2="0.06941298249442097" TOTAL_1="158" TOTAL_2="199" WEIGHT="93.20278389263784" Z="1.085175125778646">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.214830136893607" CI_START="0.5582679186538144" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.08451555713843212" LOG_CI_START="-0.253157328538504" LOG_EFFECT_SIZE="-0.08432088570003592" ORDER="2714" O_E="0.0" SE="0.19835072455437414" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.039343009931245204" WEIGHT="16.668145615626884"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="2715" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="7.545859012811839"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="2716" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="17.942557620395576"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="2717" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="17.675554644589194"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="2718" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="16.64758062616796"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="2719" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="16.723086373046378"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.32023971718074" CI_END="1.6492204557329808" CI_START="1.0428239160317045" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3114291952092036" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="105" I2="27.886693124833894" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="0.21727871283612565" LOG_CI_START="0.01821098268184433" LOG_EFFECT_SIZE="0.117744847758985" METHOD="MH" NO="2" P_CHI2="0.2155679833160018" P_Q="0.0" P_Z="0.020418675568174356" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.026116103130083168" TOTALS="YES" TOTAL_1="160" TOTAL_2="222" WEIGHT="100.0" Z="2.3185642473936556">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0028574262313701398" CI_END="1.6839839100615555" CI_START="0.7911204397084627" DF="1.0" EFFECT_SIZE="1.1542244545104188" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-008.02.01" LOG_CI_END="0.22633793763580198" LOG_CI_START="-0.10175739473361908" LOG_EFFECT_SIZE="0.06229027145109142" NO="1" P_CHI2="0.9573694877835253" P_Z="0.4567465874947255" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="27.228993454141172" Z="0.7442147241149928">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="2720" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="14.01759050748312"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2721" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="13.211402946658051"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.715229858946444" CI_END="1.918852509315305" CI_START="1.0071332082919247" DF="4.0" EFFECT_SIZE="1.3901582945642317" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="79" I2="48.15449347420711" ID="CMP-008.02.02" LOG_CI_END="0.2830415944060445" LOG_CI_START="0.0030869162339462156" LOG_EFFECT_SIZE="0.14306425531999534" NO="2" P_CHI2="0.10258475666308808" P_Z="0.04515721900477874" STUDIES="5" TAU2="0.06169836125719298" TOTAL_1="136" TOTAL_2="177" WEIGHT="72.77100654585882" Z="2.0031870139341708">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="2722" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="11.830034310961883"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="2723" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="20.703852845530438"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="2724" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="19.805036571980988"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="2725" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="16.843100828616564"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="2726" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="3.588981988768953"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.9632773966223267" CI_END="0.05732553556526088" CI_START="-0.6376636311742572" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.29016904780449815" ESTIMABLE="YES" I2="0.0" I2_Q="36.84258124478255" ID="CMP-008.03" NO="3" P_CHI2="0.5800635235518485" P_Q="0.2082795392107667" P_Z="0.1017073080244528" Q="1.5833452660181584" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="100" UNITS="" WEIGHT="100.0" Z="1.6366323687985032">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0379675079543431" CI_END="-0.011151281086968945" CI_START="-1.1415116514427857" DF="1.0" EFFECT_SIZE="-0.5763314662648773" ESTIMABLE="YES" I2="0.0" ID="CMP-008.03.01" NO="1" P_CHI2="0.8455084782037424" P_Z="0.04564785719044869" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="37.802648135111866" Z="1.9986350311993808">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="2727" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="19.883761839242663"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="2728" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="17.918886295869203"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.34196462264982525" CI_END="0.32437417383596917" CI_START="-0.5568615365697223" DF="1.0" EFFECT_SIZE="-0.11624368136687657" ESTIMABLE="YES" I2="0.0" ID="CMP-008.03.02" NO="2" P_CHI2="0.5586975754442574" P_Z="0.605102299352494" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="63" WEIGHT="62.19735186488814" Z="0.5170771593097174">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="2729" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="32.19357314656532"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="2730" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="30.00377871832282"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.8868947530104314" CI_END="0.022109799784881395" CI_START="-0.5020830779940152" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.23998663910456688" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.04" NO="4" P_CHI2="0.7565520869091964" P_Q="0.6155932894865466" P_Z="0.07271325568967792" Q="0.2521100150169342" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="109" TOTAL_2="123" UNITS="" WEIGHT="100.00000000000001" Z="1.7946263268924532">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1942360020051953" CI_END="0.20378649840438778" CI_START="-0.9458888246280452" DF="1.0" EFFECT_SIZE="-0.37105116311182873" ESTIMABLE="YES" I2="0.0" ID="CMP-008.04.01" NO="1" P_CHI2="0.6594141771007651" P_Z="0.20582316827452718" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="35" WEIGHT="20.788914470985006" Z="1.2651344280447174">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="2731" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="10.837008864248956"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="2732" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="9.951905606736052"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.440548735988302" CI_END="0.08889955031350966" CI_START="-0.5000771754503401" DF="2.0" EFFECT_SIZE="-0.20558881256841527" ESTIMABLE="YES" I2="0.0" ID="CMP-008.04.02" NO="2" P_CHI2="0.48661880039895145" P_Z="0.17122005936067566" STUDIES="3" TAU2="0.0" TOTAL_1="91" TOTAL_2="88" WEIGHT="79.21108552901501" Z="1.368294028039441">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.806334763281386" CI_START="-0.5398754786632862" EFFECT_SIZE="0.13322964230904988" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="3.64" ORDER="2733" SD_1="3.87" SD_2="2.21" SE="0.34342729064498295" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="15.161998561011723"/>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="2734" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="16.935026382117186"/>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="2735" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="47.11406058588609"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.154187873844381" CI_END="-0.06473640537804831" CI_START="-0.7084563655152492" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3865963854466487" ESTIMABLE="YES" I2="18.75451152132907" I2_Q="81.7145875429899" ID="CMP-008.05" NO="5" P_CHI2="0.2915037006933514" P_Q="0.019358555786976095" P_Z="0.01856382672633459" Q="5.468840270084415" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.030363668653650793" TOTALS="YES" TOTAL_1="79" TOTAL_2="131" UNITS="" WEIGHT="100.0" Z="2.354175849595525">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.728969955469096E-6" CI_END="-0.39924024416711845" CI_START="-1.5737987427881146" DF="1.0" EFFECT_SIZE="-0.9865194934776165" ESTIMABLE="YES" I2="0.0" ID="CMP-008.05.01" NO="1" P_CHI2="0.9986819288749194" P_Z="9.934555506061686E-4" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="25.685717575611463" Z="3.292373567656142">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="2736" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="13.324142161854962"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="2737" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="12.361575413756501"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.68534487479001" CI_END="0.1484407946091636" CI_START="-0.5130646306447432" DF="3.0" EFFECT_SIZE="-0.1823119180177898" ESTIMABLE="YES" I2="0.0" ID="CMP-008.05.02" NO="2" P_CHI2="0.8766454662656469" P_Z="0.27999161724665855" STUDIES="4" TAU2="0.0" TOTAL_1="60" TOTAL_2="94" WEIGHT="74.31428242438854" Z="1.0803382092599902">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="2738" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="19.616570948517772"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="2739" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="21.061122294560285"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="2740" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="19.949931244566613"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="2741" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="13.686657936743858"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.910259761564335" CI_END="-0.0670307317236663" CI_START="-0.5399748713416517" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.303502801532659" ESTIMABLE="YES" I2="11.50733084629223" I2_Q="76.99235261377534" ID="CMP-008.06" NO="6" P_CHI2="0.34057374334255197" P_Q="0.03708788446729361" P_Z="0.011885074637802332" Q="4.346380936795513" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.013580056220638556" TOTALS="YES" TOTAL_1="151" TOTAL_2="200" UNITS="" WEIGHT="100.00000000000001" Z="2.515538349588202">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.001279273879832639" CI_END="-0.2969248394185655" CI_START="-1.4575634666483017" DF="1.0" EFFECT_SIZE="-0.8772441530334336" ESTIMABLE="YES" I2="0.0" ID="CMP-008.06.01" NO="1" P_CHI2="0.9714681986671391" P_Z="0.003048598961307407" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="15.408717606050766" Z="2.962794629190888">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="2742" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="8.032893040139793"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="2743" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="7.375824565910973"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.562599550888989" CI_END="0.023398659451184328" CI_START="-0.44612993719247196" DF="5.0" EFFECT_SIZE="-0.2113656388706438" ESTIMABLE="YES" I2="0.0" ID="CMP-008.06.02" NO="2" P_CHI2="0.6139375651041779" P_Z="0.0776281793722107" STUDIES="6" TAU2="0.0" TOTAL_1="132" TOTAL_2="163" WEIGHT="84.59128239394924" Z="1.7646168634545014">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.9449855770700366" CI_START="-0.4064133842298303" EFFECT_SIZE="0.26928609642010315" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="21.5" ORDER="2744" SD_1="4.68" SD_2="5.17" SE="0.34475096786459586" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="10.991738002434133"/>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="2745" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="12.223397146838522"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="2746" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="28.124680213087608"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="2747" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="13.076292162969974"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="2748" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="12.300022453670058"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="2749" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.875152414948951"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.4922676137580928" CI_END="-0.23618578134050577" CI_START="-1.0123079536482513" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6242468674943785" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.07" NO="7" P_CHI2="0.6840561354478216" P_Q="0.5222897205314259" P_Z="0.001616806090686693" Q="0.4093694806681287" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="66" UNITS="" WEIGHT="100.00000000000001" Z="3.152857685054746">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.09824991293101076" CI_END="-0.18826903333729839" CI_START="-1.3364371202332923" DF="1.0" EFFECT_SIZE="-0.7623530767852954" ESTIMABLE="YES" I2="0.0" ID="CMP-008.07.01" NO="1" P_CHI2="0.7539400249444181" P_Z="0.009248531547478444" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="45.692954248255646" Z="2.602727929918204">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="2750" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="24.236182222574495"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="2751" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="21.456772025681147"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9846482201589533" CI_END="0.018542439414993783" CI_START="-1.034636101257544" DF="1.0" EFFECT_SIZE="-0.5080468309212751" ESTIMABLE="YES" I2="0.0" ID="CMP-008.07.02" NO="2" P_CHI2="0.32105415079555466" P_Z="0.05863114316934021" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="54.30704575174437" Z="1.89094907009697">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.04205136398922227" CI_START="-1.437631644300558" EFFECT_SIZE="-0.73984150414489" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.0" ORDER="2752" SD_1="1.38" SD_2="0.57" SE="0.356021919616762" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="30.927907140700402"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="2753" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="23.379138611043963"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.679242227392469" CI_END="0.29985411909378235" CI_START="-0.4747262424499804" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.08743606167809903" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.08" NO="8" P_CHI2="0.43187439284585494" P_Q="1.0" P_Z="0.6581356008233308" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="75" UNITS="" WEIGHT="100.0" Z="0.44248870833117465">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.679242227392469" CI_END="0.29985411909378235" CI_START="-0.4747262424499804" DF="2.0" EFFECT_SIZE="-0.08743606167809903" ESTIMABLE="YES" I2="0.0" ID="CMP-008.08.02" NO="2" P_CHI2="0.43187439284585494" P_Z="0.6581356008233308" STUDIES="3" TAU2="0.0" TOTAL_1="41" TOTAL_2="75" WEIGHT="100.0" Z="0.44248870833117465">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="2754" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="39.92975643607754"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="2755" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="37.12869184051787"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="2756" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="22.941551723404597"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.1603946316219" CI_END="1.8031734225726272" CI_START="0.6994312586588909" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1230297665379279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-008.09" LOG_CI_END="0.25603749757341876" LOG_CI_START="-0.15525496230457028" LOG_EFFECT_SIZE="0.05039126763442424" METHOD="MH" NO="9" P_CHI2="0.6549808115787485" P_Q="0.0" P_Z="0.6310376500361665" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="160" TOTAL_2="222" WEIGHT="100.0" Z="0.48026686279680064">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.163553450526576E-4" CI_END="3.2153052486984315" CI_START="0.43867687848046044" DF="1.0" EFFECT_SIZE="1.1876363373781" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="0.0" ID="CMP-008.09.01" LOG_CI_END="0.5072222094631642" LOG_CI_START="-0.3578552555266176" LOG_EFFECT_SIZE="0.07468347696827325" NO="1" P_CHI2="0.9786473171072452" P_Z="0.7350516397404938" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="22.604322649117957" Z="0.3384134508688682">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2757" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="14.29426619826323"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2758" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="8.310056450854727"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.143904624452376" CI_END="1.9270612538417664" CI_START="0.63854761749222" DF="4.0" EFFECT_SIZE="1.1092882278300036" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="28" I2="3.4726818663543275" ID="CMP-008.09.02" LOG_CI_END="0.28489551942072505" LOG_CI_START="-0.19480671117578346" LOG_EFFECT_SIZE="0.04504440412247076" NO="2" P_CHI2="0.38688096155143215" P_Z="0.7128104403706921" STUDIES="5" TAU2="0.014864043357142498" TOTAL_1="136" TOTAL_2="177" WEIGHT="77.39567735088204" Z="0.36808421622441745">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2759" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="7.884834264041984"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2760" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="20.011972677568522"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="2761" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="17.358211083369223"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="2762" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="29.03377772299212"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="2763" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="3.1068816029101813"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.935626998082945" CI_END="12.077139216815198" CI_START="1.4749001625516498" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.220494591163415" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-008.10" LOG_CI_END="1.081964072572413" LOG_CI_START="0.16876262348680926" LOG_EFFECT_SIZE="0.625363348029611" METHOD="MH" NO="10" P_CHI2="0.7099098890969942" P_Q="0.0" P_Z="0.007266456518030997" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="144" TOTAL_2="205" WEIGHT="100.0" Z="2.684379532285497">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.003208153667154277" CI_END="49.420640741007034" CI_START="0.5925850301921847" DF="1.0" EFFECT_SIZE="5.411647797633062" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-008.10.01" LOG_CI_END="1.6939083717516086" LOG_CI_START="-0.2272493238094713" LOG_EFFECT_SIZE="0.7333295239710687" NO="1" P_CHI2="0.9548315507244144" P_Z="0.13457947427391836" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="22.594729914083366" Z="1.496284723637358">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="2764" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="11.285268059533982"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="2765" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="11.309461854549383"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.898984756785265" CI_END="12.9666767852162" CI_START="1.188138284312853" DF="3.0" EFFECT_SIZE="3.9250738985178453" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" I2="0.0" ID="CMP-008.10.02" LOG_CI_END="1.1128286855079872" LOG_CI_START="0.07486698998775308" LOG_EFFECT_SIZE="0.5938478377478701" NO="2" P_CHI2="0.4074635225581813" P_Z="0.024915914612913072" STUDIES="4" TAU2="0.0" TOTAL_1="120" TOTAL_2="160" WEIGHT="77.40527008591664" Z="2.242703905753373">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="2766" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="38.87086968046989"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="2767" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="13.142447921331803"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="2768" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="13.027892373697624"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="2769" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="12.364060110417316"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.12" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="69.31319328145675" CI_START="0.1298454099994229" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.13" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.4771212547196624" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.4928768494435124" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="0.6857403698646046">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.31319328145675" CI_START="0.1298454099994229" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-008.13.01" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.4771212547196624" NO="1" P_CHI2="1.0" P_Z="0.4928768494435124" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="0.6857403698646046">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2770" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.42778121382439577" CI_END="1.4387099390310498" CI_START="0.7321663847909339" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0263406134530333" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="54" I2="0.0" I2_Q="0.0" ID="CMP-008.18" LOG_CI_END="0.15797324384898265" LOG_CI_START="-0.13539021431672826" LOG_EFFECT_SIZE="0.011291514766127215" METHOD="MH" NO="18" P_CHI2="0.9344456240279324" P_Q="0.0" P_Z="0.8800724051604721" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="124" WEIGHT="100.0" Z="0.15087742973094173">
<NAME>Response 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.009130901154878949" CI_END="1.6876727006573318" CI_START="0.6209123249144052" DF="1.0" EFFECT_SIZE="1.023668296011807" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="22" I2="0.0" ID="CMP-008.18.01" LOG_CI_END="0.22728822541702945" LOG_CI_START="-0.2069697194595545" LOG_EFFECT_SIZE="0.010159252978737418" NO="1" P_CHI2="0.9238734120921138" P_Z="0.9269325801218788" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="45.63693690465614" Z="0.09170480440520475">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="2771" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="23.75621373119087"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="2772" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="21.880723173465274"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.41845892213016483" CI_END="1.6262335738152922" CI_START="0.6505806447891956" DF="1.0" EFFECT_SIZE="1.0285893675469286" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="32" I2="0.0" ID="CMP-008.18.02" LOG_CI_END="0.2111829228902234" LOG_CI_START="-0.1866988614142746" LOG_EFFECT_SIZE="0.012242030737974363" NO="2" P_CHI2="0.5177070325688572" P_Z="0.9040012285492922" STUDIES="2" TAU2="0.0" TOTAL_1="38" TOTAL_2="79" WEIGHT="54.36306309534387" Z="0.12060838314578184">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="2773" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="28.714891191921772"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="2774" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="25.648171903422096"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.04517555926448578" CI_END="0.576767367839949" CI_START="-0.5554908323957526" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.010638267722098228" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.19" NO="19" P_CHI2="0.8316816866193684" P_Q="1.0" P_Z="0.9706204314256184" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="18" TOTAL_2="36" UNITS="" WEIGHT="100.0" Z="0.03683015338527383">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.04517555926448578" CI_END="0.576767367839949" CI_START="-0.5554908323957526" DF="1.0" EFFECT_SIZE="0.010638267722098228" ESTIMABLE="YES" I2="0.0" ID="CMP-008.19.01" NO="1" P_CHI2="0.8316816866193684" P_Z="0.9706204314256184" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="36" WEIGHT="100.0" Z="0.03683015338527383">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="2775" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="50.92086692918742"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="2776" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="49.07913307081258"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.19.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>SUBGROUP3: 100%agoraphobia: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="7.290764873123054" CI_END="2.0809289877181283" CI_START="0.8761570926180239" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.35026689651479" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="49" I2="45.136071871611875" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="0.31825726004421984" LOG_CI_START="-0.05741801901392978" LOG_EFFECT_SIZE="0.13041962051514497" METHOD="MH" NO="1" P_CHI2="0.12129760611269813" P_Q="0.0" P_Z="0.1735629358928465" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10026187869970549" TOTALS="YES" TOTAL_1="107" TOTAL_2="116" WEIGHT="100.0" Z="1.3608441829226627">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8592539734267173" CI_END="1.3960782037129689" CI_START="0.8040457182397279" DF="3.0" EFFECT_SIZE="1.059486055605841" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="44" I2="0.0" ID="CMP-009.01.01" LOG_CI_END="0.1449097467181801" LOG_CI_START="-0.09471925645709568" LOG_EFFECT_SIZE="0.025095245130542187" NO="1" P_CHI2="0.41383843588692293" P_Z="0.6814274289260617" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="81.06968286335302" Z="0.4105160559641447">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.5905355852063248" CI_START="0.47068186901227627" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5551592353055395" LOG_CI_START="-0.3272725306918659" LOG_EFFECT_SIZE="0.11394335230683678" ORDER="2777" O_E="0.0" SE="0.5183447874545656" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.2686813186813187" WEIGHT="13.198997062721663"/>
<DICH_DATA CI_END="2.081852540666224" CI_START="0.6537980402183219" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.31844996482728344" LOG_CI_START="-0.18455638556605694" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2778" O_E="0.0" SE="0.29546842014263947" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.08730158730158732" WEIGHT="25.962839578309524"/>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="2779" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="4.271628788932866"/>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="2780" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="37.63621743338897"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.465969572612346" CI_START="1.156543696243068" DF="0.0" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" I2="0.0" ID="CMP-009.01.02" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" NO="2" P_CHI2="1.0" P_Z="0.019963451853206967" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="18.930317136646977" Z="2.3270340727031114">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="2781" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="18.930317136646977"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.673698035017611" CI_END="2.9602115857645206" CI_START="0.6275531810418375" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3629710918443676" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="25" I2="64.74962206913094" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="0.47132275404741575" LOG_CI_START="-0.20234946466069847" LOG_EFFECT_SIZE="0.1344866446933587" METHOD="MH" NO="2" P_CHI2="0.05861011359818613" P_Q="0.0" P_Z="0.4338951123202138" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.29117896117924286" TOTALS="YES" TOTAL_1="66" TOTAL_2="78" WEIGHT="100.00000000000001" Z="0.7825437139328568">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.01906103501001709" CI_END="1.5063413482788168" CI_START="0.6225630309871126" DF="1.0" EFFECT_SIZE="0.9683968378127192" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" I2="0.0" ID="CMP-009.02.01" LOG_CI_END="0.1779233974130457" LOG_CI_START="-0.20581667214529703" LOG_EFFECT_SIZE="-0.013946637366125683" NO="1" P_CHI2="0.8901916562945521" P_Z="0.8867121369914315" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="62" WEIGHT="79.61987309911996" Z="0.14246574236830384">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9219135458330163" CI_START="0.5203147676273697" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.2837338477382853" LOG_CI_START="-0.28373384773828525" LOG_EFFECT_SIZE="0.0" ORDER="2782" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.1111111111111111" WEIGHT="38.92540724199538"/>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="2783" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="40.69446585712458"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="19.91594281822458" CI_START="1.3280305046685488" DF="0.0" EFFECT_SIZE="5.142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-009.02.02" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530306" NO="2" P_CHI2="1.0" P_Z="0.017756719487125233" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="20.380126900880054" Z="2.3706524481975335">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="2784" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="20.380126900880054"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.620882599825546" CI_END="0.4359807475729731" CI_START="-1.4472565047593395" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5056378785931832" ESTIMABLE="YES" I2="61.844914378592804" I2_Q="0.0" ID="CMP-009.03" NO="3" P_CHI2="0.10546581344978534" P_Q="1.0" P_Z="0.2925807317412622" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.30855631045333326" TOTALS="YES" TOTAL_1="42" TOTAL_2="48" UNITS="" WEIGHT="100.0" Z="1.052477089686414">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.620882599825546" CI_END="0.4359807475729731" CI_START="-1.4472565047593395" DF="1.0" EFFECT_SIZE="-0.5056378785931832" ESTIMABLE="YES" I2="61.844914378592804" ID="CMP-009.03.01" NO="1" P_CHI2="0.10546581344978534" P_Z="0.2925807317412622" STUDIES="2" TAU2="0.30855631045333326" TOTAL_1="42" TOTAL_2="48" WEIGHT="100.0" Z="1.052477089686414">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.02125413161636569" CI_START="-2.262071319946162" EFFECT_SIZE="-1.141662725781264" ESTIMABLE="YES" MEAN_1="2.17" MEAN_2="3.67" ORDER="2785" SD_1="0.75" SD_2="1.63" SE="0.5716475419969643" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="36.32867841334816"/>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="2786" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="63.67132158665185"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.2173992878339095" CI_END="0.18901180459510908" CI_START="-0.48552234646179776" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.14825527093334434" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.04" NO="4" P_CHI2="0.5285294808445071" P_Q="1.0" P_Z="0.3889310542111589" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="74" UNITS="" WEIGHT="100.0" Z="0.8615575389097493">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2173992878339095" CI_END="0.18901180459510908" CI_START="-0.48552234646179776" DF="3.0" EFFECT_SIZE="-0.14825527093334434" ESTIMABLE="YES" I2="0.0" ID="CMP-009.04.01" NO="1" P_CHI2="0.5285294808445071" P_Z="0.3889310542111589" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="100.0" Z="0.8615575389097493">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.1030659113296144" CI_START="-0.40675425774589163" EFFECT_SIZE="0.34815582679186136" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="0.27" ORDER="2787" SD_1="0.93" SD_2="0.65" SE="0.38516528389928967" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="19.95985765347047"/>
<CONT_DATA CI_END="0.7980531175789702" CI_START="-1.2390075602204103" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" MEAN_1="1.71" MEAN_2="2.14" ORDER="2788" SD_1="1.89" SD_2="1.77" SE="0.5196678851926503" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="10.964780800446652"/>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="2789" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="14.762531868574595"/>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="2790" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="54.31282967750828"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.734284529657522" CI_END="-0.13447015415984226" CI_START="-0.8909634350199978" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.51271679458992" ESTIMABLE="YES" I2="42.754326550476435" I2_Q="0.0" ID="CMP-009.05" NO="5" P_CHI2="0.12014377325365766" P_Q="0.9302433723462181" P_Z="0.007889811953247377" Q="0.007663013707539079" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09104537854725707" TOTALS="YES" TOTAL_1="107" TOTAL_2="119" UNITS="" WEIGHT="100.0" Z="2.6567491796422975">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.731099367340444" CI_END="-0.05678971852509285" CI_START="-1.0123597705405745" DF="3.0" EFFECT_SIZE="-0.5345747445328336" ESTIMABLE="YES" I2="36.58979093295962" ID="CMP-009.05.01" NO="1" P_CHI2="0.19258012153928394" P_Z="0.028312705021815467" STUDIES="4" TAU2="0.08750245792215271" TOTAL_1="64" TOTAL_2="74" WEIGHT="61.59741801028319" Z="2.1929260845275618">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1660942883799188" CI_START="-1.3689479754433111" EFFECT_SIZE="-0.6014268435316962" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.9" ORDER="2791" SD_1="8.36" SD_2="8.97" SE="0.3915996099753484" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="15.23914267287801"/>
<CONT_DATA CI_END="0.039892566655316264" CI_START="-2.175482894859469" EFFECT_SIZE="-1.0677951641020764" ESTIMABLE="YES" MEAN_1="8.57" MEAN_2="19.43" ORDER="2792" SD_1="6.16" SD_2="12.42" SE="0.5651571863027546" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="9.073938002830737"/>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="2793" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="11.586554009568058"/>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="2794" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="25.697783325006387"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.99552214860954" CI_END="0.39466230250097256" CI_START="-1.451004741829444" DF="1.0" EFFECT_SIZE="-0.5281712196642357" ESTIMABLE="YES" I2="74.97198206377095" ID="CMP-009.05.02" NO="2" P_CHI2="0.04562139259771547" P_Z="0.2619650523211543" STUDIES="2" TAU2="0.3355036105102281" TOTAL_1="43" TOTAL_2="45" WEIGHT="38.40258198971681" Z="1.12175873908834">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="2795" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="15.140383609060727"/>
<CONT_DATA CI_END="0.41452271242937677" CI_START="-0.6155982943711397" EFFECT_SIZE="-0.10053779097088145" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.5" ORDER="2796" SD_1="7.8" SD_2="7.9" SE="0.2627907999651982" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="29" TOTAL_2="29" WEIGHT="23.262198380656077"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.2974069165410373" CI_END="0.05288437265530688" CI_START="-0.7652180786518703" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3561668529982817" ESTIMABLE="YES" I2="12.945330424477502" I2_Q="47.506609284377916" ID="CMP-009.06" NO="6" P_CHI2="0.3170479582366067" P_Q="0.167519769054975" P_Z="0.08790216242914196" Q="1.9050017275839624" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.01975444042893997" TOTALS="YES" TOTAL_1="56" TOTAL_2="64" UNITS="" WEIGHT="100.0" Z="1.7065691546290074">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.3924051889570751" CI_END="0.22860510417282892" CI_START="-0.6046012430484724" DF="1.0" EFFECT_SIZE="-0.18799806943782177" ESTIMABLE="YES" I2="0.0" ID="CMP-009.06.01" NO="1" P_CHI2="0.5310382132394685" P_Z="0.3764471754799724" STUDIES="2" TAU2="0.0" TOTAL_1="42" TOTAL_2="48" WEIGHT="73.71322970015477" Z="0.8844614458111532">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5440488746719574" CI_START="-1.5255257710292496" EFFECT_SIZE="-0.4907384481786461" ESTIMABLE="YES" MEAN_1="27.29" MEAN_2="32.29" ORDER="2797" SD_1="4.82" SD_2="13.12" SE="0.5279624171734143" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="14.592062843633228"/>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="2798" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="59.12116685652154"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" DF="0.0" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" I2="0.0" ID="CMP-009.06.02" NO="2" P_CHI2="1.0" P_Z="0.03830482628234442" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="26.286770299845237" Z="2.07157786159779">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="2799" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="26.286770299845237"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.152908721506545" CI_END="-0.1300728154695941" CI_START="-0.7699897171223453" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4500312662959697" ESTIMABLE="YES" I2="3.68196682760402" I2_Q="46.72183284370715" ID="CMP-009.07" NO="7" P_CHI2="0.3857075680517985" P_Q="0.17068238733230068" P_Z="0.0058379181799240966" Q="1.876941444074971" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.005412372549441902" TOTALS="YES" TOTAL_1="78" TOTAL_2="90" UNITS="" WEIGHT="100.00000000000001" Z="2.756748795285591">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2759672774315742" CI_END="-0.008321257129870197" CI_START="-0.6887072791358819" DF="3.0" EFFECT_SIZE="-0.34851426813287606" ESTIMABLE="YES" I2="0.0" ID="CMP-009.07.01" NO="1" P_CHI2="0.5171406827628646" P_Z="0.0446533359428882" STUDIES="4" TAU2="0.0" TOTAL_1="64" TOTAL_2="74" WEIGHT="82.91319371382656" Z="2.0079054876078484">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.4847694472269716" CI_START="-1.0197910873796672" EFFECT_SIZE="-0.26751082007634774" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2800" SD_1="0.51" SD_2="0.85" SE="0.3838235157570292" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="17.44851590475179"/>
<CONT_DATA CI_END="-0.022765335912631635" CI_START="-2.264232881184172" EFFECT_SIZE="-1.1434991085484019" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="9.14" ORDER="2801" SD_1="1.99" SD_2="7.84" SE="0.5718134524287054" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="8.017744071691261"/>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="2802" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="12.94741201689465"/>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="2803" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="44.499521720488865"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" DF="0.0" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" I2="0.0" ID="CMP-009.07.02" NO="2" P_CHI2="1.0" P_Z="0.01643779073257808" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="17.086806286173452" Z="2.3990473104156176">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="2804" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="17.086806286173452"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.321393640804271" CI_END="-0.050114374351330204" CI_START="-1.0154299732774714" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5327721738144008" ESTIMABLE="YES" I2="43.623791012262295" I2_Q="69.1328258832058" ID="CMP-009.08" NO="8" P_CHI2="0.1497202604373309" P_Q="0.07187439816408936" P_Z="0.030505271067466963" Q="3.239687560047553" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1044193859663741" TOTALS="YES" TOTAL_1="68" TOTAL_2="80" UNITS="" WEIGHT="99.99999999999997" Z="2.1634671061007786">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.0817060807567174" CI_END="0.08342024519488628" CI_START="-0.6796591376748391" DF="2.0" EFFECT_SIZE="-0.2981194462399764" ESTIMABLE="YES" I2="3.924957587048818" ID="CMP-009.08.01" NO="1" P_CHI2="0.353153459688324" P_Z="0.1256618286177075" STUDIES="3" TAU2="0.005661245957582937" TOTAL_1="54" TOTAL_2="64" WEIGHT="76.73614486306387" Z="1.5314353679009887">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.4719732474819971" CI_START="-1.0333537967547248" EFFECT_SIZE="-0.28069027463636387" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.3" ORDER="2805" SD_1="0.62" SD_2="0.74" SE="0.38401905752109466" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="24.075289038480584"/>
<CONT_DATA CI_END="0.0582778375411388" CI_START="-2.149781105514995" EFFECT_SIZE="-1.045751633986928" ESTIMABLE="YES" MEAN_1="1.86" MEAN_2="2.86" ORDER="2806" SD_1="0.9" SD_2="0.9" SE="0.5632906932150337" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="14.380123359710623"/>
<CONT_DATA CI_END="0.2886432974821726" CI_START="-0.6222469115213254" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.95" ORDER="2807" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="38.28073246487266"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" DF="0.0" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" I2="0.0" ID="CMP-009.08.02" NO="2" P_CHI2="1.0" P_Z="0.006352246967967841" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="23.263855136936108" Z="2.7290219806365275">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="2808" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="23.263855136936108"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.7691313490440352" CI_END="1.627341044521682" CI_START="0.7196086390570482" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.082150023947661" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-009.09" LOG_CI_END="0.21147857827954153" LOG_CI_START="-0.14290363149618657" LOG_EFFECT_SIZE="0.034287473391677516" METHOD="MH" NO="9" P_CHI2="0.438151258558787" P_Q="0.0" P_Z="0.7044918066942061" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="107" TOTAL_2="116" WEIGHT="99.99999999999999" Z="0.3792640325319514">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.633016983470406" CI_END="1.8784215501819799" CI_START="0.7845018955295239" DF="3.0" EFFECT_SIZE="1.213929679479528" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="26" I2="0.0" ID="CMP-009.09.01" LOG_CI_END="0.2737930620374051" LOG_CI_START="-0.10540600272456782" LOG_EFFECT_SIZE="0.08419352965641862" NO="1" P_CHI2="0.6519268882653211" P_Z="0.38411397520199253" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="100" WEIGHT="87.33921992692447" Z="0.8703412069935768">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.6601562747764063" CI_START="0.8297809266717024" EFFECT_SIZE="1.4857142857142858" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.42490715064590723" LOG_CI_START="-0.08103655207686013" LOG_EFFECT_SIZE="0.17193529928452353" ORDER="2809" O_E="0.0" SE="0.2971938354410734" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.08832417582417582" WEIGHT="49.061343206967074"/>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2810" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="3.391280376716656"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2811" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="6.4380497310367"/>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="2812" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="28.448546612204044"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.541682393991823" CI_START="0.1556092503775361" DF="0.0" EFFECT_SIZE="0.489795918367347" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" I2="0.0" ID="CMP-009.09.02" LOG_CI_END="0.18799491279151292" LOG_CI_START="-0.8079645894253281" LOG_EFFECT_SIZE="-0.3099848383169076" NO="2" P_CHI2="1.0" P_Z="0.2224467633719327" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="12.660780073075516" Z="1.220047838295201">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="2813" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="12.660780073075516"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.533145101433542" CI_END="3.579967562941927" CI_START="0.265177618603538" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9743342717049688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-009.10" LOG_CI_END="0.5538790916441118" LOG_CI_START="-0.5764631338387787" LOG_EFFECT_SIZE="-0.011292021097333432" METHOD="MH" NO="10" P_CHI2="0.4652876652574288" P_Q="0.0" P_Z="0.9687630306471365" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="21" WEIGHT="100.0" Z="0.039159741473844475">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.533145101433542" CI_END="3.579967562941927" CI_START="0.265177618603538" DF="1.0" EFFECT_SIZE="0.9743342717049688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-009.10.01" LOG_CI_END="0.5538790916441118" LOG_CI_START="-0.5764631338387787" LOG_EFFECT_SIZE="-0.011292021097333432" NO="1" P_CHI2="0.4652876652574288" P_Z="0.9687630306471365" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="21" WEIGHT="100.0" Z="0.039159741473844475">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2814" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="34.50164293537788"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2815" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="65.49835706462213"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.10.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-009.11" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" METHOD="MH" NO="11" P_CHI2="0.41779777973047816" P_Q="0.0" P_Z="0.021254905136773212" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="65" WEIGHT="99.99999999999999" Z="2.3034256644443234">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" DF="1.0" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" ID="CMP-009.11.01" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" NO="1" P_CHI2="0.41779777973047816" P_Z="0.021254905136773212" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="99.99999999999999" Z="2.3034256644443234">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2816" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="17.169123126782324"/>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="2817" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="82.83087687321766"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.6964510583271646" CI_END="-0.2991250155371573" CI_START="-1.5113689966142019" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9052470060756796" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.12" NO="12" P_CHI2="0.4039791819030496" P_Q="1.0" P_Z="0.0034200846498160646" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="26" UNITS="" WEIGHT="100.0" Z="2.9272185413445753">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6964510583271646" CI_END="-0.2991250155371573" CI_START="-1.5113689966142019" DF="1.0" EFFECT_SIZE="-0.9052470060756796" ESTIMABLE="YES" I2="0.0" ID="CMP-009.12.01" NO="1" P_CHI2="0.4039791819030496" P_Z="0.0034200846498160646" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="100.0" Z="2.9272185413445753">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.07400266871028871" CI_START="-1.4743503608812065" EFFECT_SIZE="-0.700173846085459" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="11.3" ORDER="2818" SD_1="5.68" SD_2="9.61" SE="0.3949952758838189" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="61.29712374538872"/>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="2819" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="38.70287625461129"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-009.13" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-009.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="2820" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-009.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.15" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.15.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0013527877755147143" CI_END="2.1675998266309624" CI_START="1.0173285578880322" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4849785202839891" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-009.16" LOG_CI_END="0.33597910760459976" LOG_CI_START="0.007461235944821415" LOG_EFFECT_SIZE="0.1717201717747106" METHOD="MH" NO="16" P_CHI2="0.9706602145060425" P_Q="0.0" P_Z="0.040462833713559736" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="69" WEIGHT="100.0" Z="2.0489926493011015">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-009.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="68.97810190358071" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="2821" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="68.97810190358071"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8976773797442106" CI_START="0.7451141351817461" DF="0.0" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" ID="CMP-009.16.02" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" NO="2" P_CHI2="1.0" P_Z="0.26666714476630327" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="31.021898096419296" Z="1.1107705475108365">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="2822" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="31.021898096419296"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.17" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.17.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.17.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>SUBGROUP3: 100%agoraphobia: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="9.535682651779815" CI_END="1.40160924060376" CI_START="0.9955898362111232" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1812823177736531" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="105" I2="0.0" I2_Q="0.0" ID="CMP-010.01" LOG_CI_END="0.14662695207314458" LOG_CI_START="-0.0019195456712744372" LOG_EFFECT_SIZE="0.07235370320093507" METHOD="MH" NO="1" P_CHI2="0.5725713569164524" P_Q="0.0" P_Z="0.056222120665725746" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="296" TOTAL_2="280" WEIGHT="100.00000000000001" Z="1.909309940998068">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.171907946062699" CI_END="1.5594591527515533" CI_START="1.0526605002998863" DF="10.0" EFFECT_SIZE="1.281241995851169" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="93" I2="0.0" ID="CMP-010.01.01" LOG_CI_END="0.1929740036735219" LOG_CI_START="0.022288326911850002" LOG_EFFECT_SIZE="0.10763116529268592" NO="1" P_CHI2="0.8006193771042122" P_Z="0.013442245555491825" STUDIES="11" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="75.740937616965" Z="2.471832570723501">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="18.836226212300094" CI_START="0.8494270465679568" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.2749938974302595" LOG_CI_START="-0.07087391477433472" LOG_EFFECT_SIZE="0.6020599913279624" ORDER="2823" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.625" WEIGHT="1.218203998455439"/>
<DICH_DATA CI_END="8.719442885088323" CI_START="0.6244027876775635" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.9404887372649836" LOG_CI_START="-0.20453516667579466" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="2824" O_E="0.0" SE="0.6725927091345493" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.45238095238095233" WEIGHT="1.6830449978660669"/>
<DICH_DATA CI_END="2.3824152363315836" CI_START="0.3902959167635606" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3770174578735022" LOG_CI_START="-0.40860599223996596" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="2825" O_E="0.0" SE="0.46147910349544863" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="27" VAR="0.21296296296296297" WEIGHT="3.5751639085105267"/>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="2826" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="8.791755271871798"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="2827" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="8.37515248938114"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="2828" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="5.593793870458647"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="2829" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="5.814155447173686"/>
<DICH_DATA CI_END="3.3551459414051803" CI_START="0.7112931338260449" EFFECT_SIZE="1.5448275862068965" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.5257114157623739" LOG_CI_START="-0.14795138356399803" LOG_EFFECT_SIZE="0.18888001609918792" ORDER="2830" O_E="0.0" SE="0.3957128630089486" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.15658866995073892" WEIGHT="4.862277068156785"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="2831" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="1.4106281454798728"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="2832" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="15.369463142109671"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="2833" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="19.047299277501363"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.297207292520502" CI_START="0.6477590610403521" DF="0.0" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" I2="0.0" ID="CMP-010.01.02" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" NO="2" P_CHI2="1.0" P_Z="0.6233212574600568" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="24.259062383035015" Z="0.49114873323119024">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="2834" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="24.259062383035015"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.576792831178415" CI_END="1.6013030012149057" CI_START="1.0229577527746125" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2798692588049931" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="77" I2="0.0" I2_Q="0.0" ID="CMP-010.02" LOG_CI_END="0.20447351761877058" LOG_CI_START="0.009857698115162397" LOG_EFFECT_SIZE="0.10716560786696647" METHOD="MH" NO="2" P_CHI2="0.6700982699532704" P_Q="0.0" P_Z="0.030887694553594258" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="262" TOTAL_2="248" WEIGHT="99.99999999999999" Z="2.158516531043895">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.335682312759941" CI_END="1.6643055886356177" CI_START="1.0264936613289857" DF="9.0" EFFECT_SIZE="1.3070574345639399" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="69" I2="0.0" ID="CMP-010.02.01" LOG_CI_END="0.22123307151797075" LOG_CI_START="0.01135627191572551" LOG_EFFECT_SIZE="0.11629467171684811" NO="1" P_CHI2="0.6022141391059326" P_Z="0.029850514117806086" STUDIES="10" TAU2="0.0" TOTAL_1="248" TOTAL_2="234" WEIGHT="85.98593391182351" Z="2.172068266629818">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="2835" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="18.296141837341505"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2836" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="16.88874631139216"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="2837" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="1.3552697657290003"/>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="2838" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="24.5338273541915"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="2839" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="4.7522446330757155"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="2840" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="5.8082989959814295"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="2841" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="2.1867898610368335"/>
<DICH_DATA CI_END="10.324319187650293" CI_START="0.6478360451866196" EFFECT_SIZE="2.586206896551724" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0138614227695817" LOG_CI_START="-0.18853489178409377" LOG_EFFECT_SIZE="0.41266326549274396" ORDER="2842" O_E="0.0" SE="0.706293547126578" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="15" VAR="0.4988505747126437" WEIGHT="2.6197569780261865"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="2843" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="3.84490935587392"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="2844" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="5.699948819175256"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0468607675415367" CI_START="0.6183249100622165" DF="0.0" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" ID="CMP-010.02.02" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" NO="2" P_CHI2="1.0" P_Z="0.699719229637717" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="14.014066088176472" Z="0.38569950595928676">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="2845" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="14.014066088176472"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.9565276218682941" CI_END="-0.3449357808799325" CI_START="-0.872693666556698" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6088147237183152" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.03" NO="3" P_CHI2="0.965995370561355" P_Q="1.0" P_Z="6.126425556268453E-6" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="113" TOTAL_2="126" UNITS="" WEIGHT="100.00000000000001" Z="4.521978597119177">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9565276218682941" CI_END="-0.3449357808799325" CI_START="-0.872693666556698" DF="5.0" EFFECT_SIZE="-0.6088147237183152" ESTIMABLE="YES" I2="0.0" ID="CMP-010.03.01" NO="1" P_CHI2="0.965995370561355" P_Z="6.126425556268453E-6" STUDIES="6" TAU2="0.0" TOTAL_1="113" TOTAL_2="126" WEIGHT="100.00000000000001" Z="4.521978597119177">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="2846" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="11.46600020067586"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="2847" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="10.332951859181478"/>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="2848" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="13.350499770680415"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="2849" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="13.4666390092086"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="2850" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="23.02543190509165"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="2851" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="28.358477255162004"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.596137714017445" CI_END="0.3119827220159218" CI_START="-0.1913762995562834" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.06030321122981921" ESTIMABLE="YES" I2="6.934948390197871" I2_Q="0.0" ID="CMP-010.04" NO="4" P_CHI2="0.37750139989467724" P_Q="1.0" P_Z="0.6386311049138407" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.010424928009632389" TOTALS="YES" TOTAL_1="131" TOTAL_2="147" UNITS="" WEIGHT="100.0" Z="0.46961360419603687">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.596137714017445" CI_END="0.3119827220159218" CI_START="-0.1913762995562834" DF="8.0" EFFECT_SIZE="0.06030321122981921" ESTIMABLE="YES" I2="6.934948390197871" ID="CMP-010.04.01" NO="1" P_CHI2="0.37750139989467724" P_Z="0.6386311049138407" STUDIES="9" TAU2="0.010424928009632389" TOTAL_1="131" TOTAL_2="147" WEIGHT="100.0" Z="0.46961360419603687">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="2852" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="9.398909976922326"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="2853" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="8.673356437622761"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="2854" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="5.11818917024521"/>
<CONT_DATA CI_END="0.4017416085839796" CI_START="-1.088391349315334" EFFECT_SIZE="-0.3433248703656772" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="1.07" ORDER="2855" SD_1="0.93" SD_2="1.75" SE="0.38014294386358427" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="10.64275262814269"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="2856" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="11.68904973847072"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="2857" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.706914947649786"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="2858" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="7.406591278090443"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="2859" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="12.057678228420405"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="2860" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="23.306557594435663"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="22.26330301641938" CI_END="-0.11769553848687969" CI_START="-0.66946382302793" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3935796807574048" ESTIMABLE="YES" I2="46.09964212790036" I2_Q="0.0" ID="CMP-010.05" NO="5" P_CHI2="0.03467264100814982" P_Q="0.8183301305650006" P_Z="0.005172203082794149" Q="0.05275899578354526" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.11480321978602315" TOTALS="YES" TOTAL_1="210" TOTAL_2="214" UNITS="" WEIGHT="100.0" Z="2.7961085149101033">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="22.210544020635833" CI_END="-0.10579682258472622" CI_START="-0.7043732920577611" DF="11.0" EFFECT_SIZE="-0.40508505732124367" ESTIMABLE="YES" I2="50.473973128348895" ID="CMP-010.05.01" NO="1" P_CHI2="0.022791949175259396" P_Z="0.007982692261717243" STUDIES="12" TAU2="0.13618603367370322" TOTAL_1="196" TOTAL_2="200" WEIGHT="92.35982261126429" Z="2.652800982049788">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="2861" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="6.907592650808393"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="2862" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="6.547825054539235"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="2863" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="4.767834309188121"/>
<CONT_DATA CI_END="0.21869047113718676" CI_START="-1.2886598659887283" EFFECT_SIZE="-0.5349846974257708" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.5" ORDER="2864" SD_1="8.36" SD_2="9.55" SE="0.3845352131507778" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="7.543031316751088"/>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="2865" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="9.715433541245067"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="2866" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.04687565293154"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="2867" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.078713120503153"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="2868" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="7.238775364879279"/>
<CONT_DATA CI_END="-0.36766554192815826" CI_START="-2.0287561923899347" EFFECT_SIZE="-1.1982108671590466" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.9" ORDER="2869" SD_1="1.18" SD_2="1.27" SE="0.4237554015186625" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="6.730711908024467"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="2870" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.84850947851492"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="2871" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="9.652477713516776"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="2872" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.282042500362259"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.46161121298104657" CI_START="-1.028618540570797" DF="0.0" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" I2="0.0" ID="CMP-010.05.02" NO="2" P_CHI2="1.0" P_Z="0.4558285493857953" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="7.640177388735701" Z="0.7457332927338802">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="2873" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="7.640177388735701"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="11.890400479753003" CI_END="-0.3174109789558979" CI_START="-0.8476882340718617" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5825496065138798" ESTIMABLE="YES" I2="24.3086890527765" I2_Q="54.782038820789445" ID="CMP-010.06" NO="6" P_CHI2="0.2195589452071537" P_Q="0.13698456729994302" P_Z="1.6598022812947375E-5" Q="2.2115105898665792" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.04373977430931594" TOTALS="YES" TOTAL_1="163" TOTAL_2="167" UNITS="" WEIGHT="99.99999999999999" Z="4.306336871738899">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.678889889886424" CI_END="-0.373065145370958" CI_START="-0.9046901677321064" DF="8.0" EFFECT_SIZE="-0.6388776565515322" ESTIMABLE="YES" I2="17.345893061979286" ID="CMP-010.06.01" NO="1" P_CHI2="0.28829092888833385" P_Z="2.4680269208885644E-6" STUDIES="9" TAU2="0.028518214242611698" TOTAL_1="149" TOTAL_2="153" WEIGHT="90.19476662363553" Z="4.710753424686293">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="2874" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="8.657629911915029"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="2875" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="8.04333497181137"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="2876" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="5.5546277799331465"/>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="2877" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="13.592393462223058"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="2878" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="10.098300872704858"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="2879" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="10.517558101206486"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="2880" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="8.4438775140935"/>
<CONT_DATA CI_END="-0.466210138361711" CI_START="-2.154071253344198" EFFECT_SIZE="-1.3101406958529547" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="2.02" ORDER="2881" SD_1="0.56" SD_2="1.05" SE="0.43058472714195783" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="7.986256710035017"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="2882" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="17.300787299713086"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.3694913292541067E-34" CI_END="0.6983767737103312" CI_START="-0.7834115294980788" DF="0.0" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" I2="100.0" ID="CMP-010.06.02" NO="2" P_CHI2="0.0" P_Z="0.9104462991450921" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.805233376364452" Z="0.11247562044947743">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="2883" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.805233376364452"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.525484618772293" CI_END="-0.16281610645204" CI_START="-0.6457627616930082" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4042894340725241" ESTIMABLE="YES" I2="20.16276971022166" I2_Q="0.0" ID="CMP-010.07" NO="7" P_CHI2="0.2514250363555022" P_Q="0.5138688195024528" P_Z="0.001032595486946413" Q="0.42618109678416616" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.033296378330453104" TOTALS="YES" TOTAL_1="185" TOTAL_2="193" UNITS="" WEIGHT="100.00000000000003" Z="3.281491740394642">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.099303521988126" CI_END="-0.16664596299925677" CI_START="-0.6909714964287414" DF="9.0" EFFECT_SIZE="-0.4288087297139991" ESTIMABLE="YES" I2="25.615553129614003" ID="CMP-010.07.01" NO="1" P_CHI2="0.20776883651035627" P_Z="0.001346728048453353" STUDIES="11" TAU2="0.045119918890346014" TOTAL_1="171" TOTAL_2="179" WEIGHT="91.40994436316052" Z="3.205831541327518">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="2884" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="7.7823003026741455"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="2885" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="7.027401622249479"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="2886" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.4639401327102852" CI_START="-1.0220729437718097" EFFECT_SIZE="-0.27906640553076223" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="2887" SD_1="0.51" SD_2="0.8" SE="0.37909193439358485" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="8.575343611128542"/>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="2888" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="12.418445539966687"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="2889" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.967104616564711"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="2890" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="9.237527420973079"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="2891" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="8.051911295105606"/>
<CONT_DATA CI_END="-0.42277473134623855" CI_START="-2.098561793622174" EFFECT_SIZE="-1.2606682624842063" ESTIMABLE="YES" MEAN_1="45.41" MEAN_2="57.68" ORDER="2892" SD_1="9.04" SD_2="10.07" SE="0.42750455505670765" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="7.025460062394613"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="2893" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="6.209046689072301"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="2894" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="16.11540320303134"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5794802612828507" CI_START="-0.9049646208576299" DF="0.0" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" I2="0.0" ID="CMP-010.07.02" NO="2" P_CHI2="1.0" P_Z="0.6673787664267199" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.590055636839516" Z="0.42974827154093054">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="2895" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.590055636839516"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.451725878944135" CI_END="-0.17381067765794234" CI_START="-0.7678146220114139" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.47081264983467813" ESTIMABLE="YES" I2="33.02541531344524" I2_Q="63.6150814275031" ID="CMP-010.08" NO="8" P_CHI2="0.1643867452756026" P_Q="0.09735240247687593" P_Z="0.0018901639809490453" Q="2.748391474361833" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.05983782784879324" TOTALS="YES" TOTAL_1="151" TOTAL_2="137" UNITS="" WEIGHT="100.0" Z="3.1069687193616495">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.703334404582302" CI_END="-0.25598904826503266" CI_START="-0.8365255246944099" DF="6.0" EFFECT_SIZE="-0.5462572864797213" ESTIMABLE="YES" I2="22.111650814082264" ID="CMP-010.08.01" NO="1" P_CHI2="0.26065348458644555" P_Z="2.256099215856378E-4" STUDIES="7" TAU2="0.033798942776966705" TOTAL_1="137" TOTAL_2="123" WEIGHT="88.68575489998122" Z="3.6884662764961584">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8873607300917461" CI_START="-0.6116126107138591" EFFECT_SIZE="0.13787405968894345" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.0" ORDER="2896" SD_1="0.62" SD_2="0.76" SE="0.3823981850251626" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="11.143348739634884"/>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="2897" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="11.808166008470181"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="2898" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.90842958713326"/>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="2899" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="10.482439989399866"/>
<CONT_DATA CI_END="-0.38927353848264634" CI_START="-2.056043178938999" EFFECT_SIZE="-1.2226583587108226" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.0" ORDER="2900" SD_1="1.4" SD_2="1.03" SE="0.42520415007714907" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="9.54247800882416"/>
<CONT_DATA CI_END="0.26110133948943387" CI_START="-0.9235736714263485" EFFECT_SIZE="-0.33123616596845734" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.4" ORDER="2901" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="15.189577593179692"/>
<CONT_DATA CI_END="-0.2834851042937671" CI_START="-1.2716052532915705" EFFECT_SIZE="-0.7775451787926688" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.9" ORDER="2902" SD_1="0.89" SD_2="0.89" SE="0.2520760985385367" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="18.611314973339173"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8530397915242826" CI_START="-0.629894598103741" DF="0.0" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" I2="0.0" ID="CMP-010.08.02" NO="2" P_CHI2="1.0" P_Z="0.768050083208631" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="11.314245100018788" Z="0.2949264279569317">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="2903" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="11.314245100018788"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.022442651382236" CI_END="1.621323419994972" CI_START="0.9134516114460305" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.216963635721954" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="59" I2="0.0" I2_Q="0.0" ID="CMP-010.09" LOG_CI_END="0.20986965612480044" LOG_CI_START="-0.039314453717661596" LOG_EFFECT_SIZE="0.08527760120356946" METHOD="MH" NO="9" P_CHI2="0.9099292118484131" P_Q="0.0" P_Z="0.17975612451164005" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="261" TOTAL_2="247" WEIGHT="99.99999999999997" Z="1.3415063035330361">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.3215440425776808" CI_END="1.598913539245522" CI_START="0.8961235408338613" DF="8.0" EFFECT_SIZE="1.1970062916609496" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="58" I2="0.0" ID="CMP-010.09.01" LOG_CI_END="0.20382498004155084" LOG_CI_START="-0.04763211377099963" LOG_EFFECT_SIZE="0.07809643313527563" NO="1" P_CHI2="0.9125899157833237" P_Z="0.22343919095719578" STUDIES="10" TAU2="0.0" TOTAL_1="247" TOTAL_2="233" WEIGHT="98.20032046132368" Z="1.217433908468571">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2904" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="5.246879121505226"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="2905" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="3.050304302841174"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2906" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9619712520075643" CI_START="0.9320516049237294" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.47158083907544335" LOG_CI_START="-0.030560041387254936" LOG_EFFECT_SIZE="0.22051039884409415" ORDER="2907" O_E="0.0" SE="0.29496003882123506" STUDY_ID="STD-Johnston-1995" TOTAL_1="26" TOTAL_2="27" VAR="0.0870014245014245" WEIGHT="24.62575358460046"/>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="2908" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="23.087994081702433"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2909" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="5.668282011578874"/>
<DICH_DATA CI_END="8.748921872143878" CI_START="0.5394243722180654" EFFECT_SIZE="2.1724137931034484" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9419545382992105" LOG_CI_START="-0.2680694351899591" LOG_EFFECT_SIZE="0.33694255155462566" ORDER="2910" O_E="0.0" SE="0.7107740717428078" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.5051997810618502" WEIGHT="4.240848317032433"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="2911" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="4.230711392909911"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="2912" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="17.66542184179271"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="2913" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="10.38412580736048"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="25.45999296701072" CI_START="0.3534957771457977" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-010.09.02" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.4771212547196624" NO="2" P_CHI2="1.0" P_Z="0.31398534745852824" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="1.7996795386762925" Z="1.0068947944460578">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2914" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="1.7996795386762925"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.465532261825362" CI_END="4.622860472923857" CI_START="0.8543834433357309" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9873840718183615" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-010.10" LOG_CI_END="0.6649107857691033" LOG_CI_START="-0.06834717620690522" LOG_EFFECT_SIZE="0.29828180478109906" METHOD="MH" NO="10" P_CHI2="0.6508183084335022" P_Q="0.0" P_Z="0.11080475113355209" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="114" TOTAL_2="128" WEIGHT="100.0" Z="1.5945864209618763">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.465532261825362" CI_END="4.622860472923857" CI_START="0.8543834433357309" DF="4.0" EFFECT_SIZE="1.9873840718183615" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" I2="0.0" ID="CMP-010.10.01" LOG_CI_END="0.6649107857691033" LOG_CI_START="-0.06834717620690522" LOG_EFFECT_SIZE="0.29828180478109906" NO="1" P_CHI2="0.6508183084335022" P_Z="0.11080475113355209" STUDIES="5" TAU2="0.0" TOTAL_1="114" TOTAL_2="128" WEIGHT="100.0" Z="1.5945864209618763">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="2915" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="7.275992960752519"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="2916" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="7.2915915164356715"/>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="2917" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="23.85246395661199"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="2918" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="15.814748415677165"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="2919" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="45.765203150522645"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.10.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" I2_Q="0.0" ID="CMP-010.11" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" METHOD="MH" NO="11" P_CHI2="0.227899780136411" P_Q="0.0" P_Z="0.3063895529035281" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.04674841377412624" TOTALS="YES" TOTAL_1="97" TOTAL_2="88" WEIGHT="100.0" Z="1.0228272347262604">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" DF="2.0" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" ID="CMP-010.11.01" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" NO="1" P_CHI2="0.227899780136411" P_Z="0.3063895529035281" STUDIES="3" TAU2="0.04674841377412624" TOTAL_1="97" TOTAL_2="88" WEIGHT="100.0" Z="1.0228272347262604">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2920" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="8.813290868790636"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="2921" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="51.2266972676107"/>
<DICH_DATA CI_END="1.6014883037625876" CI_START="0.5676844929685975" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" ORDER="2922" O_E="0.0" SE="0.26457702275065764" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.070001000967602" WEIGHT="39.960011863598666"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.12" NO="12" P_CHI2="0.398881402393063" P_Q="1.0" P_Z="8.814533869822001E-6" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="51" TOTAL_2="50" UNITS="" WEIGHT="100.0" Z="4.444380855933662">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" DF="2.0" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" ID="CMP-010.12.01" NO="1" P_CHI2="0.398881402393063" P_Z="8.814533869822001E-6" STUDIES="3" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="100.0" Z="4.444380855933662">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.32992271565191034" CI_START="-1.9354422337814112" EFFECT_SIZE="-1.1326824747166608" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="14.6" ORDER="2923" SD_1="5.68" SD_2="9.11" SE="0.4095788317524286" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="27.363734145710712"/>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="2924" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="16.21820873164945"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="2925" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="56.41805712263983"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0018021436538582427" CI_END="25.7986852549672" CI_START="0.3165964113527592" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.8579312744259546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-010.13" LOG_CI_END="1.4115975741391282" LOG_CI_START="-0.4994940122106407" LOG_EFFECT_SIZE="0.4560517809642438" METHOD="MH" NO="13" P_CHI2="0.966138652004048" P_Q="0.0" P_Z="0.3495673656745448" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="28" WEIGHT="100.0" Z="0.9354288116379947">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0018021436538582427" CI_END="25.7986852549672" CI_START="0.3165964113527592" DF="1.0" EFFECT_SIZE="2.8579312744259546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-010.13.01" LOG_CI_END="1.4115975741391282" LOG_CI_START="-0.4994940122106407" LOG_EFFECT_SIZE="0.4560517809642438" NO="1" P_CHI2="0.966138652004048" P_Z="0.3495673656745448" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="28" WEIGHT="100.0" Z="0.9354288116379947">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="2926" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="49.09855769230769"/>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="2927" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="50.901442307692314"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6466083631688497" CI_END="1.2746208012555416" CI_START="0.7890325687589358" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.002854588167314" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="77" I2="0.0" I2_Q="0.0" ID="CMP-010.18" LOG_CI_END="0.10538100169820416" LOG_CI_START="-0.10290507012344964" LOG_EFFECT_SIZE="0.0012379657873773098" METHOD="MH" NO="18" P_CHI2="0.9767960160118097" P_Q="0.0" P_Z="0.9814122307522282" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="183" WEIGHT="100.0" Z="0.02329842159997919">
<NAME>Response 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6475226805935062" CI_END="1.30960736276641" CI_START="0.7689717115632353" DF="6.0" EFFECT_SIZE="1.0035193148227397" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="68" I2="0.0" ID="CMP-010.18.01" LOG_CI_END="0.11714110806533486" LOG_CI_START="-0.11408963645079466" LOG_EFFECT_SIZE="0.0015257358072700805" NO="1" P_CHI2="0.9491002927305745" P_Z="0.9793650468101106" STUDIES="7" TAU2="0.0" TOTAL_1="150" TOTAL_2="169" WEIGHT="81.13893516022667" Z="0.02586496219116744">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="2928" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="11.97527926334815"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="2929" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="11.029862479399613"/>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2930" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="3.2241136478245016"/>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="2931" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="10.220281440271268"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="2932" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="5.613412154694445"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="2933" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="6.415328176793653"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="2934" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="32.660657997895036"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7369962011109146" CI_START="0.5757064980110143" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" I2="0.0" ID="CMP-010.18.02" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="18.86106483977334" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="2935" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="18.86106483977334"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.725780065265083" CI_END="0.42646210446025185" CI_START="-0.32115529712908825" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.052653403665581806" ESTIMABLE="YES" I2="15.357889178966103" I2_Q="0.0" ID="CMP-010.19" NO="19" P_CHI2="0.31660871145154823" P_Q="1.0" P_Z="0.7824914118980268" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0280939617556844" TOTALS="YES" TOTAL_1="65" TOTAL_2="76" UNITS="" WEIGHT="100.0" Z="0.2760737634747454">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.725780065265083" CI_END="0.42646210446025185" CI_START="-0.32115529712908825" DF="4.0" EFFECT_SIZE="0.052653403665581806" ESTIMABLE="YES" I2="15.357889178966103" ID="CMP-010.19.01" NO="1" P_CHI2="0.31660871145154823" P_Z="0.7824914118980268" STUDIES="5" TAU2="0.0280939617556844" TOTAL_1="65" TOTAL_2="76" WEIGHT="100.0" Z="0.2760737634747454">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="2936" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="18.951105183905355"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="2937" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="18.362882531660222"/>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="2938" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="28.113338646421653"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="2939" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="18.32515440821598"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="2940" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="16.24751922979679"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.19.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" NO="11">
<NAME>SUBGROUP3: 0%agoraphobia: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="0.07044551271560649" CI_END="1.3779571267222233" CI_START="0.8402838720010873" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0760460723842835" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="78" I2="0.0" I2_Q="0.0" ID="CMP-011.01" LOG_CI_END="0.13923570529467025" LOG_CI_START="-0.07557397201329685" LOG_EFFECT_SIZE="0.0318308666406867" METHOD="MH" NO="1" P_CHI2="0.790689220819294" P_Q="0.0" P_Z="0.5613337011258805" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.5808616538537067">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07044551271560649" CI_END="1.3779571267222233" CI_START="0.8402838720010873" DF="1.0" EFFECT_SIZE="1.0760460723842835" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="78" I2="0.0" ID="CMP-011.01.02" LOG_CI_END="0.13923570529467025" LOG_CI_START="-0.07557397201329685" LOG_EFFECT_SIZE="0.0318308666406867" NO="2" P_CHI2="0.790689220819294" P_Z="0.5613337011258805" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.5808616538537067">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="2941" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="47.8318119936617"/>
<DICH_DATA CI_END="1.5648074868854178" CI_START="0.7889583297507372" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="42" LOG_CI_END="0.1944609153482074" LOG_CI_START="-0.10294593422685715" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="2942" O_E="0.0" SE="0.17469825562804145" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.03051948051948052" WEIGHT="52.16818800633829"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8368843995969304" CI_END="1.3952647027879397" CI_START="0.8486858007262903" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0881825864765122" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-011.02" LOG_CI_END="0.14465660764885035" LOG_CI_START="-0.07125306389829172" LOG_EFFECT_SIZE="0.03670177187527931" METHOD="MH" NO="2" P_CHI2="0.36028942868076974" P_Q="0.0" P_Z="0.5051966152929674" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.6663356071906794">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8368843995969304" CI_END="1.3952647027879397" CI_START="0.8486858007262903" DF="1.0" EFFECT_SIZE="1.0881825864765122" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="76" I2="0.0" ID="CMP-011.02.02" LOG_CI_END="0.14465660764885035" LOG_CI_START="-0.07125306389829172" LOG_EFFECT_SIZE="0.03670177187527931" NO="2" P_CHI2="0.36028942868076974" P_Z="0.5051966152929674" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.6663356071906794">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="2943" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="54.590020166943"/>
<DICH_DATA CI_END="1.7868745988134767" CI_START="0.8544588892874796" EFFECT_SIZE="1.2356418918918919" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="0.2520940751949005" LOG_CI_START="-0.06830882771808076" LOG_EFFECT_SIZE="0.09189262373840987" ORDER="2944" O_E="0.0" SE="0.18820625119103365" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.035421592987382455" WEIGHT="45.40997983305701"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.4217115114574125" CI_END="0.043308478368376646" CI_START="-0.548246807653985" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2524691646428042" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.03" NO="3" P_CHI2="0.5160842844547728" P_Q="1.0" P_Z="0.09433097461065083" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" UNITS="" WEIGHT="100.0" Z="1.6729813141695236">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4217115114574125" CI_END="0.043308478368376646" CI_START="-0.548246807653985" DF="1.0" EFFECT_SIZE="-0.2524691646428042" ESTIMABLE="YES" I2="0.0" ID="CMP-011.03.02" NO="2" P_CHI2="0.5160842844547728" P_Z="0.09433097461065083" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.6729813141695236">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="2945" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="49.184227471570665"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="2946" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="50.81577252842933"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.06" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.06.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.07" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.07.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.07.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.08" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Social malfunctioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.025424679194256658" CI_END="1.5968052448318433" CI_START="0.6176825924220203" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9931358432867136" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="39" I2="0.0" I2_Q="0.0" ID="CMP-011.09" LOG_CI_END="0.20325195041986605" LOG_CI_START="-0.20923463781009208" LOG_EFFECT_SIZE="-0.002991343695113039" METHOD="MH" NO="9" P_CHI2="0.8733134375978251" P_Q="0.0" P_Z="0.9773214052186291" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.028427231697210776">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.025424679194256658" CI_END="1.5968052448318433" CI_START="0.6176825924220203" DF="1.0" EFFECT_SIZE="0.9931358432867136" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="39" I2="0.0" ID="CMP-011.09.02" LOG_CI_END="0.20325195041986605" LOG_CI_START="-0.20923463781009208" LOG_EFFECT_SIZE="-0.002991343695113039" NO="2" P_CHI2="0.8733134375978251" P_Z="0.9773214052186291" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.028427231697210776">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="2947" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="48.723853387065816"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="2948" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="51.27614661293418"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.009886827140137147" CI_END="59.69933451295224" CI_START="0.6706851215441423" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="6.3276737766673605" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-011.10" LOG_CI_END="1.7759694899407008" LOG_CI_START="-0.17348132792645748" LOG_EFFECT_SIZE="0.8012440810071216" METHOD="MH" NO="10" P_CHI2="0.9207948597779587" P_Q="0.0" P_Z="0.10715134757866668" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.611130198522264">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.10.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.009886827140137147" CI_END="59.69933451295224" CI_START="0.6706851215441423" DF="1.0" EFFECT_SIZE="6.3276737766673605" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-011.10.02" LOG_CI_END="1.7759694899407008" LOG_CI_START="-0.17348132792645748" LOG_EFFECT_SIZE="0.8012440810071216" NO="2" P_CHI2="0.9207948597779587" P_Z="0.10715134757866668" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.611130198522264">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="2949" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="50.01823792630897"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="2950" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="49.98176207369102"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" I2_Q="0.0" ID="CMP-011.11" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" METHOD="MH" NO="11" P_CHI2="0.5311461848942365" P_Q="0.0" P_Z="0.14006929943098473" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.4755330132930529">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-011.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="2951" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="53.02900393223546"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="2952" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="46.97099606776454"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.12" NO="12" P_CHI2="0.7506376179413443" P_Q="1.0" P_Z="0.006311755879724431" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" UNITS="" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-011.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="2953" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="49.10532495830454"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="2954" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="50.894675041695464"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-011.13" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" METHOD="MH" NO="13" P_CHI2="0.9441919745982897" P_Q="0.0" P_Z="0.45471533666733666" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.74757701885429">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-011.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="2955" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="49.10301461068985"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="2956" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="50.89698538931015"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.2422119208092252" CI_END="1.1949035758859248" CI_START="0.46300853125965286" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7438081403613765" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="49" I2="0.0" I2_Q="0.0" ID="CMP-011.18" LOG_CI_END="0.07733286080695621" LOG_CI_START="-0.3344110067253377" LOG_EFFECT_SIZE="-0.1285390729591907" METHOD="MH" NO="18" P_CHI2="0.6226131221215001" P_Q="0.0" P_Z="0.22105358613984316" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="59" TOTAL_2="135" WEIGHT="100.00000000000001" Z="1.2237314188361075">
<NAME>Response 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-011.18.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2422119208092252" CI_END="1.1949035758859248" CI_START="0.46300853125965286" DF="1.0" EFFECT_SIZE="0.7438081403613765" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="49" I2="0.0" ID="CMP-011.18.02" LOG_CI_END="0.07733286080695621" LOG_CI_START="-0.3344110067253377" LOG_EFFECT_SIZE="-0.1285390729591907" NO="2" P_CHI2="0.6226131221215001" P_Z="0.22105358613984316" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="100.00000000000001" Z="1.2237314188361075">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="2957" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="50.629776689640615"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="2958" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="49.3702233103594"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.19" NO="19" P_CHI2="0.6011026185146243" P_Q="1.0" P_Z="0.18067877571281446" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="59" TOTAL_2="135" UNITS="" WEIGHT="100.0" Z="1.3386680075530792">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.19.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-011.19.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="100.0" Z="1.3386680075530792">
<NAME>Cognitive-behviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="2959" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="49.1429656497983"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="2960" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="50.85703435020171"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" NO="12">
<NAME>SUBGROUP4: without comorbidity: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="7.409379316655956" CI_END="1.8235844221169604" CI_START="0.8566611235554711" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2498775459815932" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="64" I2="46.01437139264584" I2_Q="0.0" ID="CMP-012.01" LOG_CI_END="0.2609258736058513" LOG_CI_START="-0.06719094152501374" LOG_EFFECT_SIZE="0.09686746604041875" METHOD="MH" NO="1" P_CHI2="0.11577239391186078" P_Q="0.0" P_Z="0.24716987508306454" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07303859816852878" TOTALS="YES" TOTAL_1="128" TOTAL_2="137" WEIGHT="99.99999999999999" Z="1.1572509298991929">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.5349591648704624" CI_END="7.030518183937001" CI_START="0.3523390368204596" DF="1.0" EFFECT_SIZE="1.5738888160467657" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="33" I2="60.55163278927609" ID="CMP-012.01.01" LOG_CI_END="0.8469873358492412" LOG_CI_START="-0.453039237214682" LOG_EFFECT_SIZE="0.19697404931727966" NO="1" P_CHI2="0.11135008716030192" P_Z="0.5525592947040547" STUDIES="2" TAU2="0.8203357871240139" TOTAL_1="56" TOTAL_2="65" WEIGHT="39.698840342707" Z="0.5939294635201301">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="2961" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="3.3382742575938344"/>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="2962" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="36.36056608511317"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.788719339479356" CI_END="2.3928353833982725" CI_START="0.7873233447547815" DF="2.0" EFFECT_SIZE="1.372565174228429" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="31" I2="47.2117140174643" ID="CMP-012.01.02" LOG_CI_END="0.3789128220815215" LOG_CI_START="-0.10384687119500025" LOG_EFFECT_SIZE="0.1375329754432606" NO="2" P_CHI2="0.15041473209327672" P_Z="0.2641034925284569" STUDIES="3" TAU2="0.11808246178122378" TOTAL_1="72" TOTAL_2="72" WEIGHT="60.301159657292985" Z="1.1167447585605306">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="2963" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="16.149840805335952"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="2964" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="35.370152905638136"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="2965" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="8.7811659463189"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.313314488343364" CI_END="2.50989740369649" CI_START="0.7161783833574418" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3407215463967128" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="39" I2="62.35871216756117" I2_Q="0.0" ID="CMP-012.02" LOG_CI_END="0.39965596932201936" LOG_CI_START="-0.14497879157636276" LOG_EFFECT_SIZE="0.1273385888728283" METHOD="MH" NO="2" P_CHI2="0.07018258162415159" P_Q="0.0" P_Z="0.35940439293678494" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.18005517631245543" TOTALS="YES" TOTAL_1="95" TOTAL_2="105" WEIGHT="100.0" Z="0.916500620053015">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7169247124253846" CI_START="0.5174309927377301" DF="0.0" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" I2="0.0" ID="CMP-012.02.01" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" NO="1" P_CHI2="1.0" P_Z="0.8466561094903486" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="37.39779178579455" Z="0.1933867272121479">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="2966" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="37.39779178579455"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.047992180387981" CI_END="10.096582129657683" CI_START="0.44857231702253647" DF="1.0" EFFECT_SIZE="2.128155830739112" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="22" I2="80.19014363997803" ID="CMP-012.02.02" LOG_CI_END="1.0041743823526899" LOG_CI_START="-0.34816753176804177" LOG_EFFECT_SIZE="0.3280034252923239" NO="2" P_CHI2="0.02465452272888824" P_Z="0.34172728428923504" STUDIES="2" TAU2="1.0418634009391432" TOTAL_1="52" TOTAL_2="52" WEIGHT="62.60220821420544" Z="0.9507579313574926">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="2967" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="15.572682855776721"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="2968" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="47.02952535842872"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.9280026572423881" CI_END="0.0536039627120376" CI_START="-0.6329771017145333" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2896865695012478" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.03" NO="3" P_CHI2="0.33538262114329875" P_Q="0.33538262114329875" P_Z="0.09814367014365796" Q="0.9280026572423881" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="63" TOTAL_2="70" UNITS="" WEIGHT="99.99999999999999" Z="1.6539204835239905">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3124802140477023" CI_START="-0.5979679222158227" DF="0.0" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" I2="0.0" ID="CMP-012.03.01" NO="1" P_CHI2="1.0" P_Z="0.5388303803196052" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="56.86868955930725" Z="0.6145826475462622">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="2969" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="56.86868955930725"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.332371116245477E-32" CI_END="0.0392849124643212" CI_START="-1.0061463786555822" DF="0.0" EFFECT_SIZE="-0.48343073309563045" ESTIMABLE="YES" I2="100.0" ID="CMP-012.03.02" NO="2" P_CHI2="0.0" P_Z="0.06988395750165902" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="43.13131044069274" Z="1.8126620734151322">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="2970" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="43.13131044069274"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.0292790811554442" CI_END="0.1671287478967933" CI_START="-0.5146000578495433" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17373565497637503" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.04" NO="4" P_CHI2="0.5977160855010009" P_Q="0.3431600514661016" P_Z="0.3178059488890077" Q="0.8985904949282243" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="70" UNITS="" WEIGHT="100.00000000000001" Z="0.9989767887580623">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1306885862272199" CI_END="0.12556747863920253" CI_START="-0.6860331208244879" DF="1.0" EFFECT_SIZE="-0.28023282109264264" ESTIMABLE="YES" I2="0.0" ID="CMP-012.04.01" NO="1" P_CHI2="0.7177192392686516" P_Z="0.17589946598154874" STUDIES="2" TAU2="0.0" TOTAL_1="44" TOTAL_2="51" WEIGHT="70.5567506177659" Z="1.3534889870475222">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="2971" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="15.07912888509385"/>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="2972" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="55.47762173267205"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.709657110863069" CI_START="-0.5467164147484286" DF="0.0" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" I2="0.0" ID="CMP-012.04.02" NO="2" P_CHI2="1.0" P_Z="0.7993485857195068" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="29.443249382234114" Z="0.2541902463641487">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7096571108630692" CI_START="-0.5467164147484287" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.8" ORDER="2973" SD_1="2.5" SD_2="2.3" SE="0.32050933984542873" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="29.443249382234114"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.678403784543782" CI_END="0.21258211085077983" CI_START="-0.9953803146663459" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.39139910190778304" ESTIMABLE="YES" I2="69.00315313573773" I2_Q="0.0" ID="CMP-012.05" NO="5" P_CHI2="0.021507281169865333" P_Q="0.9234334989208405" P_Z="0.20404219365895626" Q="0.009237062124597628" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.2547551748617338" TOTALS="YES" TOTAL_1="78" TOTAL_2="86" UNITS="" WEIGHT="100.00000000000001" Z="1.2701192141670659">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.7222471810435014" CI_END="0.39148124997074524" CI_START="-1.287258169622723" DF="1.0" EFFECT_SIZE="-0.44788845982598885" ESTIMABLE="YES" I2="63.265642923113376" ID="CMP-012.05.01" NO="1" P_CHI2="0.09895867961292415" P_Z="0.2956355669936477" STUDIES="2" TAU2="0.244799419902535" TOTAL_1="44" TOTAL_2="51" WEIGHT="50.341755379554115" Z="1.0458386097380574">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="2974" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="19.57379243700574"/>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="2975" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="30.767962942548372"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.946919541375682" CI_END="0.9563958019441933" CI_START="-1.6706057574180835" DF="1.0" EFFECT_SIZE="-0.35710497773694516" ESTIMABLE="YES" I2="85.60513053240325" ID="CMP-012.05.02" NO="2" P_CHI2="0.008396442988709674" P_Z="0.594130040152471" STUDIES="2" TAU2="0.7695643249393687" TOTAL_1="34" TOTAL_2="35" WEIGHT="49.6582446204459" Z="0.5328606620502343">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="2976" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="23.178490151726752"/>
<CONT_DATA CI_END="0.9259489927372764" CI_START="-0.33737912447830304" EFFECT_SIZE="0.2942849341294867" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="18.7" ORDER="2977" SD_1="12.0" SD_2="13.3" SE="0.3222835029573376" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="26.479754468719143"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.4574730013384274" CI_END="-0.03286884629139636" CI_START="-0.7368729912742726" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.38487091878283447" ESTIMABLE="YES" I2="18.615586054832395" I2_Q="50.2026744261025" ID="CMP-012.06" NO="6" P_CHI2="0.29266220122738773" P_Q="0.1564574095256348" P_Z="0.03211476407871409" Q="2.0081399723285034" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.01863760718480527" TOTALS="YES" TOTAL_1="77" TOTAL_2="86" UNITS="" WEIGHT="100.00000000000001" Z="2.142979256264305">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3256801113236999" CI_START="-0.584552935900024" DF="0.0" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" I2="0.0" ID="CMP-012.06.01" NO="1" P_CHI2="1.0" P_Z="0.5772410260922407" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="44.45411257943171" Z="0.5574192392742721">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="2978" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="44.45411257943171"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4493330290099239" CI_END="-0.1528766013116588" CI_START="-1.0099331622432612" DF="1.0" EFFECT_SIZE="-0.5814048817774601" ESTIMABLE="YES" I2="0.0" ID="CMP-012.06.02" NO="2" P_CHI2="0.5026518853360098" P_Z="0.00783317546519518" STUDIES="2" TAU2="0.0" TOTAL_1="43" TOTAL_2="45" WEIGHT="55.545887420568306" Z="2.659177190081695">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="2979" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="19.59789254958432"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="2980" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="35.94799487098398"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.616698009083305" CI_END="-0.06345825869648453" CI_START="-0.6859972725804695" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.37472776563847704" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.07" NO="7" P_CHI2="0.45456973602406325" P_Q="0.4209253253816374" P_Z="0.018297596685681025" Q="0.647731044833465" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="86" UNITS="" WEIGHT="100.00000000000001" Z="2.3595402321097003">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.14689688729843983" CI_END="0.13771207234523908" CI_START="-0.6735592464005735" DF="1.0" EFFECT_SIZE="-0.2679235870276672" ESTIMABLE="YES" I2="0.0" ID="CMP-012.07.01" NO="1" P_CHI2="0.7015187607317301" P_Z="0.1954713081132031" STUDIES="2" TAU2="0.0" TOTAL_1="44" TOTAL_2="51" WEIGHT="58.88448782872162" Z="1.2945621743286142">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="2981" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="12.584667002014513"/>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="2982" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="46.299820826707105"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8220700769514004" CI_END="0.10723649300049265" CI_START="-1.2194349151831703" DF="1.0" EFFECT_SIZE="-0.5560992110913388" ESTIMABLE="YES" I2="45.117368829570395" ID="CMP-012.07.02" NO="2" P_CHI2="0.17706722750071946" P_Z="0.10035989655097635" STUDIES="2" TAU2="0.10443571698372742" TOTAL_1="34" TOTAL_2="35" WEIGHT="41.1155121712784" Z="1.6431113519848644">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="2983" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="16.752729846197404"/>
<CONT_DATA CI_END="0.380172766114548" CI_START="-0.8810829019163788" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="46.0" ORDER="2984" SD_1="8.7" SD_2="10.8" SE="0.3217548072259364" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="24.362782325080993"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.044909150273325" CI_END="0.035741094995949796" CI_START="-0.8916309065611989" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.42794490578262456" ESTIMABLE="YES" I2="50.5551317545697" I2_Q="27.286753703809133" ID="CMP-012.08" NO="8" P_CHI2="0.13233048640833422" P_Q="0.24090948701782688" P_Z="0.07046821735699621" Q="1.375265238367422" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.084388501460801" TOTALS="YES" TOTAL_1="77" TOTAL_2="86" UNITS="" WEIGHT="100.0" Z="1.8088892079833685">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2886432974821726" CI_START="-0.6222469115213254" DF="0.0" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" I2="0.0" ID="CMP-012.08.01" NO="1" P_CHI2="1.0" P_Z="0.4728710888002342" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="40.444432960205354" Z="0.7178154536806854">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.2886432974821726" CI_START="-0.6222469115213254" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.95" ORDER="2985" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="40.444432960205354"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-012.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="59.555567039794646" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="2986" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="23.258141855031397"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="2987" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="36.29742518476325"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.3548304806307956" CI_END="1.3083622104776707" CI_START="0.5650360498871897" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8598091737298311" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="37" I2="0.0" I2_Q="0.0" ID="CMP-012.09" LOG_CI_END="0.11672799187450435" LOG_CI_START="-0.24792384285732955" LOG_EFFECT_SIZE="-0.06559792549141258" METHOD="MH" NO="9" P_CHI2="0.8520064973371132" P_Q="0.0" P_Z="0.4807085342496755" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="137" WEIGHT="100.0" Z="0.7051634418253295">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.1978299693787241" CI_END="1.9872045585028397" CI_START="0.4991769340927443" DF="1.0" EFFECT_SIZE="0.9959752401182336" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" I2="0.0" ID="CMP-012.09.01" LOG_CI_END="0.2982425747376085" LOG_CI_START="-0.30174549068877143" LOG_EFFECT_SIZE="-0.0017514579755814638" NO="1" P_CHI2="0.6564781728491055" P_Z="0.9908701050573401" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="36.937847380607714" Z="0.011442876118329531">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2988" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="6.816592139114518"/>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="2989" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="30.121255241493195"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.881839522131159" CI_END="1.3384454111359054" CI_START="0.4649529273729682" DF="2.0" EFFECT_SIZE="0.7888688813970008" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="23" I2="0.0" ID="CMP-012.09.02" LOG_CI_END="0.1266006630643004" LOG_CI_START="-0.3325910135982076" LOG_EFFECT_SIZE="-0.10299517526695354" NO="2" P_CHI2="0.6434443577539246" P_Z="0.37927827856476126" STUDIES="3" TAU2="0.0" TOTAL_1="72" TOTAL_2="72" WEIGHT="63.062152619392286" Z="0.8792268865665243">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="2990" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="13.405204608024537"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="2991" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="38.1867208542039"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="2992" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="11.470227157163853"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.032217029594881985" CI_END="3.271856491976486" CI_START="0.628111833535677" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4335591303608508" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-012.10" LOG_CI_END="0.5147942466773036" LOG_CI_START="-0.2019630244739171" LOG_EFFECT_SIZE="0.15641561110169327" METHOD="MH" NO="10" P_CHI2="0.9840205362421509" P_Q="0.0" P_Z="0.39231140800837305" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="68" WEIGHT="100.00000000000001" Z="0.8554331479239715">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.9129858840241205" CI_START="0.27732730768974334" DF="0.0" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-012.10.01" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" NO="1" P_CHI2="1.0" P_Z="0.691620433816067" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="26.336297413309932" Z="0.396656973526102">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="2993" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="26.336297413309932"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.02977635872647857" CI_END="3.7963471555536388" CI_START="0.5549485801151327" DF="1.0" EFFECT_SIZE="1.4514742380072112" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" I2="0.0" ID="CMP-012.10.02" LOG_CI_END="0.5793659194685447" LOG_CI_START="-0.2557472554481441" LOG_EFFECT_SIZE="0.16180933201020026" NO="2" P_CHI2="0.8629986847128919" P_Z="0.44754459146107883" STUDIES="2" TAU2="0.0" TOTAL_1="58" TOTAL_2="56" WEIGHT="73.66370258669008" Z="0.7595149319350991">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="2994" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="36.988487355953424"/>
<DICH_DATA CI_END="5.208499115067838" CI_START="0.34132246900739327" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7167125947102104" LOG_CI_START="-0.4668351214936106" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2995" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="36.675215230736654"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-012.11" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" METHOD="MH" NO="11" P_CHI2="0.41779777973047816" P_Q="0.0" P_Z="0.021254905136773212" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="65" WEIGHT="99.99999999999999" Z="2.3034256644443234">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" DF="1.0" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" ID="CMP-012.11.01" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" NO="1" P_CHI2="0.41779777973047816" P_Z="0.021254905136773212" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="99.99999999999999" Z="2.3034256644443234">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="2996" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="17.169123126782324"/>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="2997" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="82.83087687321766"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.25574887888751896" CI_START="-2.204329664505533" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.12" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.013344157097756763" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.4744498045847734">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.25574887888751896" CI_START="-2.204329664505533" DF="0.0" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" I2="0.0" ID="CMP-012.12.01" NO="1" P_CHI2="1.0" P_Z="0.013344157097756763" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="2.4744498045847734">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="2998" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-012.13" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-012.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="2999" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-012.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.15" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.15.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.004311028834568437" CI_END="2.068774683522554" CI_START="1.0771788886736944" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.492796173130511" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-012.16" LOG_CI_END="0.31571319292218025" LOG_CI_START="0.03228783320738468" LOG_EFFECT_SIZE="0.17400051306478248" METHOD="MH" NO="16" P_CHI2="0.9978468087021203" P_Q="0.0" P_Z="0.016105216183956505" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="105" WEIGHT="100.0" Z="2.4065224032291272">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-012.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="51.341748087744826" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="3000" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="51.341748087744826"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004366982019633777" CI_END="2.384447828453703" CI_START="0.9355673781266821" DF="1.0" EFFECT_SIZE="1.493590172418891" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" I2="0.0" ID="CMP-012.16.02" LOG_CI_END="0.37738782454193753" LOG_CI_START="-0.028924929815608465" LOG_EFFECT_SIZE="0.17423144736316457" NO="2" P_CHI2="0.9473116301008679" P_Z="0.09278061164036563" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="52" WEIGHT="48.65825191225518" Z="1.680908896625911">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="3001" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="23.090204475275236"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="3002" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="25.568047436979942"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-012.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.17" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.17.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.17.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" NO="13">
<NAME>SUBGROUP4: without comorbidity: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="11.607436239552099" CI_END="1.3178412095691479" CI_START="1.0056594479292533" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.151216514507036" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="177" I2="5.23316455947673" I2_Q="0.0" ID="CMP-013.01" LOG_CI_END="0.11986308403459703" LOG_CI_START="0.002450938051537334" LOG_EFFECT_SIZE="0.06115701104306721" METHOD="MH" NO="1" P_CHI2="0.39386216213663017" P_Q="0.0" P_Z="0.04117225460176093" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0030232195512668314" TOTALS="YES" TOTAL_1="321" TOTAL_2="354" WEIGHT="100.00000000000001" Z="2.0417911288977617">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.1667778134623408" CI_END="1.5143380158638444" CI_START="0.9686193107897764" DF="5.0" EFFECT_SIZE="1.2111222255531415" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="70" I2="0.0" ID="CMP-013.01.01" LOG_CI_END="0.18022282499218015" LOG_CI_START="-0.013846876931187593" LOG_EFFECT_SIZE="0.08318797403049631" NO="1" P_CHI2="0.8256200423871612" P_Z="0.09290342431277164" STUDIES="6" TAU2="0.0" TOTAL_1="173" TOTAL_2="164" WEIGHT="34.77897142284502" Z="1.680277049232628">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="3003" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="5.307309081839673"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="3004" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="5.063913177434561"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="3005" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="3.418746922219536"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="3006" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="0.8763709508049085"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="3007" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="9.049677781109478"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="3008" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="11.062953509436854"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.221625318076153" CI_END="1.4027981211886624" CI_START="0.8901127811081098" DF="5.0" EFFECT_SIZE="1.1174294326643055" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="107" I2="45.77962314084653" ID="CMP-013.01.02" LOG_CI_END="0.14699517554569042" LOG_CI_START="-0.050554962894657565" LOG_EFFECT_SIZE="0.04822010632551646" NO="2" P_CHI2="0.10054419776431067" P_Z="0.33865960970466413" STUDIES="6" TAU2="0.035187599472136816" TOTAL_1="148" TOTAL_2="190" WEIGHT="65.221028577155" Z="0.9568170640107375">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="3009" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="13.824056607529652"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="3010" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="14.199207219984103"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="3011" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="13.493575286334968"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="3012" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="11.18673847123366"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="3013" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="1.180242332579978"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="3014" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="11.33720865949263"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.997691011651993" CI_END="1.6981340927089317" CI_START="1.1087810194355645" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3721730395442466" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="113" I2="18.164640282541583" I2_Q="0.0" ID="CMP-013.02" LOG_CI_END="0.22997198121076529" LOG_CI_START="0.04484578290179342" LOG_EFFECT_SIZE="0.13740888205627935" METHOD="MH" NO="2" P_CHI2="0.275867425933087" P_Q="0.0" P_Z="0.003619558053366647" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.020728264579194605" TOTALS="YES" TOTAL_1="288" TOTAL_2="322" WEIGHT="100.0" Z="2.9095445425475206">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.6513610509969574" CI_END="2.034241976962707" CI_START="1.0401991347099886" DF="4.0" EFFECT_SIZE="1.4546534790895542" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="35" I2="0.0" ID="CMP-013.02.01" LOG_CI_END="0.3084026118163814" LOG_CI_START="0.017116488170948005" LOG_EFFECT_SIZE="0.16275954999366468" NO="1" P_CHI2="0.6177523924195361" P_Z="0.02850205997489528" STUDIES="5" TAU2="0.0" TOTAL_1="160" TOTAL_2="152" WEIGHT="32.80105420204004" Z="2.190305889859923">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="3015" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="15.980903398683775"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="3016" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="3.998693665567715"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="3017" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="4.8123350414215285"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="3018" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="3.2791151098948736"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="3019" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="4.730006986472148"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.96883002008752" CI_END="1.8415517331691738" CI_START="0.9531145978186871" DF="4.0" EFFECT_SIZE="1.3248433264057464" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="78" I2="49.804425619357495" ID="CMP-013.02.02" LOG_CI_END="0.26518392363313714" LOG_CI_START="-0.02085487878646695" LOG_EFFECT_SIZE="0.12216452242333507" NO="2" P_CHI2="0.092726735479285" P_Z="0.09409819208427074" STUDIES="5" TAU2="0.06640039015032943" TOTAL_1="128" TOTAL_2="170" WEIGHT="67.19894579795996" Z="1.6741649182758738">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="3020" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="10.374658478861678"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="3021" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="19.495946755497474"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="3022" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="18.577927756243408"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="3023" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="15.602005419449236"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="3024" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="3.1484073879081618"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.65766969191783" CI_END="-0.2130708101915736" CI_START="-0.7072156469210364" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.460143228556305" ESTIMABLE="YES" I2="0.0" I2_Q="70.7034534986345" ID="CMP-013.03" NO="3" P_CHI2="0.4590688498576283" P_Q="0.06467028452045198" P_Z="2.6203448716693154E-4" Q="3.41337160662739" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="123" TOTAL_2="152" UNITS="" WEIGHT="100.00000000000003" Z="3.65020167637246">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9023334626406148" CI_END="-0.3194698560529654" CI_START="-0.9162693479822595" DF="3.0" EFFECT_SIZE="-0.6178696020176124" ESTIMABLE="YES" I2="0.0" ID="CMP-013.03.01" NO="1" P_CHI2="0.8248647769804303" P_Z="4.942664744947924E-5" STUDIES="4" TAU2="0.0" TOTAL_1="94" TOTAL_2="89" WEIGHT="68.55697304144567" Z="4.058321709295593">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="3025" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="11.704061223948528"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="3026" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.805877693862401"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="3027" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="20.185840931355315"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="3028" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="24.86119319227942"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.34196462264982525" CI_END="0.32437417383596917" CI_START="-0.5568615365697223" DF="1.0" EFFECT_SIZE="-0.11624368136687657" ESTIMABLE="YES" I2="0.0" ID="CMP-013.03.02" NO="2" P_CHI2="0.5586975754442574" P_Z="0.605102299352494" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="63" WEIGHT="31.44302695855435" Z="0.5170771593097174">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="3029" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="16.275023903567366"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="3030" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="15.168003054986984"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.694781649692946" CI_END="0.2922406201950988" CI_START="-0.2195144285786413" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.03636309580822874" ESTIMABLE="YES" I2="22.025077862483275" I2_Q="70.16752831165896" ID="CMP-013.04" NO="4" P_CHI2="0.26132806010668985" P_Q="0.06712136718175732" P_Z="0.7806031659197696" Q="3.352052121081253" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02601910600084496" TOTALS="YES" TOTAL_1="169" TOTAL_2="160" UNITS="" WEIGHT="99.99999999999999" Z="0.2785330924288279">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.8314225280355605" CI_END="0.4940480310388357" CI_START="-0.09339397209169059" DF="4.0" EFFECT_SIZE="0.20032702947357256" ESTIMABLE="YES" I2="0.0" ID="CMP-013.04.01" NO="1" P_CHI2="0.5864209291028849" P_Z="0.1813017936996682" STUDIES="5" TAU2="0.0" TOTAL_1="94" TOTAL_2="88" WEIGHT="59.85585382511377" Z="1.3367575379551304">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="3031" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="10.879559214890003"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="3032" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="10.89452976183304"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="3033" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="7.154587866390031"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="3034" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="11.187539797131878"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="3035" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="19.739637184868815"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.5113070005761333" CI_END="0.2532594992056981" CI_START="-0.6016259804402202" DF="1.0" EFFECT_SIZE="-0.17418324061726106" ESTIMABLE="YES" I2="33.83210693665915" ID="CMP-013.04.02" NO="2" P_CHI2="0.2189401530110089" P_Z="0.42447204402909844" STUDIES="2" TAU2="0.03532194129775751" TOTAL_1="75" TOTAL_2="72" WEIGHT="40.14414617488622" Z="0.7986868099846689">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="3036" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="26.64158143107224"/>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="3037" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.502564743813975"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.276132464164773" CI_END="0.04446851548115191" CI_START="-0.3452850839802495" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1504082842495488" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.05" NO="5" P_CHI2="0.6018845086083073" P_Q="0.8353816083459349" P_Z="0.1303497700817068" Q="0.043182782350653426" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="226" UNITS="" WEIGHT="100.0" Z="1.5127240416147754">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.666982450401498" CI_END="0.1608029834970533" CI_START="-0.48852422268135326" DF="5.0" EFFECT_SIZE="-0.16386061959214998" ESTIMABLE="YES" I2="34.785294836064686" ID="CMP-013.05.01" NO="1" P_CHI2="0.1755691606071581" P_Z="0.3225597718014712" STUDIES="6" TAU2="0.05644323543230318" TOTAL_1="123" TOTAL_2="117" WEIGHT="57.79045978570633" Z="0.9892113246731616">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="3038" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="11.091336197438624"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="3039" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.522475187167628"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="3040" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.5784306226646905"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="3041" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.41397299273679"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="3042" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="10.9282553914732"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="3043" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="16.255989394225402"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.5659672314126207" CI_END="0.17372214947640333" CI_START="-0.42618608605429864" DF="4.0" EFFECT_SIZE="-0.12623196828894764" ESTIMABLE="YES" I2="0.0" ID="CMP-013.05.02" NO="2" P_CHI2="0.9667694041586712" P_Z="0.40947009513493493" STUDIES="5" TAU2="0.0" TOTAL_1="75" TOTAL_2="109" WEIGHT="42.209540214293675" Z="0.8248265214264681">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="3044" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="6.84027889045156"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="3045" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="10.12094018093049"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="3046" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="9.432262157228271"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="3047" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.884528676247884"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="3048" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.9315303094354705"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.706191353220582" CI_END="-0.15637757472022684" CI_START="-0.5466583768340356" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.35151797577713123" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.06" NO="6" P_CHI2="0.78846748179214" P_Q="0.35270907102535076" P_Z="4.1461927568800386E-4" Q="0.8636869363614998" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="228" UNITS="" WEIGHT="100.0" Z="3.5305993464710252">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.3131058388469294" CI_END="-0.15874360094328321" CI_START="-0.7630780841896155" DF="3.0" EFFECT_SIZE="-0.4609108425664494" ESTIMABLE="YES" I2="0.0" ID="CMP-013.06.01" NO="1" P_CHI2="0.5100149620532631" P_Z="0.0027931434853521774" STUDIES="4" TAU2="0.0" TOTAL_1="88" TOTAL_2="87" WEIGHT="41.706104425340754" Z="2.9896313268823693">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="3049" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="10.90594203752939"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="3050" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.210477731587636"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="3051" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.6103658781495405"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="3052" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="15.979318778074184"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.5293985780121526" CI_END="-0.01766817127764375" CI_START="-0.5288385148800555" DF="4.0" EFFECT_SIZE="-0.27325334307884963" ESTIMABLE="YES" I2="0.0" ID="CMP-013.06.02" NO="2" P_CHI2="0.8214215545777508" P_Z="0.03613074369111289" STUDIES="5" TAU2="0.0" TOTAL_1="110" TOTAL_2="141" WEIGHT="58.293895574659246" Z="2.0954529846757945">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="3053" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="6.937165462498385"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="3054" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="25.96496728526051"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="3055" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="10.141906814608033"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="3056" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="9.461794605274147"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="3057" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.788061407018176"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.305905678212203" CI_END="0.0588949233177774" CI_START="-0.40857209209365775" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17483858438794017" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.07" NO="7" P_CHI2="0.6226865265359951" P_Q="0.5233940191176969" P_Z="0.14262030820890098" Q="0.40720020028311854" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="144" TOTAL_2="142" UNITS="" WEIGHT="100.00000000000001" Z="1.4661027076176771">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.500337384973515" CI_END="0.08651328382470308" CI_START="-0.5246456371598256" DF="4.0" EFFECT_SIZE="-0.21906617666756123" ESTIMABLE="YES" I2="11.117775006027905" ID="CMP-013.07.01" NO="1" P_CHI2="0.34250759767184513" P_Z="0.15999921464115957" STUDIES="5" TAU2="0.013826871866774086" TOTAL_1="98" TOTAL_2="96" WEIGHT="67.39397176241197" Z="1.4050742016745525">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="3058" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="15.991300133190832"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="3059" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="10.458725285666796"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="3060" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="10.854284657280756"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="3061" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="6.734661397765765"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="3062" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="23.355000288507817"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.39836809295556885" CI_END="0.3438952787558457" CI_START="-0.4747618014575461" DF="2.0" EFFECT_SIZE="-0.06543326135085022" ESTIMABLE="YES" I2="0.0" ID="CMP-013.07.02" NO="2" P_CHI2="0.81939914508563" P_Z="0.7540449483882533" STUDIES="3" TAU2="0.0" TOTAL_1="46" TOTAL_2="46" WEIGHT="32.60602823758805" Z="0.3133102705353363">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="3063" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.916851072620501"/>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="3064" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="14.207723976748142"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="3065" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="8.481453188219403"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.710485301735586" CI_END="0.3948020347309157" CI_START="-0.27475377238064547" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.060024131175135116" ESTIMABLE="YES" I2="52.414894162777074" I2_Q="24.67994856206202" ID="CMP-013.08" NO="8" P_CHI2="0.03989494604816479" P_Q="0.24922070175284994" P_Z="0.7252789172626117" Q="1.3276677072160226" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.12042791902978939" TOTALS="YES" TOTAL_1="145" TOTAL_2="174" UNITS="" WEIGHT="100.0" Z="0.3514124858810185">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="11.486161875385838" CI_END="0.708457250265647" CI_START="-0.5076489606791272" DF="3.0" EFFECT_SIZE="0.1004041447932599" ESTIMABLE="YES" I2="73.88161482880699" ID="CMP-013.08.01" NO="1" P_CHI2="0.009367594435807036" P_Z="0.7462128419884104" STUDIES="4" TAU2="0.28172518815068187" TOTAL_1="90" TOTAL_2="85" WEIGHT="52.587832036484244" Z="0.3236370407819104">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="3066" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="11.43890543682384"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="3067" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="11.512811011654813"/>
<CONT_DATA CI_END="0.923573671426349" CI_START="-0.26110133948943337" EFFECT_SIZE="0.33123616596845784" ESTIMABLE="YES" MEAN_1="5.92" MEAN_2="5.6" ORDER="3068" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="13.77733746612075"/>
<CONT_DATA CI_END="1.271605253291571" CI_START="0.2834851042937672" EFFECT_SIZE="0.777545178792669" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.1" ORDER="3069" SD_1="0.89" SD_2="0.89" SE="0.25207609853853674" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="15.858778121884846"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8966557191337252" CI_END="0.2985034934444692" CI_START="-0.38806142026940765" DF="3.0" EFFECT_SIZE="-0.04477896341246921" ESTIMABLE="YES" I2="0.0" ID="CMP-013.08.02" NO="2" P_CHI2="0.5941309163838324" P_Z="0.7982098692592872" STUDIES="4" TAU2="0.0" TOTAL_1="55" TOTAL_2="89" WEIGHT="47.41216796351575" Z="0.25566455203404764">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="3070" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="11.07043419486559"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="3071" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="13.370061181748834"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="3072" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="12.932837738521172"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="3073" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="10.03883484838015"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.679744031249067" CI_END="1.4489572371366366" CI_START="0.7738741152504852" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0589194964325201" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-013.09" LOG_CI_END="0.16105556839067908" LOG_CI_START="-0.1113296794959849" LOG_EFFECT_SIZE="0.024862944447347064" METHOD="MH" NO="9" P_CHI2="0.5667143814386502" P_Q="0.0" P_Z="0.7204888433575314" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="281" TOTAL_2="314" WEIGHT="100.0" Z="0.357805542293513">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.30502085180264416" CI_END="1.4390845577471874" CI_START="0.6655884174334963" DF="3.0" EFFECT_SIZE="0.978691991049244" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="35" I2="0.0" ID="CMP-013.09.01" LOG_CI_END="0.1580863129665568" LOG_CI_START="-0.17679424424210222" LOG_EFFECT_SIZE="-0.009353965637772672" NO="1" P_CHI2="0.9590814466882416" P_Z="0.9128119598759284" STUDIES="4" TAU2="0.0" TOTAL_1="133" TOTAL_2="124" WEIGHT="66.15875114571158" Z="0.10949238687056069">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="3074" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="27.587521164712005"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="3075" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="5.055217862611484"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="3076" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="21.10816544821666"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="3077" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="12.407846670171436"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.874357158408176" CI_END="2.6800147388457747" CI_START="0.6773534753598455" DF="5.0" EFFECT_SIZE="1.3473371134845185" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" I2="27.26592632906204" ID="CMP-013.09.02" LOG_CI_END="0.42813718245482923" LOG_CI_START="-0.1691846365788829" LOG_EFFECT_SIZE="0.12947627293797315" NO="2" P_CHI2="0.23015355300704365" P_Z="0.395498131749489" STUDIES="6" TAU2="0.1932807704950176" TOTAL_1="148" TOTAL_2="190" WEIGHT="33.84124885428842" Z="0.8496888066852386">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3078" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="2.150411906172423"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="3079" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="8.777191453764992"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="3080" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="7.61325954359181"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="3081" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="12.734128204482518"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3082" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="1.2035887534547143"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="3083" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="1.3626689928219622"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.038328418817476" CI_END="6.1141389766297145" CI_START="1.2895164190615964" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.8078964722347726" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="7" I2="0.6347521393177522" I2_Q="0.0" ID="CMP-013.10" LOG_CI_END="0.786335306175714" LOG_CI_START="0.11042687626259724" LOG_EFFECT_SIZE="0.4483810912191556" METHOD="MH" NO="10" P_CHI2="0.4189103746100229" P_Q="0.0" P_Z="0.009311944968873604" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0077167207956243405" TOTALS="YES" TOTAL_1="208" TOTAL_2="242" WEIGHT="100.0" Z="2.6003841681669178">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.539012290225242" CI_END="4.175962142493917" CI_START="0.6721124767658356" DF="2.0" EFFECT_SIZE="1.6753257171284492" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" I2="0.0" ID="CMP-013.10.01" LOG_CI_END="0.6207565528820135" LOG_CI_START="-0.17255804249498016" LOG_EFFECT_SIZE="0.22409925519351667" NO="1" P_CHI2="0.46324191680604476" P_Z="0.26815571570214936" STUDIES="3" TAU2="0.0" TOTAL_1="90" TOTAL_2="83" WEIGHT="71.57800043748988" Z="1.1073197737722626">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="3084" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="20.06817050758581"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="3085" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="13.349866517271941"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="3086" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="38.15996341263212"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0427274291584738" CI_END="44.390788249233886" CI_START="2.4080940410514" DF="3.0" EFFECT_SIZE="10.339109858230284" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" I2="0.0" ID="CMP-013.10.02" LOG_CI_END="1.6472928568805867" LOG_CI_START="0.3816734430144465" LOG_EFFECT_SIZE="1.0144831499475166" NO="2" P_CHI2="0.9976809038327195" P_Z="0.001677415893886258" STUDIES="4" TAU2="0.0" TOTAL_1="118" TOTAL_2="159" WEIGHT="28.42199956251013" Z="3.1420985092919573">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3087" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="7.1744863876771445"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="3088" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="7.1121680325711525"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="3089" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="6.750967351557904"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3090" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="7.3843777907039305"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" I2_Q="0.0" ID="CMP-013.11" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" METHOD="MH" NO="11" P_CHI2="0.227899780136411" P_Q="0.0" P_Z="0.3063895529035281" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.04674841377412624" TOTALS="YES" TOTAL_1="97" TOTAL_2="88" WEIGHT="100.0" Z="1.0228272347262604">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" DF="2.0" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" ID="CMP-013.11.01" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" NO="1" P_CHI2="0.227899780136411" P_Z="0.3063895529035281" STUDIES="3" TAU2="0.04674841377412624" TOTAL_1="97" TOTAL_2="88" WEIGHT="100.0" Z="1.0228272347262604">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="3091" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="8.813290868790636"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="3092" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="51.2266972676107"/>
<DICH_DATA CI_END="1.6014883037625876" CI_START="0.5676844929685975" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" ORDER="3093" O_E="0.0" SE="0.26457702275065764" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.070001000967602" WEIGHT="39.960011863598666"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-013.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.5709100694730314" CI_END="-0.26640532013726503" CI_START="-1.6542398061920167" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9603225631646408" ESTIMABLE="YES" I2="36.34263224657702" I2_Q="0.0" ID="CMP-013.12" NO="12" P_CHI2="0.21007494260638304" P_Q="1.0" P_Z="0.006679313850203584" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.10402089190972605" TOTALS="YES" TOTAL_1="39" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="2.7124237886528966">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5709100694730314" CI_END="-0.26640532013726503" CI_START="-1.6542398061920167" DF="1.0" EFFECT_SIZE="-0.9603225631646408" ESTIMABLE="YES" I2="36.34263224657702" ID="CMP-013.12.01" NO="1" P_CHI2="0.21007494260638304" P_Z="0.006679313850203584" STUDIES="2" TAU2="0.10402089190972605" TOTAL_1="39" TOTAL_2="33" WEIGHT="100.0" Z="2.7124237886528966">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="3094" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="32.384718552364774"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="3095" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="67.61528144763523"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="59.57376743870334" CI_START="0.12485388869486465" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-013.13" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.523706034306008" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="9" WEIGHT="100.0" Z="0.6376431033323103">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.57376743870334" CI_START="0.12485388869486465" DF="0.0" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-013.13.01" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" NO="1" P_CHI2="1.0" P_Z="0.523706034306008" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="100.0" Z="0.6376431033323103">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="3096" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-013.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.772455971028087" CI_END="1.5151632072499601" CI_START="0.8026095844447456" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.10276221921902" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="60" I2="13.381755961501272" I2_Q="0.0" ID="CMP-013.14" LOG_CI_END="0.18045941580233266" LOG_CI_START="-0.09549565839907548" LOG_EFFECT_SIZE="0.042481878701628506" METHOD="MH" NO="14" P_CHI2="0.3289935219684589" P_Q="0.0" P_Z="0.5462074074606724" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.021319888800434218" TOTALS="YES" TOTAL_1="128" TOTAL_2="169" WEIGHT="100.0" Z="0.6034529532877586">
<NAME>Response/remission 6 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.759705340903951" CI_END="3.3209720574200956" CI_START="0.6080082181489023" DF="2.0" EFFECT_SIZE="1.420977939010415" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" I2="57.98059214270257" ID="CMP-013.14.01" LOG_CI_END="0.5212652214703167" LOG_CI_START="-0.21609055054206977" LOG_EFFECT_SIZE="0.1525873354641235" NO="1" P_CHI2="0.09256444936870889" P_Z="0.41725989589588974" STUDIES="3" TAU2="0.3206247321715782" TOTAL_1="76" TOTAL_2="76" WEIGHT="33.67256285228417" Z="0.8111842162445011">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.7679791990476574" CI_START="0.6422655843618458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.44216282213849034" LOG_CI_START="-0.19228534892189048" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3097" O_E="0.0" SE="0.3726779962499649" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.13888888888888884" WEIGHT="16.40082389672357"/>
<DICH_DATA CI_END="18.270642568115434" CI_START="1.1083354033392778" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2617538215112387" LOG_CI_START="0.04467120603944865" LOG_EFFECT_SIZE="0.6532125137753437" ORDER="3098" O_E="0.0" SE="0.7149203529842405" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.5111111111111111" WEIGHT="4.935016837915991"/>
<DICH_DATA CI_END="1.7689484873764416" CI_START="0.31798551739302117" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.24771518623143418" LOG_CI_START="-0.4975926594480341" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="3099" O_E="0.0" SE="0.43779751788545657" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.19166666666666665" WEIGHT="12.336722117644609"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.42487988604226223" CI_END="1.4466433068061484" CI_START="0.7147284370091582" DF="2.0" EFFECT_SIZE="1.0168368156116883" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="41" I2="0.0" ID="CMP-013.14.02" LOG_CI_END="0.16036146202296578" LOG_CI_START="-0.14585893821439244" LOG_EFFECT_SIZE="0.007251261904286649" NO="2" P_CHI2="0.8086089839217704" P_Z="0.9260438461008664" STUDIES="3" TAU2="0.0" TOTAL_1="52" TOTAL_2="93" WEIGHT="66.32743714771583" Z="0.09282341845189232">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="3100" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="26.096804691565755"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="3101" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="21.06526411684799"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="3102" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="19.16536833930208"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.308090386291652" CI_END="0.49259174222379315" CI_START="-0.42761293890936597" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.03248940165721361" ESTIMABLE="YES" I2="13.348280817834551" I2_Q="0.0" ID="CMP-013.15" NO="15" P_CHI2="0.31535854188938384" P_Q="1.0" P_Z="0.889924480503059" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02329394828265292" TOTALS="YES" TOTAL_1="47" TOTAL_2="43" UNITS="" WEIGHT="100.00000000000001" Z="0.13839976786247196">
<NAME>Global/Avoidance/Panic 6 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.308090386291652" CI_END="0.49259174222379315" CI_START="-0.42761293890936597" DF="2.0" EFFECT_SIZE="0.03248940165721361" ESTIMABLE="YES" I2="13.348280817834551" ID="CMP-013.15.01" NO="1" P_CHI2="0.31535854188938384" P_Z="0.889924480503059" STUDIES="3" TAU2="0.02329394828265292" TOTAL_1="47" TOTAL_2="43" WEIGHT="100.00000000000001" Z="0.13839976786247196">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5666531080863819" CI_START="-0.6023577933692148" EFFECT_SIZE="-0.01785234264141641" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="12.0" ORDER="3103" SD_1="11.2" SD_2="10.8" SE="0.29822254660713293" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="49.102237278656055"/>
<CONT_DATA CI_END="0.4804741442277871" CI_START="-1.3835663953045758" EFFECT_SIZE="-0.45154612553839435" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.9" ORDER="3104" SD_1="1.68" SD_2="1.73" SE="0.4755292837612519" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="13" TOTAL_2="7" WEIGHT="22.094178693516202"/>
<CONT_DATA CI_END="1.2930088844558232" CI_START="-0.31382025970232497" EFFECT_SIZE="0.4895943123767491" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="2.1" ORDER="3105" SD_1="1.44" SD_2="1.68" SE="0.4099129261641059" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="14" WEIGHT="28.803584027827757"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.5435815009815828" CI_END="1.4328989377991472" CI_START="0.750121801636743" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0367491175714942" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-013.16" LOG_CI_END="0.15621556073654333" LOG_CI_START="-0.12486821196319073" LOG_EFFECT_SIZE="0.01567367438667637" METHOD="MH" NO="16" P_CHI2="0.9092175705186447" P_Q="0.0" P_Z="0.8269761708223728" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="117" WEIGHT="100.0" Z="0.2185813646105413">
<NAME>Response/remission 18-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5435815009815828" CI_END="1.4328989377991472" CI_START="0.750121801636743" DF="3.0" EFFECT_SIZE="1.0367491175714942" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="42" I2="0.0" ID="CMP-013.16.01" LOG_CI_END="0.15621556073654333" LOG_CI_START="-0.12486821196319073" LOG_EFFECT_SIZE="0.01567367438667637" NO="1" P_CHI2="0.9092175705186447" P_Z="0.8269761708223728" STUDIES="4" TAU2="0.0" TOTAL_1="119" TOTAL_2="117" WEIGHT="100.0" Z="0.2185813646105413">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="3106" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="18.612895728303744"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3107" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="10.222991971985008"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="3108" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="11.683419396554298"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="3109" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="59.48069290315696"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-013.16.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.646504351236112" CI_END="0.7512481843951337" CI_START="-0.5885937586681784" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08132721286347765" ESTIMABLE="YES" I2="56.95688954928153" I2_Q="0.0" ID="CMP-013.17" NO="17" P_CHI2="0.09795467886811837" P_Q="1.0" P_Z="0.8119306270395139" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.19942951145512536" TOTALS="YES" TOTAL_1="47" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.23793613717003437">
<NAME>Global/Avoidance/Panic 18-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.646504351236112" CI_END="0.7512481843951337" CI_START="-0.5885937586681784" DF="2.0" EFFECT_SIZE="0.08132721286347765" ESTIMABLE="YES" I2="56.95688954928153" ID="CMP-013.17.01" NO="1" P_CHI2="0.09795467886811837" P_Z="0.8119306270395139" STUDIES="3" TAU2="0.19942951145512536" TOTAL_1="47" TOTAL_2="40" WEIGHT="100.0" Z="0.23793613717003437">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="3110" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="38.84947534580154"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="3111" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="31.589683533307696"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="3112" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="29.560841120890775"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.17.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" NO="14">
<NAME>SENSITIVITY1: blinded rater: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="8.916995173061666" CI_END="1.6448662011179165" CI_START="1.053638795428719" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3164706008062979" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="113" I2="32.712759359497454" I2_Q="0.0" ID="CMP-014.01" LOG_CI_END="0.21613057676656255" LOG_CI_START="0.022691753155725167" LOG_EFFECT_SIZE="0.1194111649611439" METHOD="MH" NO="1" P_CHI2="0.17830035893197693" P_Q="0.0" P_Z="0.015529067532731599" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.027076391279629727" TOTALS="YES" TOTAL_1="221" TOTAL_2="246" WEIGHT="100.0" Z="2.4197994829275955">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8062590937249094" CI_END="2.067118236784073" CI_START="0.6551296945200319" DF="2.0" EFFECT_SIZE="1.163714113947724" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="38" I2="28.730743199292956" ID="CMP-014.01.01" LOG_CI_END="0.31536531848228794" LOG_CI_START="-0.18367271521632567" LOG_EFFECT_SIZE="0.06584630163298111" NO="1" P_CHI2="0.24582672258174165" P_Z="0.6050021639194108" STUDIES="3" TAU2="0.0956832303442829" TOTAL_1="84" TOTAL_2="91" WEIGHT="28.548026577825098" Z="0.5172206164700688">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.5905355852063248" CI_START="0.47068186901227627" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5551592353055395" LOG_CI_START="-0.3272725306918659" LOG_EFFECT_SIZE="0.11394335230683678" ORDER="3113" O_E="0.0" SE="0.5183447874545656" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.2686813186813187" WEIGHT="4.36542382092983"/>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="3114" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="1.2102395673624704"/>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="3115" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="22.972363189532796"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.130687447314795" CI_END="1.8373338356463744" CI_START="1.0092873886092906" DF="2.0" EFFECT_SIZE="1.3617627799962153" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="64" I2="36.11626731645124" ID="CMP-014.01.02" LOG_CI_END="0.26418807291271834" LOG_CI_START="0.00401484662923194" LOG_EFFECT_SIZE="0.13410145977097515" NO="2" P_CHI2="0.20901626425763886" P_Z="0.04333630619808858" STUDIES="3" TAU2="0.025568795132405463" TOTAL_1="117" TOTAL_2="135" WEIGHT="53.895683874334395" Z="2.020454104212649">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="3116" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="25.021274958307625"/>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="3117" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="7.014720321855595"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="3118" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="21.85968859417117"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.49667451315206" CI_START="1.0725010153737002" DF="0.0" EFFECT_SIZE="1.6363636363636362" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" I2="0.0" ID="CMP-014.01.03" LOG_CI_END="0.3973619278716414" LOG_CI_START="0.030397712018520682" LOG_EFFECT_SIZE="0.21387981994508098" NO="3" P_CHI2="1.0" P_Z="0.02233196860208747" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.556289547840507" Z="2.284673687529555">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="2.49667451315206" CI_START="1.0725010153737002" EFFECT_SIZE="1.6363636363636365" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" LOG_CI_END="0.3973619278716414" LOG_CI_START="0.030397712018520682" LOG_EFFECT_SIZE="0.21387981994508104" ORDER="3119" O_E="0.0" SE="0.21555659689428774" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.04646464646464646" WEIGHT="17.556289547840507"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.612552629396639" CI_END="1.583068295003793" CI_START="1.0353443030979026" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.280242453852819" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="94" I2="28.731180549660014" I2_Q="0.0" ID="CMP-014.02" LOG_CI_END="0.19949965112483029" LOG_CI_START="0.015084798169639922" LOG_EFFECT_SIZE="0.10729222464723515" METHOD="MH" NO="2" P_CHI2="0.2300117862829142" P_Q="0.0" P_Z="0.02257171666175171" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.01635755766722867" TOTALS="YES" TOTAL_1="180" TOTAL_2="208" WEIGHT="100.00000000000001" Z="2.2806069333347914">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7169247124253846" CI_START="0.5174309927377301" DF="0.0" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" I2="0.0" ID="CMP-014.02.01" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" NO="1" P_CHI2="1.0" P_Z="0.8466561094903486" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="10.669685089890864" Z="0.1933867272121479">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="3120" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="10.669685089890864"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.731825028495612" CI_END="2.1440031836100633" CI_START="0.9172907480911592" DF="2.0" EFFECT_SIZE="1.4023816471287343" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="62" I2="57.733010245396585" ID="CMP-014.02.02" LOG_CI_END="0.33122542590098264" LOG_CI_START="-0.037492986818599396" LOG_EFFECT_SIZE="0.1468662195411916" NO="2" P_CHI2="0.09386382903534374" P_Z="0.118437030093521" STUDIES="3" TAU2="0.07371307238040527" TOTAL_1="117" TOTAL_2="135" WEIGHT="55.23414441739229" Z="1.5613676503061216">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="3121" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="31.097895972966526"/>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="3122" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="2.3776315494016775"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="3123" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="21.758616895024083"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7211088098619653" CI_START="1.0163329319635195" DF="0.0" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" I2="0.0" ID="CMP-014.02.03" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" NO="3" P_CHI2="1.0" P_Z="0.037477572623570855" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="34.096170492716865" Z="2.080523170772094">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.7211088098619653" CI_START="1.0163329319635195" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" ORDER="3124" O_E="0.0" SE="0.13438199879091275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.01805852159904088" WEIGHT="34.096170492716865"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.5550822911446094" CI_END="-0.08518645892392834" CI_START="-0.5284511757474193" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3068188173356738" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.03" NO="3" P_CHI2="0.46541870838583965" P_Q="0.3925206747298795" P_Z="0.006661789778489191" Q="1.8703324452716528" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="148" TOTAL_2="173" UNITS="" WEIGHT="100.0" Z="2.7132943766266644">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3124802140477023" CI_START="-0.5979679222158227" DF="0.0" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" I2="0.0" ID="CMP-014.03.01" NO="1" P_CHI2="1.0" P_Z="0.5388303803196052" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="23.703687043797093" Z="0.6145826475462622">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="3125" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="23.703687043797093"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6847498458729566" CI_END="-0.01971823736066869" CI_START="-0.5725159594163156" DF="1.0" EFFECT_SIZE="-0.29611709838849215" ESTIMABLE="YES" I2="0.0" ID="CMP-014.03.02" NO="2" P_CHI2="0.4079562890803875" P_Z="0.03574754639855049" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="112" WEIGHT="64.29746304887101" Z="2.099787408275626">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="3126" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="46.31971303567916"/>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="3127" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="17.977750013191844"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" DF="0.0" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" I2="0.0" ID="CMP-014.03.03" NO="3" P_CHI2="1.0" P_Z="0.03499375510595159" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.998849907331902" Z="2.1084306554609964">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.0" ORDER="3128" SD_1="0.5" SD_2="1.1" SE="0.32644894275404324" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.998849907331902"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.195706027142116" CI_END="0.2581097871483118" CI_START="-0.5103235667299512" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1261068897908197" ESTIMABLE="YES" I2="8.913125196310673" I2_Q="0.0" ID="CMP-014.04" NO="4" P_CHI2="0.33358678063014824" P_Q="1.0" P_Z="0.5200322058014835" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.011831119193463082" TOTALS="YES" TOTAL_1="76" TOTAL_2="87" UNITS="" WEIGHT="100.0" Z="0.6432957677980358">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.195706027142116" CI_END="0.2581097871483118" CI_START="-0.5103235667299512" DF="2.0" EFFECT_SIZE="-0.1261068897908197" ESTIMABLE="YES" I2="8.913125196310673" ID="CMP-014.04.01" NO="1" P_CHI2="0.33358678063014824" P_Z="0.5200322058014835" STUDIES="3" TAU2="0.011831119193463082" TOTAL_1="56" TOTAL_2="67" WEIGHT="100.0" Z="0.6432957677980358">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.1030659113296144" CI_START="-0.40675425774589163" EFFECT_SIZE="0.34815582679186136" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="0.27" ORDER="3129" SD_1="0.93" SD_2="0.65" SE="0.38516528389928967" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="23.990466464997084"/>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="3130" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="18.091556694329228"/>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="3131" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="57.91797684067369"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-014.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-014.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.8" ORDER="3132" SD_1="0.0" SD_2="2.1" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.712774695232427" CI_END="-0.13650092104170447" CI_START="-0.7896406072684796" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4630707641550921" ESTIMABLE="YES" I2="35.17248723613437" I2_Q="0.0" ID="CMP-014.05" NO="5" P_CHI2="0.17279184177023488" P_Q="0.7967094300866272" P_Z="0.005449341864709723" Q="0.4545308879875112" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.05724056387621015" TOTALS="YES" TOTAL_1="119" TOTAL_2="132" UNITS="" WEIGHT="100.0" Z="2.779197281000302">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.2627216586353756" CI_END="0.06839535498402205" CI_START="-0.9468212256886045" DF="2.0" EFFECT_SIZE="-0.4392129353522912" ESTIMABLE="YES" I2="38.70148271132345" ID="CMP-014.05.01" NO="1" P_CHI2="0.19566329447976993" P_Z="0.08990906046827549" STUDIES="3" TAU2="0.08080327037599884" TOTAL_1="56" TOTAL_2="67" WEIGHT="47.81793516046483" Z="1.6958776111876812">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1660942883799188" CI_START="-1.3689479754433111" EFFECT_SIZE="-0.6014268435316962" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.9" ORDER="3133" SD_1="8.36" SD_2="8.97" SE="0.3915996099753484" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="13.183069474055637"/>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="3134" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.65193132514981"/>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="3135" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="24.982934361259385"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.99552214860954" CI_END="0.39466230250097256" CI_START="-1.451004741829444" DF="1.0" EFFECT_SIZE="-0.5281712196642357" ESTIMABLE="YES" I2="74.97198206377095" ID="CMP-014.05.02" NO="2" P_CHI2="0.04562139259771547" P_Z="0.2619650523211543" STUDIES="2" TAU2="0.3355036105102281" TOTAL_1="43" TOTAL_2="45" WEIGHT="35.06536092557006" Z="1.12175873908834">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="3136" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="13.084023820787595"/>
<CONT_DATA CI_END="0.41452271242937677" CI_START="-0.6155982943711397" EFFECT_SIZE="-0.10053779097088145" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.5" ORDER="3137" SD_1="7.8" SD_2="7.9" SE="0.2627907999651982" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="29" TOTAL_2="29" WEIGHT="21.98133710478247"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.03724050674962909" CI_START="-1.2326820263280838" DF="0.0" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" I2="0.0" ID="CMP-014.05.03" NO="3" P_CHI2="1.0" P_Z="0.06503579171955816" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.116703913965104" Z="1.8450120089760027">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.03724050674962909" CI_START="-1.2326820263280838" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.6" ORDER="3138" SD_1="1.1" SD_2="3.3" SE="0.32396578281404653" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.116703913965104"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.47538967620923" CI_END="-0.1321822093514921" CI_START="-1.1228719342595486" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6275270718055204" ESTIMABLE="YES" I2="64.60339742936983" I2_Q="75.08116266911846" ID="CMP-014.06" NO="6" P_CHI2="0.03714370147061896" P_Q="0.018078618720838713" P_Z="0.013028908658700142" Q="8.026056647199306" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1621389176702841" TOTALS="YES" TOTAL_1="97" TOTAL_2="106" UNITS="" WEIGHT="100.0" Z="2.482978129558873">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3256801113236999" CI_START="-0.584552935900024" DF="0.0" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" I2="0.0" ID="CMP-014.06.01" NO="1" P_CHI2="1.0" P_Z="0.5772410260922407" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="29.562908694671144" Z="0.5574192392742721">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="3139" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="29.562908694671144"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4493330290099239" CI_END="-0.1528766013116588" CI_START="-1.0099331622432612" DF="1.0" EFFECT_SIZE="-0.5814048817774601" ESTIMABLE="YES" I2="0.0" ID="CMP-014.06.02" NO="2" P_CHI2="0.5026518853360098" P_Z="0.00783317546519518" STUDIES="2" TAU2="0.0" TOTAL_1="43" TOTAL_2="45" WEIGHT="48.11907256797254" Z="2.659177190081695">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="3140" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="20.732401407068615"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="3141" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="27.386671160903923"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.626858518947859" CI_START="-2.0075250794135924" DF="0.0" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" I2="0.0" ID="CMP-014.06.03" NO="3" P_CHI2="1.0" P_Z="1.8423032726965448E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="22.318018737356315" Z="3.7397132096179453">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="3142" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="22.318018737356315"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.7292632057872876" CI_END="-0.17901197770996075" CI_START="-0.7570932296179651" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.46805260366396295" ESTIMABLE="YES" I2="0.0" I2_Q="44.17096627154594" ID="CMP-014.07" NO="7" P_CHI2="0.44388416791212815" P_Q="0.16676288063209654" P_Z="0.0015044099424852343" Q="3.5823654224928343" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="90" TOTAL_2="103" UNITS="" WEIGHT="100.0" Z="3.173831509061141">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1468977832944533" CI_END="0.08920852966673715" CI_START="-0.6248697489932913" DF="2.0" EFFECT_SIZE="-0.26783060966327704" ESTIMABLE="YES" I2="0.0" ID="CMP-014.07.01" NO="1" P_CHI2="0.9291836503795498" P_Z="0.14149287879794814" STUDIES="3" TAU2="0.0" TOTAL_1="56" TOTAL_2="67" WEIGHT="65.53693464515008" Z="1.4702543532971708">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.4847694472269716" CI_START="-1.0197910873796672" EFFECT_SIZE="-0.26751082007634774" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="3143" SD_1="0.51" SD_2="0.85" SE="0.3838235157570292" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="14.762449934611864"/>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="3144" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="10.851414452981462"/>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="3145" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="39.92307025755676"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" DF="0.0" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" I2="0.0" ID="CMP-014.07.02" NO="2" P_CHI2="1.0" P_Z="0.01643779073257808" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="14.445421142317072" Z="2.3990473104156176">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="3146" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="14.445421142317072"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" DF="0.0" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" I2="0.0" ID="CMP-014.07.03" NO="3" P_CHI2="1.0" P_Z="0.01659699832819686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.01764421253284" Z="2.395515812805348">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="3147" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.01764421253284"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.6713550336409275" CI_END="-0.13676340986739566" CI_START="-0.7812710771645639" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4590172435159798" ESTIMABLE="YES" I2="29.47011822971594" I2_Q="31.91097379861323" ID="CMP-014.08" NO="8" P_CHI2="0.22507284580189113" P_Q="0.23023259263132956" P_Z="0.0052421266122868095" Q="2.937330891008199" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03963833523022882" TOTALS="YES" TOTAL_1="109" TOTAL_2="122" UNITS="" WEIGHT="100.0" Z="2.791765905119512">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0643802307268256" CI_END="0.19233324022860093" CI_START="-0.5869858704325803" DF="1.0" EFFECT_SIZE="-0.19732631510198967" ESTIMABLE="YES" I2="0.0" ID="CMP-014.08.01" NO="1" P_CHI2="0.7997021528662271" P_Z="0.32093447071545345" STUDIES="2" TAU2="0.0" TOTAL_1="46" TOTAL_2="57" WEIGHT="43.31857607719117" Z="0.9925394245080883">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.4719732474819971" CI_START="-1.0333537967547248" EFFECT_SIZE="-0.28069027463636387" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.3" ORDER="3148" SD_1="0.62" SD_2="0.74" SE="0.38401905752109466" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="14.447922086396474"/>
<CONT_DATA CI_END="0.2886432974821726" CI_START="-0.6222469115213254" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.95" ORDER="3149" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="28.87065399079469"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-014.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="38.49992499063146" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="3150" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="13.799937128451779"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="3151" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="24.699987862179682"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" DF="0.0" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" ID="CMP-014.08.03" NO="3" P_CHI2="1.0" P_Z="0.014437591269834836" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.181498932177366" Z="2.4461874573937834">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="3.0" ORDER="3152" SD_1="1.5" SD_2="2.7" SE="0.33022378325494234" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.181498932177366"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.630966792161769" CI_END="1.2222156493172565" CI_START="0.6934896995982986" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9206486645237496" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="75" I2="0.0" I2_Q="0.0" ID="CMP-014.09" LOG_CI_END="0.08714784015014634" LOG_CI_START="-0.15895998511822607" LOG_EFFECT_SIZE="-0.03590607248403988" METHOD="MH" NO="9" P_CHI2="0.46577106462075135" P_Q="0.0" P_Z="0.5673893069240205" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="221" TOTAL_2="246" WEIGHT="100.0" Z="0.5719006197243962">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9722499461143258" CI_END="1.9640242719248544" CI_START="0.8060542713317916" DF="2.0" EFFECT_SIZE="1.25821705336732" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" I2="0.0" ID="CMP-014.09.01" LOG_CI_END="0.293146850608718" LOG_CI_START="-0.09363571632588458" LOG_EFFECT_SIZE="0.09975556714141676" NO="1" P_CHI2="0.6150049937337895" P_Z="0.31201958354952153" STUDIES="3" TAU2="0.0" TOTAL_1="84" TOTAL_2="91" WEIGHT="40.487136598327496" Z="1.0109934395652438">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.6601562747764063" CI_START="0.8297809266717024" EFFECT_SIZE="1.4857142857142858" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.42490715064590723" LOG_CI_START="-0.08103655207686013" LOG_EFFECT_SIZE="0.17193529928452353" ORDER="3153" O_E="0.0" SE="0.2971938354410734" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="26" VAR="0.08832417582417582" WEIGHT="23.661727908520003"/>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="3154" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="3.1049981724853803"/>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="3155" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="13.72041051732211"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7215849956533238" CI_END="1.0568961239771786" CI_START="0.5044403711944134" DF="2.0" EFFECT_SIZE="0.7301650998869946" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="51" I2="0.0" ID="CMP-014.09.02" LOG_CI_END="0.02403230518786702" LOG_CI_START="-0.2971901634047729" LOG_EFFECT_SIZE="-0.1365789291084529" NO="2" P_CHI2="0.6971237533736996" P_Z="0.09557526464464561" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="135" WEIGHT="58.70012349541298" Z="1.6666940097461815">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="3156" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="35.19969527468765"/>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="3157" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="6.106150252245497"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="3158" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="17.39427796847983"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.09.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.8127399062595277" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3159" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.8127399062595277"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.903185073975036" CI_END="2.731788959242895" CI_START="0.30674984163918406" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.915410198020226" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="16" I2="38.81528119500728" I2_Q="0.0" ID="CMP-014.10" LOG_CI_END="0.43644714545734475" LOG_CI_START="-0.5132156528071399" LOG_EFFECT_SIZE="-0.0383842536748976" METHOD="MH" NO="10" P_CHI2="0.17902537244094185" P_Q="0.0" P_Z="0.8741109794032366" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.47383334382499065" TOTALS="YES" TOTAL_1="136" TOTAL_2="151" WEIGHT="100.0" Z="0.15843887938694678">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.9129858840241205" CI_START="0.27732730768974334" DF="0.0" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-014.10.01" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" NO="1" P_CHI2="1.0" P_Z="0.691620433816067" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="27.1321753057851" Z="0.396656973526102">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="3160" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="27.1321753057851"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.622688187594446" CI_END="4.152827744046899" CI_START="0.09212806140064353" DF="1.0" EFFECT_SIZE="0.6185401922186211" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" I2="72.39618901167354" ID="CMP-014.10.02" LOG_CI_END="0.6183439172978361" LOG_CI_START="-1.0356080673574155" LOG_EFFECT_SIZE="-0.20863207502978967" NO="2" P_CHI2="0.05699689234508043" P_Z="0.6209772492192883" STUDIES="2" TAU2="1.367359532147698" TOTAL_1="103" TOTAL_2="119" WEIGHT="62.64927164768771" Z="0.4944658090101441">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="3161" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="29.998921849623972"/>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="3162" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="32.65034979806374"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.10.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="10.218553046527184" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3163" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="10.218553046527184"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1876473359458188" CI_END="2.194117569513563" CI_START="1.2106942927536182" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6298483423437011" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-014.11" LOG_CI_END="0.3412598950814284" LOG_CI_START="0.08303449514059051" LOG_EFFECT_SIZE="0.21214719511100943" METHOD="MH" NO="11" P_CHI2="0.5522119949524318" P_Q="0.0" P_Z="0.0012798997611695136" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="168" WEIGHT="100.0" Z="3.220448971588656">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6565022832888703" CI_END="3.411737974290913" CI_START="1.1039182068388558" DF="1.0" EFFECT_SIZE="1.9406905128802105" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="14" I2="0.0" ID="CMP-014.11.01" LOG_CI_END="0.5329756694212443" LOG_CI_START="0.04293689618802043" LOG_EFFECT_SIZE="0.28795628280463237" NO="1" P_CHI2="0.41779777973047816" P_Z="0.021254905136773212" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="65" WEIGHT="27.76751591866951" Z="2.3034256644443234">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="3164" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="4.76743899732525"/>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="3165" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="23.00007692134426"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-014.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="72.2324840813305" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="3166" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="72.2324840813305"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" I2="0.0" ID="CMP-014.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3167" O_E="0.0" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.447101595855933" CI_END="-0.30948805809425695" CI_START="-0.9228109539735938" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6161495060339254" ESTIMABLE="YES" I2="12.970363171002374" I2_Q="27.289927502137942" ID="CMP-014.12" NO="12" P_CHI2="0.32768805829615577" P_Q="0.25275760622279553" P_Z="8.216576146918989E-5" Q="2.7506505375287684" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.01508480166611471" TOTALS="YES" TOTAL_1="107" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="3.93799367032345">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6964510583271646" CI_END="-0.2991250155371573" CI_START="-1.5113689966142019" DF="1.0" EFFECT_SIZE="-0.9052470060756796" ESTIMABLE="YES" I2="0.0" ID="CMP-014.12.01" NO="1" P_CHI2="0.4039791819030496" P_Z="0.0034200846498160646" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="23.644266607617364" Z="2.9272185413445753">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.07400266871028871" CI_START="-1.4743503608812065" EFFECT_SIZE="-0.700173846085459" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="11.3" ORDER="3168" SD_1="5.68" SD_2="9.61" SE="0.3949952758838189" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="14.307269777527317"/>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="3169" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.336996830090047"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-014.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="56.78407828522837" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="3170" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="56.78407828522837"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" DF="0.0" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" I2="0.0" ID="CMP-014.12.03" NO="3" P_CHI2="1.0" P_Z="0.01046097516817652" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.571655107154264" Z="2.5602072700386764">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="2.4" ORDER="3171" SD_1="1.1" SD_2="2.9" SE="0.3316581732834669" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.571655107154264"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.15508736788643443" CI_END="1.8971472761059518" CI_START="0.2676567200394752" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7125897959937005" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-014.13" LOG_CI_END="0.2781010466068509" LOG_CI_START="-0.5724218483409831" LOG_EFFECT_SIZE="-0.14716040086706608" METHOD="MH" NO="13" P_CHI2="0.9253866208814989" P_Q="0.0" P_Z="0.49761989451149546" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="113" WEIGHT="100.0" Z="0.6782394392043192">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-014.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.866750975750852" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="3172" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="13.866750975750852"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-014.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.30456919828377" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="3173" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="68.30456919828377"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.083060192649951" CI_START="0.04918297059741634" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-014.13.03" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" NO="3" P_CHI2="1.0" P_Z="0.5579989793003175" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.82867982596538" Z="0.585816288803313">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3174" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="17.82867982596538"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3372115662738713" CI_END="2.112537130665279" CI_START="1.228637159305837" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6110684712788257" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="56" I2="0.0" I2_Q="0.0" ID="CMP-014.16" LOG_CI_END="0.32480435099513794" LOG_CI_START="0.08942364612714793" LOG_EFFECT_SIZE="0.20711399856114296" METHOD="MH" NO="16" P_CHI2="0.5030583014087577" P_Q="0.0" P_Z="5.622781554360021E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="174" TOTAL_2="202" WEIGHT="100.0" Z="3.4491865261562906">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-014.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="35.41073624915468" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="3175" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="35.41073624915468"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03616172698317165" CI_END="2.1135498083600237" CI_START="1.0026681360689822" DF="2.0" EFFECT_SIZE="1.4557434687599666" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="32" I2="0.0" ID="CMP-014.16.02" LOG_CI_END="0.3250124869608847" LOG_CI_START="0.0011572136555768984" LOG_EFFECT_SIZE="0.16308485030823086" NO="2" P_CHI2="0.9820816189881668" P_Z="0.048385058681142824" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="129" WEIGHT="52.82503239392902" Z="1.9739708405297698">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="3176" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="19.26512084076013"/>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="3177" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="15.925463605478438"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="3178" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="17.634447947690454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0514801901976165" CI_START="1.4521773760684742" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-014.16.03" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" NO="3" P_CHI2="1.0" P_Z="0.003908892607536905" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.764231356916303" Z="2.88542203962941">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="7.0514801901976165" CI_START="1.4521773760684742" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" ORDER="3179" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.16250000000000003" WEIGHT="11.764231356916303"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="10.05578915203161" CI_END="0.6262294009688185" CI_START="-1.784480698893757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5791256489624692" ESTIMABLE="YES" I2="90.05547963584772" I2_Q="90.05547963584772" ID="CMP-014.17" NO="17" P_CHI2="0.0015187088582974129" P_Q="0.0015187088582974129" P_Z="0.3463536745706467" Q="10.05578915203161" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.6836610431139938" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="0.9416855345273837">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-014.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-014.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="3180" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" DF="0.0" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" I2="0.0" ID="CMP-014.17.03" NO="3" P_CHI2="1.0" P_Z="3.97783813112423E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656" Z="3.5415497659113866">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="2.4" ORDER="3181" SD_1="1.1" SD_2="1.7" SE="0.34792608783334095" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-015" NO="15">
<NAME>SENSITIVITY1: blinded rater: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="19.781203640854702" CI_END="1.350195840462182" CI_START="1.0844156687070983" CI_STUDY="95" CI_TOTAL="95" DF="19.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2100303819410236" ESTIMABLE="YES" EVENTS_1="316" EVENTS_2="297" I2="3.949221973739047" I2_Q="0.0" ID="CMP-015.01" LOG_CI_END="0.1303967657272318" LOG_CI_START="0.03519578406878511" LOG_EFFECT_SIZE="0.08279627489800842" METHOD="MH" NO="1" P_CHI2="0.40785059326391027" P_Q="0.0" P_Z="6.516311078366383E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.002481902178661182" TOTALS="YES" TOTAL_1="550" TOTAL_2="623" WEIGHT="100.00000000000001" Z="3.409160578540656">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.795523741373246" CI_END="1.5627591052445378" CI_START="1.0856494493836166" DF="10.0" EFFECT_SIZE="1.302539274696915" ESTIMABLE="YES" EVENTS_1="147" EVENTS_2="107" I2="0.0" ID="CMP-015.01.01" LOG_CI_END="0.19389203795138174" LOG_CI_START="0.03568961643626375" LOG_EFFECT_SIZE="0.11479082719382273" NO="1" P_CHI2="0.8321399213850469" P_Z="0.0044512097800166045" STUDIES="11" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="34.96668882736425" Z="2.844278676656712">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3477911253975297" CI_START="0.7572129217741901" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.3706594566631608" LOG_CI_START="-0.12078198344656102" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3182" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.08333333333333331" WEIGHT="3.644128296826054"/>
<DICH_DATA CI_END="4.474347411298529" CI_START="1.1314499154035917" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6507297019224901" LOG_CI_START="0.05363533430023487" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="3183" O_E="0.0" SE="0.35073618720610084" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.12301587301587302" WEIGHT="2.4918507722013477"/>
<DICH_DATA CI_END="2.3824152363315836" CI_START="0.3902959167635606" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3770174578735022" LOG_CI_START="-0.40860599223996596" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="3184" O_E="0.0" SE="0.46147910349544863" STUDY_ID="STD-Johnston-1995" TOTAL_1="28" TOTAL_2="27" VAR="0.21296296296296297" WEIGHT="1.451516274581348"/>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="3185" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="3.5104452370535104"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="3186" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="3.348521283355574"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="3187" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="2.2564032674158545"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="3188" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="2.343638536439214"/>
<DICH_DATA CI_END="3.3551459414051803" CI_START="0.7112931338260449" EFFECT_SIZE="1.5448275862068965" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.5257114157623739" LOG_CI_START="-0.14795138356399803" LOG_EFFECT_SIZE="0.18888001609918792" ORDER="3189" O_E="0.0" SE="0.3957128630089486" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.15658866995073892" WEIGHT="1.9659307428256407"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="3190" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="0.57673741402201"/>
<DICH_DATA CI_END="2.0632787501281444" CI_START="0.8622843856718805" EFFECT_SIZE="1.333841463414634" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.31455790536748096" LOG_CI_START="-0.0643494780741751" LOG_EFFECT_SIZE="0.12510421364665295" ORDER="3191" O_E="0.0" SE="0.22257207265542645" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04953832752613242" WEIGHT="6.011540698737711"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="3192" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="7.365976303905989"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.148801993016136" CI_END="1.3961080155494363" CI_START="0.9881467339939137" DF="8.0" EFFECT_SIZE="1.1745465405286841" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="190" I2="39.157955194327776" ID="CMP-015.01.02" LOG_CI_END="0.14491902053808822" LOG_CI_START="-0.005178560440530714" LOG_EFFECT_SIZE="0.06987023004877879" NO="2" P_CHI2="0.10683145826587648" P_Z="0.06804308132293532" STUDIES="9" TAU2="0.026505598312877694" TOTAL_1="268" TOTAL_2="357" WEIGHT="65.03331117263576" Z="1.8247214058252132">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="3193" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="8.7429994187537"/>
<DICH_DATA CI_END="1.8078009413055642" CI_START="0.8799530594388961" EFFECT_SIZE="1.2612612612612613" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="37" LOG_CI_END="0.2571506081902599" LOG_CI_START="-0.055540494407098746" LOG_EFFECT_SIZE="0.10080505689158058" ORDER="3194" O_E="0.0" SE="0.18367630151160966" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.033736983736983736" WEIGHT="8.634217208016594"/>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="3195" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="3.3013611506400755"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="3196" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="1.6224917670710126"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="3197" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="9.23376835979349"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="3198" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="9.488465588800276"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="3199" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="9.00958098792085"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="3200" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="7.449458047132732"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="3201" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="7.550968644507033"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-015.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.727398650683554" CI_END="1.4161680373917696" CI_START="1.0870770112666561" CI_STUDY="95" CI_TOTAL="95" DF="18.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2407593310304827" ESTIMABLE="YES" EVENTS_1="248" EVENTS_2="247" I2="3.8841414349718235" I2_Q="0.0" ID="CMP-015.02" LOG_CI_END="0.1511147882281793" LOG_CI_START="0.036260311688356285" LOG_EFFECT_SIZE="0.09368754995826782" METHOD="MH" NO="2" P_CHI2="0.4087876024632209" P_Q="0.0" P_Z="0.0013861914400686685" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0033946976086081724" TOTALS="YES" TOTAL_1="516" TOTAL_2="591" WEIGHT="100.0" Z="3.1975109590845543">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.335682312759942" CI_END="1.664305588635618" CI_START="1.0264936613289857" DF="9.0" EFFECT_SIZE="1.3070574345639399" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="69" I2="0.0" ID="CMP-015.02.01" LOG_CI_END="0.22123307151797075" LOG_CI_START="0.01135627191572551" LOG_EFFECT_SIZE="0.11629467171684811" NO="1" P_CHI2="0.6022141391059325" P_Z="0.029850514117806086" STUDIES="10" TAU2="0.0" TOTAL_1="248" TOTAL_2="234" WEIGHT="28.79511616871865" Z="2.172068266629818">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="3202" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="6.083231989812279"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3203" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="5.634956869404671"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="3204" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.47036945069319935"/>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="3205" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="8.032930534733461"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="3206" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="1.6349711675515308"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="3207" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="1.9928978586416457"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="3208" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="0.7573326024630107"/>
<DICH_DATA CI_END="10.324319187650293" CI_START="0.6478360451866196" EFFECT_SIZE="2.586206896551724" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0138614227695817" LOG_CI_START="-0.18853489178409377" LOG_EFFECT_SIZE="0.41266326549274396" ORDER="3209" O_E="0.0" SE="0.706293547126578" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="15" VAR="0.4988505747126437" WEIGHT="0.906264984209074"/>
<DICH_DATA CI_END="4.683574787885378" CI_START="0.47650450743216344" EFFECT_SIZE="1.4939024390243902" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6705774594879546" LOG_CI_START="-0.32193298685428545" LOG_EFFECT_SIZE="0.17432223631683458" ORDER="3210" O_E="0.0" SE="0.5830055491873771" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.3398954703832752" WEIGHT="1.3258967084663584"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="3211" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="1.956264002743423"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.012624748255668" CI_END="1.4739129123687569" CI_START="1.022243072663864" DF="8.0" EFFECT_SIZE="1.2274759730352292" ESTIMABLE="YES" EVENTS_1="160" EVENTS_2="178" I2="27.356100994296103" ID="CMP-015.02.02" LOG_CI_END="0.16847182355353815" LOG_CI_START="0.009554176194774841" LOG_EFFECT_SIZE="0.0890129998741565" NO="2" P_CHI2="0.2009849829165148" P_Z="0.028118349828930068" STUDIES="9" TAU2="0.020756628758257758" TOTAL_1="268" TOTAL_2="357" WEIGHT="71.20488383128135" Z="2.1956312191730256">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="3212" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="13.851849571436032"/>
<DICH_DATA CI_END="1.5473815458642357" CI_START="0.7657600436275381" EFFECT_SIZE="1.0885416666666667" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="42" LOG_CI_END="0.189597413138667" LOG_CI_START="-0.11590729832365816" LOG_EFFECT_SIZE="0.03684505740750443" ORDER="3213" O_E="0.0" SE="0.17945497978568117" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.032204089769879235" WEIGHT="12.786033944076484"/>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="3214" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="5.565785931925214"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="3215" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="4.901609367398134"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="3216" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="4.709504261926371"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="3217" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="10.506745151702503"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="3218" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="9.82686381865948"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="3219" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="7.786003271305843"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="3220" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="1.2704885128512846"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-015.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="8.209594248327615" CI_END="-0.26261376294045696" CI_START="-0.6023002676448748" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4324570152926659" ESTIMABLE="YES" I2="0.0" I2_Q="65.86347658168953" ID="CMP-015.03" NO="3" P_CHI2="0.6083723755500529" P_Q="0.08697922751555498" P_Z="6.022792979780575E-7" Q="2.929413718397611" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="353" UNITS="" WEIGHT="100.0" Z="4.990484832907105">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9565276218682941" CI_END="-0.3449357808799325" CI_START="-0.872693666556698" DF="5.0" EFFECT_SIZE="-0.6088147237183152" ESTIMABLE="YES" I2="0.0" ID="CMP-015.03.01" NO="1" P_CHI2="0.965995370561355" P_Z="6.126425556268453E-6" STUDIES="6" TAU2="0.0" TOTAL_1="113" TOTAL_2="126" WEIGHT="41.427347201234056" Z="4.521978597119177">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="3221" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.750059713228182"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="3222" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="4.28066784283948"/>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="3223" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.530757893099731"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="3224" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.578871298681673"/>
<CONT_DATA CI_END="0.04734040287395569" CI_START="-1.0525029604296603" EFFECT_SIZE="-0.5025812787778523" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.29" ORDER="3225" SD_1="0.62" SD_2="0.91" SE="0.280577442233388" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="9.538825619906039"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="3226" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.748164833478953"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.32365290806171" CI_END="-0.07562575115665168" CI_START="-0.5396231477342819" DF="4.0" EFFECT_SIZE="-0.3076244494454668" ESTIMABLE="YES" I2="7.485635756243061" ID="CMP-015.03.02" NO="2" P_CHI2="0.36397270676829896" P_Z="0.009353308397099143" STUDIES="5" TAU2="0.00534950976246159" TOTAL_1="136" TOTAL_2="227" WEIGHT="58.572652798765944" Z="2.598863037267936">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="3227" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="16.217793338609805"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="3228" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="16.755771912534925"/>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="3229" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="10.740675052466532"/>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="3230" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="7.6907677764756945"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="3231" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="7.1676447186789805"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-015.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="11.754565808981" CI_END="0.16891018738468572" CI_START="-0.2646720230566759" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.04788091783599511" ESTIMABLE="YES" I2="14.92667477041505" I2_Q="65.77256350427804" ID="CMP-015.04" NO="4" P_CHI2="0.30181839014005085" P_Q="0.08739953584703875" P_Z="0.6651008092842117" Q="2.921632767107722" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.019822340523885585" TOTALS="YES" TOTAL_1="205" TOTAL_2="218" UNITS="" WEIGHT="100.0" Z="0.4328815723769814">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.596137714017445" CI_END="0.3119827220159218" CI_START="-0.1913762995562834" DF="8.0" EFFECT_SIZE="0.06030321122981921" ESTIMABLE="YES" I2="6.934948390197871" ID="CMP-015.04.01" NO="1" P_CHI2="0.37750139989467724" P_Z="0.6386311049138407" STUDIES="9" TAU2="0.010424928009632387" TOTAL_1="131" TOTAL_2="147" WEIGHT="69.06982554271536" Z="0.46961360419603687">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="3232" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="6.619163230131344"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="3233" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="6.132261475532988"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="3234" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.6899181575320252"/>
<CONT_DATA CI_END="0.4017416085839796" CI_START="-1.088391349315334" EFFECT_SIZE="-0.3433248703656772" ESTIMABLE="YES" MEAN_1="0.55" MEAN_2="1.07" ORDER="3235" SD_1="0.93" SD_2="1.75" SE="0.38014294386358427" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="7.445043563620396"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="3236" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.13125763556776"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="3237" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.14290791882442"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="3238" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.272903983617976"/>
<CONT_DATA CI_END="1.0596556307306906" CI_START="-0.3335893038530581" EFFECT_SIZE="0.3630331634388162" ESTIMABLE="YES" MEAN_1="6.37" MEAN_2="6.0" ORDER="3239" SD_1="0.96" SD_2="1.04" SE="0.3554261572083688" STUDY_ID="STD-Zitrin-1980" TOTAL_1="19" TOTAL_2="14" WEIGHT="8.371198469592315"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="3240" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="15.265171108296139"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2367953278558337" CI_END="0.04169948370716947" CI_START="-0.6132904782918016" DF="1.0" EFFECT_SIZE="-0.28579549729231607" ESTIMABLE="YES" I2="0.0" ID="CMP-015.04.02" NO="2" P_CHI2="0.6265303649209744" P_Z="0.08719110375743694" STUDIES="2" TAU2="0.0" TOTAL_1="74" TOTAL_2="71" WEIGHT="30.930174457284636" Z="1.710404476817109">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="3241" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="9.755102153752857"/>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="3242" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="21.175072303531778"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="23.842717263896144" CI_END="-0.13337200373530592" CI_START="-0.5210642125635719" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3272181081494389" ESTIMABLE="YES" I2="28.699401952216807" I2_Q="0.0" ID="CMP-015.05" NO="5" P_CHI2="0.12377193801902997" P_Q="0.37949741766196965" P_Z="9.380432080606241E-4" Q="0.7723294641319782" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.049228244797184746" TOTALS="YES" TOTAL_1="312" TOTAL_2="332" UNITS="" WEIGHT="100.0" Z="3.3084786975759">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="22.210544020635837" CI_END="-0.10579682258472634" CI_START="-0.7043732920577612" DF="11.0" EFFECT_SIZE="-0.4050850573212438" ESTIMABLE="YES" I2="50.4739731283489" ID="CMP-015.05.01" NO="1" P_CHI2="0.022791949175259507" P_Z="0.007982692261717224" STUDIES="12" TAU2="0.13618603367370327" TOTAL_1="196" TOTAL_2="200" WEIGHT="62.6813051680662" Z="2.652800982049789">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="3243" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.420964718769125"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="3244" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="4.127003862658565"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="3245" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.7948960436892416"/>
<CONT_DATA CI_END="0.21869047113718676" CI_START="-1.2886598659887283" EFFECT_SIZE="-0.5349846974257708" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="13.5" ORDER="3246" SD_1="8.36" SD_2="9.55" SE="0.3845352131507778" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="4.962963709073239"/>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="3247" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="7.069723297476583"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="3248" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.414805573800341"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="3249" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.4440479844395"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="3250" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="4.699707099065775"/>
<CONT_DATA CI_END="-0.36766554192815826" CI_START="-2.0287561923899347" EFFECT_SIZE="-1.1982108671590466" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.9" ORDER="3251" SD_1="1.18" SD_2="1.27" SE="0.4237554015186625" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="4.275312512280605"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="3252" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="3.5804393246535597"/>
<CONT_DATA CI_END="1.0786567564322977" CI_START="-0.10034571852040608" EFFECT_SIZE="0.4891555189559459" ESTIMABLE="YES" MEAN_1="6.16" MEAN_2="5.71" ORDER="3253" SD_1="0.75" SD_2="1.06" SE="0.3007714642341709" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="21" WEIGHT="7.0024064149015"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="3254" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="8.889034627258162"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.8598437791283297" CI_END="0.033390839577179365" CI_START="-0.4851873350790282" DF="5.0" EFFECT_SIZE="-0.22589824775092443" ESTIMABLE="YES" I2="0.0" ID="CMP-015.05.02" NO="2" P_CHI2="0.973060352837496" P_Z="0.08771747450304536" STUDIES="6" TAU2="0.0" TOTAL_1="116" TOTAL_2="132" WEIGHT="37.3186948319338" Z="1.7075629149107239">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="3255" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="8.473946683705785"/>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="3256" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.25686803970137"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="3257" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="5.048513676681163"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="3258" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="6.658454061834545"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="3259" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="6.3501745266520695"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="3260" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.530737843358865"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-015.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.29645901848345" CI_END="-0.2747190412336994" CI_START="-0.61101160881957" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.44286532502663467" ESTIMABLE="YES" I2="7.9554645399531605" I2_Q="78.11572406876313" ID="CMP-015.06" NO="6" P_CHI2="0.3626271983434992" P_Q="0.03254629273718168" P_Z="2.4410046202708023E-7" Q="4.569490912754549" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.00934310771228224" TOTALS="YES" TOTAL_1="320" TOTAL_2="337" UNITS="" WEIGHT="100.0" Z="5.162172291138666">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.678889889886424" CI_END="-0.373065145370958" CI_START="-0.9046901677321064" DF="8.0" EFFECT_SIZE="-0.6388776565515322" ESTIMABLE="YES" I2="17.345893061979286" ID="CMP-015.06.01" NO="1" P_CHI2="0.28829092888833385" P_Z="2.4680269208885644E-6" STUDIES="9" TAU2="0.028518214242611698" TOTAL_1="149" TOTAL_2="153" WEIGHT="46.21928383599568" Z="4.710753424686293">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="3261" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.158738587883766"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="3262" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="3.811102042365802"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="3263" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.4944331143545786"/>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="3264" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="7.342602474716409"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="3265" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.012899183847681"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="3266" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="5.272304108860531"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="3267" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="4.0366911521386815"/>
<CONT_DATA CI_END="-0.466210138361711" CI_START="-2.154071253344198" EFFECT_SIZE="-1.3101406958529547" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="2.02" ORDER="3268" SD_1="0.56" SD_2="1.05" SE="0.43058472714195783" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="3.7792804087143135"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="3269" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="10.311232763113923"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.048078215842477" CI_END="-0.06877460232310217" CI_START="-0.4984495512259234" DF="6.0" EFFECT_SIZE="-0.2836120767745128" ESTIMABLE="YES" I2="0.0" ID="CMP-015.06.02" NO="2" P_CHI2="0.9152241498466663" P_Z="0.009670460003900044" STUDIES="7" TAU2="0.0" TOTAL_1="171" TOTAL_2="184" WEIGHT="53.78071616400432" Z="2.5873952273832646">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="3270" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="9.65180360482034"/>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="3271" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="6.408253112695444"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="3272" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="4.834547316883709"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="3273" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="15.487952847773466"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="3274" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="6.873084605652479"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="3275" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="6.449916377564071"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="3276" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.075158298614805"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-015.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.146019414426966" CI_END="-0.2098683488261363" CI_START="-0.6124313360470366" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4111498424365864" ESTIMABLE="YES" I2="8.717615411166053" I2_Q="0.0" ID="CMP-015.07" NO="7" P_CHI2="0.3585174782566555" P_Q="0.8712418958321823" P_Z="6.240115613346044E-5" Q="0.026270330596524616" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.011950766834711515" TOTALS="YES" TOTAL_1="239" TOTAL_2="229" UNITS="" WEIGHT="100.00000000000003" Z="4.003541850621432">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.099303521988126" CI_END="-0.16664596299925666" CI_START="-0.6909714964287412" DF="9.0" EFFECT_SIZE="-0.42880872971399897" ESTIMABLE="YES" I2="25.615553129614003" ID="CMP-015.07.01" NO="1" P_CHI2="0.20776883651035627" P_Z="0.0013467280484533572" STUDIES="11" TAU2="0.04511991889034602" TOTAL_1="171" TOTAL_2="179" WEIGHT="74.1563816532126" Z="3.205831541327517">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="3277" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="6.0717510542954605"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="3278" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="5.418191920444992"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="3279" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.4639401327102852" CI_START="-1.0220729437718097" EFFECT_SIZE="-0.27906640553076223" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.0" ORDER="3280" SD_1="0.51" SD_2="0.8" SE="0.37909193439358485" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="6.775329284834011"/>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="3281" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="10.454206031607553"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="3282" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.129521377614926"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="3283" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.3766279116372635"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="3284" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="6.308961099003707"/>
<CONT_DATA CI_END="-0.42277473134623855" CI_START="-2.098561793622174" EFFECT_SIZE="-1.2606682624842063" ESTIMABLE="YES" MEAN_1="45.41" MEAN_2="57.68" ORDER="3285" SD_1="9.04" SD_2="10.07" SE="0.42750455505670765" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="5.416530852160033"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="3286" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.7268694992625875"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="3287" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="14.478392622352068"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0204455618423156" CI_END="-0.012049880723555617" CI_START="-0.7577513683968898" DF="2.0" EFFECT_SIZE="-0.3849006245602227" ESTIMABLE="YES" I2="0.0" ID="CMP-015.07.02" NO="2" P_CHI2="0.6003618872256332" P_Z="0.043041549362263634" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="50" WEIGHT="25.843618346787416" Z="2.0233065757151394">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="3288" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="13.183742477524646"/>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="3289" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="6.788550246689787"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="3290" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.871325622572984"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-015.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="27.870420879400076" CI_END="0.23315048512390074" CI_START="-0.45603484471044003" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.11144217979326963" ESTIMABLE="YES" I2="64.11966635426262" I2_Q="0.0" ID="CMP-015.08" NO="8" P_CHI2="0.0018935122362113699" P_Q="0.9262665253683681" P_Z="0.526173801669734" Q="0.008564231028749703" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.21409986572385634" TOTALS="YES" TOTAL_1="192" TOTAL_2="212" UNITS="" WEIGHT="99.99999999999999" Z="0.6338575396140484">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="25.9652009292376" CI_END="0.3431734834561535" CI_START="-0.7285579462705529" DF="6.0" EFFECT_SIZE="-0.19269223140719968" ESTIMABLE="YES" I2="76.8921487788534" ID="CMP-015.08.01" NO="1" P_CHI2="2.2599074276541398E-4" P_Z="0.4809443798212695" STUDIES="7" TAU2="0.3961657099877707" TOTAL_1="137" TOTAL_2="123" WEIGHT="63.710012916063974" Z="0.7047844696596718">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8873607300917461" CI_START="-0.6116126107138591" EFFECT_SIZE="0.13787405968894345" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.0" ORDER="3291" SD_1="0.62" SD_2="0.76" SE="0.3823981850251626" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="16" WEIGHT="8.578622906746185"/>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="3292" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.864026442448129"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="3293" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.905840162434682"/>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="3294" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="8.28006981029078"/>
<CONT_DATA CI_END="-0.38927353848264634" CI_START="-2.056043178938999" EFFECT_SIZE="-1.2226583587108226" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.0" ORDER="3295" SD_1="1.4" SD_2="1.03" SE="0.42520415007714907" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="7.8276331319942125"/>
<CONT_DATA CI_END="0.923573671426349" CI_START="-0.26110133948943337" EFFECT_SIZE="0.33123616596845784" ESTIMABLE="YES" MEAN_1="5.92" MEAN_2="5.6" ORDER="3296" SD_1="0.81" SD_2="1.1" SE="0.30221856632579674" STUDY_ID="STD-Zitrin-1980" TOTAL_1="25" TOTAL_2="20" WEIGHT="10.12035518563026"/>
<CONT_DATA CI_END="1.271605253291571" CI_START="0.2834851042937672" EFFECT_SIZE="0.777545178792669" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.1" ORDER="3297" SD_1="0.89" SD_2="0.89" SE="0.25207609853853674" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.13346527651973"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8966557191337252" CI_END="0.2985034934444692" CI_START="-0.38806142026940765" DF="3.0" EFFECT_SIZE="-0.044778963412469217" ESTIMABLE="YES" I2="0.0" ID="CMP-015.08.02" NO="2" P_CHI2="0.5941309163838324" P_Z="0.7982098692592872" STUDIES="4" TAU2="0.0" TOTAL_1="55" TOTAL_2="89" WEIGHT="36.28998708393601" Z="0.2556645520340477">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="3298" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.653371156330996"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="3299" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="9.911037077834662"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="3300" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="9.682022607941057"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="3301" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="8.043556241829299"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="9.50723417309841" CI_END="1.4521124638375615" CI_START="0.9362013900503462" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1659629956195685" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="129" I2="0.0" I2_Q="0.0" ID="CMP-015.09" LOG_CI_END="0.16200025309453853" LOG_CI_START="-0.028630718377614557" LOG_EFFECT_SIZE="0.06668476735846193" METHOD="MH" NO="9" P_CHI2="0.922993915713997" P_Q="0.0" P_Z="0.17030232467609774" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="515" TOTAL_2="590" WEIGHT="100.0" Z="1.371233030296024">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.3215440425776803" CI_END="1.5989135392455223" CI_START="0.8961235408338614" DF="8.0" EFFECT_SIZE="1.1970062916609496" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="58" I2="0.0" ID="CMP-015.09.01" LOG_CI_END="0.20382498004155086" LOG_CI_START="-0.04763211377099957" LOG_EFFECT_SIZE="0.07809643313527563" NO="1" P_CHI2="0.9125899157833237" P_Z="0.22343919095719567" STUDIES="10" TAU2="0.0" TOTAL_1="247" TOTAL_2="233" WEIGHT="57.472374194277606" Z="1.2174339084685715">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3302" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="3.0707700219986243"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3303" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="1.7852103687212344"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3304" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9619712520075643" CI_START="0.9320516049237294" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.47158083907544335" LOG_CI_START="-0.030560041387254936" LOG_EFFECT_SIZE="0.22051039884409415" ORDER="3305" O_E="0.0" SE="0.29496003882123506" STUDY_ID="STD-Johnston-1995" TOTAL_1="26" TOTAL_2="27" VAR="0.0870014245014245" WEIGHT="14.412381937059445"/>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="3306" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="13.512398218511708"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3307" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="3.3173987954189865"/>
<DICH_DATA CI_END="8.748921872143878" CI_START="0.5394243722180654" EFFECT_SIZE="2.1724137931034484" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9419545382992105" LOG_CI_START="-0.2680694351899591" LOG_EFFECT_SIZE="0.33694255155462566" ORDER="3308" O_E="0.0" SE="0.7107740717428078" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.5051997810618502" WEIGHT="2.481983971464272"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="3309" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="2.4760512709026887"/>
<DICH_DATA CI_END="1.8429220764982854" CI_START="0.4705854818551801" EFFECT_SIZE="0.9312638580931264" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.265506972515735" LOG_CI_START="-0.32736147547585515" LOG_EFFECT_SIZE="-0.030927251480060067" ORDER="3310" O_E="0.0" SE="0.3482538610964086" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.12128075176855667" WEIGHT="10.338802659927591"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="3311" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="6.0773769502730595"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.1214592713012745" CI_END="1.5755155083896688" CI_START="0.8037169210367641" DF="8.0" EFFECT_SIZE="1.1252859518578453" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="71" I2="0.0" ID="CMP-015.09.02" LOG_CI_END="0.1974226824544219" LOG_CI_START="-0.09489688816642235" LOG_EFFECT_SIZE="0.051262897143999835" NO="2" P_CHI2="0.6336288324255869" P_Z="0.49181692794096" STUDIES="9" TAU2="0.0" TOTAL_1="268" TOTAL_2="357" WEIGHT="42.5276258057224" Z="0.6874218645849122">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="3312" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="10.406600562575578"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="3313" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="10.951727728712859"/>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="3314" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="3.4894738038605033"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3315" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="1.693861884941639"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3316" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="1.053274117545528"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="3317" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="4.299078030798074"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="3318" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="3.7289829006270256"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="3319" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="6.237190004756469"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="3320" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="0.6674367719047237"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-015.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.334435099108674" CI_END="5.410254841499107" CI_START="1.4986614315026374" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.8474796339140207" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-015.10" LOG_CI_END="0.733217722343199" LOG_CI_START="0.1757035307549404" LOG_EFFECT_SIZE="0.4544606265490697" METHOD="MH" NO="10" P_CHI2="0.7713897648424091" P_Q="0.0" P_Z="0.001396614041183236" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="352" TOTAL_2="454" WEIGHT="99.99999999999997" Z="3.195349908098889">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.465532261825362" CI_END="4.622860472923857" CI_START="0.8543834433357309" DF="4.0" EFFECT_SIZE="1.9873840718183615" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" I2="0.0" ID="CMP-015.10.01" LOG_CI_END="0.6649107857691033" LOG_CI_START="-0.06834717620690522" LOG_EFFECT_SIZE="0.29828180478109906" NO="1" P_CHI2="0.6508183084335022" P_Z="0.11080475113355209" STUDIES="5" TAU2="0.0" TOTAL_1="114" TOTAL_2="128" WEIGHT="57.809375649392855" Z="1.5945864209618763">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="3321" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="4.2062061029048055"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="3322" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="4.2152235305555585"/>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="3323" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="13.788960490313864"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="3324" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="9.14240731962522"/>
<DICH_DATA CI_END="7.928714182045078" CI_START="0.6535865062747394" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8992027624852539" LOG_CI_START="-0.1846969226796112" LOG_EFFECT_SIZE="0.35725291990282126" ORDER="3325" O_E="0.0" SE="0.6366880404558152" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.4053716608594657" WEIGHT="26.456578205993413"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.147703356696575" CI_END="12.520301159307182" CI_START="1.7349913269885402" DF="6.0" EFFECT_SIZE="4.660752506053344" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="2" I2="0.0" ID="CMP-015.10.02" LOG_CI_END="1.0976147753801824" LOG_CI_START="0.2392973081468159" LOG_EFFECT_SIZE="0.668456041763499" NO="2" P_CHI2="0.7900934074032571" P_Z="0.0022669236872819073" STUDIES="7" TAU2="0.0" TOTAL_1="238" TOTAL_2="326" WEIGHT="42.19062435060712" Z="3.052832587288932">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="3326" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="4.090869973675757"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="3327" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="4.087886702444595"/>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="3328" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="5.161642964288612"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3329" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="14.4878161876787"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3330" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="4.898407761534124"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="3331" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="4.8557110137884285"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="3332" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="4.608289747196907"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3432988163666737" CI_END="1.5105817348812547" CI_START="0.9968292684519511" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2271072022111844" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="100" I2="0.0" I2_Q="0.0" ID="CMP-015.11" LOG_CI_END="0.17914422914425504" LOG_CI_START="-0.0013792189387527324" LOG_EFFECT_SIZE="0.08888250510275121" METHOD="MH" NO="11" P_CHI2="0.5021015221936571" P_Q="0.0" P_Z="0.05360494141861331" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="162" TOTAL_2="228" WEIGHT="100.0" Z="1.9300153050144129">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.9576991298507442" CI_END="1.9045823419280374" CI_START="0.8167557377140012" DF="2.0" EFFECT_SIZE="1.2472283494687306" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="32.37986988551716" ID="CMP-015.11.01" LOG_CI_END="0.27979975351150127" LOG_CI_START="-0.08790780592044445" LOG_EFFECT_SIZE="0.09594597379552838" NO="1" P_CHI2="0.227899780136411" P_Z="0.3063895529035281" STUDIES="3" TAU2="0.04674841377412624" TOTAL_1="97" TOTAL_2="88" WEIGHT="43.762773632369715" Z="1.0228272347262604">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="3333" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="2.3299922018144454"/>
<DICH_DATA CI_END="1.9724823019803561" CI_START="0.8641798053229738" EFFECT_SIZE="1.3055954088952655" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.29501311520883244" LOG_CI_START="-0.0633958867626641" LOG_EFFECT_SIZE="0.11580861422308418" ORDER="3334" O_E="0.0" SE="0.21053122191123" STUDY_ID="STD-Zitrin-1980" TOTAL_1="41" TOTAL_2="35" VAR="0.04432339539943557" WEIGHT="25.36935479369806"/>
<DICH_DATA CI_END="1.6014883037625876" CI_START="0.5676844929685975" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" ORDER="3335" O_E="0.0" SE="0.26457702275065764" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.070001000967602" WEIGHT="16.06342663685721"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-015.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="56.23722636763029" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="3336" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="29.822040981870824"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="3337" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="26.415185385759468"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.133972258048254" CI_END="-0.3334892460847305" CI_START="-0.9718365394537507" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6526628927692406" ESTIMABLE="YES" I2="34.78940184720129" I2_Q="76.16092516404896" ID="CMP-015.12" NO="12" P_CHI2="0.189364218538703" P_Q="0.04054842406948567" P_Z="6.127753920015621E-5" Q="4.1947936607503244" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.044746681824347254" TOTALS="YES" TOTAL_1="116" TOTAL_2="190" UNITS="" WEIGHT="100.0" Z="4.007836414946472">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.838182545268325" CI_END="-0.532291650527807" CI_START="-1.372144636810797" DF="2.0" EFFECT_SIZE="-0.952218143669302" ESTIMABLE="YES" I2="0.0" ID="CMP-015.12.01" NO="1" P_CHI2="0.398881402393063" P_Z="8.814533869822001E-6" STUDIES="3" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="41.598193787798095" Z="4.444380855933662">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.32992271565191034" CI_START="-1.9354422337814112" EFFECT_SIZE="-1.1326824747166608" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="14.6" ORDER="3338" SD_1="5.68" SD_2="9.11" SE="0.4095788317524286" STUDY_ID="STD-Johnston-1995" TOTAL_1="12" TOTAL_2="17" WEIGHT="12.479462107116134"/>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="3339" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="8.090341478248416"/>
<CONT_DATA CI_END="-0.1562318992923345" CI_START="-1.2743668108607866" EFFECT_SIZE="-0.7152993550765606" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="2.04" ORDER="3340" SD_1="0.69" SD_2="0.86" SE="0.2852437392697411" STUDY_ID="STD-Zitrin-1980" TOTAL_1="29" TOTAL_2="24" WEIGHT="21.02839020243355"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-015.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="58.401806212201905" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="3341" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="28.935824294395545"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="3342" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="29.465981917806364"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.377180751169058" CI_END="2.3233067078716396" CI_START="0.3333060340435928" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8799841729642484" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-015.13" LOG_CI_END="0.36610654632353345" LOG_CI_START="-0.4771568239688877" LOG_EFFECT_SIZE="-0.05552513882267714" METHOD="MH" NO="13" P_CHI2="0.7108924890777757" P_Q="0.0" P_Z="0.7963221643362426" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="94" TOTAL_2="168" WEIGHT="100.00000000000001" Z="0.2581098056975854">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0018021436538582427" CI_END="25.7986852549672" CI_START="0.3165964113527592" DF="1.0" EFFECT_SIZE="2.8579312744259546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-015.13.01" LOG_CI_END="1.4115975741391282" LOG_CI_START="-0.4994940122106407" LOG_EFFECT_SIZE="0.4560517809642438" NO="1" P_CHI2="0.966138652004048" P_Z="0.3495673656745448" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="28" WEIGHT="19.46988878060047" Z="0.9354288116379947">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3343" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="9.559434575571265"/>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="3344" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="9.910454205029207"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-015.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="80.53011121939954" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3345" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="39.54271227806654"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="3346" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="40.987398941333"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.7394669378591563" CI_END="1.1821767170077373" CI_START="0.7988895550224155" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9718171800334522" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="154" I2="0.0" I2_Q="0.0" ID="CMP-015.14" LOG_CI_END="0.07268240165926004" LOG_CI_START="-0.09751325693099748" LOG_EFFECT_SIZE="-0.01241542763586874" METHOD="MH" NO="14" P_CHI2="0.986908069119497" P_Q="0.0" P_Z="0.7749158171115449" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="254" TOTAL_2="390" WEIGHT="100.00000000000001" Z="0.28595078418009545">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5525072172119435" CI_END="1.355278945824324" CI_START="0.7871586629438999" DF="5.0" EFFECT_SIZE="1.0328695769123482" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="64" I2="0.0" ID="CMP-015.14.01" LOG_CI_END="0.13202869164164296" LOG_CI_START="-0.10393772063201738" LOG_EFFECT_SIZE="0.014045485504812818" NO="1" P_CHI2="0.990074346988249" P_Z="0.8155076378412937" STUDIES="6" TAU2="0.0" TOTAL_1="143" TOTAL_2="162" WEIGHT="52.023141799045504" Z="0.23332681519848072">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="3347" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="7.995804124394545"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="3348" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="7.364556430363398"/>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="3349" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="6.824005244095346"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3350" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="3.7480331833099427"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="3351" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="4.283466495211364"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="3352" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="21.807276321670912"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.789555744768248" CI_END="1.2071180634987027" CI_START="0.6855422667382742" DF="4.0" EFFECT_SIZE="0.909687008520852" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="90" I2="0.0" ID="CMP-015.14.02" LOG_CI_END="0.081749748820173" LOG_CI_START="-0.16396576385722889" LOG_EFFECT_SIZE="-0.041108007518527924" NO="2" P_CHI2="0.774392671583904" P_Z="0.5119523092847124" STUDIES="5" TAU2="0.0" TOTAL_1="111" TOTAL_2="228" WEIGHT="47.97685820095451" Z="0.65580079446019">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="3353" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="8.650648947983862"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="3354" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="8.435440530569728"/>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="3355" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="12.593391495921413"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="3356" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="9.664782781544677"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="3357" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="8.632594444934824"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.444940660489292" CI_END="0.36835221203552704" CI_START="-0.08865228724814173" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.13984996239369266" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.15" NO="15" P_CHI2="0.4881363973992512" P_Q="0.5043245973472993" P_Z="0.2303124491680576" Q="0.44582441569009834" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="211" UNITS="" WEIGHT="100.0" Z="1.1995544462278063">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.7257800652650825" CI_END="0.4264621044602518" CI_START="-0.3211552971290882" DF="4.0" EFFECT_SIZE="0.052653403665581806" ESTIMABLE="YES" I2="15.357889178966087" ID="CMP-015.15.01" NO="1" P_CHI2="0.31660871145154845" P_Z="0.7824914118980268" STUDIES="5" TAU2="0.028093961755684366" TOTAL_1="65" TOTAL_2="76" WEIGHT="44.62831664206247" Z="0.27607376347474544">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="3358" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="8.295561571930895"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="3359" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="7.995523148733882"/>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="3360" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="13.418554658271567"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="3361" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="7.976387302368537"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="3362" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="6.94228996075759"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-015.15.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="55.37168335793752" Z="1.3386680075530792">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="3363" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="27.211287332306316"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="3364" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="28.160396025631204"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-016" NO="16">
<NAME>SENSITIVITY2: demonstrated effectiveness: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="5.538106959945878" CI_END="1.6082604431130403" CI_START="0.9465853187109851" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2338378030010375" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="96" I2="45.82986530059149" I2_Q="0.0" ID="CMP-016.01" LOG_CI_END="0.20635638013871516" LOG_CI_START="-0.023840235608835296" LOG_EFFECT_SIZE="0.0912580722649399" METHOD="MH" NO="1" P_CHI2="0.13637718593189163" P_Q="0.0" P_Z="0.1201849046767173" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.03232829651395812" TOTALS="YES" TOTAL_1="160" TOTAL_2="188" WEIGHT="100.0" Z="1.5539979539402868">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3454484283806656" CI_START="0.6891723310327431" DF="0.0" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" I2="0.0" ID="CMP-016.01.01" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" NO="1" P_CHI2="1.0" P_Z="0.8248574926107333" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="29.75219237158415" Z="0.2213017435913201">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.3454484283806656" CI_START="0.6891723310327431" EFFECT_SIZE="0.9629360465116279" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" LOG_CI_END="0.1288670557237475" LOG_CI_START="-0.16167216697707917" LOG_EFFECT_SIZE="-0.01640255562666585" ORDER="3365" O_E="0.0" SE="0.17066417760681282" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.02912626151820975" WEIGHT="29.75219237158415"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.130687447314795" CI_END="1.837333835646374" CI_START="1.0092873886092906" DF="2.0" EFFECT_SIZE="1.361762779996215" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="64" I2="36.11626731645124" ID="CMP-016.01.02" LOG_CI_END="0.26418807291271823" LOG_CI_START="0.00401484662923194" LOG_EFFECT_SIZE="0.13410145977097507" NO="2" P_CHI2="0.20901626425763886" P_Z="0.04333630619808858" STUDIES="3" TAU2="0.02556879513240546" TOTAL_1="117" TOTAL_2="135" WEIGHT="70.24780762841586" Z="2.020454104212649">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="3366" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="32.16066405388657"/>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="3367" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="9.658334309888017"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="3368" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="28.428809264641266"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.580650292841913" CI_END="1.7802823032655835" CI_START="0.9100901965395375" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2728776340539714" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="79" I2="46.24282399762648" I2_Q="0.0" ID="CMP-016.02" LOG_CI_END="0.2504888747972417" LOG_CI_START="-0.040915563812712906" LOG_EFFECT_SIZE="0.10478665549226446" METHOD="MH" NO="2" P_CHI2="0.1338937437171831" P_Q="0.0" P_Z="0.15866548689657706" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.050422094131069364" TOTALS="YES" TOTAL_1="160" TOTAL_2="188" WEIGHT="100.00000000000003" Z="1.4095740737850835">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7169247124253846" CI_START="0.5174309927377301" DF="0.0" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" I2="0.0" ID="CMP-016.02.01" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" NO="1" P_CHI2="1.0" P_Z="0.8466561094903486" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="20.34086679878105" Z="0.1933867272121479">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7169247124253846" CI_START="0.5174309927377301" EFFECT_SIZE="0.9425444596443229" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.23475125165766306" LOG_CI_START="-0.28614756175813233" LOG_EFFECT_SIZE="-0.025698155050234626" ORDER="3369" O_E="0.0" SE="0.30597854149115" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.09362286785305139" WEIGHT="20.34086679878105"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.731825028495612" CI_END="2.1440031836100633" CI_START="0.9172907480911592" DF="2.0" EFFECT_SIZE="1.4023816471287343" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="62" I2="57.733010245396585" ID="CMP-016.02.02" LOG_CI_END="0.33122542590098264" LOG_CI_START="-0.037492986818599396" LOG_EFFECT_SIZE="0.1468662195411916" NO="2" P_CHI2="0.09386382903534374" P_Z="0.118437030093521" STUDIES="3" TAU2="0.07371307238040527" TOTAL_1="117" TOTAL_2="135" WEIGHT="79.65913320121898" Z="1.5613676503061216">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="3370" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="40.80846734831189"/>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="3371" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="5.553399642410236"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="3372" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="33.297266210496836"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.0033532773881708" CI_END="-0.018545664898118958" CI_START="-0.4910643529890264" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.25480500894357266" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.03" NO="3" P_CHI2="0.6055146427681143" P_Q="0.5724482669465609" P_Z="0.034531036846638975" Q="0.3186034315152142" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="153" UNITS="" WEIGHT="99.99999999999999" Z="2.113815403270264">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3124802140477023" CI_START="-0.5979679222158227" DF="0.0" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" I2="0.0" ID="CMP-016.03.01" NO="1" P_CHI2="1.0" P_Z="0.5388303803196052" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="26.93565597590069" Z="0.6145826475462622">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.3124802140477023" CI_START="-0.5979679222158227" EFFECT_SIZE="-0.14274385408406018" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="3.3" ORDER="3373" SD_1="1.04" SD_2="1.04" SE="0.23226144547681074" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="26.93565597590069"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6847498458729566" CI_END="-0.01971823736066869" CI_START="-0.5725159594163156" DF="1.0" EFFECT_SIZE="-0.29611709838849215" ESTIMABLE="YES" I2="0.0" ID="CMP-016.03.02" NO="2" P_CHI2="0.4079562890803875" P_Z="0.03574754639855049" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="112" WEIGHT="73.0643440240993" Z="2.099787408275626">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="3374" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="52.635349636797905"/>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="3375" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="20.428994387301397"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.13838361650368852" CI_START="-0.7768937595033552" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.17153193259507415" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="41" UNITS="" WEIGHT="100.0" Z="1.3672979545309287">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13838361650368852" CI_START="-0.7768937595033552" DF="0.0" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" I2="0.0" ID="CMP-016.04.01" NO="1" P_CHI2="1.0" P_Z="0.17153193259507415" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="100.0" Z="1.3672979545309287">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.13838361650368852" CI_START="-0.7768937595033552" EFFECT_SIZE="-0.3192550714998333" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="6.35" ORDER="3376" SD_1="1.24" SD_2="1.24" SE="0.23349341702874" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.215270220455541" CI_END="0.38974940651516243" CI_START="-1.4369839946943603" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5236172940895989" ESTIMABLE="YES" I2="76.27672847289182" I2_Q="76.27672847289182" ID="CMP-016.05" NO="5" P_CHI2="0.04006182935862701" P_Q="0.04006182935862701" P_Z="0.2611770992649557" Q="4.215270220455541" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.3357209113418183" TOTALS="YES" TOTAL_1="48" TOTAL_2="57" UNITS="" WEIGHT="99.99999999999999" Z="1.123613371736033">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3466073732357574" CI_START="-0.5633279692173963" DF="0.0" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" I2="0.0" ID="CMP-016.05.01" NO="1" P_CHI2="1.0" P_Z="0.6406376735207575" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="55.74026672420189" Z="0.46680741258705016">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.3466073732357574" CI_START="-0.5633279692173963" EFFECT_SIZE="-0.10836029799081941" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.8" ORDER="3377" SD_1="1.37" SD_2="1.37" SE="0.23213062832547116" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="55.74026672420189"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" DF="0.0" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" I2="0.0" ID="CMP-016.05.02" NO="2" P_CHI2="1.0" P_Z="0.007841660328735718" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="44.2597332757981" Z="2.6588124438509673">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="3378" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="44.2597332757981"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.4574730013384274" CI_END="-0.03286884629139636" CI_START="-0.7368729912742726" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.38487091878283447" ESTIMABLE="YES" I2="18.615586054832395" I2_Q="50.2026744261025" ID="CMP-016.06" NO="6" P_CHI2="0.29266220122738773" P_Q="0.1564574095256348" P_Z="0.03211476407871409" Q="2.0081399723285034" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.018637607184805272" TOTALS="YES" TOTAL_1="77" TOTAL_2="86" UNITS="" WEIGHT="100.00000000000001" Z="2.142979256264305">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3256801113236999" CI_START="-0.584552935900024" DF="0.0" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" I2="0.0" ID="CMP-016.06.01" NO="1" P_CHI2="1.0" P_Z="0.5772410260922407" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="44.45411257943171" Z="0.5574192392742721">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.32568011132369995" CI_START="-0.5845529359000241" EFFECT_SIZE="-0.12943641228816205" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="22.75" ORDER="3379" SD_1="9.94" SD_2="9.94" SE="0.23220657481553897" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="44.45411257943171"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4493330290099239" CI_END="-0.1528766013116588" CI_START="-1.0099331622432612" DF="1.0" EFFECT_SIZE="-0.5814048817774601" ESTIMABLE="YES" I2="0.0" ID="CMP-016.06.02" NO="2" P_CHI2="0.5026518853360098" P_Z="0.00783317546519518" STUDIES="2" TAU2="0.0" TOTAL_1="43" TOTAL_2="45" WEIGHT="55.545887420568306" Z="2.659177190081695">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="3380" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="19.59789254958432"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="3381" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="35.94799487098398"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.8844388320437033" CI_END="0.04722065224037719" CI_START="-1.132788156588934" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5427837521742783" ESTIMABLE="YES" I2="46.93380421823061" I2_Q="46.93380421823061" ID="CMP-016.07" NO="7" P_CHI2="0.16983071648179993" P_Q="0.16983071648179993" P_Z="0.07137260057634524" Q="1.8844388320437033" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09066768863307301" TOTALS="YES" TOTAL_1="48" TOTAL_2="57" UNITS="" WEIGHT="100.0" Z="1.803099430606004">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14817511557983737" CI_START="-0.7667318166107648" DF="0.0" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" I2="0.0" ID="CMP-016.07.01" NO="1" P_CHI2="1.0" P_Z="0.1851359271053889" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="62.43368981920722" Z="1.3251062089055847">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.14817511557983737" CI_START="-0.7667318166107648" EFFECT_SIZE="-0.30927835051546376" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.45" ORDER="3382" SD_1="0.48" SD_2="0.48" SE="0.23339891431864854" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="62.43368981920722"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" DF="0.0" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" I2="0.0" ID="CMP-016.07.02" NO="2" P_CHI2="1.0" P_Z="0.01643779073257808" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="37.56631018079279" Z="2.3990473104156176">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="3383" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="37.56631018079279"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.044909150273324" CI_END="0.03574109499594974" CI_START="-0.8916309065611987" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4279449057826245" ESTIMABLE="YES" I2="50.555131754569686" I2_Q="27.286753703809083" ID="CMP-016.08" NO="8" P_CHI2="0.13233048640833445" P_Q="0.240909487017827" P_Z="0.07046821735699618" Q="1.375265238367421" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.08438850146080093" TOTALS="YES" TOTAL_1="77" TOTAL_2="86" UNITS="" WEIGHT="100.00000000000001" Z="1.8088892079833687">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2886432974821726" CI_START="-0.6222469115213254" DF="0.0" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" I2="0.0" ID="CMP-016.08.01" NO="1" P_CHI2="1.0" P_Z="0.4728710888002342" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="41" WEIGHT="40.44443296020536" Z="0.7178154536806854">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.2886432974821726" CI_START="-0.6222469115213254" EFFECT_SIZE="-0.16680180701957642" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.95" ORDER="3384" SD_1="0.89" SD_2="0.89" SE="0.23237422120724763" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="41" WEIGHT="40.44443296020536"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-016.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="59.55556703979465" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="3385" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="23.258141855031393"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="3386" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="36.297425184763256"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.0167526245899547" CI_END="1.0651947331547813" CI_START="0.5473076170747473" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7635372886267668" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-016.09" LOG_CI_END="0.027429010407280612" LOG_CI_START="-0.26176850758468073" LOG_EFFECT_SIZE="-0.11716974858870005" METHOD="MH" NO="9" P_CHI2="0.7971984231489165" P_Q="0.0" P_Z="0.11224622033174965" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="160" TOTAL_2="188" WEIGHT="100.0" Z="1.5881774429187758">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9864518604309112" CI_START="0.43018900867792964" DF="0.0" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" I2="0.0" ID="CMP-016.09.01" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" NO="1" P_CHI2="1.0" P_Z="0.8404112420084036" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="18.945469961474444" Z="0.20136747958561435">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9864518604309112" CI_START="0.43018900867792964" EFFECT_SIZE="0.9244186046511628" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.29807804484945316" LOG_CI_START="-0.3663406900236481" LOG_EFFECT_SIZE="-0.034131322587097446" ORDER="3387" O_E="0.0" SE="0.3902828537902404" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.15232070596265418" WEIGHT="18.945469961474444"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7215849956533236" CI_END="1.0568961239771786" CI_START="0.5044403711944134" DF="2.0" EFFECT_SIZE="0.7301650998869946" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="51" I2="0.0" ID="CMP-016.09.02" LOG_CI_END="0.02403230518786702" LOG_CI_START="-0.2971901634047729" LOG_EFFECT_SIZE="-0.1365789291084529" NO="2" P_CHI2="0.6971237533736998" P_Z="0.09557526464464561" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="135" WEIGHT="81.05453003852556" Z="1.6666940097461815">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="3388" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="48.604578459056675"/>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="3389" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="8.431517849856968"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="3390" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="24.01843372961191"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.622688187594446" CI_END="4.152827744046899" CI_START="0.09212806140064353" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6185401922186211" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" I2="72.39618901167354" I2_Q="0.0" ID="CMP-016.10" LOG_CI_END="0.6183439172978361" LOG_CI_START="-1.0356080673574155" LOG_EFFECT_SIZE="-0.20863207502978967" METHOD="MH" NO="10" P_CHI2="0.05699689234508043" P_Q="0.0" P_Z="0.6209772492192883" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.367359532147698" TOTALS="YES" TOTAL_1="103" TOTAL_2="119" WEIGHT="99.99999999999999" Z="0.4944658090101441">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.10.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.622688187594446" CI_END="4.152827744046899" CI_START="0.09212806140064353" DF="1.0" EFFECT_SIZE="0.6185401922186211" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" I2="72.39618901167354" ID="CMP-016.10.02" LOG_CI_END="0.6183439172978361" LOG_CI_START="-1.0356080673574155" LOG_EFFECT_SIZE="-0.20863207502978967" NO="2" P_CHI2="0.05699689234508043" P_Z="0.6209772492192883" STUDIES="2" TAU2="1.367359532147698" TOTAL_1="103" TOTAL_2="119" WEIGHT="99.99999999999999" Z="0.4944658090101441">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="3391" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="48.88500379028739"/>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="3392" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="51.114996209712594"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.14263978170301211" CI_END="2.1358764039639064" CI_START="1.1613580474465677" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5749657933094035" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-016.11" LOG_CI_END="0.3295761179120023" LOG_CI_START="0.06496613365568658" LOG_EFFECT_SIZE="0.19727112578384443" METHOD="MH" NO="11" P_CHI2="0.7056708127846751" P_Q="0.0" P_Z="0.003473772369520621" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="108" TOTAL_2="136" WEIGHT="99.99999999999999" Z="2.9223712235399333">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.245586804362536" CI_START="0.9394138303632902" DF="0.0" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" I2="0.0" ID="CMP-016.11.01" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" NO="1" P_CHI2="1.0" P_Z="0.07800900911302784" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="24.151484197404148" Z="1.7623569397545615">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.245586804362536" CI_START="0.9394138303632902" EFFECT_SIZE="1.746124031007752" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.5112932289813987" LOG_CI_START="-0.027143050277695445" LOG_EFFECT_SIZE="0.2420750893518516" ORDER="3393" O_E="0.0" SE="0.31628013573935965" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.10003312426330778" WEIGHT="24.151484197404148"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-016.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="75.84851580259584" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="3394" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="75.84851580259584"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.12" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.013458861325997886" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="83" UNITS="" WEIGHT="100.0" Z="2.47139089503999">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-016.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="100.0" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="3395" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-016.13" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.6021176621936886" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="83" WEIGHT="100.0" Z="0.5213576320788783">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-016.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="100.0" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="3396" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.04299164078710571" CI_END="1.9618612775380158" CI_START="1.10176018403788" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4702042858722302" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="51" I2="0.0" I2_Q="0.0" ID="CMP-016.16" LOG_CI_END="0.29266829533256095" LOG_CI_START="0.04208707356908014" LOG_EFFECT_SIZE="0.16737768445082052" METHOD="MH" NO="16" P_CHI2="0.997659544957454" P_Q="0.0" P_Z="0.008835703243805178" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="154" TOTAL_2="182" WEIGHT="100.0" Z="2.6183465068181575">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.352651264972499" CI_START="0.9462496720234227" DF="0.0" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" I2="0.0" ID="CMP-016.16.01" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" NO="1" P_CHI2="1.0" P_Z="0.08503686018295603" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="40.13195192121254" Z="1.7221803118708217">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.352651264972499" CI_START="0.9462496720234227" EFFECT_SIZE="1.4920440636474908" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.3715575561932012" LOG_CI_START="-0.02399425802126835" LOG_EFFECT_SIZE="0.1737816490859664" ORDER="3397" O_E="0.0" SE="0.2323490936826382" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="53" VAR="0.05398610133514338" WEIGHT="40.13195192121254"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03616172698317165" CI_END="2.1135498083600237" CI_START="1.0026681360689822" DF="2.0" EFFECT_SIZE="1.4557434687599666" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="32" I2="0.0" ID="CMP-016.16.02" LOG_CI_END="0.3250124869608847" LOG_CI_START="0.0011572136555768984" LOG_EFFECT_SIZE="0.16308485030823086" NO="2" P_CHI2="0.9820816189881668" P_Z="0.048385058681142824" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="129" WEIGHT="59.86804807878747" Z="1.9739708405297698">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="3398" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="21.833686198947408"/>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="3399" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="18.04876168744833"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="3400" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="19.985600192391725"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-016.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.17" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="59" TOTAL_2="77" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-016.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="100.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="3401" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-016.17.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-017" NO="17">
<NAME>SENSITIVITY2: demonstrated effectiveness: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="11.291649480009147" CI_END="1.353760584406503" CI_START="0.963327226150617" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.141978296049603" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="184" I2="29.151183676368248" I2_Q="0.0" ID="CMP-017.01" LOG_CI_END="0.13154186518748098" LOG_CI_START="-0.016226165240790406" LOG_EFFECT_SIZE="0.057657849973345256" METHOD="MH" NO="1" P_CHI2="0.18571530961929494" P_Q="0.0" P_Z="0.12613481230754509" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.019165381541598664" TOTALS="YES" TOTAL_1="206" TOTAL_2="340" WEIGHT="99.99999999999997" Z="1.5295231187185079">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.873233185524661" CI_END="1.9995321213118191" CI_START="0.9628376586343039" DF="2.0" EFFECT_SIZE="1.3875247118692895" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" I2="30.392005421766907" ID="CMP-017.01.01" LOG_CI_END="0.30092838521193793" LOG_CI_START="-0.016446931881395028" LOG_EFFECT_SIZE="0.14224072666527146" NO="1" P_CHI2="0.23773110288123456" P_Z="0.07894736775362068" STUDIES="3" TAU2="0.032791537806304095" TOTAL_1="67" TOTAL_2="86" WEIGHT="25.3894369861981" Z="1.7568266111680844">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3477911253975297" CI_START="0.7572129217741901" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.3706594566631608" LOG_CI_START="-0.12078198344656102" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3402" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.08333333333333331" WEIGHT="7.350514747178424"/>
<DICH_DATA CI_END="4.474347411298529" CI_START="1.1314499154035917" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6507297019224901" LOG_CI_START="0.05363533430023487" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="3403" O_E="0.0" SE="0.35073618720610084" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.12301587301587302" WEIGHT="5.29899892640546"/>
<DICH_DATA CI_END="1.6796505485866526" CI_START="0.7671023161413875" EFFECT_SIZE="1.1351052048726467" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.2252189361266033" LOG_CI_START="-0.1151467059700687" LOG_EFFECT_SIZE="0.05503611507826728" ORDER="3404" O_E="0.0" SE="0.19993246300468623" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.03997298976312023" WEIGHT="12.739923312614218"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.4111905238116815" CI_END="1.2813009606178625" CI_START="0.889752158844177" DF="5.0" EFFECT_SIZE="1.0677266952918527" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="144" I2="22.011364637666055" ID="CMP-017.01.02" LOG_CI_END="0.1076511517461747" LOG_CI_START="-0.05073094957533769" LOG_EFFECT_SIZE="0.028460101085418486" NO="2" P_CHI2="0.26823826143808926" P_Z="0.4811947408456526" STUDIES="6" TAU2="0.011358850731576562" TOTAL_1="139" TOTAL_2="254" WEIGHT="74.61056301380188" Z="0.7043822838359215">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="3405" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="14.364033836667696"/>
<DICH_DATA CI_END="1.8078009413055642" CI_START="0.8799530594388961" EFFECT_SIZE="1.2612612612612613" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="37" LOG_CI_END="0.2571506081902599" LOG_CI_START="-0.055540494407098746" LOG_EFFECT_SIZE="0.10080505689158058" ORDER="3406" O_E="0.0" SE="0.18367630151160966" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.033736983736983736" WEIGHT="14.241675420135635"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="3407" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="3.597554623698479"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="3408" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="14.904222252135833"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="3409" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="14.659829845465753"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="3410" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="12.843247035698488"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-017.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.084097717160047" CI_END="1.2929705467291046" CI_START="0.9490365136346697" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1077347425715698" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="179" I2="0.0" I2_Q="0.0" ID="CMP-017.02" LOG_CI_END="0.11158863196568887" LOG_CI_START="-0.02271707802055771" LOG_EFFECT_SIZE="0.044435776972565545" METHOD="MH" NO="2" P_CHI2="0.525694080190521" P_Q="0.0" P_Z="0.19465542550433465" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="347" WEIGHT="100.0" Z="1.2969295572049973">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.941234134063896" CI_END="2.000862931240113" CI_START="0.7475036779857381" DF="3.0" EFFECT_SIZE="1.222968683265156" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="35" I2="39.28642281249961" ID="CMP-017.02.01" LOG_CI_END="0.30121733838883596" LOG_CI_START="-0.1263866661139262" LOG_EFFECT_SIZE="0.08741533613745488" NO="1" P_CHI2="0.17615134171085856" P_Z="0.4229272297055888" STUDIES="4" TAU2="0.09483878642536857" TOTAL_1="74" TOTAL_2="93" WEIGHT="20.116743677202503" Z="0.801353161905515">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="3411" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="8.7134911363857"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3412" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="8.043222587432956"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="3413" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.6454437878804222"/>
<DICH_DATA CI_END="6.336779014557195" CI_START="0.9698597501547399" EFFECT_SIZE="2.4790697674418603" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.801868562035793" LOG_CI_START="-0.013291063813859147" LOG_EFFECT_SIZE="0.3942887491109669" ORDER="3414" O_E="0.0" SE="0.478828799329311" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.22927701906714956" WEIGHT="2.7145861655034285"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.774159804077818" CI_END="1.2857586382162038" CI_START="0.9096858079496755" DF="5.0" EFFECT_SIZE="1.0814972887779155" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="144" I2="0.0" ID="CMP-017.02.02" LOG_CI_END="0.1091594507586565" LOG_CI_START="-0.04110858068465682" LOG_EFFECT_SIZE="0.03402543503699986" NO="2" P_CHI2="0.734754831239692" P_Z="0.37475829182321585" STUDIES="6" TAU2="0.0" TOTAL_1="139" TOTAL_2="254" WEIGHT="79.8832563227975" Z="0.8875956727493886">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="3415" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="21.12311752218571"/>
<DICH_DATA CI_END="1.5473815458642357" CI_START="0.7657600436275381" EFFECT_SIZE="1.0885416666666667" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="42" LOG_CI_END="0.189597413138667" LOG_CI_START="-0.11590729832365816" LOG_EFFECT_SIZE="0.03684505740750443" ORDER="3416" O_E="0.0" SE="0.17945497978568117" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.032204089769879235" WEIGHT="19.326496369715095"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="3417" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="6.956738891146647"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="3418" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="6.674163423614579"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="3419" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="14.499873339061454"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="3420" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="11.302866777074017"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-017.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.187558520262311" CI_END="-0.15224895081144088" CI_START="-0.5704842356532119" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3613665932323264" ESTIMABLE="YES" I2="3.0312201435851547" I2_Q="79.02645718704815" ID="CMP-017.03" NO="3" P_CHI2="0.40251136900767615" P_Q="0.028995071877511047" P_Z="7.068103133524582E-4" Q="4.76791169197446" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.002494264970659794" TOTALS="YES" TOTAL_1="147" TOTAL_2="274" UNITS="" WEIGHT="100.0" Z="3.3869237418323044">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.4028449708684842" CI_END="-0.334710726115195" CI_START="-1.0799008599536355" DF="2.0" EFFECT_SIZE="-0.7073057930344152" ESTIMABLE="YES" I2="0.0" ID="CMP-017.03.01" NO="1" P_CHI2="0.8175670265186904" P_Z="1.9871480368039476E-4" STUDIES="3" TAU2="0.0" TOTAL_1="53" TOTAL_2="71" WEIGHT="30.628060447770515" Z="3.7206447521339516">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="3421" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="7.089003420491488"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="3422" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="6.398302311542254"/>
<CONT_DATA CI_END="-0.3124624017271237" CI_START="-1.303507180021926" EFFECT_SIZE="-0.8079847908745248" ESTIMABLE="YES" MEAN_1="3.15" MEAN_2="4.0" ORDER="3423" SD_1="1.04" SD_2="1.04" SE="0.2528221911504591" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="17.140754715736772"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.016801857419367" CI_END="0.03542541101846197" CI_START="-0.45573021611231257" DF="3.0" EFFECT_SIZE="-0.2101524025469253" ESTIMABLE="YES" I2="0.0" ID="CMP-017.03.02" NO="2" P_CHI2="0.7971865110811265" P_Z="0.09349698624012638" STUDIES="4" TAU2="0.0" TOTAL_1="94" TOTAL_2="203" WEIGHT="69.37193955222948" Z="1.677232703869104">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="3424" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="23.32867858178653"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="3425" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="24.061741446899898"/>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="3426" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="11.368406145639815"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="3427" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="10.613113377903238"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-017.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.512212437526894" CI_END="0.4641158406163108" CI_START="-0.36071009632258416" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0517028721468633" ESTIMABLE="YES" I2="38.57694234681543" I2_Q="0.0" ID="CMP-017.04" NO="4" P_CHI2="0.1640225941546154" P_Q="0.3907557009438578" P_Z="0.8059033954692723" Q="0.7365892068904856" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.08358202493285374" TOTALS="YES" TOTAL_1="78" TOTAL_2="95" UNITS="" WEIGHT="100.0" Z="0.24571430835749383">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.775623230636408" CI_END="0.6318232743805761" CI_START="-0.42581837853832827" DF="3.0" EFFECT_SIZE="0.10300244792112388" ESTIMABLE="YES" I2="48.05755361453115" ID="CMP-017.04.01" NO="1" P_CHI2="0.12305200111893855" P_Z="0.7026415667351684" STUDIES="4" TAU2="0.1375527926224666" TOTAL_1="59" TOTAL_2="76" WEIGHT="76.59536757281904" Z="0.3817570680725541">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="3428" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="17.810537554238493"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="3429" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="16.817697175140275"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="3430" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="11.199880840987937"/>
<CONT_DATA CI_END="0.9198755718808731" CI_START="-0.04289777229789776" EFFECT_SIZE="0.4384888997914877" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.4" ORDER="3431" SD_1="1.24" SD_2="1.24" SE="0.24560995808418015" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="30.767252002452338"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4867205387128699" CI_START="-0.7870704644153357" DF="0.0" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" I2="0.0" ID="CMP-017.04.02" NO="2" P_CHI2="1.0" P_Z="0.6439779657627757" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="23.404632427180957" Z="0.4621441317221052">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="3432" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="23.404632427180957"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.430864286590005" CI_END="-0.11764030166466227" CI_START="-0.6522947586001175" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3849675301323899" ESTIMABLE="YES" I2="16.971739052494467" I2_Q="45.15872772889882" ID="CMP-017.05" NO="5" P_CHI2="0.2961371397950907" P_Q="0.1769040115003202" P_Z="0.00476556074004506" Q="1.8234442028562379" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02516266643273608" TOTALS="YES" TOTAL_1="122" TOTAL_2="174" UNITS="" WEIGHT="100.0" Z="2.8224677994890826">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.172924862676096" CI_END="0.004496096818788375" CI_START="-1.10105659328464" DF="3.0" EFFECT_SIZE="-0.5482802482329258" ESTIMABLE="YES" I2="51.40067201952892" ID="CMP-017.05.01" NO="1" P_CHI2="0.10349361837563265" P_Z="0.051892762379548873" STUDIES="4" TAU2="0.1603358718885946" TOTAL_1="60" TOTAL_2="78" WEIGHT="45.51518373940668" Z="1.9440222968851568">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="3433" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="9.43404210585028"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="3434" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="8.735859844018536"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="3435" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="5.707906791560912"/>
<CONT_DATA CI_END="-0.021779814166502376" CI_START="-0.9884613670385711" EFFECT_SIZE="-0.5051205906025368" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="3.35" ORDER="3436" SD_1="1.37" SD_2="1.37" SE="0.24660696841807542" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="21.637374997976952"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4344952210576711" CI_END="0.09249311940020125" CI_START="-0.5605203497116623" DF="3.0" EFFECT_SIZE="-0.23401361515573052" ESTIMABLE="YES" I2="0.0" ID="CMP-017.05.02" NO="2" P_CHI2="0.9330279473482025" P_Z="0.16009752489855594" STUDIES="4" TAU2="0.0" TOTAL_1="62" TOTAL_2="96" WEIGHT="54.48481626059332" Z="1.404743636363429">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="3437" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="14.064526938933128"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="3438" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="10.963108374696317"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="3439" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="15.14407994555322"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="3440" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="14.31310100141066"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-017.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.191716067530507" CI_END="-0.12380754249857986" CI_START="-0.6095909474189845" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.36669924495878214" ESTIMABLE="YES" I2="2.665790274953645" I2_Q="79.08849236978054" ID="CMP-017.06" NO="6" P_CHI2="0.409195446097265" P_Q="0.028757866048096714" P_Z="0.003086359441163201" Q="4.782055974552921" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0033462879906041537" TOTALS="YES" TOTAL_1="122" TOTAL_2="174" UNITS="" WEIGHT="100.0" Z="2.9590031524234783">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.0691961791323976" CI_END="-0.30393114688278183" CI_START="-1.0076694653413434" DF="3.0" EFFECT_SIZE="-0.6558003061120626" ESTIMABLE="YES" I2="0.0" ID="CMP-017.06.01" NO="1" P_CHI2="0.5581697256429348" P_Z="2.5928911760703647E-4" STUDIES="4" TAU2="0.0" TOTAL_1="60" TOTAL_2="78" WEIGHT="45.99197827446987" Z="3.6529060513440577">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="3441" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="8.98221599826138"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="3442" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="8.207313709455994"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="3443" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="5.313006111758746"/>
<CONT_DATA CI_END="-0.15332493379431417" CI_START="-1.129658135725466" EFFECT_SIZE="-0.6414915347598901" ESTIMABLE="YES" MEAN_1="21.45" MEAN_2="27.9" ORDER="3444" SD_1="9.94" SD_2="9.94" SE="0.24906916903380458" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="23.48944245499375"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.34046391384518837" CI_END="0.204548657340123" CI_START="-0.4464971274793103" DF="3.0" EFFECT_SIZE="-0.12097423506959365" ESTIMABLE="YES" I2="0.0" ID="CMP-017.06.02" NO="2" P_CHI2="0.9522470151987223" P_Z="0.4663795429638766" STUDIES="4" TAU2="0.0" TOTAL_1="62" TOTAL_2="96" WEIGHT="54.00802172553013" Z="0.7283823943640053">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="3445" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="14.108470066206403"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="3446" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="10.50171030440579"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="3447" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="15.192557192794427"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="3448" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="14.20528416212351"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-017.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.6715103952873873" CI_END="-0.19607357774897594" CI_START="-0.858177069114376" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.527125323431676" ESTIMABLE="YES" I2="0.0" I2_Q="13.479284941262312" ID="CMP-017.07" NO="7" P_CHI2="0.6432862249641421" P_Q="0.28233988296295676" P_Z="0.001803598139012349" Q="1.1557925744385193" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="74" TOTAL_2="92" UNITS="" WEIGHT="100.0" Z="3.120801091486594">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.515717820848868" CI_END="-0.2477364902618584" CI_START="-0.9875010809936062" DF="2.0" EFFECT_SIZE="-0.6176187856277323" ESTIMABLE="YES" I2="0.0" ID="CMP-017.07.01" NO="1" P_CHI2="0.7727042569373979" P_Z="0.0010652875017795424" STUDIES="4" TAU2="0.0" TOTAL_1="60" TOTAL_2="78" WEIGHT="80.10593179904735" Z="3.2726913160531987">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="3449" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="17.63826178109224"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="3450" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="15.615502412490894"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="3451" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.031242440089498502" CI_START="-0.9985420972996016" EFFECT_SIZE="-0.5148922686945501" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.55" ORDER="3452" SD_1="0.48" SD_2="0.48" SE="0.24676465099359973" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="46.85216760546422"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5794802612828507" CI_START="-0.9049646208576299" DF="0.0" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" I2="0.0" ID="CMP-017.07.02" NO="2" P_CHI2="1.0" P_Z="0.6673787664267199" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="19.89406820095265" Z="0.42974827154093054">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="3453" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="19.89406820095265"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-017.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.916281708775264" CI_END="0.6635008065280951" CI_START="-0.39423381453969253" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1346334959942013" ESTIMABLE="YES" I2="66.35368757979633" I2_Q="87.93873136270788" ID="CMP-017.08" NO="8" P_CHI2="0.030424952330007193" P_Q="0.003984240693301611" P_Z="0.6178166636601401" Q="8.291001801486374" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.19155951164278973" TOTALS="YES" TOTAL_1="77" TOTAL_2="111" UNITS="" WEIGHT="99.99999999999999" Z="0.4989470856025634">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.271605253291571" CI_START="0.2834851042937672" DF="0.0" EFFECT_SIZE="0.777545178792669" ESTIMABLE="YES" I2="0.0" ID="CMP-017.08.01" NO="1" P_CHI2="1.0" P_Z="0.002038498761624244" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="28.54194874037697" Z="3.084565269379556">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="1.271605253291571" CI_START="0.2834851042937672" EFFECT_SIZE="0.777545178792669" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.1" ORDER="3454" SD_1="0.89" SD_2="0.89" SE="0.25207609853853674" STUDY_ID="STD-Zitrin-1983" TOTAL_1="34" TOTAL_2="34" WEIGHT="28.54194874037697"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6252799072888904" CI_END="0.24176601664178796" CI_START="-0.5165294298253975" DF="2.0" EFFECT_SIZE="-0.1373817065918048" ESTIMABLE="YES" I2="0.0" ID="CMP-017.08.02" NO="2" P_CHI2="0.7315132879274999" P_Z="0.47759241723384693" STUDIES="3" TAU2="0.0" TOTAL_1="43" TOTAL_2="77" WEIGHT="71.45805125962302" Z="0.7101801766291853">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="3455" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="21.755723930076766"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="3456" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="25.163981123958614"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="3457" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="24.53834620558764"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.084323517448119" CI_END="1.6103999387219845" CI_START="0.8370928654826739" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1610574056772165" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="74" I2="0.0" I2_Q="0.0" ID="CMP-017.09" LOG_CI_END="0.2069337453550737" LOG_CI_START="-0.07722635953424102" LOG_EFFECT_SIZE="0.06485369291041633" METHOD="MH" NO="9" P_CHI2="0.8494364749481951" P_Q="0.0" P_Z="0.37097805043524446" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="347" WEIGHT="100.0" Z="0.8946428452252193">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0028807283449606225" CI_END="2.347484364667138" CI_START="0.6224144109406837" DF="2.0" EFFECT_SIZE="1.208763044614933" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" I2="0.0" ID="CMP-017.09.01" LOG_CI_END="0.3706027083454337" LOG_CI_START="-0.20592036055634316" LOG_EFFECT_SIZE="0.08234117389454532" NO="1" P_CHI2="0.998560673151636" P_Z="0.5755758062698391" STUDIES="4" TAU2="0.0" TOTAL_1="74" TOTAL_2="93" WEIGHT="24.29365329938775" Z="0.5598587254643024">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3458" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="6.823176079399323"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3459" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="3.9666938902270643"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3460" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.986060624322492" CI_START="0.5032932669067358" EFFECT_SIZE="1.2259136212624584" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4750986207170227" LOG_CI_START="-0.2981788795865888" LOG_EFFECT_SIZE="0.08845987056521698" ORDER="3461" O_E="0.0" SE="0.45422703146370164" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.20632219611232658" WEIGHT="13.50378332976136"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.0667401140881445" CI_END="1.6693017620570445" CI_START="0.7869539251471935" DF="5.0" EFFECT_SIZE="1.1461516365236835" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="59" I2="0.0" ID="CMP-017.09.02" LOG_CI_END="0.2225348518081477" LOG_CI_START="-0.10405069412136077" LOG_EFFECT_SIZE="0.05924207884339348" NO="2" P_CHI2="0.5398477073003158" P_Z="0.4770418175515788" STUDIES="6" TAU2="0.0" TOTAL_1="139" TOTAL_2="254" WEIGHT="75.70634670061224" Z="0.7110684618442706">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="3462" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="23.123212587641"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="3463" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="24.334471852767532"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3464" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="3.7637197876569664"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3465" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="2.3403493952339676"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="3466" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="8.285709039027092"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="3467" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="13.858884038285677"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-017.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.7681940948469257" CI_END="11.451256865170635" CI_START="1.5253377484579982" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.179358128197867" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-017.10" LOG_CI_END="1.0588531565144546" LOG_CI_START="0.1833660181423402" LOG_EFFECT_SIZE="0.6211095873283975" METHOD="MH" NO="10" P_CHI2="0.8373277220505166" P_Q="0.0" P_Z="0.005419648284824163" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="149" TOTAL_2="285" WEIGHT="99.99999999999999" Z="2.7809715717349004">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.003208153667154277" CI_END="49.420640741007034" CI_START="0.5925850301921847" DF="1.0" EFFECT_SIZE="5.411647797633062" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-017.10.01" LOG_CI_END="1.6939083717516086" LOG_CI_START="-0.2272493238094713" LOG_EFFECT_SIZE="0.7333295239710687" NO="1" P_CHI2="0.9548315507244144" P_Z="0.13457947427391836" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="20.76698795822911" Z="1.496284723637358">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="3468" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="10.372375628692595"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="3469" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="10.394612329536516"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.712770993728258" CI_END="12.119145428296045" CI_START="1.25869771261315" DF="4.0" EFFECT_SIZE="3.9056805590603987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" I2="0.0" ID="CMP-017.10.02" LOG_CI_END="1.0834719969870101" LOG_CI_START="0.09992144296963226" LOG_EFFECT_SIZE="0.5916967199783212" NO="2" P_CHI2="0.6069819172538411" P_Z="0.01836381603932944" STUDIES="5" TAU2="0.0" TOTAL_1="125" TOTAL_2="240" WEIGHT="79.23301204177088" Z="2.3581995987722277">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="3470" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="10.087960260863388"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="3471" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="10.080603605232435"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3472" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="35.72651169762652"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="3473" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="11.974034877799035"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="3474" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="11.363901600249505"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1299534889195757" CI_END="1.4860683899429858" CI_START="0.9114496405198185" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1638197883699175" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="81" I2="0.0" I2_Q="0.0" ID="CMP-017.11" LOG_CI_END="0.1720387964308866" LOG_CI_START="-0.04026732201564005" LOG_EFFECT_SIZE="0.06588573720762322" METHOD="MH" NO="11" P_CHI2="0.5683735205050899" P_Q="0.0" P_Z="0.22380000124165855" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="108" TOTAL_2="181" WEIGHT="100.0" Z="1.2164856384422755">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9878064107451656E-31" CI_END="1.6014883037625876" CI_START="0.5676844929685975" DF="0.0" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" I2="100.0" ID="CMP-017.11.01" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" NO="1" P_CHI2="0.0" P_Z="0.8571401507218324" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="41" WEIGHT="22.217540187168428" Z="0.1800158172999783">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.6014883037625876" CI_START="0.5676844929685975" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.20452377120470083" LOG_CI_START="-0.24589296892440282" LOG_EFFECT_SIZE="-0.02068459885985102" ORDER="3475" O_E="0.0" SE="0.26457702275065764" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.070001000967602" WEIGHT="22.217540187168428"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-017.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="77.78245981283158" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="3476" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="41.24726367273592"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="3477" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="36.53519614009565"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.12" NO="12" P_CHI2="0.7506376179413443" P_Q="1.0" P_Z="0.006311755879724431" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" UNITS="" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-017.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-017.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="3478" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="49.10532495830454"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="3479" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="50.894675041695464"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.8023876951080955" CI_END="2.160983969655498" CI_START="0.2793931616617512" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7770226145887978" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-017.13" LOG_CI_END="0.3346515452654801" LOG_CI_START="-0.5537842277454987" LOG_EFFECT_SIZE="-0.10956634124000932" METHOD="MH" NO="13" P_CHI2="0.6695204974901191" P_Q="0.0" P_Z="0.6287939210138515" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="159" WEIGHT="100.0" Z="0.4834251147282208">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.31319328145675" CI_START="0.1298454099994229" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-017.13.01" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.4771212547196624" NO="1" P_CHI2="1.0" P_Z="0.4928768494435124" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="10.611036487326718" Z="0.6857403698646046">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3480" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="10.611036487326718"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-017.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="89.38896351267329" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3481" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="43.89267581397218"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="3482" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="45.49628769870111"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.268831062638095" CI_END="1.1804966341890046" CI_START="0.7696428856958929" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9531845760877136" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="126" I2="0.0" I2_Q="0.0" ID="CMP-017.14" LOG_CI_END="0.0720647531638129" LOG_CI_START="-0.11371074073354687" LOG_EFFECT_SIZE="-0.020822993784867024" METHOD="MH" NO="14" P_CHI2="0.8590698682347016" P_Q="0.0" P_Z="0.66039167966719" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="185" TOTAL_2="300" WEIGHT="100.0" Z="0.43937245987018475">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2207243452939565" CI_END="1.4065865980227534" CI_START="0.7316855113075991" DF="2.0" EFFECT_SIZE="1.0144846150497773" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" I2="0.0" ID="CMP-017.14.01" LOG_CI_END="0.14816647513305842" LOG_CI_START="-0.13567554469526533" LOG_EFFECT_SIZE="0.006245465218896568" NO="1" P_CHI2="0.5431543960970966" P_Z="0.9312665654518589" STUDIES="3" TAU2="0.0" TOTAL_1="74" TOTAL_2="72" WEIGHT="42.83743632941463" Z="0.08625140775941778">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7608433440481477" CI_START="0.5679096913306425" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.24572072005486098" LOG_CI_START="-0.24572072005486104" LOG_EFFECT_SIZE="0.0" ORDER="3483" O_E="0.0" SE="0.2886751345948129" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="24" TOTAL_2="24" VAR="0.08333333333333334" WEIGHT="14.290035222100238"/>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3484" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="2.564878116787222"/>
<DICH_DATA CI_END="1.6681778780724583" CI_START="0.7207491274998095" EFFECT_SIZE="1.0965116279069766" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.22224235766053635" LOG_CI_START="-0.14221587467301516" LOG_EFFECT_SIZE="0.040013241493760614" ORDER="3485" O_E="0.0" SE="0.2140845697700743" STUDY_ID="STD-Zitrin-1983" TOTAL_1="43" TOTAL_2="41" VAR="0.04583220301363782" WEIGHT="25.98252299052717"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7895557447682484" CI_END="1.2071180634987027" CI_START="0.6855422667382742" DF="4.0" EFFECT_SIZE="0.909687008520852" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="90" I2="0.0" ID="CMP-017.14.02" LOG_CI_END="0.081749748820173" LOG_CI_START="-0.16396576385722889" LOG_EFFECT_SIZE="-0.041108007518527924" NO="2" P_CHI2="0.7743926715839039" P_Z="0.5119523092847125" STUDIES="5" TAU2="0.0" TOTAL_1="111" TOTAL_2="228" WEIGHT="57.16256367058538" Z="0.6558007944601898">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="3486" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="10.306912328643728"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="3487" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="10.050499855543592"/>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="3488" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="15.004536983205254"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="3489" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="11.515213413900318"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="3490" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="10.285401089292485"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.6856153769402233" CI_END="0.4343999213695414" CI_START="-0.10545080006919372" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.16447456065017385" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.15" NO="15" P_CHI2="0.876582046042094" P_Q="0.5445875473930457" P_Z="0.23237173160978053" Q="0.3671036381416267" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="77" TOTAL_2="171" UNITS="" WEIGHT="100.0" Z="1.1942716845437171">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.04517555926448578" CI_END="0.576767367839949" CI_START="-0.5554908323957526" DF="1.0" EFFECT_SIZE="0.010638267722098228" ESTIMABLE="YES" I2="0.0" ID="CMP-017.15.01" NO="1" P_CHI2="0.8316816866193684" P_Z="0.9706204314256184" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="36" WEIGHT="22.732982771187583" Z="0.03683015338527383">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="3491" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="11.575831905951532"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="3492" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="11.157150865236051"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-017.15.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="77.26701722881242" Z="1.3386680075530792">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="3493" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="37.97130373537902"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="3494" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="39.2957134934334"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-018" NO="18">
<NAME>SENSITIVITY3: operationalised criteria: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="17.178186077337454" CI_END="1.8469933427030998" CI_START="1.0313369810219886" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3801711988123526" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="120" I2="59.250645158426586" I2_Q="0.0" ID="CMP-018.01" LOG_CI_END="0.2664653300734202" LOG_CI_START="0.013400590682716512" LOG_EFFECT_SIZE="0.13993296037806843" METHOD="MH" NO="1" P_CHI2="0.016282656882493085" P_Q="0.0" P_Z="0.03019394991724026" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.08590075682110532" TOTALS="YES" TOTAL_1="242" TOTAL_2="259" WEIGHT="100.0" Z="2.1675367595771773">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="34.053326159696454" CI_START="0.6255416885866658" DF="0.0" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" I2="0.0" ID="CMP-018.01.01" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" NO="1" P_CHI2="1.0" P_Z="0.13364541411879302" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="1.9630767706172" Z="1.499880291166049">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="34.053326159696454" CI_START="0.6255416885866658" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5321595380477" LOG_CI_START="-0.20374374189408612" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="3495" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="1.9630767706172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.973189893949896" CI_END="2.0203301078828795" CI_START="1.0510598677349974" DF="4.0" EFFECT_SIZE="1.4572192340112766" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="74" I2="42.637443396307134" ID="CMP-018.01.02" LOG_CI_END="0.30542233594117163" LOG_CI_START="0.021627453884056434" LOG_EFFECT_SIZE="0.16352489491261396" NO="2" P_CHI2="0.13731199479108092" P_Z="0.023902423353751714" STUDIES="5" TAU2="0.05359269251564066" TOTAL_1="159" TOTAL_2="177" WEIGHT="61.21690884896637" Z="2.2586940418461645">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.438919612627209" CI_START="1.2175955706334904" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.8088130031305857" LOG_CI_START="0.08550305955385278" LOG_EFFECT_SIZE="0.4471580313422192" ORDER="3496" O_E="0.0" SE="0.4248758412989382" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.18051948051948052" WEIGHT="8.294138203521168"/>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="3497" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="20.01114779940007"/>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="3498" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="9.09796877867834"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="3499" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="18.74432066030274"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="3500" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.069333407064045"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.0556176345316315" CI_END="2.1994848884552236" CI_START="0.6130397449648672" DF="1.0" EFFECT_SIZE="1.1611940643461238" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="45" I2="83.48640782242282" ID="CMP-018.01.03" LOG_CI_END="0.3423209825060827" LOG_CI_START="-0.21251136812534555" LOG_EFFECT_SIZE="0.06490480719036863" NO="3" P_CHI2="0.013862185397878979" P_Z="0.6465524382451928" STUDIES="2" TAU2="0.1778545297737446" TOTAL_1="70" TOTAL_2="70" WEIGHT="36.82001438041643" Z="0.4585568392753808">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1547728590043567" CI_START="0.6300015148834446" EFFECT_SIZE="0.8529411764705882" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="34" LOG_CI_END="0.0624965679665984" LOG_CI_START="-0.20065840625319653" LOG_EFFECT_SIZE="-0.06908091914329904" ORDER="3501" O_E="0.0" SE="0.15457853449483858" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.023894523326571996" WEIGHT="20.125876683820966"/>
<DICH_DATA CI_END="2.49667451315206" CI_START="1.0725010153737002" EFFECT_SIZE="1.6363636363636365" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" LOG_CI_END="0.3973619278716414" LOG_CI_START="0.030397712018520682" LOG_EFFECT_SIZE="0.21387981994508104" ORDER="3502" O_E="0.0" SE="0.21555659689428774" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.04646464646464646" WEIGHT="16.694137696595465"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="15.053165743394118" CI_END="1.673731331245756" CI_START="0.8175323129583835" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1697561483079528" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="103" I2="73.42751638966476" I2_Q="0.0" ID="CMP-018.02" LOG_CI_END="0.22368574593811244" LOG_CI_START="-0.0874950728423767" LOG_EFFECT_SIZE="0.0680953365478679" METHOD="MH" NO="2" P_CHI2="0.004592216941666227" P_Q="0.0" P_Z="0.39100663149822257" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10767016774702257" TOTALS="YES" TOTAL_1="187" TOTAL_2="205" WEIGHT="100.0" Z="0.8577932770535099">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-018.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.731825028495612" CI_END="2.1440031836100633" CI_START="0.9172907480911592" DF="2.0" EFFECT_SIZE="1.4023816471287343" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="62" I2="57.733010245396585" ID="CMP-018.02.02" LOG_CI_END="0.33122542590098264" LOG_CI_START="-0.037492986818599396" LOG_EFFECT_SIZE="0.1468662195411916" NO="2" P_CHI2="0.09386382903534374" P_Z="0.11843703009352091" STUDIES="3" TAU2="0.07371307238040525" TOTAL_1="117" TOTAL_2="135" WEIGHT="54.608216133760436" Z="1.561367650306122">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="3503" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="25.8912681124012"/>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="3504" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="5.712869949573583"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="3505" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="23.004078071785653"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.637345853053072" CI_END="2.610017219986153" CI_START="0.28290896344282673" DF="1.0" EFFECT_SIZE="0.8593004516897513" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="41" I2="93.16816033426292" ID="CMP-018.02.03" LOG_CI_END="0.416643372671727" LOG_CI_START="-0.5483532925144117" LOG_EFFECT_SIZE="-0.06585495992134241" NO="3" P_CHI2="1.3030890879728307E-4" P_Z="0.7890761639182248" STUDIES="2" TAU2="0.5996929524601315" TOTAL_1="70" TOTAL_2="70" WEIGHT="45.391783866239564" Z="0.2675104574050787">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.9040336721887139" CI_START="0.3207190587275412" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.043815393226618926" LOG_CI_START="-0.49387523135854094" LOG_EFFECT_SIZE="-0.26884531229257996" ORDER="3506" O_E="0.0" SE="0.2643673767508198" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.06989010989010988" WEIGHT="18.81720113115191"/>
<DICH_DATA CI_END="1.7211088098619653" CI_START="1.0163329319635195" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" ORDER="3507" O_E="0.0" SE="0.13438199879091275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.01805852159904088" WEIGHT="26.574582735087652"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.9010083735260406" CI_END="-0.10405792337880165" CI_START="-0.6115291091060759" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.35779351624243877" ESTIMABLE="YES" I2="0.0" I2_Q="17.780638140345097" ID="CMP-018.03" NO="3" P_CHI2="0.38654615302855166" P_Q="0.2700962402532131" P_Z="0.005714084456564233" Q="1.216258527653084" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="114" TOTAL_2="132" UNITS="" WEIGHT="100.0" Z="2.763752604917357">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6847498458729566" CI_END="-0.01971823736066869" CI_START="-0.5725159594163156" DF="1.0" EFFECT_SIZE="-0.29611709838849215" ESTIMABLE="YES" I2="0.0" ID="CMP-018.03.02" NO="2" P_CHI2="0.4079562890803875" P_Z="0.03574754639855049" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="112" WEIGHT="84.27335549724438" Z="2.099787408275626">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="3508" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="60.710290236788374"/>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="3509" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="23.563065260456007"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" DF="0.0" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" I2="0.0" ID="CMP-018.03.03" NO="3" P_CHI2="1.0" P_Z="0.03499375510595159" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.726644502755612" Z="2.1084306554609964">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.0" ORDER="3510" SD_1="0.5" SD_2="1.1" SE="0.32644894275404324" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="15.726644502755612"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.132839687741656" CI_END="0.2750049601314257" CI_START="-0.841422844901754" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.28320894238516414" ESTIMABLE="YES" I2="71.69712465167588" I2_Q="0.0" ID="CMP-018.04" NO="4" P_CHI2="0.006882944002670532" P_Q="0.6042410295988762" P_Z="0.3200356592546265" Q="1.00756442797441" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.2856589061910182" TOTALS="YES" TOTAL_1="107" TOTAL_2="130" UNITS="" WEIGHT="100.00000000000003" Z="0.9943846340482434">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7411297858483754" CI_START="-1.0144619120667326" DF="0.0" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" I2="0.0" ID="CMP-018.04.01" NO="1" P_CHI2="1.0" P_Z="0.7602509069947896" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="16.68222883212071" Z="0.3051513195476739">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7411297858483754" CI_START="-1.0144619120667326" EFFECT_SIZE="-0.13666606310917861" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.75" ORDER="3511" SD_1="1.1" SD_2="1.0" SE="0.447863254570745" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="16.68222883212071"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.125275259767246" CI_END="0.5021175543559193" CI_START="-1.4230436158392366" DF="2.0" EFFECT_SIZE="-0.4604630307416586" ESTIMABLE="YES" I2="84.7622243311683" ID="CMP-018.04.02" NO="2" P_CHI2="0.0014121641345352653" P_Z="0.3484631613278639" STUDIES="3" TAU2="0.6105472502537722" TOTAL_1="57" TOTAL_2="68" WEIGHT="61.21035765995728" Z="0.9375744435717288">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.8051814322011425" CI_START="-2.3712031782502496" EFFECT_SIZE="-1.588192305225696" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="9.07" ORDER="3512" SD_1="3.87" SD_2="1.98" SE="0.3995026843354487" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="18.21755813669801"/>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="3513" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="22.10741350792203"/>
<CONT_DATA CI_END="0.7096571108630692" CI_START="-0.5467164147484287" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.8" ORDER="3514" SD_1="2.5" SD_2="2.3" SE="0.32050933984542873" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="20.885386015337243"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5856257622309741" CI_START="-0.5317774780726351" DF="0.0" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" I2="0.0" ID="CMP-018.04.03" NO="3" P_CHI2="1.0" P_Z="0.9247503046351875" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="52" WEIGHT="22.10741350792203" Z="0.09445175543874984">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="3515" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="22.10741350792203"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.8" ORDER="3516" SD_1="0.0" SD_2="2.1" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="23.113126734058724" CI_END="0.4350417236732267" CI_START="-0.7365792298163782" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.15076875307157578" ESTIMABLE="YES" I2="78.36727130201658" I2_Q="56.079542077217646" ID="CMP-018.05" NO="5" P_CHI2="3.211643394323005E-4" P_Q="0.10260773760186404" P_Z="0.61395810681212" Q="4.553686583860873" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.413281387982677" TOTALS="YES" TOTAL_1="104" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="0.504431616956265">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.047292230914828925" CI_START="-1.928834989217858" DF="0.0" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" I2="0.0" ID="CMP-018.05.01" NO="1" P_CHI2="1.0" P_Z="0.03954305765211288" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.878766862427693" Z="2.0584906525443625">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.047292230914828925" CI_START="-1.928834989217858" EFFECT_SIZE="-0.9880636100663435" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="28.4" ORDER="3517" SD_1="10.3" SD_2="11.2" SE="0.4799942175326685" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.878766862427693"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.414991453911986" CI_END="0.8707172162654895" CI_START="-0.9310658417091482" DF="2.0" EFFECT_SIZE="-0.03017431272182935" ESTIMABLE="YES" I2="82.47918092558372" ID="CMP-018.05.02" NO="2" P_CHI2="0.003320988649858636" P_Z="0.9476590989855873" STUDIES="3" TAU2="0.5207187592968399" TOTAL_1="54" TOTAL_2="67" WEIGHT="50.939543045038185" Z="0.0656467113854578">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="3518" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="17.943519872554457"/>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="3519" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="15.721614086498073"/>
<CONT_DATA CI_END="0.9259489927372764" CI_START="-0.33737912447830304" EFFECT_SIZE="0.2942849341294867" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="18.7" ORDER="3520" SD_1="12.0" SD_2="13.3" SE="0.3222835029573376" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="17.274409085985653"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.144448696285867" CI_END="1.1331160192914684" CI_START="-1.1473798884999484" DF="1.0" EFFECT_SIZE="-0.007131934604240072" ESTIMABLE="YES" I2="86.00311874980834" ID="CMP-018.05.03" NO="3" P_CHI2="0.007519659688866032" P_Z="0.9902189534582193" STUDIES="2" TAU2="0.5822974907269153" TOTAL_1="40" TOTAL_2="52" WEIGHT="35.181690092534126" Z="0.012259030956072193">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="3521" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="17.943519872554457"/>
<CONT_DATA CI_END="0.03724050674962909" CI_START="-1.2326820263280838" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.6" ORDER="3522" SD_1="1.1" SD_2="3.3" SE="0.32396578281404653" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.23817021997967"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="28.26553139460065" CI_END="0.12076640644874148" CI_START="-1.0978236610416565" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4885286272964575" ESTIMABLE="YES" I2="82.31061029705207" I2_Q="0.0" ID="CMP-018.06" NO="6" P_CHI2="3.229659924397499E-5" P_Q="0.6740298067676682" P_Z="0.11606984208534973" Q="0.17692439279765182" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.4728184516897857" TOTALS="YES" TOTAL_1="120" TOTAL_2="146" UNITS="" WEIGHT="99.99999999999999" Z="1.5714858350843937">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.042629281981027" CI_END="0.1756184708303944" CI_START="-1.1977263848644593" DF="3.0" EFFECT_SIZE="-0.5110539570170324" ESTIMABLE="YES" I2="78.6364793959954" ID="CMP-018.06.02" NO="2" P_CHI2="0.0028477129411813573" P_Z="0.1446483860644282" STUDIES="4" TAU2="0.3821443065425787" TOTAL_1="80" TOTAL_2="94" WEIGHT="66.41597848369945" Z="1.458697494306008">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.5404249278343514" CI_START="-2.0341743515424784" EFFECT_SIZE="-1.2872996396884149" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="28.71" ORDER="3523" SD_1="4.68" SD_2="4.18" SE="0.3810655286246665" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="15.636875098196969"/>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="3524" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="17.39295926053868"/>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="3525" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="15.618315394306675"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="3526" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="17.76782873065712"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.04597771982197" CI_END="1.2175195093439213" CI_START="-2.123103798736285" DF="1.0" EFFECT_SIZE="-0.45279214469618195" ESTIMABLE="YES" I2="92.8805240906172" ID="CMP-018.06.03" NO="3" P_CHI2="1.7839593308055512E-4" P_Z="0.595202730025378" STUDIES="2" TAU2="1.3494009453066427" TOTAL_1="40" TOTAL_2="52" WEIGHT="33.58402151630054" Z="0.531311802764838">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="3527" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="17.39295926053868"/>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="3528" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="16.19106225576186"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.036199825252303" CI_END="-0.2902420605746426" CI_START="-0.9279814427547763" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6091117516647094" ESTIMABLE="YES" I2="0.896878916296964" I2_Q="0.0" ID="CMP-018.07" NO="7" P_CHI2="0.40112913315422694" P_Q="0.4627983608181089" P_Z="1.8113859628861705E-4" Q="1.5409282220381604" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0012012970202074638" TOTALS="YES" TOTAL_1="81" TOTAL_2="82" UNITS="" WEIGHT="100.0" Z="3.743965416536653">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.609598451072095E-34" CI_END="0.7616598530313163" CI_START="-0.9932132162914462" DF="0.0" EFFECT_SIZE="-0.11577668163006492" ESTIMABLE="YES" I2="100.0" ID="CMP-018.07.01" NO="1" P_CHI2="0.0" P_Z="0.7959324171441016" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.128033427586136" Z="0.25861485962863306">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7616598530313163" CI_START="-0.9932132162914462" EFFECT_SIZE="-0.11577668163006491" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.7" ORDER="3529" SD_1="5.7" SD_2="14.1" SE="0.44767992758157227" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.128033427586136"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.4952716032141424" CI_END="-0.20363113883379647" CI_START="-1.1011784486237866" DF="2.0" EFFECT_SIZE="-0.6524047937287916" ESTIMABLE="YES" I2="19.848404581536794" ID="CMP-018.07.02" NO="2" P_CHI2="0.2871830438275931" P_Z="0.004381581266422707" STUDIES="3" TAU2="0.03140651077211372" TOTAL_1="51" TOTAL_2="52" WEIGHT="62.77590963293365" Z="2.8492980483645027">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17860078902451304" CI_START="-1.595980151651918" EFFECT_SIZE="-0.8872904703382155" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="12.2" ORDER="3530" SD_1="1.38" SD_2="4.46" SE="0.3615830121898954" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="20.06051433374413"/>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="3531" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="17.44164103346775"/>
<CONT_DATA CI_END="0.380172766114548" CI_START="-0.8810829019163788" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="46.0" ORDER="3532" SD_1="8.7" SD_2="10.8" SE="0.3217548072259364" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="25.27375426572177"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" DF="0.0" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" I2="0.0" ID="CMP-018.07.03" NO="3" P_CHI2="1.0" P_Z="0.01659699832819686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.09605693948022" Z="2.395515812805348">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="3533" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.09605693948022"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.119440129589804" CI_END="-0.2046076914596916" CI_START="-1.1205956420310828" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6626016667453871" ESTIMABLE="YES" I2="35.88593090699923" I2_Q="0.0" ID="CMP-018.08" NO="8" P_CHI2="0.21019500714703454" P_Q="0.5024317702088702" P_Z="0.004574354326671095" Q="0.4497962176839012" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.05939372744520993" TOTALS="YES" TOTAL_1="63" TOTAL_2="65" UNITS="" WEIGHT="100.0" Z="2.8355731144870617">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behavour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-018.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="67.58288857989535" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="3534" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="25.320571861154757"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="3535" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="42.26231671874059"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" DF="0.0" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" ID="CMP-018.08.03" NO="3" P_CHI2="1.0" P_Z="0.014437591269834836" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.41711142010465" Z="2.4461874573937834">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="3.0" ORDER="3536" SD_1="1.5" SD_2="2.7" SE="0.33022378325494234" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.41711142010465"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.372337672678168" CI_END="1.1119455236465425" CI_START="0.576965148444556" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.800970545097001" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-018.09" LOG_CI_END="0.04608351084384809" LOG_CI_START="-0.23885041959183476" LOG_EFFECT_SIZE="-0.09638345437399333" METHOD="MH" NO="9" P_CHI2="0.8824726593285761" P_Q="0.0" P_Z="0.18484689705580323" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="192" TOTAL_2="209" WEIGHT="100.0" Z="1.3259782644329758">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.9129858840241205" CI_START="0.27732730768974334" DF="0.0" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-018.09.01" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" NO="1" P_CHI2="1.0" P_Z="0.691620433816067" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="4.161968999725798" Z="0.396656973526102">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="3537" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="4.161968999725798"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1916579856605611" CI_END="1.0788036449232927" CI_START="0.5498178381129171" DF="4.0" EFFECT_SIZE="0.7701593911652703" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="60" I2="0.0" ID="CMP-018.09.02" LOG_CI_END="0.03294240512178687" LOG_CI_START="-0.2597811741536351" LOG_EFFECT_SIZE="-0.1134193845159241" NO="2" P_CHI2="0.8794701725135323" P_Z="0.12880661385765377" STUDIES="5" TAU2="0.0" TOTAL_1="159" TOTAL_2="177" WEIGHT="94.74862672149982" Z="1.5188247516661604">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9732644695315953" CI_START="0.33633065953179025" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.47323354107503623" LOG_CI_START="-0.47323354107503623" LOG_EFFECT_SIZE="0.0" ORDER="3538" O_E="0.0" SE="0.5559594491425693" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.3090909090909091" WEIGHT="9.063111226778464"/>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="3539" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="47.182005397374986"/>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="3540" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="8.184741711835349"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="3541" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="23.315455164818573"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="3542" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="7.003313220692449"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-018.09.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="1.0894042787743807" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3543" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0894042787743807"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.193714612297098" CI_END="2.243565544900645" CI_START="0.43798862912175907" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.99129016809199" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" I2="22.983831446393957" I2_Q="0.0" ID="CMP-018.10" LOG_CI_END="0.35093876179993966" LOG_CI_START="-0.35853716432187543" LOG_EFFECT_SIZE="-0.0037992012609678965" METHOD="MH" NO="10" P_CHI2="0.26799247015350425" P_Q="0.0" P_Z="0.983252850661995" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.19918936983033853" TOTALS="YES" TOTAL_1="156" TOTAL_2="171" WEIGHT="100.00000000000001" Z="0.02099098043317595">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.9129858840241205" CI_START="0.27732730768974334" DF="0.0" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-018.10.01" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" NO="1" P_CHI2="1.0" P_Z="0.691620433816067" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="19.91138367524791" Z="0.396656973526102">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="6.9129858840241205" CI_START="0.27732730768974334" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8396656700754479" LOG_CI_START="-0.5570073644825093" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="3544" O_E="0.0" SE="0.820412654142367" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.673076923076923" WEIGHT="19.91138367524791"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.384594429417225" CI_END="2.6755611074468897" CI_START="0.24598168207620338" DF="2.0" EFFECT_SIZE="0.8112576789821194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" I2="54.385746910100686" ID="CMP-018.10.02" LOG_CI_END="0.42741487432500946" LOG_CI_START="-0.6090972330162566" LOG_EFFECT_SIZE="-0.09084117934562358" NO="2" P_CHI2="0.11166003559667514" P_Z="0.7311868047068162" STUDIES="3" TAU2="0.6047389436672939" TOTAL_1="123" TOTAL_2="139" WEIGHT="73.81996824938051" Z="0.34354724574759943">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="3545" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="22.772795347769907"/>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="3546" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="25.600358100348625"/>
<DICH_DATA CI_END="5.208499115067838" CI_START="0.34132246900739327" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7167125947102104" LOG_CI_START="-0.4668351214936106" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3547" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="25.446814801261976"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-018.10.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.268648075371589" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3548" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="6.268648075371589"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.249475187893522" CI_END="2.6689760871021972" CI_START="0.5922358832751319" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2572443717850459" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="79" I2="82.22139285082059" I2_Q="0.0" ID="CMP-018.11" LOG_CI_END="0.42634468270991843" LOG_CI_START="-0.2275052824646827" LOG_EFFECT_SIZE="0.0994197001226178" METHOD="MH" NO="11" P_CHI2="0.0036075171657362626" P_Q="0.0" P_Z="0.5511512362911366" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.3223958022639676" TOTALS="YES" TOTAL_1="133" TOTAL_2="153" WEIGHT="100.00000000000001" Z="0.5960359164110963">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="12.607562875295223" CI_START="0.8279054346767073" DF="0.0" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" I2="0.0" ID="CMP-018.11.01" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" NO="1" P_CHI2="1.0" P_Z="0.09139034090085832" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="18.32472234571469" Z="1.688108823998179">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="3549" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="18.32472234571469"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-018.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="41.641263815249566" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="3550" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="41.641263815249566"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0175880523999328" CI_START="0.4386845857324744" DF="0.0" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" I2="0.0" ID="CMP-018.11.03" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" NO="3" P_CHI2="1.0" P_Z="0.06028032235338007" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="58" WEIGHT="40.03401383903576" Z="1.878737663869856">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.0175880523999328" CI_START="0.4386845857324744" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" ORDER="3551" O_E="0.0" SE="0.2146492963334045" STUDY_ID="STD-Berger-2004" TOTAL_1="35" TOTAL_2="38" VAR="0.04607432041642569" WEIGHT="40.03401383903576"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3552" O_E="0.0" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="12.556785513539094" CI_END="0.14747428375995786" CI_START="-1.0433469471300563" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4479363316850492" ESTIMABLE="YES" I2="76.1085351281559" I2_Q="53.15227605913555" ID="CMP-018.12" NO="12" P_CHI2="0.005700074399868638" P_Q="0.11829486973957304" P_Z="0.14034425002681608" Q="4.269150839696259" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.2670094944533948" TOTALS="YES" TOTAL_1="116" TOTAL_2="142" UNITS="" WEIGHT="100.0" Z="1.474510287011791">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.25574887888751896" CI_START="-2.204329664505533" DF="0.0" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" I2="0.0" ID="CMP-018.12.01" NO="1" P_CHI2="1.0" P_Z="0.013344157097756763" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="17.950540792168066" Z="2.4744498045847734">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.25574887888751896" CI_START="-2.204329664505533" EFFECT_SIZE="-1.2300392716965258" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="23.8" ORDER="3553" SD_1="8.1" SD_2="9.3" SE="0.4970960693635624" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" WEIGHT="17.950540792168066"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-018.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="31.27960851166603" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="3554" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="31.27960851166603"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.287634673842835" CI_END="1.0375944505760968" CI_START="-1.4473213765007107" DF="1.0" EFFECT_SIZE="-0.20486346296230684" ESTIMABLE="YES" I2="87.93383107056869" ID="CMP-018.12.03" NO="3" P_CHI2="0.003991634919482956" P_Z="0.7465665699207483" STUDIES="2" TAU2="0.7069141587221924" TOTAL_1="41" TOTAL_2="49" WEIGHT="50.7698506961659" Z="0.3231699076315359">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="3555" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="26.29117226095402"/>
<CONT_DATA CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="2.4" ORDER="3556" SD_1="1.1" SD_2="2.9" SE="0.3316581732834669" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.47867843521188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.15508736788643443" CI_END="1.8971472761059518" CI_START="0.2676567200394752" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7125897959937005" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-018.13" LOG_CI_END="0.2781010466068509" LOG_CI_START="-0.5724218483409831" LOG_EFFECT_SIZE="-0.14716040086706608" METHOD="MH" NO="13" P_CHI2="0.9253866208814989" P_Q="0.0" P_Z="0.49761989451149546" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="113" WEIGHT="100.0" Z="0.6782394392043192">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.867772482168174" CI_START="0.07210963413813187" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-018.13.01" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="13.866750975750852" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086857" LOG_CI_START="-1.1420067079086857" LOG_EFFECT_SIZE="0.0" ORDER="3557" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="13.866750975750852"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-018.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.30456919828377" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="3558" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="68.30456919828377"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.083060192649951" CI_START="0.04918297059741634" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-018.13.03" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" NO="3" P_CHI2="1.0" P_Z="0.5579989793003175" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.82867982596538" Z="0.585816288803313">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3559" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="17.82867982596538"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.1641671997682317" CI_END="2.3821139188628533" CI_START="1.1908901026532428" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6842909158949655" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="37" I2="5.188322531763068" I2_Q="0.0" ID="CMP-018.16" LOG_CI_END="0.37696252673135466" LOG_CI_START="0.07587168590477063" LOG_EFFECT_SIZE="0.2264171063180626" METHOD="MH" NO="16" P_CHI2="0.36700014746335463" P_Q="0.0" P_Z="0.0032010192837466068" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0065438471690655526" TOTALS="YES" TOTAL_1="131" TOTAL_2="149" WEIGHT="100.0" Z="2.9477440937685118">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-018.16.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03616172698317163" CI_END="2.1135498083600237" CI_START="1.0026681360689822" DF="2.0" EFFECT_SIZE="1.4557434687599666" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="32" I2="0.0" ID="CMP-018.16.02" LOG_CI_END="0.3250124869608847" LOG_CI_START="0.0011572136555768984" LOG_EFFECT_SIZE="0.16308485030823086" NO="2" P_CHI2="0.9820816189881668" P_Z="0.048385058681142824" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="129" WEIGHT="81.49577395808926" Z="1.9739708405297698">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="3560" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="29.57262898894103"/>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="3561" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="24.7111576538257"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="3562" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="27.21198731532253"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0514801901976165" CI_START="1.4521773760684742" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-018.16.03" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" NO="3" P_CHI2="1.0" P_Z="0.003908892607536905" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.504226041910744" Z="2.88542203962941">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="7.0514801901976165" CI_START="1.4521773760684742" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" ORDER="3563" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.16250000000000003" WEIGHT="18.504226041910744"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="10.05578915203161" CI_END="0.6262294009688185" CI_START="-1.784480698893757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5791256489624692" ESTIMABLE="YES" I2="90.05547963584772" I2_Q="90.05547963584772" ID="CMP-018.17" NO="17" P_CHI2="0.0015187088582974129" P_Q="0.0015187088582974129" P_Z="0.3463536745706467" Q="10.05578915203161" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.6836610431139938" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="0.9416855345273837">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-018.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="3564" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" DF="0.0" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" I2="0.0" ID="CMP-018.17.03" NO="3" P_CHI2="1.0" P_Z="3.97783813112423E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656" Z="3.5415497659113866">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="2.4" ORDER="3565" SD_1="1.1" SD_2="1.7" SE="0.34792608783334095" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-019" NO="19">
<NAME>SENSITIVITY3: operationalised criteria: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="21.429878505830068" CI_END="1.3452660062437203" CI_START="1.0078735983471327" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1644131957543828" ESTIMABLE="YES" EVENTS_1="228" EVENTS_2="251" I2="30.004269525283583" I2_Q="0.0" ID="CMP-019.01" LOG_CI_END="0.12880816807178838" LOG_CI_START="0.0034060688331774024" LOG_EFFECT_SIZE="0.06610711845248289" METHOD="MH" NO="1" P_CHI2="0.12364769388109687" P_Q="0.0" P_Z="0.03878753258714575" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.024213689683934118" TOTALS="YES" TOTAL_1="387" TOTAL_2="496" WEIGHT="100.0" Z="2.0664338487994973">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.39784268040722" CI_END="1.8633133082978992" CI_START="0.9684861707848411" DF="4.0" EFFECT_SIZE="1.343351469618382" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="40" I2="9.0463145073298" ID="CMP-019.01.01" LOG_CI_END="0.27028588582734" LOG_CI_START="-0.013906576281692761" LOG_EFFECT_SIZE="0.1281896547728236" NO="1" P_CHI2="0.354833217688721" P_Z="0.0770362355392094" STUDIES="5" TAU2="0.01296091048982849" TOTAL_1="77" TOTAL_2="97" WEIGHT="17.790580137448607" Z="1.768147576334832">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3477911253975297" CI_START="0.7572129217741901" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.3706594566631608" LOG_CI_START="-0.12078198344656102" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3566" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.08333333333333331" WEIGHT="5.045293366970797"/>
<DICH_DATA CI_END="4.474347411298529" CI_START="1.1314499154035917" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6507297019224901" LOG_CI_START="0.05363533430023487" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="3567" O_E="0.0" SE="0.35073618720610084" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.12301587301587302" WEIGHT="3.685443819274387"/>
<DICH_DATA CI_END="1.9862760542852527" CI_START="0.6091801778456267" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.29803960695960363" LOG_CI_START="-0.21525423664315357" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="3568" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.09090909090909093" WEIGHT="4.713283322999843"/>
<DICH_DATA CI_END="1.8318221259186125" CI_START="0.43133197574731574" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.26288330040035734" LOG_CI_START="-0.36518834529511995" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="3569" O_E="0.0" SE="0.3689323936863109" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.13611111111111113" WEIGHT="3.3844188745328783"/>
<DICH_DATA CI_END="9.73940026408782" CI_START="0.5467938109719964" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9885322145771267" LOG_CI_START="-0.2621764097514755" LOG_EFFECT_SIZE="0.36317790241282566" ORDER="3570" O_E="0.0" SE="0.7346724370381603" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5397435897435897" WEIGHT="0.9621407536706994"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.89591115663086" CI_END="1.3277395972766126" CI_START="0.9601493934072616" DF="10.0" EFFECT_SIZE="1.129082976989708" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="211" I2="37.090740496315775" ID="CMP-019.01.02" LOG_CI_END="0.12311290744529844" LOG_CI_START="-0.01766118812228482" LOG_EFFECT_SIZE="0.05272585966150681" NO="2" P_CHI2="0.10265117530656642" P_Z="0.14205560481455187" STUDIES="11" TAU2="0.02647305639538627" TOTAL_1="310" TOTAL_2="399" WEIGHT="82.20941986255139" Z="1.4681790079887882">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.214830136893607" CI_START="0.5582679186538144" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.08451555713843212" LOG_CI_START="-0.253157328538504" LOG_EFFECT_SIZE="-0.08432088570003592" ORDER="3571" O_E="0.0" SE="0.19835072455437414" STUDY_ID="STD-Azhar-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.039343009931245204" WEIGHT="8.537357747520353"/>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="3572" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="9.436625977548802"/>
<DICH_DATA CI_END="1.8078009413055642" CI_START="0.8799530594388961" EFFECT_SIZE="1.2612612612612613" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="37" LOG_CI_END="0.2571506081902599" LOG_CI_START="-0.055540494407098746" LOG_EFFECT_SIZE="0.10080505689158058" ORDER="3573" O_E="0.0" SE="0.18367630151160966" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.033736983736983736" WEIGHT="9.363243769840578"/>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="3574" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="4.659289337485238"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="3575" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="2.5299463994629816"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="3576" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="9.759286393825183"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="3577" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="9.92151162660801"/>
<DICH_DATA CI_END="1.2506715946222424" CI_START="0.6187641667652692" EFFECT_SIZE="0.8796992481203008" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="0.09714328621846557" LOG_CI_START="-0.20847484466031388" LOG_EFFECT_SIZE="-0.055665779220924146" ORDER="3578" O_E="0.0" SE="0.17952160291234157" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.032228005912216445" WEIGHT="9.61357160048682"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="3579" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="8.516693034284105"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="3580" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="1.2790871559820494"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="3581" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="8.592806819507253"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-019.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.854125154629802" CI_END="1.4176282119857935" CI_START="1.048904267751607" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2194081685953144" ESTIMABLE="YES" EVENTS_1="193" EVENTS_2="217" I2="12.482223862587421" I2_Q="0.0" ID="CMP-019.02" LOG_CI_END="0.15156234745200292" LOG_CI_START="0.020735852460044897" LOG_EFFECT_SIZE="0.08614909995602395" METHOD="MH" NO="2" P_CHI2="0.31654794023631583" P_Q="0.0" P_Z="0.009843808389456785" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.010107870833139366" TOTALS="YES" TOTAL_1="339" TOTAL_2="449" WEIGHT="100.0" Z="2.5812681632222474">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.9062750712070873" CI_END="1.684761393750086" CI_START="0.8769315200788019" DF="4.0" EFFECT_SIZE="1.2154918222642817" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="39" I2="0.0" ID="CMP-019.02.01" LOG_CI_END="0.2265384021121824" LOG_CI_START="-0.05703431953371883" LOG_EFFECT_SIZE="0.0847520412892318" NO="1" P_CHI2="0.4188388751026876" P_Z="0.24137457014033836" STUDIES="5" TAU2="0.0" TOTAL_1="71" TOTAL_2="92" WEIGHT="19.182434201084785" Z="1.1715580227816802">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="3582" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="7.242939521852863"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3583" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="6.750159602483916"/>
<DICH_DATA CI_END="1.7131813219780507" CI_START="0.036481835984434545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2338033308388881" LOG_CI_START="-1.4379233134948128" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="3584" O_E="0.0" SE="0.9819805060619657" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.9642857142857144" WEIGHT="0.6060831363710014"/>
<DICH_DATA CI_END="5.589897580584607" CI_START="0.7155766169836816" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7474038507138955" LOG_CI_START="-0.14534385938593308" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="3585" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.275" WEIGHT="2.0713687012669286"/>
<DICH_DATA CI_END="4.053968093818964" CI_START="0.6314800562696091" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.607880326317303" LOG_CI_START="-0.1996403610054535" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="3586" O_E="0.0" SE="0.47434164902525694" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.22500000000000003" WEIGHT="2.511883239110074"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.012624748255671" CI_END="1.4739129123687569" CI_START="1.022243072663864" DF="8.0" EFFECT_SIZE="1.2274759730352292" ESTIMABLE="YES" EVENTS_1="160" EVENTS_2="178" I2="27.35610099429613" ID="CMP-019.02.02" LOG_CI_END="0.16847182355353815" LOG_CI_START="0.009554176194774841" LOG_EFFECT_SIZE="0.0890129998741565" NO="2" P_CHI2="0.20098498291651457" P_Z="0.02811834982893009" STUDIES="9" TAU2="0.020756628758257782" TOTAL_1="268" TOTAL_2="357" WEIGHT="80.81756579891521" Z="2.195631219173025">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="3587" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="14.923451701852581"/>
<DICH_DATA CI_END="1.5473815458642357" CI_START="0.7657600436275381" EFFECT_SIZE="1.0885416666666667" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="42" LOG_CI_END="0.189597413138667" LOG_CI_START="-0.11590729832365816" LOG_EFFECT_SIZE="0.03684505740750443" ORDER="3588" O_E="0.0" SE="0.17945497978568117" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.032204089769879235" WEIGHT="13.957365995620808"/>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="3589" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="6.673585088065178"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="3590" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="5.930903203547612"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="3591" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="5.713554686569817"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="3592" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="11.803100117292566"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="3593" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="11.136016349081714"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="3594" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="9.061494773057909"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="3595" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="1.6180938838270233"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-019.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.504173895813235" CI_END="-0.1764736820504415" CI_START="-0.5593469405338647" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.36791031129215307" ESTIMABLE="YES" I2="0.0" I2_Q="9.445732768171357" ID="CMP-019.03" NO="3" P_CHI2="0.7025775572675189" P_Q="0.2933226498235092" P_Z="1.653967154064693E-4" Q="1.1043101894247487" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="186" TOTAL_2="295" UNITS="" WEIGHT="100.0" Z="3.7667345195630078">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.07621079832677577" CI_END="-0.16449451827013367" CI_START="-0.9214053387560461" DF="3.0" EFFECT_SIZE="-0.5429499285130899" ESTIMABLE="YES" I2="0.0" ID="CMP-019.03.01" NO="1" P_CHI2="0.9945306484984665" P_Z="0.004925647287767478" STUDIES="4" TAU2="0.0" TOTAL_1="50" TOTAL_2="68" WEIGHT="25.587074949690052" Z="2.811856500112114">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="3596" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="6.034656457157983"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="3597" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="5.438323178717243"/>
<CONT_DATA CI_END="0.17554326132084808" CI_START="-1.2688517153542491" EFFECT_SIZE="-0.5466542270167005" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="3598" SD_1="1.67" SD_2="1.91" SE="0.3684748771070031" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.026485107044898"/>
<CONT_DATA CI_END="0.23383491690104852" CI_START="-1.2043181838000103" EFFECT_SIZE="-0.4852416334494809" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.1" ORDER="3599" SD_1="1.67" SD_2="1.91" SE="0.36688253254779857" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.087610206769929"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.32365290806171" CI_END="-0.07562575115665168" CI_START="-0.5396231477342819" DF="4.0" EFFECT_SIZE="-0.3076244494454668" ESTIMABLE="YES" I2="7.485635756243061" ID="CMP-019.03.02" NO="2" P_CHI2="0.36397270676829896" P_Z="0.009353308397099143" STUDIES="5" TAU2="0.00534950976246159" TOTAL_1="136" TOTAL_2="227" WEIGHT="74.41292505030995" Z="2.598863037267936">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="3600" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="20.60370125856437"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="3601" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="21.287169692847165"/>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="3602" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="13.645361947577099"/>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="3603" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="9.770643786553618"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="3604" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="9.106048364767702"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.9426679936545534" CI_END="0.0830710283119956" CI_START="-0.3321089922018788" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.12451898194494158" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.04" NO="4" P_CHI2="0.7456423899763938" P_Q="0.8067899618331522" P_Z="0.23973570299318692" Q="0.059814128633171926" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="177" TOTAL_2="190" UNITS="" WEIGHT="99.99999999999999" Z="1.175647709162937">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.566100059734219" CI_END="0.2397231861975817" CI_START="-0.42412438248119144" DF="5.0" EFFECT_SIZE="-0.09220059814180488" ESTIMABLE="YES" I2="0.0" ID="CMP-019.04.01" NO="1" P_CHI2="0.6134104561974187" P_Z="0.5861443943803493" STUDIES="6" TAU2="0.0" TOTAL_1="66" TOTAL_2="82" WEIGHT="39.114353284998494" Z="0.5444317648723099">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="3605" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="6.79829629593392"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="3606" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="6.243051368810198"/>
<CONT_DATA CI_END="1.8180054280337987" CI_START="-0.3706475543719796" EFFECT_SIZE="0.7236789368309096" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.0" ORDER="3607" SD_1="0.8" SD_2="1.0" SE="0.5583401020808529" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.598479852120304"/>
<CONT_DATA CI_END="0.5634458507391538" CI_START="-0.8533812804773098" EFFECT_SIZE="-0.14496771486907795" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.6" ORDER="3608" SD_1="1.97" SD_2="2.07" SE="0.361442134241296" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="8.586954519302383"/>
<CONT_DATA CI_END="0.8046034136187712" CI_START="-0.6110559018995076" EFFECT_SIZE="0.09677375585963172" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.2" ORDER="3609" SD_1="1.94" SD_2="2.07" SE="0.3611442165990852" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="8.601127585312673"/>
<CONT_DATA CI_END="0.7214546160702255" CI_START="-1.084282986370039" EFFECT_SIZE="-0.1814141851499067" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.78" ORDER="3610" SD_1="1.1" SD_2="0.74" SE="0.46065581221994184" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="5.286443663519017"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.316753805287162" CI_END="0.12076019331675297" CI_START="-0.4113223176575623" DF="3.0" EFFECT_SIZE="-0.14528106217040465" ESTIMABLE="YES" I2="0.0" ID="CMP-019.04.02" NO="2" P_CHI2="0.5093190603142691" P_Z="0.2844814457865015" STUDIES="4" TAU2="0.0" TOTAL_1="111" TOTAL_2="108" WEIGHT="60.88564671500149" Z="1.0703063664630124">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.806334763281386" CI_START="-0.5398754786632862" EFFECT_SIZE="0.13322964230904988" ESTIMABLE="YES" MEAN_1="4.07" MEAN_2="3.64" ORDER="3611" SD_1="3.87" SD_2="2.21" SE="0.34342729064498295" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="9.51145836895326"/>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="3612" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="10.623718091151469"/>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="3613" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="29.55569637154055"/>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="3614" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.194773883356222"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.251213980625687" CI_END="-0.08050175069892254" CI_START="-0.46989535730653886" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2751985540027307" ESTIMABLE="YES" I2="0.0" I2_Q="17.229002527658388" ID="CMP-019.05" NO="5" P_CHI2="0.5939322900282373" P_Q="0.27169836093309296" P_Z="0.005599523289025491" Q="1.2081526507327105" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="203" TOTAL_2="236" UNITS="" WEIGHT="100.0" Z="2.7703549585310703">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.868674151054919" CI_END="-0.0016391614940297616" CI_START="-0.8525709514046272" DF="5.0" EFFECT_SIZE="-0.4271050564493285" ESTIMABLE="YES" I2="36.456893448438564" ID="CMP-019.05.01" NO="1" P_CHI2="0.16362340108696083" P_Z="0.04912386890657623" STUDIES="6" TAU2="0.10220204043470303" TOTAL_1="67" TOTAL_2="84" WEIGHT="33.75059468298738" Z="1.9675149951644917">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="3615" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="5.736082524654091"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="3616" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="5.254692801097558"/>
<CONT_DATA CI_END="1.6250566771188566" CI_START="-0.524690857505451" EFFECT_SIZE="0.5501829098067028" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.6" ORDER="3617" SD_1="4.7" SD_2="8.4" SE="0.5484150605779601" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.2809734355835642"/>
<CONT_DATA CI_END="0.45905533712212815" CI_START="-0.9619959513642371" EFFECT_SIZE="-0.2514703071210545" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.8" ORDER="3618" SD_1="8.8" SD_2="9.87" SE="0.362519745182931" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="7.508585454345707"/>
<CONT_DATA CI_END="0.6043495220639079" CI_START="-0.8114458718942708" EFFECT_SIZE="-0.10354817491518142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.3" ORDER="3619" SD_1="8.8" SD_2="9.87" SE="0.3611789311247023" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="7.56443757198134"/>
<CONT_DATA CI_END="0.3051678094344761" CI_START="-1.549966249806378" EFFECT_SIZE="-0.622399220185951" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="23.3" ORDER="3620" SD_1="10.3" SD_2="7.8" SE="0.4732571807119709" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.4058228953251195"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1743871788380569" CI_END="0.04193810411451865" CI_START="-0.436469225196231" DF="6.0" EFFECT_SIZE="-0.19726556054085617" ESTIMABLE="YES" I2="0.0" ID="CMP-019.05.02" NO="2" P_CHI2="0.9781309164960221" P_Z="0.10602177814221508" STUDIES="7" TAU2="0.0" TOTAL_1="136" TOTAL_2="152" WEIGHT="66.24940531701262" Z="1.616335580005489">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="3621" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="14.904874694016417"/>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="3622" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="9.212927420327743"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="3623" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="6.827648786150536"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="3624" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="10.102252561294392"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="3625" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="9.414846134175951"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="3626" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.866277574188032"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="3627" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.92057814685955"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.322247927285138" CI_END="-0.11833151201791944" CI_START="-0.47395324978506825" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.29614238090149386" ESTIMABLE="YES" I2="0.0" I2_Q="33.06011896039726" ID="CMP-019.06" NO="6" P_CHI2="0.5877128527921527" P_Q="0.2216161365577176" P_Z="0.0010973407486940439" Q="1.4938777668403436" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="245" TOTAL_2="276" UNITS="" WEIGHT="100.00000000000001" Z="3.2643021459105444">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.4443821323741" CI_END="-0.11184665172362435" CI_START="-0.8707810573570982" DF="4.0" EFFECT_SIZE="-0.49131385454036125" ESTIMABLE="YES" I2="9.9987381628843" ID="CMP-019.06.01" NO="1" P_CHI2="0.34919345989938866" P_Z="0.011159742042694171" STUDIES="5" TAU2="0.018895344359495428" TOTAL_1="57" TOTAL_2="75" WEIGHT="24.57422477852204" Z="2.5376566218549272">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="3628" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="4.909742195057649"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="3629" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="4.478462696075592"/>
<CONT_DATA CI_END="1.0476448172235973" CI_START="-1.0476448172235973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.6" ORDER="3630" SD_1="0.5" SD_2="0.5" SE="0.5345224838248488" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="2.8806365756112853"/>
<CONT_DATA CI_END="0.10135118838086432" CI_START="-1.3520823214994477" EFFECT_SIZE="-0.6253655665592918" ESTIMABLE="YES" MEAN_1="30.1" MEAN_2="35.5" ORDER="3631" SD_1="7.61" SD_2="9.3" SE="0.3707806677430836" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="5.986682990833835"/>
<CONT_DATA CI_END="0.6960202687482964" CI_START="-0.7187125248505224" EFFECT_SIZE="-0.011346128051113055" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.4" ORDER="3632" SD_1="7.61" SD_2="9.3" SE="0.3609078546233631" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="6.31870032094368"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.383988028070695" CI_END="-0.028112554841239673" CI_START="-0.4375885137131078" DF="7.0" EFFECT_SIZE="-0.23285053427717373" ESTIMABLE="YES" I2="0.0" ID="CMP-019.06.02" NO="2" P_CHI2="0.7346382905347938" P_Z="0.025808151609731707" STUDIES="8" TAU2="0.0" TOTAL_1="188" TOTAL_2="201" WEIGHT="75.42577522147798" Z="2.2290864754137054">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.9449855770700366" CI_START="-0.4064133842298303" EFFECT_SIZE="0.26928609642010315" ESTIMABLE="YES" MEAN_1="22.86" MEAN_2="21.5" ORDER="3633" SD_1="4.68" SD_2="5.17" SE="0.34475096786459586" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="6.924835132258817"/>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="3634" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="12.300289495344622"/>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="3635" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="7.800657403768008"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="3636" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="5.759758510452346"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="3637" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="21.55807614844401"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="3638" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="8.420576733168394"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="3639" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="7.855896229733695"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="3640" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.805685568308078"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.59639594741286" CI_END="-0.11650628444037267" CI_START="-0.5799755206759052" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.34824090255813894" ESTIMABLE="YES" I2="6.214790955698797" I2_Q="0.0" ID="CMP-019.07" NO="7" P_CHI2="0.38413560138064284" P_Q="0.9514583892598287" P_Z="0.003225892090089005" Q="0.003705829033101793" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.008739700714300894" TOTALS="YES" TOTAL_1="172" TOTAL_2="171" UNITS="" WEIGHT="99.99999999999999" Z="2.9453502998451957">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.46267059844604" CI_END="0.04826607778230374" CI_START="-0.7728543314003463" DF="4.0" EFFECT_SIZE="-0.3622941268090213" ESTIMABLE="YES" I2="26.775742232418782" ID="CMP-019.07.01" NO="1" P_CHI2="0.24303051326037384" P_Z="0.08371112463329027" STUDIES="6" TAU2="0.05871772356894945" TOTAL_1="67" TOTAL_2="84" WEIGHT="41.52061470313551" Z="1.7295476580904667">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="3641" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="8.199582939786426"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="3642" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="7.302181441613981"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.1" ORDER="3643" SD_1="0.0" SD_2="0.4" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.1660902945592465" CI_START="-1.2793880660482784" EFFECT_SIZE="-0.5566488857445159" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="7.7" ORDER="3644" SD_1="8.51" SD_2="8.65" SE="0.36875125563767336" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="9.659742112454996"/>
<CONT_DATA CI_END="0.9135860975227219" CI_START="-0.5053092638018191" EFFECT_SIZE="0.20413841686045137" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.9" ORDER="3645" SD_1="8.51" SD_2="8.65" SE="0.361969753657875" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="10.00223733952802"/>
<CONT_DATA CI_END="0.9423936038113165" CI_START="-0.8589355986386695" EFFECT_SIZE="0.04172900258632352" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.0" ORDER="3646" SD_1="5.7" SD_2="11.9" SE="0.4595311997206686" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="6.356870869752089"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.130019519933718" CI_END="-0.04647121023388057" CI_START="-0.6382275298797727" DF="4.0" EFFECT_SIZE="-0.34234937005682664" ESTIMABLE="YES" I2="3.1481575161127773" ID="CMP-019.07.02" NO="2" P_CHI2="0.3886958007077529" P_Z="0.02334141083627799" STUDIES="5" TAU2="0.0036773392906802402" TOTAL_1="105" TOTAL_2="87" WEIGHT="58.47938529686448" Z="2.267799812743456">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.04205136398922227" CI_START="-1.437631644300558" EFFECT_SIZE="-0.73984150414489" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.0" ORDER="3647" SD_1="1.38" SD_2="0.57" SE="0.356021919616762" STUDY_ID="STD-Azhar-2000" TOTAL_1="17" TOTAL_2="17" WEIGHT="10.317493781774255"/>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="3648" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="18.205596756373417"/>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="3649" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.188012471723713"/>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="3650" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.844289931033572"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="3651" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.923992355959524"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.4991057802477643" CI_END="0.11665918990963187" CI_START="-0.45183145469912556" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.16758613239474685" ESTIMABLE="YES" I2="0.0" I2_Q="36.05382023860468" ID="CMP-019.08" NO="8" P_CHI2="0.6235230657670956" P_Q="0.2111075349813344" P_Z="0.24786082393331876" Q="1.5638150765711665" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="86" TOTAL_2="120" UNITS="" WEIGHT="100.0" Z="1.1555609117476944">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0386349845428727" CI_END="0.07153904266936312" CI_START="-0.942362581729058" DF="1.0" EFFECT_SIZE="-0.43541176952984745" ESTIMABLE="YES" I2="0.0" ID="CMP-019.08.01" NO="1" P_CHI2="0.8441736504034025" P_Z="0.09230135076170906" STUDIES="2" TAU2="0.0" TOTAL_1="31" TOTAL_2="31" WEIGHT="31.4380070130045" Z="1.683381042474804">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.23257590352413376" CI_START="-1.2057040497945535" EFFECT_SIZE="-0.48656407313520983" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.8" ORDER="3652" SD_1="0.95" SD_2="1.06" SE="0.36691489350407863" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="17" TOTAL_2="14" WEIGHT="15.622832969442209"/>
<CONT_DATA CI_END="0.32987200858893545" CI_START="-1.099635149194897" EFFECT_SIZE="-0.3848815703029808" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.8" ORDER="3653" SD_1="0.95" SD_2="1.06" SE="0.36467689433571293" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="14" TOTAL_2="17" WEIGHT="15.81517404356229"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8966557191337252" CI_END="0.2985034934444692" CI_START="-0.38806142026940765" DF="3.0" EFFECT_SIZE="-0.04477896341246921" ESTIMABLE="YES" I2="0.0" ID="CMP-019.08.02" NO="2" P_CHI2="0.5941309163838324" P_Z="0.7982098692592872" STUDIES="4" TAU2="0.0" TOTAL_1="55" TOTAL_2="89" WEIGHT="68.5619929869955" Z="0.25566455203404764">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="3654" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="14.69612275073057"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="3655" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="21.508510787514172"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="3656" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="19.99969296723604"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="3657" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="12.357666481514723"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.310992387862584" CI_END="1.5632982317973136" CI_START="0.8426588401070958" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.147748698430017" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="82" I2="0.0" I2_Q="0.0" ID="CMP-019.09" LOG_CI_END="0.19404183666842065" LOG_CI_START="-0.07434821878900513" LOG_EFFECT_SIZE="0.05984680893970773" METHOD="MH" NO="9" P_CHI2="0.7603797601616622" P_Q="0.0" P_Z="0.3820730733532465" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="332" TOTAL_2="441" WEIGHT="100.0" Z="0.874082982780885">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.08377478202762167" CI_END="2.4531852359655764" CI_START="0.4849716400670389" DF="2.0" EFFECT_SIZE="1.0907452806565203" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" I2="0.0" ID="CMP-019.09.01" LOG_CI_END="0.38973034230357895" LOG_CI_START="-0.3142836571142437" LOG_EFFECT_SIZE="0.037723342594667586" NO="1" P_CHI2="0.9589777650439282" P_Z="0.833634585626866" STUDIES="4" TAU2="0.0" TOTAL_1="44" TOTAL_2="64" WEIGHT="14.533501161249802" Z="0.2100423938249956">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3658" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="6.0868585598513185"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3659" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="3.5386313322525464"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3660" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.7236963680632957" CI_START="0.22882397534477933" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5709742611786153" LOG_CI_START="-0.6404984736970392" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="3661" O_E="0.0" SE="0.7116250813527136" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.5064102564102563" WEIGHT="4.908011269145938"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.220612138027674" CI_END="1.6172086149448126" CI_START="0.82880377929573" DF="9.0" EFFECT_SIZE="1.157734257926176" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="71" I2="0.0" ID="CMP-019.09.02" LOG_CI_END="0.2087660461745161" LOG_CI_START="-0.0815482772374295" LOG_EFFECT_SIZE="0.06360888446854326" NO="2" P_CHI2="0.5120761394772577" P_Z="0.3904122847042" STUDIES="10" TAU2="0.0" TOTAL_1="288" TOTAL_2="377" WEIGHT="85.4664988387502" Z="0.8588699392431303">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="3662" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="20.627889832023076"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="3663" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="21.708437034724565"/>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="3664" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="6.916810226830709"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3665" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="3.3575610155437174"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3666" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="2.0877924860290022"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="3667" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="8.521601983791845"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="3668" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="7.391563459854233"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="3669" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="12.36331379357461"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3670" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="1.1685405705386205"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="3671" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="1.3229884358398298"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-019.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.6107568409849757" CI_END="10.316277921568275" CI_START="2.093764289661389" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.647564342147602" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-019.10" LOG_CI_END="1.0135230335606709" LOG_CI_START="0.32092778839281877" LOG_EFFECT_SIZE="0.6672254109767448" METHOD="MH" NO="10" P_CHI2="0.9632031996192727" P_Q="0.0" P_Z="1.5914932262315432E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="295" TOTAL_2="403" WEIGHT="100.0" Z="3.7763406093480265">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.18674931983249832" CI_END="17.661076300695854" CI_START="0.8255197481225357" DF="2.0" EFFECT_SIZE="3.818319952455965" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" I2="0.0" ID="CMP-019.10.01" LOG_CI_END="1.2470171668072176" LOG_CI_START="-0.0832725330637428" LOG_EFFECT_SIZE="0.5818723168717373" NO="1" P_CHI2="0.910852231287621" P_Z="0.08642095403566694" STUDIES="3" TAU2="0.0" TOTAL_1="37" TOTAL_2="57" WEIGHT="27.106069933635766" Z="1.7145871080263317">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="3672" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="6.491390069559573"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="3673" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="6.505306563158079"/>
<DICH_DATA CI_END="23.135786473503835" CI_START="0.33146221599325854" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.364284267410471" LOG_CI_START="-0.47956597048956995" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="3674" O_E="0.0" SE="1.0830867569483633" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="1.1730769230769231" WEIGHT="14.109373300918117"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.33186524099875" CI_END="12.722427723704758" CI_START="1.964983951519963" DF="7.0" EFFECT_SIZE="4.999936629743672" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="2" I2="0.0" ID="CMP-019.10.02" LOG_CI_END="1.1045699923191301" LOG_CI_START="0.29335900774208934" LOG_EFFECT_SIZE="0.6989645000306098" NO="2" P_CHI2="0.8527001517280022" P_Z="7.313962812380342E-4" STUDIES="8" TAU2="0.0" TOTAL_1="258" TOTAL_2="346" WEIGHT="72.89393006636423" Z="3.3775313021588826">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="3675" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="6.313393132266882"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="3676" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="6.308789083684623"/>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="3677" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="7.965904917939169"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3678" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="22.3588820493969"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3679" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="7.559657021541769"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="3680" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="7.493763616050417"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="3681" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="7.111921187587182"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3682" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="7.78161905789729"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.3223069706219417" CI_END="1.7584505034853375" CI_START="0.951960160027747" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2938217893893942" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="66" I2="13.878741040665437" I2_Q="0.0" ID="CMP-019.11" LOG_CI_END="0.2451301483903956" LOG_CI_START="-0.021381226659809082" LOG_EFFECT_SIZE="0.11187446086529321" METHOD="MH" NO="11" P_CHI2="0.3131248325412854" P_Q="0.0" P_Z="0.09987032970023424" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.011551061220724582" TOTALS="YES" TOTAL_1="78" TOTAL_2="152" WEIGHT="99.99999999999999" Z="1.6454825918368776">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="12.607562875295223" CI_START="0.8279054346767073" DF="0.0" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" I2="0.0" ID="CMP-019.11.01" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" NO="1" P_CHI2="1.0" P_Z="0.09139034090085832" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="12" WEIGHT="4.959596305447161" Z="1.688108823998179">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="12.607562875295223" CI_START="0.8279054346767073" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1006311427106612" LOG_CI_START="-0.08201926652853381" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="3683" O_E="0.0" SE="0.6946947046010445" STUDY_ID="STD-Telch-1985" TOTAL_1="13" TOTAL_2="12" VAR="0.4826007326007326" WEIGHT="4.959596305447161"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-019.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="95.04040369455282" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="3684" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="49.75564106935006"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="3685" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="45.28476262520276"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.7542342175256036" CI_END="-0.1297007863501729" CI_START="-0.9908325327534175" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5602666595517952" ESTIMABLE="YES" I2="46.72681873007407" I2_Q="72.62702417146596" ID="CMP-019.12" NO="12" P_CHI2="0.15303074293684904" P_Q="0.055960514146016216" P_Z="0.010760851273647705" Q="3.6532381654959987" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0659379383852589" TOTALS="YES" TOTAL_1="75" TOTAL_2="149" UNITS="" WEIGHT="100.00000000000001" Z="2.5503704376168033">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.4291707624014598" CI_START="-2.51463058801477" DF="0.0" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" I2="0.0" ID="CMP-019.12.01" NO="1" P_CHI2="1.0" P_Z="0.005663492379937387" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="13.828826387326112" Z="2.7666534514801167">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.4291707624014598" CI_START="-2.51463058801477" EFFECT_SIZE="-1.471900675208115" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="25.6" ORDER="3686" SD_1="8.1" SD_2="8.8" SE="0.5320148334518264" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" WEIGHT="13.828826387326112"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-019.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="86.1711736126739" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="3687" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="42.768459545543294"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="3688" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="43.4027140671306"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.3771807511690577" CI_END="2.3233067078716396" CI_START="0.3333060340435928" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8799841729642484" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-019.13" LOG_CI_END="0.36610654632353345" LOG_CI_START="-0.4771568239688877" LOG_EFFECT_SIZE="-0.05552513882267714" METHOD="MH" NO="13" P_CHI2="0.7108924890777757" P_Q="0.0" P_Z="0.7963221643362426" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="94" TOTAL_2="168" WEIGHT="100.00000000000001" Z="0.25810980569758535">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0018021436538582427" CI_END="25.7986852549672" CI_START="0.3165964113527592" DF="1.0" EFFECT_SIZE="2.8579312744259546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-019.13.01" LOG_CI_END="1.4115975741391282" LOG_CI_START="-0.4994940122106407" LOG_EFFECT_SIZE="0.4560517809642438" NO="1" P_CHI2="0.966138652004048" P_Z="0.3495673656745448" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="28" WEIGHT="19.46988878060047" Z="0.9354288116379947">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3689" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="9.559434575571265"/>
<DICH_DATA CI_END="59.57376743870334" CI_START="0.12485388869486465" EFFECT_SIZE="2.727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7750550657040625" LOG_CI_START="-0.9035979265811878" LOG_EFFECT_SIZE="0.43572856956143735" ORDER="3690" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Telch-1985" TOTAL_1="10" TOTAL_2="9" VAR="2.4757575757575756" WEIGHT="9.910454205029207"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-019.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="80.53011121939954" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3691" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="39.54271227806654"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="3692" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="40.987398941333"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.0452507021722157" CI_END="1.1742626567178822" CI_START="0.7434879657827691" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9343715288566151" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="127" I2="0.0" I2_Q="0.0" ID="CMP-019.14" LOG_CI_END="0.06976524989689775" LOG_CI_START="-0.1287260566463105" LOG_EFFECT_SIZE="-0.029480403374706383" METHOD="MH" NO="14" P_CHI2="0.9624738813007475" P_Q="0.0" P_Z="0.5604339474547997" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="320" WEIGHT="100.00000000000001" Z="0.5821970732159977">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.169443578455897" CI_END="1.4478708837115608" CI_START="0.6667859061113212" DF="4.0" EFFECT_SIZE="0.9825578350040329" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="37" I2="0.0" ID="CMP-019.14.01" LOG_CI_END="0.1607298346568556" LOG_CI_START="-0.17601358845226592" LOG_EFFECT_SIZE="-0.007641876897705158" NO="1" P_CHI2="0.8831034658676736" P_Z="0.9291162669958576" STUDIES="5" TAU2="0.0" TOTAL_1="71" TOTAL_2="92" WEIGHT="34.744393594719256" Z="0.08895676925477634">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="3693" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="10.875473434499101"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="3694" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="10.01688342651233"/>
<DICH_DATA CI_END="1.9009298496763338" CI_START="0.1315145848451834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2789660903211985" LOG_CI_START="-0.881026081649161" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3695" O_E="0.0" SE="0.681385143869247" STUDY_ID="STD-Fava-1997" TOTAL_1="7" TOTAL_2="7" VAR="0.46428571428571436" WEIGHT="2.9280120785189885"/>
<DICH_DATA CI_END="3.301716901302548" CI_START="0.4361367261475116" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5187398328659169" LOG_CI_START="-0.3603773407706673" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3696" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="5.097878172421454"/>
<DICH_DATA CI_END="2.577326316861588" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" ORDER="3697" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="20" TOTAL_2="20" VAR="0.23333333333333334" WEIGHT="5.826146482767377"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7895557447682484" CI_END="1.2071180634987027" CI_START="0.6855422667382742" DF="4.0" EFFECT_SIZE="0.909687008520852" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="90" I2="0.0" ID="CMP-019.14.02" LOG_CI_END="0.081749748820173" LOG_CI_START="-0.16396576385722889" LOG_EFFECT_SIZE="-0.041108007518527924" NO="2" P_CHI2="0.7743926715839039" P_Z="0.5119523092847125" STUDIES="5" TAU2="0.0" TOTAL_1="111" TOTAL_2="228" WEIGHT="65.25560640528076" Z="0.6558007944601898">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="3698" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="11.766159020572552"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="3699" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="11.473443817691662"/>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="3700" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="17.12887065933609"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="3701" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="13.145530675296836"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="3702" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="11.741602232383626"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.444840439732734" CI_END="0.3960212106689402" CI_START="-0.12712372102773756" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.13444874482060132" ESTIMABLE="YES" I2="8.169944457629862" I2_Q="0.0" ID="CMP-019.15" NO="15" P_CHI2="0.3640323275438395" P_Q="0.4545654155523893" P_Z="0.3137304929304111" Q="0.559243249783111" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.009154724598225278" TOTALS="YES" TOTAL_1="102" TOTAL_2="193" UNITS="" WEIGHT="100.0" Z="1.0074252148839777">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.612261010415512" CI_END="0.5293447823410569" CI_START="-0.4857319945787466" DF="3.0" EFFECT_SIZE="0.021806393881155125" ESTIMABLE="YES" I2="34.95597943773494" ID="CMP-019.15.01" NO="1" P_CHI2="0.20249285367640457" P_Z="0.932889563222961" STUDIES="4" TAU2="0.09375477730207286" TOTAL_1="43" TOTAL_2="58" WEIGHT="38.84729121558681" Z="0.08420987970870568">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="3703" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="10.295251763000165"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="3704" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="9.941915552552693"/>
<CONT_DATA CI_END="0.2262056102662784" CI_START="-1.3919391044700584" EFFECT_SIZE="-0.58286674710189" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.3" ORDER="3705" SD_1="1.39" SD_2="2.57" SE="0.4127996043549922" STUDY_ID="STD-Mavissakalian-1986a" TOTAL_1="14" TOTAL_2="11" WEIGHT="9.919334505783423"/>
<CONT_DATA CI_END="1.5775381627870646" CI_START="-0.15694105781944812" EFFECT_SIZE="0.7102985524838082" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.3" ORDER="3706" SD_1="1.24" SD_2="0.51" SE="0.4424773195548141" STUDY_ID="STD-Mavissakalian-1986b" TOTAL_1="11" TOTAL_2="11" WEIGHT="8.690789394250519"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-019.15.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="61.15270878441319" Z="1.3386680075530792">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="3707" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="30.134605199379184"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="3708" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="31.018103585034012"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-020" NO="20">
<NAME>SENSITIVITY5: without benzo: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="3.3818926509358156" CI_END="2.046959953810536" CI_START="0.9116210557233463" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3660350632821154" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="32" I2="40.86151730905554" I2_Q="0.0" ID="CMP-020.01" LOG_CI_END="0.3111093463218955" LOG_CI_START="-0.04018565247053767" LOG_EFFECT_SIZE="0.13546184692567892" METHOD="MH" NO="1" P_CHI2="0.1843452324451641" P_Q="0.0" P_Z="0.1306478527803171" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.05381756589803742" TOTALS="YES" TOTAL_1="61" TOTAL_2="61" WEIGHT="100.0" Z="1.5115520697206546">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.081852540666224" CI_START="0.6537980402183219" DF="0.0" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-020.01.01" LOG_CI_END="0.31844996482728344" LOG_CI_START="-0.18455638556605694" LOG_EFFECT_SIZE="0.06694678963061322" NO="1" P_CHI2="1.0" P_Z="0.6018679021905543" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="30.174020167780615" Z="0.5217162624447006">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.081852540666224" CI_START="0.6537980402183219" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.31844996482728344" LOG_CI_START="-0.18455638556605694" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3709" O_E="0.0" SE="0.29546842014263947" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.08730158730158732" WEIGHT="30.174020167780615"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.1950700236144502" CI_END="3.3427501376478728" CI_START="0.7534067916644659" DF="1.0" EFFECT_SIZE="1.5869627142882834" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="26" I2="68.70178141295503" ID="CMP-020.01.02" LOG_CI_END="0.5241039153612689" LOG_CI_START="-0.12297046912199223" LOG_EFFECT_SIZE="0.20056672311963836" NO="2" P_CHI2="0.07386065383890461" P_Z="0.22435919978224694" STUDIES="2" TAU2="0.20739848938985686" TOTAL_1="52" TOTAL_2="52" WEIGHT="69.82597983221939" Z="1.21501812848188">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="5.465969572612346" CI_START="1.156543696243068" EFFECT_SIZE="2.5142857142857142" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.7376672097782779" LOG_CI_START="0.06316204582150807" LOG_EFFECT_SIZE="0.400414627799893" ORDER="3710" O_E="0.0" SE="0.3962076721626166" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.15698051948051947" WEIGHT="20.200051471334437"/>
<DICH_DATA CI_END="1.6653657579290821" CI_START="0.8261069654813951" EFFECT_SIZE="1.1729323308270676" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.22150963075861116" LOG_CI_START="-0.08296371598385956" LOG_EFFECT_SIZE="0.06927295738737577" ORDER="3711" O_E="0.0" SE="0.17884915104390095" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.031987018829124095" WEIGHT="49.62592836088495"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.493835364006178" CI_END="2.730610546481659" CI_START="0.7183444710850893" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4005423909156531" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="28" I2="63.59555997794639" I2_Q="0.0" ID="CMP-020.02" LOG_CI_END="0.4362597632759381" LOG_CI_START="-0.1436672465431494" LOG_EFFECT_SIZE="0.14629625836639437" METHOD="MH" NO="2" P_CHI2="0.06412524953256704" P_Q="0.0" P_Z="0.32272813618944995" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.20968674962226386" TOTALS="YES" TOTAL_1="61" TOTAL_2="61" WEIGHT="100.0" Z="0.9888671940303272">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9219135458330163" CI_START="0.5203147676273697" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" I2="0.0" ID="CMP-020.02.01" LOG_CI_END="0.2837338477382853" LOG_CI_START="-0.28373384773828525" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="36.17349014911807" Z="0.0">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9219135458330163" CI_START="0.5203147676273697" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.2837338477382853" LOG_CI_START="-0.28373384773828525" LOG_EFFECT_SIZE="0.0" ORDER="3712" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.1111111111111111" WEIGHT="36.17349014911807"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.047992180387981" CI_END="10.096582129657683" CI_START="0.44857231702253647" DF="1.0" EFFECT_SIZE="2.128155830739112" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="22" I2="80.19014363997803" ID="CMP-020.02.02" LOG_CI_END="1.0041743823526899" LOG_CI_START="-0.34816753176804177" LOG_EFFECT_SIZE="0.3280034252923239" NO="2" P_CHI2="0.02465452272888824" P_Z="0.34172728428923504" STUDIES="2" TAU2="1.0418634009391432" TOTAL_1="52" TOTAL_2="52" WEIGHT="63.826509850881926" Z="0.9507579313574926">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="19.91594281822458" CI_START="1.3280305046685488" EFFECT_SIZE="5.142857142857143" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2992008706780764" LOG_CI_START="0.1232080508279847" LOG_EFFECT_SIZE="0.7112044607530305" ORDER="3713" O_E="0.0" SE="0.6907840036382862" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.47718253968253976" WEIGHT="16.894594700604465"/>
<DICH_DATA CI_END="1.6622456282399865" CI_START="0.7775084201410078" EFFECT_SIZE="1.1368421052631579" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="20" LOG_CI_END="0.22069519941633137" LOG_CI_START="-0.10929489902012753" LOG_EFFECT_SIZE="0.05570015019810193" ORDER="3714" O_E="0.0" SE="0.19383781729890762" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.03757309941520469" WEIGHT="46.93191515027746"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.0888682653610322" CI_END="-0.09755657797679418" CI_START="-1.1391421175676018" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.618349347772198" ESTIMABLE="YES" I2="8.161525887758927" I2_Q="8.161525887758927" ID="CMP-020.03" NO="3" P_CHI2="0.2967225625840264" P_Q="0.2967225625840264" P_Z="0.019959371674248237" Q="1.0888682653610322" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.017680695334786608" TOTALS="YES" TOTAL_1="37" TOTAL_2="36" UNITS="" WEIGHT="100.0" Z="2.3271107468973864">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.02125413161636569" CI_START="-2.262071319946162" DF="0.0" EFFECT_SIZE="-1.141662725781264" ESTIMABLE="YES" I2="0.0" ID="CMP-020.03.01" NO="1" P_CHI2="1.0" P_Z="0.04580949158157472" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="20.497122014092632" Z="1.9971444673636445">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.02125413161636569" CI_START="-2.262071319946162" EFFECT_SIZE="-1.141662725781264" ESTIMABLE="YES" MEAN_1="2.17" MEAN_2="3.67" ORDER="3715" SD_1="0.75" SD_2="1.63" SE="0.5716475419969643" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="20.497122014092632"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.332371116245477E-32" CI_END="0.0392849124643212" CI_START="-1.0061463786555822" DF="0.0" EFFECT_SIZE="-0.48343073309563045" ESTIMABLE="YES" I2="100.0" ID="CMP-020.03.02" NO="2" P_CHI2="0.0" P_Z="0.06988395750165902" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="79.50287798590738" Z="1.8126620734151322">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.03928491246432125" CI_START="-1.006146378655582" EFFECT_SIZE="-0.4834307330956304" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.28" ORDER="3716" SD_1="1.06" SD_2="1.22" SE="0.26669655650974505" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="79.50287798590738"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7980531175789702" CI_START="-1.2390075602204103" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-020.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.671372105124532" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="7" UNITS="" WEIGHT="100.0" Z="0.4242656273419418">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7980531175789702" CI_START="-1.2390075602204103" DF="0.0" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" I2="0.0" ID="CMP-020.04.01" NO="1" P_CHI2="1.0" P_Z="0.671372105124532" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="100.0" Z="0.4242656273419418">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7980531175789702" CI_START="-1.2390075602204103" EFFECT_SIZE="-0.22047722132071995" ESTIMABLE="YES" MEAN_1="1.71" MEAN_2="2.14" ORDER="3717" SD_1="1.89" SD_2="1.77" SE="0.5196678851926503" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.04.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.238618726796217" CI_END="0.07021312660650869" CI_START="-1.36550791735618" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6476473953748356" ESTIMABLE="YES" I2="61.82199728012769" I2_Q="19.555727403037768" ID="CMP-020.05" NO="5" P_CHI2="0.07285328509858635" P_Q="0.26487518578394775" P_Z="0.07701709316199316" Q="1.2430965781866767" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.24509166580974928" TOTALS="YES" TOTAL_1="51" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="1.7682621216059002">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.039892566655316264" CI_START="-2.175482894859469" DF="0.0" EFFECT_SIZE="-1.0677951641020764" ESTIMABLE="YES" I2="0.0" ID="CMP-020.05.01" NO="1" P_CHI2="1.0" P_Z="0.058841289087672215" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="23.76426514517491" Z="1.8893773095013937">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.039892566655316264" CI_START="-2.175482894859469" EFFECT_SIZE="-1.0677951641020764" ESTIMABLE="YES" MEAN_1="8.57" MEAN_2="19.43" ORDER="3718" SD_1="6.16" SD_2="12.42" SE="0.5651571863027546" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="23.76426514517491"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.99552214860954" CI_END="0.39466230250097256" CI_START="-1.451004741829444" DF="1.0" EFFECT_SIZE="-0.5281712196642357" ESTIMABLE="YES" I2="74.97198206377095" ID="CMP-020.05.02" NO="2" P_CHI2="0.04562139259771547" P_Z="0.2619650523211543" STUDIES="2" TAU2="0.3355036105102281" TOTAL_1="43" TOTAL_2="45" WEIGHT="76.2357348548251" Z="1.12175873908834">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.27508758018185875" CI_START="-1.8180880477863752" EFFECT_SIZE="-1.046587813984117" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="19.0" ORDER="3719" SD_1="8.26" SD_2="13.16" SE="0.3936298013064289" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="33.53395591137413"/>
<CONT_DATA CI_END="0.41452271242937677" CI_START="-0.6155982943711397" EFFECT_SIZE="-0.10053779097088145" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.5" ORDER="3720" SD_1="7.8" SD_2="7.9" SE="0.2627907999651982" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="29" TOTAL_2="29" WEIGHT="42.70177894345097"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.47450665823976756" CI_END="-0.17221078416644436" CI_START="-0.9640534073500047" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5681320957582245" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-020.06" NO="6" P_CHI2="0.7887914456880338" P_Q="0.8739352000298999" P_Z="0.0049161978015732554" Q="0.025173629229843675" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="51" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="2.812474129443906">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5440488746719574" CI_START="-1.5255257710292496" DF="0.0" EFFECT_SIZE="-0.4907384481786461" ESTIMABLE="YES" I2="0.0" ID="CMP-020.06.01" NO="1" P_CHI2="1.0" P_Z="0.3526326053794122" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="14.639139858490186" Z="0.9294950402074895">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5440488746719574" CI_START="-1.5255257710292496" EFFECT_SIZE="-0.4907384481786461" ESTIMABLE="YES" MEAN_1="27.29" MEAN_2="32.29" ORDER="3721" SD_1="4.82" SD_2="13.12" SE="0.5279624171734143" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="14.639139858490186"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4493330290099239" CI_END="-0.1528766013116588" CI_START="-1.0099331622432612" DF="1.0" EFFECT_SIZE="-0.5814048817774601" ESTIMABLE="YES" I2="0.0" ID="CMP-020.06.02" NO="2" P_CHI2="0.5026518853360098" P_Z="0.00783317546519518" STUDIES="2" TAU2="0.0" TOTAL_1="43" TOTAL_2="45" WEIGHT="85.36086014150982" Z="2.659177190081695">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.042639621379945036" CI_START="-1.5401616934048423" EFFECT_SIZE="-0.7914006573923937" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="19.88" ORDER="3722" SD_1="11.08" SD_2="9.75" SE="0.3820279565943967" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="27.959621376596324"/>
<CONT_DATA CI_END="0.0434566908945247" CI_START="-1.0016923893870333" EFFECT_SIZE="-0.4791178492462543" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="7.9" ORDER="3723" SD_1="5.7" SD_2="7.0" SE="0.2666245626260382" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="57.40123876491349"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.09468683327142621" CI_END="-0.3686115883679437" CI_START="-1.6271903732535016" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9979009808107226" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-020.07" NO="7" P_CHI2="0.7583013121404795" P_Q="0.7583013121404795" P_Z="0.0018833928082898138" Q="0.09468683327142621" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="23" UNITS="" WEIGHT="100.00000000000001" Z="3.1080294789873752">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.022765335912631635" CI_START="-2.264232881184172" DF="0.0" EFFECT_SIZE="-1.1434991085484019" ESTIMABLE="YES" I2="0.0" ID="CMP-020.07.01" NO="1" P_CHI2="1.0" P_Z="0.04552440249937667" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="31.527962381357636" Z="1.9997765069911067">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.022765335912631635" CI_START="-2.264232881184172" EFFECT_SIZE="-1.1434991085484019" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="9.14" ORDER="3724" SD_1="1.99" SD_2="7.84" SE="0.5718134524287054" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="31.527962381357636"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" DF="0.0" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" I2="0.0" ID="CMP-020.07.02" NO="2" P_CHI2="1.0" P_Z="0.01643779073257808" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="16" WEIGHT="68.47203761864237" Z="2.3990473104156176">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17036981009392027" CI_START="-1.6913507818543705" EFFECT_SIZE="-0.9308602959741454" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="12.0" ORDER="3725" SD_1="5.84" SD_2="7.4" SE="0.3880124797592594" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="68.47203761864237"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.364413774345487" CI_END="-0.13247840136065503" CI_START="-1.2648844905610677" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6986814459608613" ESTIMABLE="YES" I2="40.55427976039957" I2_Q="0.0" ID="CMP-020.08" NO="8" P_CHI2="0.18596335186969204" P_Q="0.4045471067060291" P_Z="0.015582496506565372" Q="0.6947698624395842" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.10375408639691687" TOTALS="YES" TOTAL_1="51" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="2.4185501717260767">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0582778375411388" CI_START="-2.149781105514995" DF="0.0" EFFECT_SIZE="-1.045751633986928" ESTIMABLE="YES" I2="0.0" ID="CMP-020.08.01" NO="1" P_CHI2="1.0" P_Z="0.06338170060751774" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="7" WEIGHT="19.82047417059595" Z="1.8565043708040052">
<NAME>Behavour therapy</NAME>
<CONT_DATA CI_END="0.0582778375411388" CI_START="-2.149781105514995" EFFECT_SIZE="-1.045751633986928" ESTIMABLE="YES" MEAN_1="1.86" MEAN_2="2.86" ORDER="3726" SD_1="0.9" SD_2="0.9" SE="0.5632906932150337" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="8" TOTAL_2="7" WEIGHT="19.82047417059595"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.669643911905903" CI_END="0.11876579334294224" CI_START="-1.3881521923594302" DF="1.0" EFFECT_SIZE="-0.634693199508244" ESTIMABLE="YES" I2="62.54182081961323" ID="CMP-020.08.02" NO="2" P_CHI2="0.10227896450052787" P_Z="0.0987345057734768" STUDIES="2" TAU2="0.18872400297156355" TOTAL_1="43" TOTAL_2="45" WEIGHT="80.17952582940406" Z="1.6510199281865203">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.30400314835374076" CI_START="-1.8535227554169653" EFFECT_SIZE="-1.078762951885353" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="5.88" ORDER="3727" SD_1="2.81" SD_2="3.46" SE="0.3952928776461295" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" WEIGHT="32.09646891041397"/>
<CONT_DATA CI_END="0.21594600718033197" CI_START="-0.8197499551427975" EFFECT_SIZE="-0.30190197398123275" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.24" ORDER="3728" SD_1="2.77" SD_2="2.85" SE="0.264213008629895" STUDY_ID="STD-Sharp-1996" TOTAL_1="29" TOTAL_2="29" WEIGHT="48.08305691899009"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.8330921605368007" CI_END="1.2827779156809023" CI_START="0.41425642563596154" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7289711888920709" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-020.09" LOG_CI_END="0.1081514745020526" LOG_CI_START="-0.38273074640507054" LOG_EFFECT_SIZE="-0.137289635951509" METHOD="MH" NO="9" P_CHI2="0.6593201459836087" P_Q="0.0" P_Z="0.27293745155484594" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="61" TOTAL_2="61" WEIGHT="100.0" Z="1.0963230300674691">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.583089049830795" CI_START="0.054548361875977475" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-020.09.01" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" NO="1" P_CHI2="1.0" P_Z="0.5397481693511708" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="6.5069051892089025" Z="0.6131938572300601">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3729" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="6.5069051892089025"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7117790693321085" CI_END="1.3425944421910991" CI_START="0.4171265090317178" DF="1.0" EFFECT_SIZE="0.7483526793675289" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" I2="0.0" ID="CMP-020.09.02" LOG_CI_END="0.1279448450455849" LOG_CI_START="-0.37973220919429773" LOG_EFFECT_SIZE="-0.12589368207435644" NO="2" P_CHI2="0.39885431219313816" P_Z="0.3310191367557327" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="52" WEIGHT="93.49309481079109" Z="0.9720631676620308">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.5416823939918227" CI_START="0.15560925037753603" EFFECT_SIZE="0.4897959183673469" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18799491279151284" LOG_CI_START="-0.8079645894253282" LOG_EFFECT_SIZE="-0.30998483831690765" ORDER="3730" O_E="0.0" SE="0.5850315416812197" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.34226190476190477" WEIGHT="24.292446039713234"/>
<DICH_DATA CI_END="1.7130815466486988" CI_START="0.4402330561140497" EFFECT_SIZE="0.868421052631579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.23377803688063603" LOG_CI_START="-0.35631735035848133" LOG_EFFECT_SIZE="-0.06126965673892266" ORDER="3731" O_E="0.0" SE="0.34662495148353395" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.12014885699096227" WEIGHT="69.20064877107785"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7525727022930565" CI_END="3.670012171782851" CI_START="0.3627762639048312" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1538601753092261" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-020.10" LOG_CI_END="0.564667504614313" LOG_CI_START="-0.44036113614441874" LOG_EFFECT_SIZE="0.06215318423494713" METHOD="MH" NO="10" P_CHI2="0.3856629519566228" P_Q="0.0" P_Z="0.8084570808220503" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="47" TOTAL_2="45" WEIGHT="100.0" Z="0.24241697735701198">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.583089049830795" CI_START="0.054548361875977475" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-020.10.01" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" NO="1" P_CHI2="1.0" P_Z="0.5397481693511708" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="27.275753037111006" Z="0.6131938572300601">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3732" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Mavissakalian-1983" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="27.275753037111006"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.132395888163894" CI_START="0.4065417232856148" DF="0.0" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-020.10.02" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" NO="2" P_CHI2="1.0" P_Z="0.509384322524731" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="36" WEIGHT="72.724246962889" Z="0.659796673441616">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.132395888163894" CI_START="0.4065417232856148" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7876301837712506" LOG_CI_START="-0.3908948762375836" LOG_EFFECT_SIZE="0.19836765376683346" ORDER="3733" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.47923976608187135" WEIGHT="72.724246962889"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-020.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychdynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-020.12" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-020.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.004366982019633777" CI_END="2.384447828453703" CI_START="0.9355673781266821" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.493590172418891" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-020.16" LOG_CI_END="0.37738782454193753" LOG_CI_START="-0.028924929815608465" LOG_EFFECT_SIZE="0.17423144736316457" METHOD="MH" NO="16" P_CHI2="0.9473116301008679" P_Q="0.0" P_Z="0.09278061164036563" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="52" TOTAL_2="52" WEIGHT="100.0" Z="1.680908896625911">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.16.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004366982019633777" CI_END="2.384447828453703" CI_START="0.9355673781266821" DF="1.0" EFFECT_SIZE="1.493590172418891" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" I2="0.0" ID="CMP-020.16.02" LOG_CI_END="0.37738782454193753" LOG_CI_START="-0.028924929815608465" LOG_EFFECT_SIZE="0.17423144736316457" NO="2" P_CHI2="0.9473116301008679" P_Z="0.09278061164036563" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="52" WEIGHT="100.0" Z="1.680908896625911">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.8976773797442106" CI_START="0.7451141351817461" EFFECT_SIZE="1.469387755102041" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4620500305497785" LOG_CI_START="-0.1277771977442688" LOG_EFFECT_SIZE="0.1671364164027548" ORDER="3734" O_E="0.0" SE="0.3464674335917916" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.12003968253968253" WEIGHT="47.453830682025966"/>
<DICH_DATA CI_END="2.8900018437325614" CI_START="0.7950229282775766" EFFECT_SIZE="1.5157894736842106" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.4608981198231991" LOG_CI_START="-0.09962034621039526" LOG_EFFECT_SIZE="0.18063888680640192" ORDER="3735" O_E="0.0" SE="0.32925132155928855" STUDY_ID="STD-Sharp-1996" TOTAL_1="38" TOTAL_2="36" VAR="0.10840643274853802" WEIGHT="52.54616931797403"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-020.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-020.17" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.17.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-020.17.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic psychotherapy and others</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-021" NO="21">
<NAME>SENSITIVITY5: without benzo: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="8.317649195750219" CI_END="1.5090383817944621" CI_START="1.0581603956451784" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2636473602723934" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="107" I2="15.84160577995346" I2_Q="0.0" ID="CMP-021.01" LOG_CI_END="0.17870028602446586" LOG_CI_START="0.024551502920257973" LOG_EFFECT_SIZE="0.10162589447236195" METHOD="MH" NO="1" P_CHI2="0.3054191309056701" P_Q="0.0" P_Z="0.009757782206474601" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.01033605096136158" TOTALS="YES" TOTAL_1="255" TOTAL_2="226" WEIGHT="100.0" Z="2.5842966652269386">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.04032982098371413" CI_END="2.1799715452010497" CI_START="1.0041174604489316" DF="2.0" EFFECT_SIZE="1.4795092063985986" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="23" I2="0.0" ID="CMP-021.01.01" LOG_CI_END="0.3384508248693666" LOG_CI_START="0.0017845190251465075" LOG_EFFECT_SIZE="0.17011767194725655" NO="1" P_CHI2="0.9800370483682448" P_Z="0.04762023801153931" STUDIES="3" TAU2="0.0" TOTAL_1="93" TOTAL_2="66" WEIGHT="19.17261528251794" Z="1.9807417871196331">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.5220873101778074" CI_START="0.7957474098321183" EFFECT_SIZE="1.4166666666666667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" LOG_CI_END="0.4017601169999873" LOG_CI_START="-0.09922476633868907" LOG_EFFECT_SIZE="0.1512676753306491" ORDER="3736" O_E="0.0" SE="0.29428100038830657" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.08660130718954248" WEIGHT="8.457932709787391"/>
<DICH_DATA CI_END="3.0971191073783437" CI_START="0.749727532054179" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.49095790754680874" LOG_CI_START="-0.12509654037483536" LOG_EFFECT_SIZE="0.18293068358598666" ORDER="3737" O_E="0.0" SE="0.36187343222787294" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.13095238095238093" WEIGHT="5.802949620146217"/>
<DICH_DATA CI_END="3.3551459414051803" CI_START="0.7112931338260449" EFFECT_SIZE="1.5448275862068965" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.5257114157623739" LOG_CI_START="-0.14795138356399803" LOG_EFFECT_SIZE="0.18888001609918792" ORDER="3738" O_E="0.0" SE="0.3957128630089486" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.15658866995073892" WEIGHT="4.911732952584331"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.3582208928255755" CI_END="1.5517048289964" CI_START="0.9579135638175009" DF="4.0" EFFECT_SIZE="1.2191796843520513" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="84" I2="45.639033425864035" ID="CMP-021.01.02" LOG_CI_END="0.19080911168389425" LOG_CI_START="-0.01867367719564929" LOG_EFFECT_SIZE="0.08606771724412249" NO="2" P_CHI2="0.11812619221580001" P_Z="0.10728122690392852" STUDIES="5" TAU2="0.033998656219480304" TOTAL_1="162" TOTAL_2="160" WEIGHT="80.82738471748206" Z="1.610534468557765">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.57010894775883" CI_START="0.781457025947348" EFFECT_SIZE="1.4171907756813418" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.4099515336066266" LOG_CI_START="-0.10709489980358258" LOG_EFFECT_SIZE="0.15142831690152203" ORDER="3739" O_E="0.0" SE="0.30371563440628013" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.09224318658280922" WEIGHT="7.992744652170581"/>
<DICH_DATA CI_END="1.297207292520502" CI_START="0.6477590610403521" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.11300938148452362" LOG_CI_START="-0.1885865032633232" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="3740" O_E="0.0" SE="0.17715891562459227" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.031385281385281405" WEIGHT="19.651569261806603"/>
<DICH_DATA CI_END="2.365414232882115" CI_START="1.1931948158446122" EFFECT_SIZE="1.68" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="25" LOG_CI_END="0.37390720566663627" LOG_CI_START="0.07671135778508939" LOG_EFFECT_SIZE="0.22530928172586284" ORDER="3741" O_E="0.0" SE="0.17457431218879393" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.030476190476190487" WEIGHT="20.089307115352696"/>
<DICH_DATA CI_END="1.6705207394810173" CI_START="0.7665100371787238" EFFECT_SIZE="1.131578947368421" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="26" LOG_CI_END="0.22285187176478286" LOG_CI_START="-0.11548215383923015" LOG_EFFECT_SIZE="0.053684858962776354" ORDER="3742" O_E="0.0" SE="0.1987390814202345" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.0394972224837586" WEIGHT="16.45265493561898"/>
<DICH_DATA CI_END="1.6945140306903963" CI_START="0.7818742686143323" EFFECT_SIZE="1.1510416666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.2290451691758693" LOG_CI_START="-0.10686307921274711" LOG_EFFECT_SIZE="0.06109104498156111" ORDER="3743" O_E="0.0" SE="0.19731416787611966" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.03893288084464554" WEIGHT="16.641108752533206"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.160433243919691" CI_END="1.6096770440217876" CI_START="1.0756828517883905" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3158654920513961" ESTIMABLE="YES" EVENTS_1="142" EVENTS_2="109" I2="12.667886037922251" I2_Q="0.0" ID="CMP-021.02" LOG_CI_END="0.2067387505234288" LOG_CI_START="0.0316842452886789" LOG_EFFECT_SIZE="0.11921149790605383" METHOD="MH" NO="2" P_CHI2="0.3289434941760826" P_Q="0.0" P_Z="0.007597398685070882" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.012007320833246496" TOTALS="YES" TOTAL_1="274" TOTAL_2="262" WEIGHT="100.0" Z="2.669457059966669">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2287079661674278" CI_END="1.9273726811492848" CI_START="0.8427049512144652" DF="2.0" EFFECT_SIZE="1.2744436045741692" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="21" I2="0.0" ID="CMP-021.02.01" LOG_CI_END="0.28496569894059476" LOG_CI_START="-0.07432445442478525" LOG_EFFECT_SIZE="0.10532062225790476" NO="1" P_CHI2="0.5409905633896446" P_Z="0.2505274625263392" STUDIES="3" TAU2="0.0" TOTAL_1="93" TOTAL_2="66" WEIGHT="20.002634013298348" Z="1.1490692106160643">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.8494268655002606" CI_START="0.7483848487343736" EFFECT_SIZE="1.1764705882352942" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.26703716207062433" LOG_CI_START="-0.12587501349920974" LOG_EFFECT_SIZE="0.07058107428570727" ORDER="3744" O_E="0.0" SE="0.23079855687635734" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.053267973856209155" WEIGHT="16.198430897603917"/>
<DICH_DATA CI_END="6.093988160375955" CI_START="0.29433700514100414" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.7849016061242022" LOG_CI_START="-0.5311551333532031" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="3745" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="15" VAR="0.5976190476190476" WEIGHT="1.7344350655833258"/>
<DICH_DATA CI_END="10.324319187650293" CI_START="0.6478360451866196" EFFECT_SIZE="2.586206896551724" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0138614227695817" LOG_CI_START="-0.18853489178409377" LOG_EFFECT_SIZE="0.41266326549274396" ORDER="3746" O_E="0.0" SE="0.706293547126578" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="15" VAR="0.4988505747126437" WEIGHT="2.0697680501111044"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.922059932720401" CI_END="1.7341536626898908" CI_START="1.0158507264949417" DF="5.0" EFFECT_SIZE="1.32726834441924" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="88" I2="36.885102581103276" ID="CMP-021.02.02" LOG_CI_END="0.23908757751247037" LOG_CI_START="0.006829895524268667" LOG_EFFECT_SIZE="0.12295873651836958" NO="2" P_CHI2="0.16058378937560336" P_Z="0.03796471259199239" STUDIES="6" TAU2="0.039722429519795106" TOTAL_1="181" TOTAL_2="196" WEIGHT="79.99736598670165" Z="2.0752355151189046">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3777646776153984" CI_START="0.7934912612757744" EFFECT_SIZE="1.3735849056603773" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="10" LOG_CI_END="0.3761688711951392" LOG_CI_START="-0.10045785177064294" LOG_EFFECT_SIZE="0.1378555097122481" ORDER="3747" O_E="0.0" SE="0.27997289641043005" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.07838482272444539" WEIGHT="11.697447463152942"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="3748" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="10.045073165233621"/>
<DICH_DATA CI_END="2.747449077599816" CI_START="1.255338859583079" EFFECT_SIZE="1.8571428571428572" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="21" LOG_CI_END="0.4389296517698316" LOG_CI_START="0.09876097281532834" LOG_EFFECT_SIZE="0.26884531229257996" ORDER="3749" O_E="0.0" SE="0.19981676587999297" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.039926739926739924" WEIGHT="20.359612456157876"/>
<DICH_DATA CI_END="1.365032351472348" CI_START="0.6059507537526843" EFFECT_SIZE="0.9094736842105263" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="0.13514294434338767" LOG_CI_START="-0.21756266996329657" LOG_EFFECT_SIZE="-0.04120986280995447" ORDER="3750" O_E="0.0" SE="0.20718102376469502" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.04292397660818713" WEIGHT="19.248723398081168"/>
<DICH_DATA CI_END="2.0484207477233984" CI_START="0.8164591225049831" EFFECT_SIZE="1.2932330827067668" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.31141916599859704" LOG_CI_START="-0.08806555411767085" LOG_EFFECT_SIZE="0.1116768059404631" ORDER="3751" O_E="0.0" SE="0.23465930207755273" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.05506498805152414" WEIGHT="15.764439422599953"/>
<DICH_DATA CI_END="7.968425658883279" CI_START="0.7713276905908247" EFFECT_SIZE="2.4791666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.90137252526085" LOG_CI_START="-0.11276107722696299" LOG_EFFECT_SIZE="0.3943057240169435" ORDER="3752" O_E="0.0" SE="0.5957070981436359" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="0.35486694677871145" WEIGHT="2.882070081476098"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.595213871550393" CI_END="0.10129588178056098" CI_START="-0.8059705963107708" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3523373572651049" ESTIMABLE="YES" I2="44.37048611137217" I2_Q="0.0" ID="CMP-021.03" NO="3" P_CHI2="0.1656949951618385" P_Q="1.0" P_Z="0.1279324645499714" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0714090595410014" TOTALS="YES" TOTAL_1="71" TOTAL_2="87" UNITS="" WEIGHT="100.00000000000001" Z="1.5223058435938601">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.595213871550393" CI_END="0.10129588178056098" CI_START="-0.8059705963107708" DF="2.0" EFFECT_SIZE="-0.3523373572651049" ESTIMABLE="YES" I2="44.37048611137217" ID="CMP-021.03.02" NO="2" P_CHI2="0.1656949951618385" P_Z="0.1279324645499714" STUDIES="3" TAU2="0.0714090595410014" TOTAL_1="71" TOTAL_2="87" WEIGHT="100.00000000000001" Z="1.5223058435938601">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.22399428988250636" CI_START="-1.2604780561601996" EFFECT_SIZE="-0.7422361730213529" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.8" ORDER="3753" SD_1="1.1" SD_2="1.0" SE="0.2644139827194134" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="37.90514892220681"/>
<CONT_DATA CI_END="0.3692826332227135" CI_START="-0.8555970869675733" EFFECT_SIZE="-0.24315722687242994" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="2.03" ORDER="3754" SD_1="1.06" SD_2="1.33" SE="0.3124750581775945" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="31.688311344095133"/>
<CONT_DATA CI_END="0.654327970904905" CI_START="-0.6144629377034192" EFFECT_SIZE="0.01993251660074294" ESTIMABLE="YES" MEAN_1="1.72" MEAN_2="1.7" ORDER="3755" SD_1="1.06" SD_2="0.95" SE="0.32367709779781284" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="30.40653973369807"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.04729995046957258" CI_START="-0.7163878408919031" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-021.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.08594658374764667" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="1.7171783843522672">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.04729995046957258" CI_START="-0.7163878408919031" DF="0.0" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" I2="0.0" ID="CMP-021.04.02" NO="2" P_CHI2="1.0" P_Z="0.08594658374764667" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="52" WEIGHT="100.0" Z="1.7171783843522672">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.04729995046957258" CI_START="-0.7163878408919031" EFFECT_SIZE="-0.33454394521116526" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-9.8" ORDER="3756" SD_1="18.4" SD_2="18.4" SE="0.19482189402084618" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.450293828616195" CI_END="-0.0815111316007309" CI_START="-0.5637695772875232" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.32264035444412703" ESTIMABLE="YES" I2="6.043974089808904" I2_Q="52.04505987164977" ID="CMP-021.05" NO="5" P_CHI2="0.3835462747820729" P_Q="0.14872393985959875" P_Z="0.008728504994143405" Q="2.0852908945846336" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0073883608094731205" TOTALS="YES" TOTAL_1="155" TOTAL_2="157" UNITS="" WEIGHT="100.0" Z="2.6225086582741635">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.689855880099087" CI_END="-0.008307930927552665" CI_START="-1.2930685335524121" DF="2.0" EFFECT_SIZE="-0.6506882322399824" ESTIMABLE="YES" I2="57.35476630557474" ID="CMP-021.05.01" NO="1" P_CHI2="0.09585430679917084" P_Z="0.0471097386794785" STUDIES="3" TAU2="0.18463836650094365" TOTAL_1="58" TOTAL_2="44" WEIGHT="32.87868613472484" Z="1.9853122795777163">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.45682131974137874" CI_START="-0.7134813609714431" EFFECT_SIZE="-0.12833002061503215" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.7" ORDER="3757" SD_1="9.4" SD_2="10.5" SE="0.29855208818733914" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="15.681171431101765"/>
<CONT_DATA CI_END="-0.008408879559885007" CI_START="-1.5710189475587208" EFFECT_SIZE="-0.789713913559303" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="3758" SD_1="1.0" SD_2="1.27" SE="0.3986323423094773" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="9.101677292384018"/>
<CONT_DATA CI_END="-0.36766554192815826" CI_START="-2.0287561923899347" EFFECT_SIZE="-1.1982108671590466" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="3.9" ORDER="3759" SD_1="1.18" SD_2="1.27" SE="0.4237554015186625" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="8.095837411239053"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6751470539324744" CI_END="0.08270983347818595" CI_START="-0.4842534779569887" DF="4.0" EFFECT_SIZE="-0.20077182223940138" ESTIMABLE="YES" I2="0.0" ID="CMP-021.05.02" NO="2" P_CHI2="0.9543580609493811" P_Z="0.1651015977516751" STUDIES="5" TAU2="0.0" TOTAL_1="97" TOTAL_2="113" WEIGHT="67.12131386527516" Z="1.3881164186924542">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.203467565393967" CI_START="-0.8051456448536862" EFFECT_SIZE="-0.30083903972985965" ESTIMABLE="YES" MEAN_1="31.4" MEAN_2="40.2" ORDER="3760" SD_1="30.7" SD_2="25.4" SE="0.257304016350164" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="20.566612647875502"/>
<CONT_DATA CI_END="0.46161121298104657" CI_START="-1.028618540570797" EFFECT_SIZE="-0.28350366379487524" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.14" ORDER="3761" SD_1="8.26" SD_2="6.26" SE="0.38016763708583057" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.963239852496615"/>
<CONT_DATA CI_END="0.3624733737623621" CI_START="-0.8626496613949858" EFFECT_SIZE="-0.25008814381631184" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="7.2" ORDER="3762" SD_1="7.8" SD_2="10.6" SE="0.31253712946282736" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="14.405681124284845"/>
<CONT_DATA CI_END="0.5716017626290368" CI_START="-0.6974583764966225" EFFECT_SIZE="-0.06292830693379281" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" ORDER="3763" SD_1="7.8" SD_2="5.4" SE="0.3237457803142924" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="13.48999689238777"/>
<CONT_DATA CI_END="0.8116618600044833" CI_START="-0.7886578630740556" EFFECT_SIZE="0.011501998465213789" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-5.9" ORDER="3764" SD_1="6.7" SD_2="9.8" SE="0.40825232904830305" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="8.695783348230421"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.177932744075274" CI_END="-0.19968926050232175" CI_START="-0.6651459976773177" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.43241762908981973" ESTIMABLE="YES" I2="21.398576693711025" I2_Q="77.8724933237604" ID="CMP-021.06" NO="6" P_CHI2="0.2527589744616431" P_Q="0.033515335065396834" P_Z="2.7086131733693115E-4" Q="4.519261996534812" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.026681524799410338" TOTALS="YES" TOTAL_1="210" TOTAL_2="209" UNITS="" WEIGHT="100.00000000000003" Z="3.6416831537991317">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.8649847080352093" CI_END="-0.29430313215265314" CI_START="-1.485567769057945" DF="2.0" EFFECT_SIZE="-0.889935450605299" ESTIMABLE="YES" I2="48.25335283107205" ID="CMP-021.06.01" NO="1" P_CHI2="0.14478702941331634" P_Z="0.003407265902902723" STUDIES="3" TAU2="0.13417641277009898" TOTAL_1="58" TOTAL_2="44" WEIGHT="25.70138342240914" Z="2.928386149836632">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.18959203311508932" CI_START="-0.9922123497967845" EFFECT_SIZE="-0.4013101583408476" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="12.7" ORDER="3765" SD_1="9.4" SD_2="9.2" SE="0.30148624980708727" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="11.99183638556071"/>
<CONT_DATA CI_END="-0.3377253031268893" CI_START="-1.968079242439344" EFFECT_SIZE="-1.1529022727831166" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="2.02" ORDER="3766" SD_1="0.66" SD_2="1.05" SE="0.41591425969366747" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="7.0615156159189825"/>
<CONT_DATA CI_END="-0.466210138361711" CI_START="-2.154071253344198" EFFECT_SIZE="-1.3101406958529547" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="2.02" ORDER="3767" SD_1="0.56" SD_2="1.05" SE="0.43058472714195783" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="6.648031420929447"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7936860395052527" CI_END="-0.07520632416773884" CI_START="-0.5316560420863822" DF="5.0" EFFECT_SIZE="-0.3034311831270605" ESTIMABLE="YES" I2="0.0" ID="CMP-021.06.02" NO="2" P_CHI2="0.8768919358997631" P_Z="0.009165310291468338" STUDIES="6" TAU2="0.0" TOTAL_1="152" TOTAL_2="165" WEIGHT="74.29861657759089" Z="2.605825646808339">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.08481450726307865" CI_START="-0.9291683981481176" EFFECT_SIZE="-0.42217694544251944" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="14.4" ORDER="3768" SD_1="7.6" SD_2="6.6" SE="0.2586738617161754" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="15.064540562856685"/>
<CONT_DATA CI_END="0.6983767737103312" CI_START="-0.7834115294980788" EFFECT_SIZE="-0.04251737789387382" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="11.86" ORDER="3769" SD_1="11.08" SD_2="8.37" SE="0.37801416630524004" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="8.314525704743236"/>
<CONT_DATA CI_END="-0.014176136168789766" CI_START="-0.7800959402035252" EFFECT_SIZE="-0.3971360381861575" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-4.3" ORDER="3770" SD_1="5.5" SD_2="5.5" SE="0.19539129547180792" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="55" TOTAL_2="52" WEIGHT="21.738537556539416"/>
<CONT_DATA CI_END="0.3519816397369558" CI_START="-0.8735298320494969" EFFECT_SIZE="-0.2607740961562705" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" ORDER="3771" SD_1="5.7" SD_2="6.7" SE="0.3126362222604932" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="11.331881807003882"/>
<CONT_DATA CI_END="0.6141053278526194" CI_START="-0.6546866695393172" EFFECT_SIZE="-0.02029067084334895" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.9" ORDER="3772" SD_1="5.7" SD_2="4.4" SE="0.3236773755538382" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="10.726217724364323"/>
<CONT_DATA CI_END="0.3816595893909357" CI_START="-1.2405636695254647" EFFECT_SIZE="-0.42945204006726445" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="-10.0" ORDER="3773" SD_1="10.6" SD_2="13.1" SE="0.41384006841765725" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.122913222083334"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.278982144739613" CI_END="-0.10112816053571277" CI_START="-0.7789141097803938" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4400211351580533" ESTIMABLE="YES" I2="31.30907727788001" I2_Q="0.0" ID="CMP-021.07" NO="7" P_CHI2="0.20070517742659866" P_Q="0.7300493349504975" P_Z="0.010933042546179293" Q="0.1190663897141011" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.05560407872630441" TOTALS="YES" TOTAL_1="126" TOTAL_2="94" UNITS="" WEIGHT="100.0" Z="2.5448316782231784">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.139470193183197" CI_END="0.14221362525300474" CI_START="-1.327529585462889" DF="2.0" EFFECT_SIZE="-0.5926579801049422" ESTIMABLE="YES" I2="67.42389917910754" ID="CMP-021.07.01" NO="1" P_CHI2="0.046433621566489" P_Z="0.11395388613266696" STUDIES="3" TAU2="0.2832537621025071" TOTAL_1="58" TOTAL_2="44" WEIGHT="47.408592215035455" Z="1.5806683612304593">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5844926973905126" CI_START="-0.5844926973905126" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" ORDER="3774" SD_1="4.9" SD_2="2.7" SE="0.29821603968282906" STUDY_ID="STD-Marks-1983" TOTAL_1="23" TOTAL_2="22" WEIGHT="20.68474916448428"/>
<CONT_DATA CI_END="0.10984317112925901" CI_START="-1.4345160753979447" EFFECT_SIZE="-0.6623364521343428" ESTIMABLE="YES" MEAN_1="51.11" MEAN_2="57.68" ORDER="3775" SD_1="9.38" SD_2="10.07" SE="0.39397643495209916" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="14.181234220100347"/>
<CONT_DATA CI_END="-0.42277473134623855" CI_START="-2.098561793622174" EFFECT_SIZE="-1.2606682624842063" ESTIMABLE="YES" MEAN_1="45.41" MEAN_2="57.68" ORDER="3776" SD_1="9.04" SD_2="10.07" SE="0.42750455505670765" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="12.542608830450831"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0204455618423156" CI_END="-0.012049880723555617" CI_START="-0.7577513683968898" DF="2.0" EFFECT_SIZE="-0.3849006245602227" ESTIMABLE="YES" I2="0.0" ID="CMP-021.07.02" NO="2" P_CHI2="0.6003618872256332" P_Z="0.043041549362263634" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="50" WEIGHT="52.591407784964545" Z="2.0233065757151394">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.05350786449645217" CI_START="-1.0760462062346543" EFFECT_SIZE="-0.5647770353655532" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.3" ORDER="3777" SD_1="4.5" SD_2="5.1" SE="0.26085641108812563" STUDY_ID="STD-Fahy-1992" TOTAL_1="42" TOTAL_2="24" WEIGHT="24.1787762541414"/>
<CONT_DATA CI_END="0.5794802612828507" CI_START="-0.9049646208576299" EFFECT_SIZE="-0.16274217978738956" ESTIMABLE="YES" MEAN_1="5.57" MEAN_2="6.5" ORDER="3778" SD_1="5.84" SD_2="5.24" SE="0.3786918774655025" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="15.022787416067612"/>
<CONT_DATA CI_END="0.6011662158221984" CI_START="-1.003984577112618" EFFECT_SIZE="-0.20140918064520977" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-8.6" ORDER="3779" SD_1="10.4" SD_2="7.6" SE="0.409484767474311" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="13.389844114755535"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.295958494595073" CI_END="0.11278763470116937" CI_START="-0.7400069063298237" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.31360963581432716" ESTIMABLE="YES" I2="51.43725567051596" I2_Q="87.29817009584008" ID="CMP-021.08" NO="8" P_CHI2="0.06727084126520522" P_Q="0.005018180846644182" P_Z="0.14943558155491665" Q="7.872881368632515" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.14483654898249637" TOTALS="YES" TOTAL_1="90" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="1.4415279691112968">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.5264214068288324" CI_END="-0.42740879960734324" CI_START="-1.567983035291801" DF="1.0" EFFECT_SIZE="-0.9976959174495721" ESTIMABLE="YES" I2="0.0" ID="CMP-021.08.01" NO="1" P_CHI2="0.4681153448569151" P_Z="6.060697090397353E-4" STUDIES="2" TAU2="0.0" TOTAL_1="35" TOTAL_2="22" WEIGHT="30.100555196180956" Z="3.42888345983082">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.01750830443977247" CI_START="-1.581656169613193" EFFECT_SIZE="-0.7995822370264827" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="4.0" ORDER="3780" SD_1="1.13" SD_2="1.03" SE="0.39902464471572413" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="18" TOTAL_2="11" WEIGHT="15.566011075676377"/>
<CONT_DATA CI_END="-0.38927353848264634" CI_START="-2.056043178938999" EFFECT_SIZE="-1.2226583587108226" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="4.0" ORDER="3781" SD_1="1.4" SD_2="1.03" SE="0.42520415007714907" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="17" TOTAL_2="11" WEIGHT="14.534544120504577"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8966557191337252" CI_END="0.2985034934444692" CI_START="-0.38806142026940765" DF="3.0" EFFECT_SIZE="-0.04477896341246921" ESTIMABLE="YES" I2="0.0" ID="CMP-021.08.02" NO="2" P_CHI2="0.5941309163838324" P_Z="0.7982098692592872" STUDIES="4" TAU2="0.0" TOTAL_1="55" TOTAL_2="89" WEIGHT="69.89944480381904" Z="0.25566455203404764">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.8530397915242826" CI_START="-0.629894598103741" EFFECT_SIZE="0.11157259671027078" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="2.07" ORDER="3782" SD_1="2.81" SD_2="2.2" SE="0.37830654066228275" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" WEIGHT="16.436599227373566"/>
<CONT_DATA CI_END="0.3445678515193306" CI_START="-0.8812280114503745" EFFECT_SIZE="-0.268330079965522" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="2.1" ORDER="3783" SD_1="2.77" SD_2="2.58" SE="0.31270877236485634" STUDY_ID="STD-Sharp-1996i" TOTAL_1="15" TOTAL_2="33" WEIGHT="19.507431889531293"/>
<CONT_DATA CI_END="0.45610646370920943" CI_START="-0.8150870196973137" EFFECT_SIZE="-0.1794902779940521" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.87" ORDER="3784" SD_1="2.77" SD_2="2.64" SE="0.3242900107944674" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="14" TOTAL_2="30" WEIGHT="18.93178955858967"/>
<CONT_DATA CI_END="1.1849746502467584" CI_START="-0.4321931563177866" EFFECT_SIZE="0.3763907469644859" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-4.0" ORDER="3785" SD_1="2.5" SD_2="2.1" SE="0.41255038850727827" STUDY_ID="STD-Stein-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.023624128324503"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.048918272466067" CI_END="1.6792882671965965" CI_START="0.8299181169947931" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1805387569255186" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="49" I2="0.0" I2_Q="0.0" ID="CMP-021.09" LOG_CI_END="0.22512525367637917" LOG_CI_START="-0.08096475472221096" LOG_EFFECT_SIZE="0.07208024947708416" METHOD="MH" NO="9" P_CHI2="0.5313642852543785" P_Q="0.0" P_Z="0.3559590222669914" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="274" TOTAL_2="262" WEIGHT="100.0" Z="0.9230924832265625">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3748711201516293" CI_END="1.8161152609314077" CI_START="0.6688837570980065" DF="2.0" EFFECT_SIZE="1.102166048767075" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="19" I2="0.0" ID="CMP-021.09.01" LOG_CI_END="0.2591434078403526" LOG_CI_START="-0.17464935015045513" LOG_EFFECT_SIZE="0.04224702884494873" NO="1" P_CHI2="0.5028640324350602" P_Z="0.7026383885281235" STUDIES="3" TAU2="0.0" TOTAL_1="93" TOTAL_2="66" WEIGHT="49.78903533382885" Z="0.3817613524644364">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.686988688624148" CI_START="0.5111148069773971" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22711217062434488" LOG_CI_START="-0.29148153736714744" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="3786" O_E="0.0" SE="0.3046245111544585" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.0927960927960928" WEIGHT="34.837246386288484"/>
<DICH_DATA CI_END="4.448928977693058" CI_START="0.3995967988456458" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6482554727648582" LOG_CI_START="-0.3983779995482583" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3787" O_E="0.0" SE="0.6147976825559693" STUDY_ID="STD-Sheehan-1980a" TOTAL_1="28" TOTAL_2="16" VAR="0.37797619047619047" WEIGHT="8.552814780078094"/>
<DICH_DATA CI_END="8.748921872143878" CI_START="0.5394243722180654" EFFECT_SIZE="2.1724137931034484" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9419545382992105" LOG_CI_START="-0.2680694351899591" LOG_EFFECT_SIZE="0.33694255155462566" ORDER="3788" O_E="0.0" SE="0.7107740717428078" STUDY_ID="STD-Sheehan-1980b" TOTAL_1="29" TOTAL_2="14" VAR="0.5051997810618502" WEIGHT="6.398974167462272"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.5306522987752444" CI_END="2.1888283422331147" CI_START="0.753082322075824" DF="5.0" EFFECT_SIZE="1.283887818539568" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="30" I2="9.594750675119402" ID="CMP-021.09.02" LOG_CI_END="0.3402117035760944" LOG_CI_START="-0.12315754694789394" LOG_EFFECT_SIZE="0.10852707831410023" NO="2" P_CHI2="0.35459655352701425" P_Z="0.35856763172784745" STUDIES="6" TAU2="0.04403635122748003" TOTAL_1="181" TOTAL_2="196" WEIGHT="50.21096466617115" Z="0.9180978867391747">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="6.353426858842818" CI_START="0.6060478358570285" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.8030080346540611" LOG_CI_START="-0.21749309525807844" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="3789" O_E="0.0" SE="0.5994474152724544" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="0.3593372036768263" WEIGHT="8.99645323485567"/>
<DICH_DATA CI_END="25.45999296701072" CI_START="0.3534957771457977" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.405858279349496" LOG_CI_START="-0.45161576991017127" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3790" O_E="0.0" SE="1.0910894511799618" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="1.1904761904761905" WEIGHT="2.7155186926747947"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="3791" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="11.08374976601957"/>
<DICH_DATA CI_END="8.855892532102235" CI_START="0.9121116022568005" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.9472323376585875" LOG_CI_START="-0.03995201991830849" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="3792" O_E="0.0" SE="0.5798769782820494" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.3362573099415204" WEIGHT="9.61394816661263"/>
<DICH_DATA CI_END="2.096016843668134" CI_START="0.3614833055400689" EFFECT_SIZE="0.8704453441295547" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.3213947683320771" LOG_CI_START="-0.44191175502019775" LOG_EFFECT_SIZE="-0.060258493344060395" ORDER="3793" O_E="0.0" SE="0.44837003024535454" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.20103568402222016" WEIGHT="16.080530002151573"/>
<DICH_DATA CI_END="15.596487314068941" CI_START="0.07238208368763017" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1930267963097887" LOG_CI_START="-1.14036891886509" LOG_EFFECT_SIZE="0.026328938722349145" ORDER="3794" O_E="0.0" SE="1.370648193588798" STUDY_ID="STD-Stein-2000" TOTAL_1="16" TOTAL_2="17" VAR="1.8786764705882353" WEIGHT="1.7207648038569197"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Psychodynamic and other therapies</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.694036312037815" CI_END="16.215920106520894" CI_START="1.032089888778293" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.091000755215871" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="3" I2="29.751062676864862" I2_Q="0.0" ID="CMP-021.10" LOG_CI_END="1.2099415959844966" LOG_CI_START="0.013717523357425989" LOG_EFFECT_SIZE="0.6118295596709612" METHOD="MH" NO="10" P_CHI2="0.22319274905975184" P_Q="0.0" P_Z="0.04497211546672763" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.7343562769201024" TOTALS="YES" TOTAL_1="187" TOTAL_2="201" WEIGHT="100.0" Z="2.0049151811475543">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.754896240474159" CI_START="0.11836397492259897" DF="0.0" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-021.10.01" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" NO="1" P_CHI2="1.0" P_Z="0.6456926496737698" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="32.65201486011768" Z="0.4597542177291952">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="3.754896240474159" CI_START="0.11836397492259897" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.574597940591288" LOG_CI_START="-0.9267804587026505" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="3795" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="32.65201486011768"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.08026116252343712" CI_END="42.07778379929493" CI_START="2.3030836404095023" DF="3.0" EFFECT_SIZE="9.844219394794294" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="0" I2="0.0" ID="CMP-021.10.02" LOG_CI_END="1.624052857830969" LOG_CI_START="0.36230971039528137" LOG_EFFECT_SIZE="0.9931812841131251" NO="2" P_CHI2="0.9940960334983152" P_Z="0.00203161155906932" STUDIES="4" TAU2="0.0" TOTAL_1="151" TOTAL_2="165" WEIGHT="67.34798513988231" Z="3.0855718153685294">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="126.48109941841062" CI_START="0.4447304795629587" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.102025631981663" LOG_CI_START="-0.3519031051982624" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="3796" O_E="0.0" SE="1.4414498873626433" STUDY_ID="STD-Fahy-1992" TOTAL_1="53" TOTAL_2="26" VAR="2.0777777777777775" WEIGHT="17.557563993793913"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3797" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Oehrberg-1995" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="16.887052890437044"/>
<DICH_DATA CI_END="238.39434748267425" CI_START="0.7034667632469267" EFFECT_SIZE="12.95" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.3772959537268123" LOG_CI_START="-0.15275641689227126" LOG_EFFECT_SIZE="1.1122697684172707" ORDER="3798" O_E="0.0" SE="1.486165286462868" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="2.2086872586872586" WEIGHT="16.77658622005255"/>
<DICH_DATA CI_END="218.74332481542444" CI_START="0.553159736883856" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.3399348089397938" LOG_CI_START="-0.25714943862334355" LOG_EFFECT_SIZE="1.041392685158225" ORDER="3799" O_E="0.0" SE="1.5255401427929476" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="2.327272727272727" WEIGHT="16.126782035598804"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-021.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-021.12" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-021.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-021.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6934701169365437" CI_END="1.3450500978693705" CI_START="0.7105630198793897" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9776210203504876" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="52" I2="0.0" I2_Q="0.0" ID="CMP-021.14" LOG_CI_END="0.1287384604150303" LOG_CI_START="-0.14839739842314636" LOG_EFFECT_SIZE="-0.009829469004058072" METHOD="MH" NO="14" P_CHI2="0.8747387770855981" P_Q="0.0" P_Z="0.889424697650375" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="129" WEIGHT="99.99999999999999" Z="0.13903220836070818">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7322501664675163" CI_START="0.3864461961452258" DF="0.0" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" I2="0.0" ID="CMP-021.14.01" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" NO="1" P_CHI2="1.0" P_Z="0.6000382520081402" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="18.09371905597901" Z="0.5243455082099362">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.7322501664675163" CI_START="0.3864461961452258" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.23861061174071593" LOG_CI_START="-0.4129109631785163" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="3800" O_E="0.0" SE="0.38270699819136633" STUDY_ID="STD-Marks-1983" TOTAL_1="36" TOTAL_2="36" VAR="0.14646464646464646" WEIGHT="18.09371905597901"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.42487988604226223" CI_END="1.4466433068061484" CI_START="0.7147284370091581" DF="2.0" EFFECT_SIZE="1.0168368156116883" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="41" I2="0.0" ID="CMP-021.14.02" LOG_CI_END="0.16036146202296578" LOG_CI_START="-0.1458589382143925" LOG_EFFECT_SIZE="0.007251261904286649" NO="2" P_CHI2="0.8086089839217704" P_Z="0.9260438461008664" STUDIES="3" TAU2="0.0" TOTAL_1="52" TOTAL_2="93" WEIGHT="81.90628094402098" Z="0.09282341845189229">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7369962011109146" CI_START="0.5757064980110143" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2397988686265049" LOG_CI_START="-0.23979886862650487" LOG_EFFECT_SIZE="0.0" ORDER="3801" O_E="0.0" SE="0.2817180849095055" STUDY_ID="STD-Loerch-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.07936507936507936" WEIGHT="33.391136076034"/>
<DICH_DATA CI_END="1.674634322461539" CI_START="0.47474450082305053" EFFECT_SIZE="0.891640866873065" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.2239199880444335" LOG_CI_START="-0.32354005718817763" LOG_EFFECT_SIZE="-0.04981003457187205" ORDER="3802" O_E="0.0" SE="0.3215807405405655" STUDY_ID="STD-Sharp-1996i" TOTAL_1="19" TOTAL_2="36" VAR="0.10341417268661852" WEIGHT="25.625986225266363"/>
<DICH_DATA CI_END="2.3515078305965216" CI_START="0.6195562405656124" EFFECT_SIZE="1.207017543859649" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.3713464292990649" LOG_CI_START="-0.20791926417302511" LOG_EFFECT_SIZE="0.0817135825630199" ORDER="3803" O_E="0.0" SE="0.34026353575693336" STUDY_ID="STD-Sharp-1996ii" TOTAL_1="19" TOTAL_2="43" VAR="0.11577927376580986" WEIGHT="22.889158642720616"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7666035164361011" CI_START="-0.48097419137434017" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-021.15" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.6536278036479393" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="18" UNITS="" WEIGHT="100.0" Z="0.448728112521385">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7666035164361011" CI_START="-0.48097419137434017" DF="0.0" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" I2="0.0" ID="CMP-021.15.01" NO="1" P_CHI2="1.0" P_Z="0.6536278036479393" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="18" WEIGHT="100.0" Z="0.448728112521385">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.7666035164361011" CI_START="-0.48097419137434017" EFFECT_SIZE="0.14281466253088046" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="13.7" ORDER="3804" SD_1="2.7" SD_2="2.8" SE="0.31826546754205054" STUDY_ID="STD-Marks-1983" TOTAL_1="22" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-021.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-022" NO="22">
<NAME>SENSITIVITY5: allowed benzo: Psychotherapy+Antidepressant vs Antidepressant alone</NAME>
<DICH_OUTCOME CHI2="6.851514449848253" CI_END="1.5198421167619913" CI_START="0.8588923022956276" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1425325793129781" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="91" I2="56.21406008905894" I2_Q="0.0" ID="CMP-022.01" LOG_CI_END="0.18179847519451767" LOG_CI_START="-0.06606128954598203" LOG_EFFECT_SIZE="0.057868592824267796" METHOD="MH" NO="1" P_CHI2="0.07678421801579016" P_Q="0.0" P_Z="0.3600878011187102" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.043581317221682965" TOTALS="YES" TOTAL_1="155" TOTAL_2="173" WEIGHT="100.0" Z="0.9151978167196676">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6675098058887675" CI_END="1.707146813691322" CI_START="0.9430796854276406" DF="1.0" EFFECT_SIZE="1.2688480917883003" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="43" I2="0.0" ID="CMP-022.01.02" LOG_CI_END="0.23227087180849554" LOG_CI_START="-0.025451610041657684" LOG_EFFECT_SIZE="0.10340963088341892" NO="2" P_CHI2="0.41392147128779655" P_Z="0.11575400534626379" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="103" WEIGHT="36.51060585313707" Z="1.572848055249795">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.7813330371231189" CI_START="0.9641539165244966" EFFECT_SIZE="1.3105263157894738" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" LOG_CI_END="0.25074512253087006" LOG_CI_START="-0.015853630245055247" LOG_EFFECT_SIZE="0.11744574614290741" ORDER="3805" O_E="0.0" SE="0.15660142706568841" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.024524006959010126" WEIGHT="31.12477393885762"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="3806" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.385831914279454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.065916026918609" CI_END="1.8492207962635874" CI_START="0.6537283565358964" DF="1.0" EFFECT_SIZE="1.09949446202034" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="48" I2="83.51444372849348" ID="CMP-022.01.03" LOG_CI_END="0.2669887688519921" LOG_CI_START="-0.18460267639255165" LOG_EFFECT_SIZE="0.04119304622972021" NO="3" P_CHI2="0.013781586316294003" P_Z="0.7206680816779845" STUDIES="2" TAU2="0.1175354148526344" TOTAL_1="70" TOTAL_2="70" WEIGHT="63.489394146862935" Z="0.35756606053520273">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1547728590043567" CI_START="0.6300015148834446" EFFECT_SIZE="0.8529411764705882" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="34" LOG_CI_END="0.0624965679665984" LOG_CI_START="-0.20065840625319653" LOG_EFFECT_SIZE="-0.06908091914329904" ORDER="3807" O_E="0.0" SE="0.15457853449483858" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.023894523326571996" WEIGHT="31.415137654206024"/>
<DICH_DATA CI_END="1.8970926050149208" CI_START="1.053618012148746" EFFECT_SIZE="1.4137931034482758" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.2780885311339763" LOG_CI_START="0.022683186507582456" LOG_EFFECT_SIZE="0.1503858588207794" ORDER="3808" O_E="0.0" SE="0.15002636371038966" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.022507909808162127" WEIGHT="32.074256492656914"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.736655638787454" CI_END="1.6621767978206103" CI_START="0.6476320602526751" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0375350519749953" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="81" I2="82.95937052638425" I2_Q="0.0" ID="CMP-022.02" LOG_CI_END="0.22067721573826926" LOG_CI_START="-0.18867166015618064" LOG_EFFECT_SIZE="0.016002777791044337" METHOD="MH" NO="2" P_CHI2="0.002827614147028479" P_Q="0.0" P_Z="0.8782068677916781" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.13992262016005244" TOTALS="YES" TOTAL_1="135" TOTAL_2="153" WEIGHT="99.99999999999997" Z="0.15324272262631888">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.785691062136034" CI_START="1.0067038852886236" DF="0.0" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" I2="0.0" ID="CMP-022.02.02" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" NO="2" P_CHI2="1.0" P_Z="0.04489224275826041" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="35.8451027129943" Z="2.0056627432757965">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.785691062136034" CI_START="1.0067038852886236" EFFECT_SIZE="1.3407692307692307" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="40" LOG_CI_END="0.25180632486881654" LOG_CI_START="0.0029017447374962064" LOG_EFFECT_SIZE="0.12735403480315638" ORDER="3809" O_E="0.0" SE="0.14620778246668023" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.021376715653824086" WEIGHT="35.8451027129943"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.637345853053072" CI_END="2.610017219986153" CI_START="0.28290896344282673" DF="1.0" EFFECT_SIZE="0.8593004516897513" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="41" I2="93.16816033426292" ID="CMP-022.02.03" LOG_CI_END="0.416643372671727" LOG_CI_START="-0.5483532925144117" LOG_EFFECT_SIZE="-0.06585495992134241" NO="3" P_CHI2="1.3030890879728307E-4" P_Z="0.7890761639182248" STUDIES="2" TAU2="0.5996929524601315" TOTAL_1="70" TOTAL_2="70" WEIGHT="64.15489728700568" Z="0.2675104574050787">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="0.9040336721887139" CI_START="0.3207190587275412" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.043815393226618926" LOG_CI_START="-0.49387523135854094" LOG_EFFECT_SIZE="-0.26884531229257996" ORDER="3810" O_E="0.0" SE="0.2643673767508198" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.06989010989010988" WEIGHT="27.556913531432745"/>
<DICH_DATA CI_END="1.7211088098619653" CI_START="1.0163329319635195" EFFECT_SIZE="1.3225806451612903" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.23580832763658463" LOG_CI_START="0.007035998134340967" LOG_EFFECT_SIZE="0.12142216288546279" ORDER="3811" O_E="0.0" SE="0.13438199879091275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.01805852159904088" WEIGHT="36.59798375557294"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.6106739472284537" CI_END="0.053146634283112504" CI_START="-0.7950009978998525" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.37092718180837" ESTIMABLE="YES" I2="37.91418792607051" I2_Q="37.91418792607051" ID="CMP-022.03" NO="3" P_CHI2="0.20439714635980177" P_Q="0.20439714635980177" P_Z="0.08646750792590248" Q="1.6106739472284537" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.04096857735239893" TOTALS="YES" TOTAL_1="85" TOTAL_2="103" UNITS="" WEIGHT="100.0" Z="1.714333424147353">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1022330143445232" CI_START="-0.5490657188353458" DF="0.0" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.02" NO="2" P_CHI2="1.0" P_Z="0.17873473351770594" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.26895717992812" Z="1.3446610031633186">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.1022330143445232" CI_START="-0.5490657188353458" EFFECT_SIZE="-0.2234163522454113" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.05" ORDER="3812" SD_1="0.74" SD_2="0.77" SE="0.16615068907317437" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="68.26895717992812"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" DF="0.0" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.03" NO="3" P_CHI2="1.0" P_Z="0.03499375510595159" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="31.73104282007188" Z="2.1084306554609964">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.048466787756353935" CI_START="-1.3281231289345592" EFFECT_SIZE="-0.6882949583454566" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.0" ORDER="3813" SD_1="0.5" SD_2="1.1" SE="0.32644894275404324" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="31.73104282007188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.020754688884557237" CI_END="0.3768086317082903" CI_START="-0.2920420651959598" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04238328325616527" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-022.04" NO="4" P_CHI2="0.9896763149031901" P_Q="0.946024881209317" P_Z="0.8038285144868782" Q="0.004583216548300597" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="80" TOTAL_2="103" UNITS="" WEIGHT="100.0" Z="0.24839537168198647">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.01617147233625664" CI_END="0.4684901670648061" CI_START="-0.3664605634414307" DF="1.0" EFFECT_SIZE="0.051014801811687716" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.02" NO="2" P_CHI2="0.8988081452374272" P_Z="0.8107145087095603" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="51" WEIGHT="64.17068419312993" Z="0.2395043697218725">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="3814" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="35.82931580687006"/>
<CONT_DATA CI_END="0.7096571108630692" CI_START="-0.5467164147484287" EFFECT_SIZE="0.08147034805732019" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.8" ORDER="3815" SD_1="2.5" SD_2="2.3" SE="0.32050933984542873" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="28.341368386259866"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5856257622309741" CI_START="-0.5317774780726351" DF="0.0" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.03" NO="3" P_CHI2="1.0" P_Z="0.9247503046351875" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="52" WEIGHT="35.82931580687006" Z="0.09445175543874984">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.5856257622309741" CI_START="-0.5317774780726351" EFFECT_SIZE="0.026924142079169478" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.56" ORDER="3816" SD_1="1.14" SD_2="1.63" SE="0.28505708500705706" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="35.82931580687006"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.8" ORDER="3817" SD_1="0.0" SD_2="2.1" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.225654671219276" CI_END="0.7464631057654836" CI_START="-0.3068423236227254" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.21981039107137906" ESTIMABLE="YES" I2="67.4819825051666" I2_Q="40.81355457564507" ID="CMP-022.05" NO="5" P_CHI2="0.026436415804168112" P_Q="0.19365694902595598" P_Z="0.4133371054055518" Q="1.6895760386186414" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.19465426606197617" TOTALS="YES" TOTAL_1="80" TOTAL_2="103" UNITS="" WEIGHT="99.99999999999999" Z="0.8180351831620216">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3916299363147675" CI_END="0.8672016333474672" CI_START="0.020834031000155517" DF="1.0" EFFECT_SIZE="0.44401783217381136" ESTIMABLE="YES" I2="0.0" ID="CMP-022.05.02" NO="2" P_CHI2="0.5314442551303722" P_Z="0.03973856219413665" STUDIES="2" TAU2="0.0" TOTAL_1="40" TOTAL_2="51" WEIGHT="50.04388261304" Z="2.0564562186469533">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="3818" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="25.85712248770429"/>
<CONT_DATA CI_END="0.9259489927372764" CI_START="-0.33737912447830304" EFFECT_SIZE="0.2942849341294867" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="18.7" ORDER="3819" SD_1="12.0" SD_2="13.3" SE="0.3222835029573376" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="24.18676012533571"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.144448696285867" CI_END="1.1331160192914684" CI_START="-1.1473798884999484" DF="1.0" EFFECT_SIZE="-0.007131934604240072" ESTIMABLE="YES" I2="86.00311874980834" ID="CMP-022.05.03" NO="3" P_CHI2="0.007519659688866032" P_Z="0.9902189534582193" STUDIES="2" TAU2="0.5822974907269153" TOTAL_1="40" TOTAL_2="52" WEIGHT="49.95611738695999" Z="0.012259030956072193">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="1.1359676475903302" CI_START="-0.004066387034166508" EFFECT_SIZE="0.5659506302780819" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.13" ORDER="3820" SD_1="0.95" SD_2="0.34" SE="0.2908303529087625" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="25.85712248770429"/>
<CONT_DATA CI_END="0.03724050674962909" CI_START="-1.2326820263280838" EFFECT_SIZE="-0.5977207597892273" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.6" ORDER="3821" SD_1="1.1" SD_2="3.3" SE="0.32396578281404653" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="24.0989948992557"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.560870637935732" CI_END="0.8699352257219921" CI_START="-1.1945949474236457" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.16232986085082673" ESTIMABLE="YES" I2="88.61104303291481" I2_Q="71.54963114675364" ID="CMP-022.06" NO="6" P_CHI2="1.5371239261308123E-4" P_Q="0.0608197202315488" P_Z="0.7579179310447024" Q="3.5148929181137625" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.736048053533925" TOTALS="YES" TOTAL_1="60" TOTAL_2="84" UNITS="" WEIGHT="100.0" Z="0.3082160629294663">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9514293494058191" CI_START="-0.17660753046268896" DF="0.0" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" I2="0.0" ID="CMP-022.06.02" NO="2" P_CHI2="1.0" P_Z="0.1782209875021376" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="32" WEIGHT="33.874812367362914" Z="1.3462528456883176">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="3822" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="33.874812367362914"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.04597771982197" CI_END="1.2175195093439213" CI_START="-2.123103798736285" DF="1.0" EFFECT_SIZE="-0.45279214469618195" ESTIMABLE="YES" I2="92.8805240906172" ID="CMP-022.06.03" NO="3" P_CHI2="1.7839593308055512E-4" P_Z="0.595202730025378" STUDIES="2" TAU2="1.3494009453066427" TOTAL_1="40" TOTAL_2="52" WEIGHT="66.12518763263708" Z="0.531311802764838">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9514293494058191" CI_START="-0.17660753046268896" EFFECT_SIZE="0.3874109094715651" ESTIMABLE="YES" MEAN_1="1.75" MEAN_2="0.97" ORDER="3823" SD_1="2.02" SD_2="1.96" SE="0.28776979800810604" STUDY_ID="STD-Berger-2004" TOTAL_1="20" TOTAL_2="32" WEIGHT="33.874812367362914"/>
<CONT_DATA CI_END="-0.626858518947859" CI_START="-2.0075250794135924" EFFECT_SIZE="-1.3171917991807256" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="16.0" ORDER="3824" SD_1="4.7" SD_2="10.0" SE="0.3522173293377467" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.250375265274165"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3699799236802304" CI_END="0.012986553899889453" CI_START="-1.0435407657000288" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5152771059000697" ESTIMABLE="YES" I2="27.0062296012586" I2_Q="27.0062296012586" ID="CMP-022.07" NO="7" P_CHI2="0.24181551571174953" P_Q="0.24181551571174953" P_Z="0.05590425533855782" Q="1.3699799236802304" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03924948248882914" TOTALS="YES" TOTAL_1="40" TOTAL_2="39" UNITS="" WEIGHT="100.0" Z="1.9117812684760531">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.07.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.380172766114548" CI_START="-0.8810829019163788" DF="0.0" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" I2="0.0" ID="CMP-022.07.02" NO="2" P_CHI2="1.0" P_Z="0.4363311830916393" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="50.88047753414523" Z="0.7784034994232293">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.380172766114548" CI_START="-0.8810829019163788" EFFECT_SIZE="-0.25045506790091543" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="46.0" ORDER="3825" SD_1="8.7" SD_2="10.8" SE="0.3217548072259364" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="19" WEIGHT="50.88047753414523"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" DF="0.0" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" I2="0.0" ID="CMP-022.07.03" NO="3" P_CHI2="1.0" P_Z="0.01659699832819686" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="49.11952246585478" Z="2.395515812805348">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.14356353916921416" CI_START="-1.4356227064349634" EFFECT_SIZE="-0.7895931228020887" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="7.4" ORDER="3826" SD_1="2.7" SD_2="6.1" SE="0.32961298714092374" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="49.11952246585478"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-022.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.014437591269834836" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="2.4461874573937834">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behavour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" DF="0.0" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" I2="0.0" ID="CMP-022.08.03" NO="3" P_CHI2="1.0" P_Z="0.014437591269834836" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0" Z="2.4461874573937834">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.1605625547131152" CI_START="-1.4550159987496114" EFFECT_SIZE="-0.8077892767313632" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="3.0" ORDER="3827" SD_1="1.5" SD_2="2.7" SE="0.33022378325494234" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.436700332026985" CI_END="1.292926807820211" CI_START="0.6229797500980693" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8974782557983951" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-022.09" LOG_CI_END="0.11157394030227435" LOG_CI_START="-0.20552606981530386" LOG_EFFECT_SIZE="-0.04697606475651474" METHOD="MH" NO="9" P_CHI2="0.4868396536842795" P_Q="0.0" P_Z="0.5614366821544334" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="155" TOTAL_2="173" WEIGHT="100.0" Z="0.5807088749322393">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.23884456260922093" CI_END="1.1705849402463695" CI_START="0.4800877191606528" DF="1.0" EFFECT_SIZE="0.74965555693711" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="36" I2="0.0" ID="CMP-022.09.02" LOG_CI_END="0.06840293254941424" LOG_CI_START="-0.318679403318436" LOG_EFFECT_SIZE="-0.1251382353845109" NO="2" P_CHI2="0.6250419070983673" P_Z="0.20506337170402378" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="103" WEIGHT="67.10977850764196" Z="1.2672571787221576">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.1579651462928415" CI_START="0.4455321384425781" EFFECT_SIZE="0.7182692307692308" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.06369548771569017" LOG_CI_START="-0.35112096268245335" LOG_EFFECT_SIZE="-0.1437127374833816" ORDER="3828" O_E="0.0" SE="0.2436652363384154" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.05937274739985583" WEIGHT="58.43601205121296"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="3829" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="8.673766456428996"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2891052038056161" CI_END="2.4488813231295468" CI_START="0.6855624612458576" DF="1.0" EFFECT_SIZE="1.295708727756244" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" I2="0.0" ID="CMP-022.09.03" LOG_CI_END="0.38896773900024634" LOG_CI_START="-0.16395297072329848" LOG_EFFECT_SIZE="0.11250738413847393" NO="3" P_CHI2="0.5907945818087244" P_Z="0.4250908118289174" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="32.89022149235804" Z="0.7976204075136739">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="2.3945374130296906" CI_START="0.6525268686543702" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.3792216269895729" LOG_CI_START="-0.18540160097346" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="3830" O_E="0.0" SE="0.33166247903553997" STUDY_ID="STD-Berger-2004" TOTAL_1="50" TOTAL_2="50" VAR="0.11" WEIGHT="31.54096893246908"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3831" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.3492525598889549"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.9514177335704534" CI_END="3.218069292686991" CI_START="0.17467835730600745" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7497513306046671" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" I2="49.385255246277794" I2_Q="0.0" ID="CMP-022.10" LOG_CI_END="0.5075953912569829" LOG_CI_START="-0.7577609008833452" LOG_EFFECT_SIZE="-0.12508275481318115" METHOD="MH" NO="10" P_CHI2="0.13866316469592455" P_Q="0.0" P_Z="0.6983920372293946" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.7993228976811636" TOTALS="YES" TOTAL_1="105" TOTAL_2="123" WEIGHT="99.99999999999999" Z="0.38749195944836884">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.10.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.054247053987038" CI_END="3.2783262541128084" CI_START="0.09865463639829597" DF="1.0" EFFECT_SIZE="0.5687021053191967" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="67.258706243341" ID="CMP-022.10.02" LOG_CI_END="0.5156521717208289" LOG_CI_START="-1.0058824997186306" LOG_EFFECT_SIZE="-0.24511516399890093" NO="2" P_CHI2="0.08052654581251328" P_Z="0.527720250681456" STUDIES="2" TAU2="1.0752027849657277" TOTAL_1="85" TOTAL_2="103" WEIGHT="83.61018205362397" Z="0.6314899062378546">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.0110135411104764" CI_START="0.053314718450067376" EFFECT_SIZE="0.23216783216783216" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="0.004756972396318387" LOG_CI_START="-1.2731528799183696" LOG_EFFECT_SIZE="-0.6341979537610255" ORDER="3832" O_E="0.0" SE="0.7506505730054371" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.5634762827533911" WEIGHT="40.53862352894268"/>
<DICH_DATA CI_END="5.208499115067838" CI_START="0.34132246900739327" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7167125947102104" LOG_CI_START="-0.4668351214936106" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3833" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="43.07155852468129"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-022.10.03" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.4771212547196624" NO="3" P_CHI2="1.0" P_Z="0.49327758741034355" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="16.38981794637601" Z="0.6851051308492763">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3834" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="16.38981794637601"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.758740727269007" CI_END="2.28666425990717" CI_START="0.453030197995954" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0178054639350376" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="77" I2="88.58283363855432" I2_Q="0.0" ID="CMP-022.11" LOG_CI_END="0.359202403883772" LOG_CI_START="-0.34387284790792966" LOG_EFFECT_SIZE="0.007664777987921226" METHOD="MH" NO="11" P_CHI2="0.003081237215801891" P_Q="0.0" P_Z="0.9659133950481436" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.30230615733546773" TOTALS="YES" TOTAL_1="120" TOTAL_2="141" WEIGHT="100.0" Z="0.042734227289432956">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.162322542898215" CI_START="1.0742096659761902" DF="0.0" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" I2="0.0" ID="CMP-022.11.02" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" NO="2" P_CHI2="1.0" P_Z="0.01822257374012913" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="51.04184806492424" Z="2.361064238972274">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.162322542898215" CI_START="1.0742096659761902" EFFECT_SIZE="1.5240694789081886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="31" LOG_CI_END="0.334920475997004" LOG_CI_START="0.031089055934877353" LOG_EFFECT_SIZE="0.18300476596594062" ORDER="3835" O_E="0.0" SE="0.17847208013427854" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.03185228338745634" WEIGHT="51.04184806492424"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0175880523999328" CI_START="0.4386845857324744" DF="0.0" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" I2="0.0" ID="CMP-022.11.03" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" NO="3" P_CHI2="1.0" P_Z="0.06028032235338007" STUDIES="2" TAU2="0.0" TOTAL_1="55" TOTAL_2="58" WEIGHT="48.95815193507577" Z="1.878737663869856">
<NAME>Psychdynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.0175880523999328" CI_START="0.4386845857324744" EFFECT_SIZE="0.6681318681318681" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.007571999240618106" LOG_CI_START="-0.3578476253373355" LOG_EFFECT_SIZE="-0.17513781304835868" ORDER="3836" O_E="0.0" SE="0.2146492963334045" STUDY_ID="STD-Berger-2004" TOTAL_1="35" TOTAL_2="38" VAR="0.04607432041642569" WEIGHT="48.95815193507577"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3837" O_E="0.0" SE="0.0" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="9.350451086264773" CI_END="0.35646565691104365" CI_START="-0.9098815670163427" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2767079550526495" ESTIMABLE="YES" I2="78.61065758701336" I2_Q="5.910372825236352" ID="CMP-022.12" NO="12" P_CHI2="0.009323448953108104" P_Q="0.3025740940486846" P_Z="0.3916999515517281" Q="1.0628164124219381" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.24295870493666438" TOTALS="YES" TOTAL_1="106" TOTAL_2="132" UNITS="" WEIGHT="100.0" Z="0.8565385794536544">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08561925475675414" CI_START="-0.74186417367335" DF="0.0" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" I2="0.0" ID="CMP-022.12.02" NO="2" P_CHI2="1.0" P_Z="0.013458861325997886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="38.51262681043331" Z="2.47139089503999">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="-0.08561925475675414" CI_START="-0.74186417367335" EFFECT_SIZE="-0.41374171421505207" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.14" ORDER="3838" SD_1="0.86" SD_2="0.87" SE="0.1674124943348378" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" WEIGHT="38.51262681043331"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.287634673842835" CI_END="1.0375944505760968" CI_START="-1.4473213765007107" DF="1.0" EFFECT_SIZE="-0.20486346296230684" ESTIMABLE="YES" I2="87.93383107056869" ID="CMP-022.12.03" NO="3" P_CHI2="0.003991634919482956" P_Z="0.7465665699207483" STUDIES="2" TAU2="0.7069141587221924" TOTAL_1="41" TOTAL_2="49" WEIGHT="61.487373189566696" Z="0.3231699076315359">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="3839" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="31.918889839063738"/>
<CONT_DATA CI_END="-0.19907559159413957" CI_START="-1.4991517412220188" EFFECT_SIZE="-0.8491136664080792" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="2.4" ORDER="3840" SD_1="1.1" SD_2="2.9" SE="0.3316581732834669" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="29.568483350502955"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0809442516033915" CI_END="1.9380471644516182" CI_START="0.23492628253706166" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6747578941562018" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-022.13" LOG_CI_END="0.28736434186430104" LOG_CI_START="-0.6290683935148683" LOG_EFFECT_SIZE="-0.17085202582528364" METHOD="MH" NO="13" P_CHI2="0.776021855359509" P_Q="0.0" P_Z="0.4649022679898228" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="85" TOTAL_2="103" WEIGHT="100.0" Z="0.7307984631620891">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3860574479793515" CI_START="0.2231374564984133" DF="0.0" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-022.13.02" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" NO="2" P_CHI2="1.0" P_Z="0.6021176621936886" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="83" WEIGHT="79.30104805294636" Z="0.5213576320788783">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.3860574479793515" CI_START="0.2231374564984133" EFFECT_SIZE="0.7296703296703296" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3776808957635266" LOG_CI_START="-0.6514275216696789" LOG_EFFECT_SIZE="-0.13687331295307612" ORDER="3841" O_E="0.0" SE="0.6045033785690889" STUDY_ID="STD-Barlow-2000" TOTAL_1="65" TOTAL_2="83" VAR="0.36542433470144314" WEIGHT="79.30104805294636"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.083060192649951" CI_START="0.04918297059741634" DF="0.0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-022.13.03" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" NO="3" P_CHI2="1.0" P_Z="0.5579989793003175" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.69895194705364" Z="0.585816288803313">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3842" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="20.69895194705364"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-022.14" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" METHOD="MH" NO="14" P_CHI2="1.0" P_Q="0.0" P_Z="0.23602467635869728" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Response/remission immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1122988184661988" CI_START="0.6492757757564591" DF="0.0" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-022.14.03" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" NO="3" P_CHI2="1.0" P_Z="0.23602467635869728" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.184981768862055">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="1.1122988184661988" CI_START="0.6492757757564591" EFFECT_SIZE="0.8498168498168498" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.046221475894761825" LOG_CI_START="-0.18757080019447464" LOG_EFFECT_SIZE="-0.07067466214985638" ORDER="3843" O_E="0.0" SE="0.13733074026524866" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" VAR="0.018859732221801193" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-022.15" NO="15" P_CHI2="0.0" P_Q="1.0" P_Z="0.14838783259194901" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Global/Avoidance/Panic immediately after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.15.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.15.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6681503377508255E-32" CI_END="0.9869633099662499" CI_START="-0.14918429537679379" DF="0.0" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" I2="100.0" ID="CMP-022.15.03" NO="3" P_CHI2="0.0" P_Z="0.14838783259194901" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.4452494445939592">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="0.9869633099662499" CI_START="-0.14918429537679379" EFFECT_SIZE="0.41888950729472807" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.14" ORDER="3844" SD_1="1.03" SD_2="0.58" SE="0.28983889864937085" STUDY_ID="STD-Berger-2004" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6479609030910822" CI_END="4.5786843997837225" CI_START="0.9017300930585593" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.031929504166606" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="20" I2="62.23509195952796" I2_Q="0.0" ID="CMP-022.16" LOG_CI_END="0.6607407094468779" LOG_CI_START="-0.044923436556312854" LOG_EFFECT_SIZE="0.3079086364452825" METHOD="MH" NO="16" P_CHI2="0.10368287079094773" P_Q="0.0" P_Z="0.08718886181128276" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.21566081651033744" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" WEIGHT="100.0" Z="1.710416609316756">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>AD</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-022.16.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5810912337081713" CI_START="0.7508125415637287" DF="0.0" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" I2="0.0" ID="CMP-022.16.02" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" NO="2" P_CHI2="1.0" P_Z="0.2936490530586643" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="54.564555517860896" Z="1.050150251868255">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.5810912337081713" CI_START="0.7508125415637287" EFFECT_SIZE="1.392090395480226" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.41180335580142424" LOG_CI_START="-0.12446848154026177" LOG_EFFECT_SIZE="0.14366743713058122" ORDER="3845" O_E="0.0" SE="0.31500873184291384" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" VAR="0.09923050113728078" WEIGHT="54.564555517860896"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0514801901976165" CI_START="1.4521773760684742" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-022.16.03" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" NO="3" P_CHI2="1.0" P_Z="0.003908892607536905" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="45.43544448213911" Z="2.88542203962941">
<NAME>Psychodynamic psychotherapy and others</NAME>
<DICH_DATA CI_END="7.0514801901976165" CI_START="1.4521773760684742" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8482802901772888" LOG_CI_START="0.16201966646252317" LOG_EFFECT_SIZE="0.505149978319906" ORDER="3846" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.16250000000000003" WEIGHT="45.43544448213911"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="10.05578915203161" CI_END="0.6262294009688185" CI_START="-1.784480698893757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5791256489624692" ESTIMABLE="YES" I2="90.05547963584772" I2_Q="90.05547963584772" ID="CMP-022.17" NO="17" P_CHI2="0.0015187088582974129" P_Q="0.0015187088582974129" P_Z="0.3463536745706467" Q="10.05578915203161" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.6836610431139938" TOTALS="YES" TOTAL_1="79" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="0.9416855345273837">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-022.17.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33911435701046155" CI_START="-0.33911435701046155" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-022.17.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.33911435701046155" CI_START="-0.33911435701046155" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.45" ORDER="3847" SD_1="0.9" SD_2="0.83" SE="0.17302070838308883" STUDY_ID="STD-Barlow-2000" TOTAL_1="59" TOTAL_2="77" WEIGHT="53.000584472043435"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" DF="0.0" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" I2="0.0" ID="CMP-022.17.03" NO="3" P_CHI2="1.0" P_Z="3.97783813112423E-4" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656" Z="3.5415497659113866">
<NAME>Psychodynamic psychotherapy and others</NAME>
<CONT_DATA CI_END="-0.5502749534853654" CI_START="-1.9141201563559012" EFFECT_SIZE="-1.2321975549206332" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="2.4" ORDER="3848" SD_1="1.1" SD_2="1.7" SE="0.34792608783334095" STUDY_ID="STD-Wiborg-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="46.99941552795656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-023" NO="23">
<NAME>SENSITIVITY5: allowed benzo: Psychotherapy+Antidepressant vs Psychotherapy alone or +Placebo</NAME>
<DICH_OUTCOME CHI2="5.904191991319975" CI_END="1.6775885454385198" CI_START="1.039011261065706" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3202398987098747" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="101" I2="15.314406995051478" I2_Q="0.0" ID="CMP-023.01" LOG_CI_END="0.22468545210808205" LOG_CI_START="0.016620254575650487" LOG_EFFECT_SIZE="0.1206528533418663" METHOD="MH" NO="1" P_CHI2="0.3156536244043471" P_Q="0.0" P_Z="0.023020880137665675" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.014030968138858685" TOTALS="YES" TOTAL_1="131" TOTAL_2="226" WEIGHT="100.0" Z="2.2730879549924836">
<NAME>Response at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3400394409125012" CI_END="2.778047061802391" CI_START="1.0017748698047784" DF="1.0" EFFECT_SIZE="1.6682259240428547" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" I2="25.375330794812353" ID="CMP-023.01.01" LOG_CI_END="0.44373959867588186" LOG_CI_START="7.701329214690861E-4" LOG_EFFECT_SIZE="0.2222548657986754" NO="1" P_CHI2="0.24702716619773923" P_Z="0.049208688928558064" STUDIES="2" TAU2="0.03508343437986123" TOTAL_1="24" TOTAL_2="45" WEIGHT="26.241192060197527" Z="1.9667790492615798">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="2.3477911253975297" CI_START="0.7572129217741901" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.3706594566631608" LOG_CI_START="-0.12078198344656102" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="3849" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.08333333333333331" WEIGHT="15.341730088779666"/>
<DICH_DATA CI_END="4.474347411298529" CI_START="1.1314499154035917" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6507297019224901" LOG_CI_START="0.05363533430023487" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="3850" O_E="0.0" SE="0.35073618720610084" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.12301587301587302" WEIGHT="10.89946197141786"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.04462728604652" CI_END="1.5326912333589724" CI_START="0.9443007909665522" DF="3.0" EFFECT_SIZE="1.2030467754698395" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="82" I2="1.4657717301242803" ID="CMP-023.01.02" LOG_CI_END="0.18545467334456858" LOG_CI_START="-0.024889646539333878" LOG_EFFECT_SIZE="0.08028251340261743" NO="2" P_CHI2="0.3847958034058676" P_Z="0.1346207446697868" STUDIES="4" TAU2="0.0011011966883285231" TOTAL_1="107" TOTAL_2="181" WEIGHT="73.75880793980248" Z="1.496126303237782">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.4857287135191628" CI_START="0.7266810347556257" EFFECT_SIZE="1.0390625" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" LOG_CI_END="0.17193951670753702" LOG_CI_START="-0.13865617406910224" LOG_EFFECT_SIZE="0.016641671319217427" ORDER="3851" O_E="0.0" SE="0.18244544623566333" STUDY_ID="STD-Barlow-2000i" TOTAL_1="32" TOTAL_2="63" VAR="0.03328634085213032" WEIGHT="31.568507705148782"/>
<DICH_DATA CI_END="1.8078009413055642" CI_START="0.8799530594388961" EFFECT_SIZE="1.2612612612612613" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="37" LOG_CI_END="0.2571506081902599" LOG_CI_START="-0.055540494407098746" LOG_EFFECT_SIZE="0.10080505689158058" ORDER="3852" O_E="0.0" SE="0.18367630151160966" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="33" TOTAL_2="77" VAR="0.033736983736983736" WEIGHT="31.270690385709553"/>
<DICH_DATA CI_END="5.386312282017674" CI_START="0.9743706246537854" EFFECT_SIZE="2.290909090909091" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.7312915288797084" LOG_CI_START="-0.011275817633070251" LOG_EFFECT_SIZE="0.36000785562331905" ORDER="3853" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.19025974025974024" WEIGHT="7.311819735601772"/>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="3854" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="3.607790113342365"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.5404040810991568" CI_END="1.3390071920279847" CI_START="0.9101526522813629" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1039478915456518" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="116" I2="0.0" I2_Q="0.0" ID="CMP-023.02" LOG_CI_END="0.12678290968540637" LOG_CI_START="-0.040885760993747126" LOG_EFFECT_SIZE="0.04294857434582956" METHOD="MH" NO="2" P_CHI2="0.8194612289709649" P_Q="0.0" P_Z="0.31533271251850736" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="206" WEIGHT="99.99999999999997" Z="1.0040952619735048">
<NAME>Remission at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0028574262313701398" CI_END="1.6839839100615555" CI_START="0.7911204397084627" DF="1.0" EFFECT_SIZE="1.1542244545104188" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-023.02.01" LOG_CI_END="0.22633793763580198" LOG_CI_START="-0.10175739473361908" LOG_EFFECT_SIZE="0.06229027145109142" NO="1" P_CHI2="0.9573694877835253" P_Z="0.4567465874947255" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="26.115824314639816" Z="0.7442147241149928">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.929679257411404" CI_START="0.6768598687906862" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.28548512853506125" LOG_CI_START="-0.16950123457968785" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="3855" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.07142857142857142" WEIGHT="13.580228643612703"/>
<DICH_DATA CI_END="2.012469004517675" CI_START="0.6763389190370792" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.30372920020979444" LOG_CI_START="-0.16983562094856805" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3856" O_E="0.0" SE="0.27817432013209337" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.07738095238095237" WEIGHT="12.535595671027112"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.4706119398111397" CI_END="1.3603280769127932" CI_START="0.8681206270353741" DF="2.0" EFFECT_SIZE="1.0867055089136886" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="90" I2="0.0" ID="CMP-023.02.02" LOG_CI_END="0.1336436619069442" LOG_CI_START="-0.061419924574683434" LOG_EFFECT_SIZE="0.03611186866613042" NO="2" P_CHI2="0.4793588567218424" P_Z="0.46802811623122975" STUDIES="3" TAU2="0.0" TOTAL_1="87" TOTAL_2="161" WEIGHT="73.88417568536016" Z="0.7256911787246605">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.3705783259114348" CI_START="0.6993267434940689" EFFECT_SIZE="0.9790209790209791" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="39" LOG_CI_END="0.13690385967786567" LOG_CI_START="-0.15531986325151323" LOG_EFFECT_SIZE="-0.009208001786823765" ORDER="3857" O_E="0.0" SE="0.17165366137947502" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.029464979464979474" WEIGHT="32.920991268279415"/>
<DICH_DATA CI_END="1.5473815458642357" CI_START="0.7657600436275381" EFFECT_SIZE="1.0885416666666667" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="42" LOG_CI_END="0.189597413138667" LOG_CI_START="-0.11590729832365816" LOG_EFFECT_SIZE="0.03684505740750443" ORDER="3858" O_E="0.0" SE="0.17945497978568117" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.032204089769879235" WEIGHT="30.120905096777065"/>
<DICH_DATA CI_END="2.668603393583873" CI_START="0.8261905940229951" EFFECT_SIZE="1.4848484848484849" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.4262840339685562" LOG_CI_START="-0.08291975366730392" LOG_EFFECT_SIZE="0.17168214015062616" ORDER="3859" O_E="0.0" SE="0.29910882545670475" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.08946608946608947" WEIGHT="10.842279320303689"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.4498617634560913" CI_END="-0.06003761708659705" CI_START="-0.5841584887816831" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.32209805293414007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-023.03" NO="3" P_CHI2="0.6938896129147891" P_Q="0.31969795085052277" P_Z="0.015996800864923777" Q="0.9901827440443357" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="177" UNITS="" WEIGHT="100.0" Z="2.4089885266338245">
<NAME>Global severity at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0379675079543431" CI_END="-0.011151281086968945" CI_START="-1.1415116514427857" DF="1.0" EFFECT_SIZE="-0.5763314662648773" ESTIMABLE="YES" I2="0.0" ID="CMP-023.03.01" NO="1" P_CHI2="0.8455084782037424" P_Z="0.04564785719044869" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="21.499534815443987" Z="1.9986350311993808">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.25629768993845303" CI_START="-1.3022810887387417" EFFECT_SIZE="-0.5229916994001443" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.11" ORDER="3860" SD_1="0.84" SD_2="1.05" SE="0.3976039332791483" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="11.30851014449782"/>
<CONT_DATA CI_END="0.18538415775284744" CI_START="-1.4564244496102936" EFFECT_SIZE="-0.6355201459287231" ESTIMABLE="YES" MEAN_1="1.58" MEAN_2="2.28" ORDER="3861" SD_1="0.84" SD_2="1.16" SE="0.4188364225857" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="10.191024670946165"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4217115114574125" CI_END="0.043308478368376646" CI_START="-0.548246807653985" DF="1.0" EFFECT_SIZE="-0.2524691646428042" ESTIMABLE="YES" I2="0.0" ID="CMP-023.03.02" NO="2" P_CHI2="0.5160842844547728" P_Z="0.09433097461065083" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="78.50046518455602" Z="1.6729813141695236">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.26889015998425864" CI_START="-0.5746046452731846" EFFECT_SIZE="-0.15285724264446293" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.99" ORDER="3862" SD_1="0.74" SD_2="0.7" SE="0.2151812002441939" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="38.609847362613166"/>
<CONT_DATA CI_END="0.0660387915275914" CI_START="-0.7638044728998299" EFFECT_SIZE="-0.34888284068611924" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.14" ORDER="3863" SD_1="0.74" SD_2="0.74" SE="0.21169860032457713" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="39.89061782194285"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5021325045682505" CI_END="0.20632647611303395" CI_START="-0.4968652523309796" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.14526938810897283" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-023.04" NO="4" P_CHI2="0.6817782664608523" P_Q="0.3305209078006065" P_Z="0.4180544241435926" Q="0.9468565215286412" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="74" UNITS="" WEIGHT="100.0" Z="0.8098012454719223">
<NAME>Frequency of panic attacks at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1942360020051953" CI_END="0.20378649840438778" CI_START="-0.9458888246280452" DF="1.0" EFFECT_SIZE="-0.37105116311182873" ESTIMABLE="YES" I2="0.0" ID="CMP-023.04.01" NO="1" P_CHI2="0.6594141771007651" P_Z="0.20582316827452718" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="35" WEIGHT="37.41080796613791" Z="1.2651344280447174">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.5489882937929467" CI_START="-1.043353894178747" EFFECT_SIZE="-0.24718280019290018" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="0.52" ORDER="3864" SD_1="0.5" SD_2="1.57" SE="0.40621720616600243" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="19.5018002557852"/>
<CONT_DATA CI_END="0.32488587661446067" CI_START="-1.336758154442933" EFFECT_SIZE="-0.5059361389142362" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.65" ORDER="3865" SD_1="0.5" SD_2="3.46" SE="0.4238965726320049" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="16" WEIGHT="17.909007710352714"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.36103998103441404" CI_END="0.43410538203165333" CI_START="-0.45473562125120587" DF="1.0" EFFECT_SIZE="-0.010315119609776286" ESTIMABLE="YES" I2="0.0" ID="CMP-023.04.02" NO="2" P_CHI2="0.5479294661661193" P_Z="0.9637157154736684" STUDIES="2" TAU2="0.0" TOTAL_1="39" TOTAL_2="39" WEIGHT="62.58919203386209" Z="0.04549129227097676">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.4867205387128699" CI_START="-0.7870704644153357" EFFECT_SIZE="-0.15017496285123286" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.3" ORDER="3866" SD_1="0.6" SD_2="0.7" SE="0.3249526555527822" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="30.4755219791352"/>
<CONT_DATA CI_END="0.7428489122247686" CI_START="-0.49802822544055" EFFECT_SIZE="0.12241034339210927" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.7" ORDER="3867" SD_1="2.5" SD_2="2.3" SE="0.3165561070134959" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.11367005472689"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.996611756768436" CI_END="-0.05858176183713537" CI_START="-0.9880196977884192" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5233007298127773" ESTIMABLE="YES" I2="39.95931351007641" I2_Q="77.77486133082348" ID="CMP-023.05" NO="5" P_CHI2="0.17204558668993342" P_Q="0.03390660733594375" P_Z="0.027311680962704657" Q="4.499409496989439" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.08956524369366882" TOTALS="YES" TOTAL_1="58" TOTAL_2="76" UNITS="" WEIGHT="100.0" Z="2.2070340446493857">
<NAME>Phobic avoidance at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.728969955469096E-6" CI_END="-0.39924024416711845" CI_START="-1.5737987427881146" DF="1.0" EFFECT_SIZE="-0.9865194934776165" ESTIMABLE="YES" I2="0.0" ID="CMP-023.05.01" NO="1" P_CHI2="0.9986819288749194" P_Z="9.934555506061686E-4" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="41.7605371968574" Z="3.292373567656142">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.17311952071257597" CI_START="-1.7989719385578054" EFFECT_SIZE="-0.9860457296351907" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.71" ORDER="3868" SD_1="2.0" SD_2="1.28" SE="0.41476589127906066" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="21.490847205626064"/>
<CONT_DATA CI_END="-0.13768966321483767" CI_START="-1.8363836557556876" EFFECT_SIZE="-0.9870366594852626" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="6.07" ORDER="3869" SD_1="2.0" SD_2="1.86" SE="0.4333482670957047" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="20.26968999123134"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.49719953080904156" CI_END="0.25714009358479517" CI_START="-0.6343339024723135" DF="1.0" EFFECT_SIZE="-0.18859690444375915" ESTIMABLE="YES" I2="0.0" ID="CMP-023.05.02" NO="2" P_CHI2="0.4807332660280026" P_Z="0.40694299475138795" STUDIES="2" TAU2="0.0" TOTAL_1="39" TOTAL_2="39" WEIGHT="58.2394628031426" Z="0.82928530039104">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.28690026573004546" CI_START="-0.9959914235455751" EFFECT_SIZE="-0.35454557890776484" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" ORDER="3870" SD_1="0.5" SD_2="0.6" SE="0.32727430182261164" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="28.585006846241964"/>
<CONT_DATA CI_END="0.5862062100904806" CI_START="-0.6534810892012228" EFFECT_SIZE="-0.03363743955537116" ESTIMABLE="YES" MEAN_1="22.5" MEAN_2="22.9" ORDER="3871" SD_1="12.0" SD_2="11.3" SE="0.316252571238604" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="29.654455956900637"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8964808049350355" CI_END="-0.046121739886977764" CI_START="-1.0910145534568327" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5685681466719053" ESTIMABLE="YES" I2="30.9506903483568" I2_Q="65.46009010863109" ID="CMP-023.06" NO="6" P_CHI2="0.2349834476908219" P_Q="0.08884380091242028" P_Z="0.03292552627819717" Q="2.8952015310552026" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.06659475724549228" TOTALS="YES" TOTAL_1="38" TOTAL_2="56" UNITS="" WEIGHT="100.0" Z="2.1329902469639705">
<NAME>General anxiety at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.001279273879832639" CI_END="-0.2969248394185655" CI_START="-1.4575634666483017" DF="1.0" EFFECT_SIZE="-0.8772441530334336" ESTIMABLE="YES" I2="0.0" ID="CMP-023.06.01" NO="1" P_CHI2="0.9714681986671391" P_Z="0.003048598961307407" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="58.71453938401739" Z="2.962794629190888">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="-0.06465956744341794" CI_START="-1.6696001383875947" EFFECT_SIZE="-0.8671298529155064" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.8" ORDER="3872" SD_1="1.28" SD_2="1.36" SE="0.4094311384300281" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="30.335234876529377"/>
<CONT_DATA CI_END="-0.04811090371259563" CI_START="-1.72855403278863" EFFECT_SIZE="-0.8883324682506129" ESTIMABLE="YES" MEAN_1="2.61" MEAN_2="3.91" ORDER="3873" SD_1="1.28" SD_2="1.48" SE="0.42869234902558295" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="28.379304507488015"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5072471570567509" CI_START="-0.766029266325877" DF="0.0" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" I2="0.0" ID="CMP-023.06.02" NO="2" P_CHI2="1.0" P_Z="0.690375711342318" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="41.285460615982615" Z="0.3983452490727365">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.5072471570567509" CI_START="-0.766029266325877" EFFECT_SIZE="-0.12939105463456302" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.7" ORDER="3874" SD_1="1.7" SD_2="1.3" SE="0.3248213827973549" STUDY_ID="STD-Kampman-2002" TOTAL_1="19" TOTAL_2="19" WEIGHT="41.285460615982615"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.9485656988000715" CI_END="0.17215860306530434" CI_START="-1.0338105422574781" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.43082596959608693" ESTIMABLE="YES" I2="49.34869639859913" I2_Q="74.02810430068949" ID="CMP-023.07" NO="7" P_CHI2="0.13886104012095968" P_Q="0.04973667597088227" P_Z="0.1614016166738657" Q="3.8503157858690606" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1403300407941929" TOTALS="YES" TOTAL_1="39" TOTAL_2="57" UNITS="" WEIGHT="100.0" Z="1.400373114499328">
<NAME>Depression at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.09824991293101076" CI_END="-0.18826903333729839" CI_START="-1.3364371202332923" DF="1.0" EFFECT_SIZE="-0.7623530767852954" ESTIMABLE="YES" I2="0.0" ID="CMP-023.07.01" NO="1" P_CHI2="0.7539400249444181" P_Z="0.009248531547478444" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="37" WEIGHT="60.632954166000076" Z="2.602727929918204">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.1122902420770423" CI_START="-1.4642243177194443" EFFECT_SIZE="-0.675967037821201" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.45" ORDER="3875" SD_1="0.97" SD_2="1.37" SE="0.40217947172290724" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="10" TOTAL_2="19" WEIGHT="31.332611440910224"/>
<CONT_DATA CI_END="-0.022172476578999123" CI_START="-1.6976858442713993" EFFECT_SIZE="-0.8599291604251992" ESTIMABLE="YES" MEAN_1="2.58" MEAN_2="3.78" ORDER="3876" SD_1="0.97" SD_2="1.5" SE="0.4274347337269041" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="18" WEIGHT="29.30034272508985"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7037553881495326" CI_START="-0.5364360156494632" DF="0.0" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" I2="0.0" ID="CMP-023.07.02" NO="2" P_CHI2="1.0" P_Z="0.7914510011333901" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="39.367045833999924" Z="0.26442688040847634">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7037553881495326" CI_START="-0.5364360156494632" EFFECT_SIZE="0.08365968625003467" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="42.7" ORDER="3877" SD_1="8.7" SD_2="10.0" SE="0.31638117169026253" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="39.367045833999924"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-023.08" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Social functioning at 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-023.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-023.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive-behaviour therapy</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.5100587150568097" CI_END="1.6521113002487797" CI_START="0.7260061525704518" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0951908366635392" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="49" I2="0.0" I2_Q="0.0" ID="CMP-023.09" LOG_CI_END="0.21803930173475367" LOG_CI_START="-0.13905969883699365" LOG_EFFECT_SIZE="0.039489801448880014" METHOD="MH" NO="9" P_CHI2="0.7749794841048883" P_Q="0.0" P_Z="0.6646622244441489" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="226" WEIGHT="100.0" Z="0.4334853274443248">
<NAME>Dropouts for any reason within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.163553450526576E-4" CI_END="3.2153052486984315" CI_START="0.43867687848046044" DF="1.0" EFFECT_SIZE="1.1876363373781" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="0.0" ID="CMP-023.09.01" LOG_CI_END="0.5072222094631642" LOG_CI_START="-0.3578552555266176" LOG_EFFECT_SIZE="0.07468347696827325" NO="1" P_CHI2="0.9786473171072452" P_Z="0.7350516397404938" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="17.03990901793805" Z="0.3384134508688682">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="4.198626539467562" CI_START="0.34296929876087767" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6231072466166074" LOG_CI_START="-0.46474475452135766" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="3878" O_E="0.0" SE="0.6390096504226938" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.4083333333333333" WEIGHT="10.77550516675611"/>
<DICH_DATA CI_END="6.03008222860176" CI_START="0.22572015762158554" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7803232343929722" LOG_CI_START="-0.6464296551317459" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="3879" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.7023809523809523" WEIGHT="6.264403851181942"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.502343877428565" CI_END="1.6915768479449236" CI_START="0.6858519661819976" DF="3.0" EFFECT_SIZE="1.0771124858207577" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="41" I2="0.0" ID="CMP-023.09.02" LOG_CI_END="0.2282917324700315" LOG_CI_START="-0.1637696120016715" LOG_EFFECT_SIZE="0.03226106023418003" NO="2" P_CHI2="0.4748679245618871" P_Z="0.7470328866193934" STUDIES="4" TAU2="0.0" TOTAL_1="107" TOTAL_2="181" WEIGHT="82.96009098206196" Z="0.3225541974676046">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.8847929177657778" CI_START="0.48342553508396485" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.27526364121979363" LOG_CI_START="-0.31567041339636753" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="3880" O_E="0.0" SE="0.34711758885227995" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.12049062049062048" WEIGHT="36.51734819835701"/>
<DICH_DATA CI_END="2.001629210086063" CI_START="0.5313054771289405" EFFECT_SIZE="1.03125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="0.3013836301224412" LOG_CI_START="-0.2746557070064782" LOG_EFFECT_SIZE="0.013363961557981502" ORDER="3881" O_E="0.0" SE="0.33836835807023347" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.11449314574314573" WEIGHT="38.43023016384795"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3882" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="5.943856870492808"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3883" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="2.0686557493641855"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9670519403564057" CI_END="10.274074831484038" CI_START="1.2140276763662718" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.531715050011787" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-023.10" LOG_CI_END="1.0117427245946875" LOG_CI_START="0.08422858752683565" LOG_EFFECT_SIZE="0.5479856560607616" METHOD="MH" NO="10" P_CHI2="0.8536850256976414" P_Q="0.0" P_Z="0.02056170923233035" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="226" WEIGHT="100.0" Z="2.3159369911470704">
<NAME>Dropouts due to side effects within 2-4 months</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.003208153667154277" CI_END="49.420640741007034" CI_START="0.5925850301921847" DF="1.0" EFFECT_SIZE="5.411647797633062" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-023.10.01" LOG_CI_END="1.6939083717516086" LOG_CI_START="-0.2272493238094713" LOG_EFFECT_SIZE="0.7333295239710687" NO="1" P_CHI2="0.9548315507244144" P_Z="0.13457947427391836" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="23.308538658396046" Z="1.496284723637358">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="131.91963228680433" CI_START="0.25230530961666725" EFFECT_SIZE="5.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.120309432084352" LOG_CI_START="-0.5980736099146255" LOG_EFFECT_SIZE="0.7611179110848633" ORDER="3884" O_E="0.0" SE="1.5967916550832766" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="2.5497435897435894" WEIGHT="11.641790268626066"/>
<DICH_DATA CI_END="115.70110292995908" CI_START="0.22277357152418284" EFFECT_SIZE="5.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0633374989181466" LOG_CI_START="-0.6521363324480826" LOG_EFFECT_SIZE="0.7056005832350318" ORDER="3885" O_E="0.0" SE="1.595082770356775" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="2.544289044289044" WEIGHT="11.666748389769982"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.796254245744388" CI_END="10.500671757258022" CI_START="0.9164157446079189" DF="3.0" EFFECT_SIZE="3.102092991402894" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-023.10.02" LOG_CI_END="1.0212170829878822" LOG_CI_START="-0.03790745796190712" LOG_EFFECT_SIZE="0.4916548125129875" NO="2" P_CHI2="0.6157505345103795" P_Z="0.0688100950124475" STUDIES="4" TAU2="0.0" TOTAL_1="107" TOTAL_2="181" WEIGHT="76.69146134160395" Z="1.8196646156213119">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="134.9089831831153" CI_START="0.23637620419329136" EFFECT_SIZE="5.647058823529412" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.130040868997068" LOG_CI_START="-0.6263962456744788" LOG_EFFECT_SIZE="0.7518223116612945" ORDER="3886" O_E="0.0" SE="1.6191448057418412" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="2.6216299019607843" WEIGHT="11.322566960488015"/>
<DICH_DATA CI_END="169.59899857141727" CI_START="0.29646986219888627" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.229423283556358" LOG_CI_START="-0.5280194484918476" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="3887" O_E="0.0" SE="1.619735510366777" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="2.6235431235431235" WEIGHT="11.314309966622776"/>
<DICH_DATA CI_END="7.731212717431891" CI_START="0.26517228030250284" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882476226608089" LOG_CI_START="-0.5764718767260204" LOG_EFFECT_SIZE="0.1558878729673943" ORDER="3888" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Kampman-2002" TOTAL_1="22" TOTAL_2="21" VAR="0.7402597402597402" WEIGHT="40.0988713774348"/>
<DICH_DATA CI_END="156.90994575594544" CI_START="0.5162196673369944" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.195650472267817" LOG_CI_START="-0.2871654533891673" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="3889" O_E="0.0" SE="1.4584183648679576" STUDY_ID="STD-Spinhoven-1996" TOTAL_1="20" TOTAL_2="20" VAR="2.1269841269841274" WEIGHT="13.955713037058374"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" I2_Q="0.0" ID="CMP-023.11" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" METHOD="MH" NO="11" P_CHI2="0.5311461848942365" P_Q="0.0" P_Z="0.14006929943098473" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.4755330132930529">
<NAME>Response/remission on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-023.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3921989353450585" CI_END="1.6254591202723538" CI_START="0.9337933709409164" DF="1.0" EFFECT_SIZE="1.232007691228337" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="0.0" ID="CMP-023.11.02" LOG_CI_END="0.21097605161535804" LOG_CI_START="-0.029749213478675377" LOG_EFFECT_SIZE="0.09061341906834129" NO="2" P_CHI2="0.5311461848942365" P_Z="0.14006929943098473" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="1.4755330132930529">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.6585012511277002" CI_START="0.7747198094485307" EFFECT_SIZE="1.1335227272727273" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" LOG_CI_END="0.2197158034754296" LOG_CI_START="-0.1108553390581952" LOG_EFFECT_SIZE="0.054430232208617216" ORDER="3890" O_E="0.0" SE="0.19417912547779753" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.03770553277132224" WEIGHT="53.02900393223546"/>
<DICH_DATA CI_END="2.0280768796756123" CI_START="0.9033210552709258" EFFECT_SIZE="1.353515625" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="0.30708441406664466" LOG_CI_START="-0.04415786679469273" LOG_EFFECT_SIZE="0.13146327363597599" ORDER="3891" O_E="0.0" SE="0.2063214544552809" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.04256854256854256" WEIGHT="46.97099606776454"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-023.12" NO="12" P_CHI2="0.7506376179413443" P_Q="1.0" P_Z="0.006311755879724431" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="140" UNITS="" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Global/Avoidance/Panic on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-023.12.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10099605202960485" CI_END="-0.11703176987805586" CI_START="-0.7119180418899302" DF="1.0" EFFECT_SIZE="-0.41447490588399305" ESTIMABLE="YES" I2="0.0" ID="CMP-023.12.02" NO="2" P_CHI2="0.7506376179413443" P_Z="0.006311755879724431" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="100.0" Z="2.7311300537526604">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.059087739852396404" CI_START="-0.7898379032111531" EFFECT_SIZE="-0.3653750816793783" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.08" ORDER="3892" SD_1="0.86" SD_2="0.79" SE="0.2165666435097192" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" WEIGHT="49.10532495830454"/>
<CONT_DATA CI_END="-0.04491403568594632" CI_START="-0.8787829307102192" EFFECT_SIZE="-0.46184848319808275" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.18" ORDER="3893" SD_1="0.86" SD_2="0.86" SE="0.2127255657761378" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" WEIGHT="50.894675041695464"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.8023876951080955" CI_END="2.160983969655498" CI_START="0.2793931616617512" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7770226145887978" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-023.13" LOG_CI_END="0.3346515452654801" LOG_CI_START="-0.5537842277454987" LOG_EFFECT_SIZE="-0.10956634124000932" METHOD="MH" NO="13" P_CHI2="0.6695204974901191" P_Q="0.0" P_Z="0.6287939210138515" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="159" WEIGHT="100.0" Z="0.4834251147282208">
<NAME>Dropouts for any reason on continued treatment</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.31319328145675" CI_START="0.1298454099994229" DF="0.0" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-023.13.01" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.4771212547196624" NO="1" P_CHI2="1.0" P_Z="0.4928768494435124" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="10.611036487326718" Z="0.6857403698646046">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="69.31319328145675" CI_START="0.1298454099994229" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8408159073966481" LOG_CI_START="-0.8865733979573234" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="3894" O_E="0.0" SE="1.6020819787597222" STUDY_ID="STD-de-Beurs-1995" TOTAL_1="19" TOTAL_2="19" VAR="2.566666666666667" WEIGHT="10.611036487326718"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004900296404698655" CI_END="1.9526956626478564" CI_START="0.2243601306122431" DF="1.0" EFFECT_SIZE="0.661896558321339" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-023.13.02" LOG_CI_END="0.29063456160225637" LOG_CI_START="-0.6490543158359924" LOG_EFFECT_SIZE="-0.179209877116868" NO="2" P_CHI2="0.9441919745982897" P_Z="0.45471533666733666" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="140" WEIGHT="89.38896351267329" Z="0.74757701885429">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="2.9799381815735604" CI_START="0.13589499278542466" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.4742072547876802" LOG_CI_START="-0.8667965450756165" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3895" O_E="0.0" SE="0.7877122701155673" STUDY_ID="STD-Barlow-2000i" TOTAL_1="33" TOTAL_2="63" VAR="0.6204906204906204" WEIGHT="43.89267581397218"/>
<DICH_DATA CI_END="3.13221798638725" CI_START="0.1509014545137611" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.49585197911730805" LOG_CI_START="-0.8213065741127075" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="3896" O_E="0.0" SE="0.7737054542073035" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="32" TOTAL_2="77" VAR="0.5986201298701298" WEIGHT="45.49628769870111"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.111392701647489" CI_END="1.2204393811333472" CI_START="0.6133763416333213" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8652101726082555" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-023.14" LOG_CI_END="0.0865162130091771" LOG_CI_START="-0.21227297908103263" LOG_EFFECT_SIZE="-0.06287838303592776" METHOD="MH" NO="14" P_CHI2="0.7743246110249616" P_Q="0.0" P_Z="0.40941406959397153" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="83" TOTAL_2="180" WEIGHT="100.0" Z="0.8249251942106702">
<NAME>Response/remission 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PT+placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PT+AD</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.009130901154878949" CI_END="1.6876727006573318" CI_START="0.6209123249144052" DF="1.0" EFFECT_SIZE="1.023668296011807" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="22" I2="0.0" ID="CMP-023.14.01" LOG_CI_END="0.22728822541702945" LOG_CI_START="-0.2069697194595545" LOG_EFFECT_SIZE="0.010159252978737418" NO="1" P_CHI2="0.9238734120921138" P_Z="0.9269325801218788" STUDIES="2" TAU2="0.0" TOTAL_1="24" TOTAL_2="45" WEIGHT="47.34065063816857" Z="0.09170480440520475">
<NAME>Behaviour therapy</NAME>
<DICH_DATA CI_END="1.9996095013570478" CI_START="0.5000976437256092" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.30094519168183936" LOG_CI_START="-0.3009451916818394" LOG_EFFECT_SIZE="0.0" ORDER="3897" O_E="0.0" SE="0.3535533905932738" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="12" TOTAL_2="24" VAR="0.12500000000000003" WEIGHT="24.643078414389116"/>
<DICH_DATA CI_END="2.1615585792121315" CI_START="0.5100486337047831" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3347670096054344" LOG_CI_START="-0.2923884114655583" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="3898" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="12" TOTAL_2="21" VAR="0.13571428571428573" WEIGHT="22.697572223779453"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2422119208092252" CI_END="1.1949035758859248" CI_START="0.46300853125965286" DF="1.0" EFFECT_SIZE="0.7438081403613765" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="49" I2="0.0" ID="CMP-023.14.02" LOG_CI_END="0.07733286080695621" LOG_CI_START="-0.3344110067253377" LOG_EFFECT_SIZE="-0.1285390729591907" NO="2" P_CHI2="0.6226131221215001" P_Z="0.22105358613984316" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="52.65934936183143" Z="1.2237314188361075">
<NAME>Cognitive-behaviour therapy</NAME>
<DICH_DATA CI_END="1.2875107388103977" CI_START="0.33969563483554355" EFFECT_SIZE="0.6613333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="0.1097508600717902" LOG_CI_START="-0.4689100338747954" LOG_EFFECT_SIZE="-0.17957958690150258" ORDER="3899" O_E="0.0" SE="0.33990827352184616" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" VAR="0.11553763440860217" WEIGHT="26.66131098811294"/>
<DICH_DATA CI_END="1.6474095092624548" CI_START="0.42737158794429525" EFFECT_SIZE="0.8390804597701149" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="0.21680156851199206" LOG_CI_START="-0.3691943535083173" LOG_EFFECT_SIZE="-0.07619639249816264" ORDER="3900" O_E="0.0" SE="0.34421690532132604" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" VAR="0.11848527790899072" WEIGHT="25.998038373718494"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.6856153769402233" CI_END="0.4343999213695414" CI_START="-0.10545080006919372" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.16447456065017385" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-023.15" NO="15" P_CHI2="0.876582046042094" P_Q="0.5445875473930457" P_Z="0.23237173160978053" Q="0.3671036381416267" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="77" TOTAL_2="171" UNITS="" WEIGHT="100.0" Z="1.1942716845437171">
<NAME>Global/Avoidance/Panic 6-24 months after treatment discontinuation</NAME>
<GROUP_LABEL_1>PT+AD</GROUP_LABEL_1>
<GROUP_LABEL_2>PT+placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.04517555926448578" CI_END="0.576767367839949" CI_START="-0.5554908323957526" DF="1.0" EFFECT_SIZE="0.010638267722098228" ESTIMABLE="YES" I2="0.0" ID="CMP-023.15.01" NO="1" P_CHI2="0.8316816866193684" P_Z="0.9706204314256184" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="36" WEIGHT="22.732982771187583" Z="0.03683015338527383">
<NAME>Behaviour therapy</NAME>
<CONT_DATA CI_END="0.8642658759644667" CI_START="-0.7224442022432994" EFFECT_SIZE="0.07091083686058361" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.15" ORDER="3901" SD_1="2.39" SD_2="2.69" SE="0.4047804170697861" STUDY_ID="STD-de-Beurs-1995i" TOTAL_1="9" TOTAL_2="19" WEIGHT="11.575831905951532"/>
<CONT_DATA CI_END="0.7562075148603318" CI_START="-0.859999670753973" EFFECT_SIZE="-0.05189607794682066" ESTIMABLE="YES" MEAN_1="3.34" MEAN_2="3.46" ORDER="3902" SD_1="2.39" SD_2="2.16" SE="0.4123053276393701" STUDY_ID="STD-de-Beurs-1995ii" TOTAL_1="9" TOTAL_2="17" WEIGHT="11.157150865236051"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2733361795341108" CI_END="0.5168117659780431" CI_START="-0.09734128324449554" DF="1.0" EFFECT_SIZE="0.2097352413667738" ESTIMABLE="YES" I2="0.0" ID="CMP-023.15.02" NO="2" P_CHI2="0.6011026185146243" P_Z="0.18067877571281446" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="135" WEIGHT="77.26701722881242" Z="1.3386680075530792">
<NAME>Cognitive-behaviour therapy</NAME>
<CONT_DATA CI_END="0.7311056104491684" CI_START="-0.1449787583922183" EFFECT_SIZE="0.29306342602847507" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.18" ORDER="3903" SD_1="0.9" SD_2="0.92" SE="0.22349501719210874" STUDY_ID="STD-Barlow-2000i" TOTAL_1="30" TOTAL_2="62" WEIGHT="37.97130373537902"/>
<CONT_DATA CI_END="0.5598126228207659" CI_START="-0.3013815781437864" EFFECT_SIZE="0.12921552233848974" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" ORDER="3904" SD_1="0.9" SD_2="0.93" SE="0.21969643517879467" STUDY_ID="STD-Barlow-2000ii" TOTAL_1="29" TOTAL_2="73" WEIGHT="39.2957134934334"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot for response at 2-4 months on PT+AD vs AD alone</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-02" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAmIAAAGQCAMAAAA6OvxbAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>